Diabetes & Endocrine Publications-Lists key published studies supported by ABCD

http://dx.doi.org/10.1046/j.1365-2265.2001.01275.x

Ahmad Aftab M., Hopkins Marion T., Thomas Joegi, Ibrahim Hisham, Fraser William D. and Vora Jiten P. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement. 54: 709-717. 2001: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2001.01415.x

Belfiore Antonino, Russo Diego, Vigneri Riccardo and Filetti Sebastiano. Graves' disease, thyroid nodules and thyroid cancer. 55: 711-718. 2001: Thyroid.

http://dx.doi.org/10.1046/j.1365-2265.2001.01345.x

Bretz James D. and Baker James R. Apoptosis and autoimmune thyroid disease: following a TRAIL to thyroid destruction? 55: 1-11. 2001: Thyroid.

http://dx.doi.org/10.1046/j.1365-2265.2001.01284.x

Clanget C., Seck T., Hinke V., Wüster C., Ziegler R. and Pfeilschifter J. Effects of 6 years of growth hormone (GH) treatment on bone mineral density in GH-deficient adults. 55: 93-99. 2001: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2001.01218.x

Colao Annamaria, Marzullo Paolo, Di Somma Carolina and Lombardi Gaetano. Growth hormone and the heart. 54: 137-154. 2001: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2001.01329.x

Dale J., Daykin J., Holder R., Sheppard M. C. and Franklyn J. A. Weight gain following treatment of hyperthyroidism. 55: 233-239. 2001: Thyroid.

http://dx.doi.org/10.1046/j.1365-2265.2001.01246.x

Drake W. M., Rodríguez-Arnao J., Weaver J. U., James I. T., Coyte D., Spector T. D., Besser G. M. and Monson J. P. The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study. 54: 525-532. 2001: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2001.01294.x

Epaminonda Paolo, Porretti Silvia, Cappiello Vincenzo, Beck-Peccoz Paolo, Faglia Giovanni and Arosio Maura. Efficacy of radiotherapy in normalizing serum IGF-I, acid-labile subunit (ALS) and IGFBP-3 levels in acromegaly. 55: 183-189. 2001: Bone.

http://dx.doi.org/10.1046/j.1365-2265.2001.01149.x

Hobson Emma E. and Ralston Stuart H. Role of genetic factors in the pathophysiology and management of osteoporosis. 54: 1-9. 2001: Bone.

http://dx.doi.org/10.1046/j.1365-2265.2001.01280.x

Kaji Hiroshi, Sugimoto Toshitsugu, Nakaoka Daiki, Okimura Yasuhiko, Kaji Hidesuke, Abe Hiromi and Chihara Kazuo. Bone metabolism and body composition in Japanese patients with active acromegaly. 55: 175-181. 2001: Acromegaly.

http://dx.doi.org/10.1046/j.1365-2265.2001.01214.x

Katznelson Laurence, Kleinberg David, Vance Mary Lee, Stravou Stavros, Pulaski Karen J., Schoenfeld David A., Hayden Douglas L., Wright Margaret E., Woodburn Carol J. and Klibanski Anne. Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study. 54: 183-188. 2001: Acromegaly.

http://dx.doi.org/10.1046/j.1365-2265.2001.01331.x

Kendall-Taylor P. Thyroid cancer in the UK: can we do it better? 54: 705-706. 2001: Thyroid.

http://dx.doi.org/10.1046/j.1365-2265.2001.01344.x

Lange Kai Henrik Wiborg, Isaksson Fredrik, Rasmussen Michael Højby, Juul Anders, Bülow Jens and Kjær Michael. GH administration and discontinuation in healthy elderly men: effects on body composition, GH-related serum markers, resting heart rate and resting oxygen uptake. 55: 77-86. 2001: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2001.01267.x

Leong King S., Mann Paul, Wallymahmed Maureen, MacFarlane Ian A. and Wilding John P. H. The influence of growth hormone replacement on heart rate variability in adults with growth hormone deficiency. 54: 819-826. 2001: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2001.01343.x

Minniti Giuseppe, Moroni Carlo, Jaffrain-Rea Marie-Lise, Esposito Vincenzo, Santoro Antonio, Affricano Cesare, Cantore Giampaolo, Tamburrano Guido and Cassone Rosario. Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients. 55: 307-313. 2001: Acromegaly.

http://dx.doi.org/10.1046/j.1365-2265.2001.01309.x

Mukherjee J. J., Kaltsas G. A., Islam N., Plowman P. N., Foley R., Hikmat J., Britton K. E., Jenkins P. J., Chew S. L., Monson J. P., Besser G. M. and Grossman A. B. Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with 131I-meta-iodobenzylguanidine (131I-mIBG). 55: 47-60. 2001: Thyroid.

http://dx.doi.org/10.1046/j.1365-2265.2001.01374.x

Muller A. F., Janssen J. A. M. J. L., Lamberts S. W. J., Bidlingmaier M., Strasburger C. J., Hofland L. and Van Der Lely A. J. Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion. 55: 461-467. 2001: Acromegaly.

http://dx.doi.org/10.1046/j.1365-2265.2001.01189.x

Murray R. D., Peacey S. R., Rahim A., Toogood A. A., Thorner M. O. and Shalet S. M. The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients. 54: 37-44. 2001: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2001.01263.x

Oleksik A., Duong T., Popp-Snijders C., Pliester N., Asma G. and Lips P. Effects of the selective oestrogen receptor modulator—raloxifene—on calcium and PTH secretory dynamics in women with osteoporosis. 54: 575-582. 2001: Bone.

http://dx.doi.org/10.1046/j.1365-2265.2001.01300.x

Randell Kaisa M., Honkanen Risto J., Komulainen Marja H., Tuppurainen Marjo T., Kröger Heikki and Saarikoski Seppo. Hormone replacement therapy and risk of falling in early postmenopausal women – a population-based study. 54: 769-774. 2001: HRT.

http://dx.doi.org/10.1046/j.1365-2265.2001.01417.x

Sohmiya Motoi and Kato Yuzuru. Effect of long-term administration of recombinant human growth hormone (rhGH) on plasma erythropoietin (EPO) and haemoglobin levels in anaemic patients with adult GH deficiency. 55: 749-754. 2001: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2001.01180.x

Tan K. C. B., Tso A. W. K. and Lam K. S. L. Effect of Sandostatin® LAR® on serum leptin levels in patients with acromegaly. 54: 31-35. 2001: Acromegaly.

http://dx.doi.org/10.1046/j.1365-2265.2001.01398.x

Thivolet Charles. New therapeutic approaches to type 1 diabetes: from prevention to cellular or gene therapies. 55: 565-574. 2001: Diabetes.

http://dx.doi.org/10.1046/j.1365-2265.2001.01392.x

Toogood Andy A. and Thorner Michael O. Ghrelin, not just another growth hormone secretagogue. 55: 589-591. 2001: Ghrelin.

http://dx.doi.org/10.1046/j.1365-2265.2001.01271.x

Wang Christina, Swerdloff Ronald S., Iranmanesh Ali, Dobs Adrian, Snyder Peter J., Cunningham Glenn, Matsumoto Alvin M., Weber Thomas, Berman Nancy and the Testosterone Gel Study Group. Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men. 54: 739-750. 2001: Bone.

http://dx.doi.org/10.1046/j.1365-2265.2001.01361.x

Yamauchi Mika, Sugimoto Toshitsugu, Yamaguchi Toru, Nakaoka Daiki, Kanzawa Michiko, Yano Shozo, Ozuru Rieko, Sugishita Takeshi and Chihara Kazuo. Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. 55: 341-347. 2001: Leptin.

http://dx.doi.org/10.1046/j.1365-2265.2002.01582.x

Abrahamsen B., Hangaard J., Horn H. C., Hansen T. B., Gregersen G., Hansen-Nord M., Vahl N., Junker P., Andersen M. and Hagen C. Evaluation of the optimum dose of growth hormone (GH) for restoring bone mass in adult-onset GH deficiency: results from two 12-month randomized studies. 57: 273-281. 2002: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2002.01491.x

Ahmad Aftab M., Hopkins Marion T., Weston Philip J., Fraser William D. and Vora Jiten P. Effects of GH replacement on 24-h ambulatory blood pressure and its circadian rhythm in adult GH deficiency. 56: 431-437. 2002: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2002.01547.x

Aimaretti Gianluca, Baffoni Claudia, Broglio Fabio, Janssen Joop A. M., Corneli Ginevra, Deghenghi Romano, Van Der Lely Aart Jan, Ghigo Ezio and Arvat Emanuela. Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency. 56: 765-771. 2002: Growth Hormone.

http://dx.doi.org/10.1046/j.0300-0664.2001.01438.x

Amato Giovanni, Mazziotti Gherardo, Rotondi Mario, Iorio Sergio, Doga Mauro, Sorvillo Francesca, Manganella Giovanni, Di Salle Francesco, Giustina Andrea and Carella Carlo. Long-term effects of lanreotide SR and octreotide LAR® on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 56: 65-71. 2002: Acromegaly.

http://dx.doi.org/10.1046/j.1365-2265.2002.01591.x

Cianfarani Stefano, Tondinelli Tiziana, Spadoni Gian Luigi, Scirè Giuseppe, Boemi Sergio and Boscherini Brunetto. Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test? 57: 161-167. 2002: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2002.01536.x

Compston Juliet E. and Watts Nelson B. Combination therapy for postmenopausal osteoporosis. 56: 565-569. 2002: Bone.

http://dx.doi.org/10.1046/j.1365-2265.2002.01581.x

Davies M., Fraser W. D. and Hosking D. J. The management of primary hyperparathyroidism. 57: 145-155. 2002: Parathyroid.

http://dx.doi.org/10.1046/j.0300-0664.2001.01457.x

Eaton S. E. M., Euinton H. A., Newman C. M., Weetman A. P. and Bennet W. M. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography*. 56: 33-38. 2002: Thyroid.

http://dx.doi.org/10.1046/j.0300-0664.2001.01440.x

Edén Engström Britt, Burman Pia and Karlsson F. Anders. Men with acromegaly need higher doses of octreotide than women. 56: 73-77. 2002: Acromegaly.

http://dx.doi.org/10.1046/j.1365-2265.2002.01624.x

Fairfield W. P., Sesmilo G., Katznelson L., Pulaski K., Freda P. U., Stavrou S., Kleinberg D. and Klibanski A. Effects of a growth hormone receptor antagonist on bone markers in acromegaly. 57: 385-390. 2002: Acromegaly.

http://dx.doi.org/10.1046/j.1365-2265.2002.01608.x

Gilchrist F. J., Murray R. D. and Shalet S. M. The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults. 57: 363-370. 2002: Growth Hormone.

http://dx.doi.org/10.1046/j.0300-0664.2001.01456.x

Hansen Troels Krarup, Dall Rolf, Hosoda Hiroshi, Kojima Masayasu, Kangawa Kenji, Christiansen Jens Sandahl and Jørgensen Jens Otto Lunde. Weight loss increases circulating levels of ghrelin in human obesity. 56: 203-206. 2002: Ghrelin.

http://dx.doi.org/10.1046/j.1365-2265.2002.01500.x

Haugen Bryan R., Woodmansee Whitney W. and McDermott Michael T. Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumours. 56: 281-290. 2002: Thyroid.

http://dx.doi.org/10.1046/j.1365-2265.2002.01575.x

Kamp G. A., Zwinderman A. H., Van Doorn J., Hackeng W., Frölich M., Schönau E. and Wit J. M. Biochemical markers of growth hormone (GH) sensitivity in children with idiopathic short stature: individual capacity of IGF-I generation after high-dose GH treatment determines the growth response to GH. 57: 315-325. 2002: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2002.01291.x

Kiesel L. A., Rody A., Greb R. R. and Szilágyi A. Clinical use of GnRH analogues. 56: 677-687. 2002: GnRH.

http://dx.doi.org/10.1046/j.1365-2265.2002.01614.x

Lanes Roberto, Gunczler Peter, Esaa Sara and Weisinger Jose R. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study. 57: 725-730. 2002: Growth Hormone.

http://dx.doi.org/10.1046/j.0300-0664.2001.01455.x

Li Voon Chong J. S. W., Groves T., Foy P., Wallymahmed M. E. and MacFarlane I. A. Elderly people with hypothalamic-pituitary disease and untreated GH deficiency: clinical outcome, body composition, lipid profiles and quality of life after 2 years compared to controls. 56: 175-181. 2002: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2002.01556.x

Lissett C. A., Murray R. D. and Shalet S. M. Timing of onset of growth hormone deficiency is a major influence on insulin-like growth factor I status in adult life. 57: 35-40. 2002: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2002.01508.x

Murray R. D., Wieringa G. E., Lissett C. A., Darzy K. H., Smethurst L. E. and Shalet S. M. Low-dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome. 56: 525-532. 2002: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2002.01560.x

Parkinson C., Renehan A. G., Ryder W. D. J., O'Dwyer S. T., Shalet S. M. and Trainer P. J. Gender and age influence the relationship between serum GH and IGF-I in patients with acromegaly. 57: 59-64. 2002: Acromegaly.

http://dx.doi.org/10.1046/j.1365-2265.2002.01654.x

Saravanan P., Chau W. F., Roberts N., Vedhara K., Greenwood R. and Dayan C. M. Psychological well-being in patients on ‘adequate’ doses of l-thyroxine: results of a large, controlled community-based questionnaire study. 57: 577-585. 2002: Thyroid.

http://dx.doi.org/10.1046/j.1365-2265.2002.01670.x

Sneppen S. B., Mersebach H., Ullum H. and Feldt-Rasmussen U. Immune function during GH treatment in GH-deficient adults: an 18-month randomized, placebo-controlled, double-blinded trial. 57: 787-792. 2002: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2002.01597.x

Webb S. M., Prieto L., Badia X., Albareda M., Catalá M., Gaztambide S., Lucas T., Páramo C., Picó A., Lucas A., Halperin I., Obiols G. and Astorga R. Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. 57: 251-258. 2002: Acromegaly.

http://dx.doi.org/10.1046/j.1365-2265.2002.01630.x

Whipple Tom, Sharkey Neil, Demers Laurence and Williams Nancy. Leptin and the skeleton. 57: 701-711. 2002: Leptin.

http://dx.doi.org/10.1046/j.1365-2265.2002.01534.x

Wu Fiona, Ames Ruth, Clearwater Judy, Evans Margaret C., Gamble Greg and Reid Ian R. Prospective 10-year study of the determinants of bone density and bone loss in normal postmenopausal women, including the effect of hormone replacement therapy. 56: 703-711. 2002: Bone.

http://dx.doi.org/10.1046/j.1365-2265.2002.01601.x

Yuen K., Cook D., Ong K., Chatelain P., Fryklund L., Gluckman P., Ranke M. B., Rosenfeld R. and Dunger D. The metabolic effects of short-term administration of physiological versus high doses of GH therapy in GH deficient adults. 57: 333-341. 2002: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2003.01905.x

Arends N. J. T., Boonstra V. H., Mulder P. G. H., Odink R. J. H., Stokvis-Brantsma W. H., Rongen-Westerlaken C., Mulder J. C., Delemarre-Van de Waal H., Reeser H. M., Jansen M., Waelkens J. J. J. and Hokken-Koelega A. C. S. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial. 59: 779-787. 2003: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2003.01679.x

Beauregard Catherine, Truong Uyen, Hardy Jules and Serri Omar. Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. 58: 86-91. 2003: Acromegaly.

http://dx.doi.org/10.1046/j.1365-2265.2003.01899.x

Carvalho Luciani R., Justamante de Faria Maria Estela, Farah Osorio Maria Geralda, Estefan Vivian, Lima Jorge Alexander Augusto, Arnhold Ivo Jorge Prado and Mendonca Berenice Bilharinho. Acromegalic features in growth hormore (GH)-deficient patients after long-term GH therapy. 59: 788-792. 2003: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2003.01908.x

Castro Margaret, Elias Lucila L. K., Elias Paula C. L. and Moreira Ayrton C. A dose–response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome. 59: 800-805. 2003: Cortisol.

http://dx.doi.org/10.1046/j.1365-2265.2003.01714.x

Christ E. R., Simpson H. L., Breen L., Russell-Jones D. L. and Kohner E. M. The effect of growth hormone (GH) replacement therapy in adult patients with type 1 diabetes mellitus and GH deficiency. 58: 309-315. 2003: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2003.01774.x

Davison Sonia and Davis Susan R. Hormone replacement therapy: current controversies. 58: 249-261. 2003: HRT.

http://dx.doi.org/10.1046/j.1365-2265.2003.01713.x

Di Somma Carolina, Pivonello Rosario, Loche Sandro, Faggiano Antongiulio, Klain Michele, Salvatore Marco, Lombardi Gaetano and Colao Annamaria. Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study. 58: 302-308. 2003: Bone.

http://dx.doi.org/10.1046/j.1365-2265.2003.01772.x

Diver Michael J., Imtiaz Komal E., Ahmad Aftab M., Vora Jiten P. and Fraser William D. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. 58: 710-717. 2003: Testosterone.

http://dx.doi.org/10.1046/j.1365-2265.2003.01739.x

Donaubauer Juliane, Kiess Wieland, Kratzsch Jürgen, Nowak Tanja, Steinkamp Heinz, Willgerodt Helmut, Keller Eberhard and Group Study. Re-assessment of growth hormone secretion in young adult patients with childhood-onset growth hormone deficiency. 58: 456-463. 2003: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2003.01625.x

Fukao Atsushi, Takamatsu Junta, Murakami Yasuhiro, Sakane Sadaki, Miyauchi Akira, Kuma Kanji, Hayashi Shunichiro and Hanafusa Toshiaki. The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves’ disease. 58: 550-555. 2003: Thyroid.

http://dx.doi.org/10.1046/j.1365-2265.2003.01759.x

Isidori A. M., Kaltsas G. A., Perry L., Burrin J. M., Besser G. M. and Monson J. P. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism. 58: 601-611. 2003: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2003.01692.x

Kelly Brian P., Paterson Wendy F. and Donaldson Malcolm D. C. Final height outcome and value of height prediction in boys with constitutional delay in growth and adolescence treated with intramuscular testosterone 125 mg per month for 3 months. 58: 267-272. 2003: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2003.01752.x

Kendall-Taylor Pat. Guidelines for the management of thyroid cancer. 58: 400-402. 2003: Thyroid.

http://dx.doi.org/10.1046/j.1365-2265.2003.01733.x

Koh Jung-Min, Kim Eun Sook, Ryu Jin Sook, Hong Suck Joon, Kim Won Bae and Shong Young Kee. Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study. 58: 421-427. 2003: Thyroid.

http://dx.doi.org/10.1046/j.1365-2265.2003.01741.x

Lucas Tomás, Astorga Ricardo, Catalá Miguel and The Spanish Multicentre Lanreotide Study Group on Acromegaly. Preoperative lanreotide treatment for GH-secreting pituitary adenomas: effect on tumour volume and predictive factors of significant tumour shrinkage. 58: 471-481. 2003: Acromegaly.

http://dx.doi.org/10.1046/j.1365-2265.2003.01799.x

Malik I. A., Foy P., Wallymahmed M., Wilding J. P. H. and MacFarlane I. A. Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects. 59: 75-81. 2003: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2003.01870.x

McMillan C. V., Bradley C., Gibney J., Healy M. L., Russell-Jones D. L. and Sönksen P. H. Psychological effects of withdrawal of growth hormone therapy from adults with growth hormone deficiency. 59: 467-475. 2003: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2003.01736.x

McMillan C. V., Bradley C., Gibney J., Russell-Jones D. L. and Sönksen P. H. Evaluation of two health status measures in adults with growth hormone deficiency. 58: 436-445. 2003: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2003.01744.x

Pellegriti Gabriella, Scollo Claudia, Regalbuto Concetto, Attard Marco, Marozzi Paola, Vermiglio Francesco, Violi Maria Antonella, Cianci Michelangela, Vigneri Riccardo, Pezzino Vincenzo and Squatrito Sebastiano. The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels. 58: 556-561. 2003: Thyroid.

http://dx.doi.org/10.1046/j.1365-2265.2003.01822.x

Pop Victor J., Brouwers Evelien P., Vader Huib L., Vulsma Thomas, Van Baar Anneloes L. and De Vijlder Jan J. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. 59: 282-288. 2003: Thyroid.

http://dx.doi.org/10.1046/j.1365-2265.2003.01773.x

Radetti Giorgio, Buzi Fabio, Cassar Walburga, Paganini Claudio, Stacul Elisabetta and Maghnie Mohamad. Growth hormone secretory pattern and response to treatment in children with short stature followed to adult height. 59: 27-33. 2003: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2003.01734.x

Sheppard Michael C. Primary medical therapy for acromegaly. 58: 387-399. 2003: Acromegaly.

http://dx.doi.org/10.1046/j.1365-2265.2003.01852.x

Strachan Mark W. J., Teoh Wei Leng, Don-Wauchope Andrew C., Seth John, Stoddart Mary and Beckett Geoffrey J. Clinical and radiological features of patients with macroprolactinaemia. 59: 339-346. 2003: Prolactin.

http://dx.doi.org/10.1046/j.1365-2265.2003.01754.x

Svensson J., Monson J. P., Vetter T., Hansen T. K., Savine R., Kann P., Bex M., Reincke M., Hagen C., Beckers A., Ilondo M. M., Zdravkovic M., Bengtsson B. Å, Korbonits M. and the N. N. Clinical Research Group. Oral administration of the growth hormone secretagogue NN703 in adult patients with growth hormone deficiency. 58: 572-580. 2003: Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2003.01686.x

Tong Stephen, Wallace Euan M. and Burger Henry G. Inhibins and activins: clinical advances in reproductive medicine. 58: 115-127. 2003: Inhibins/Activins.

http://dx.doi.org/10.1046/j.1365-2265.2003.01854.x

Vermiglio Francesco, Lo Presti Vincenzo Pio, Violi Maria Antonia, Moleti Mariacarla, Castagna Maria Grazia, Finocchiaro Maria Daniela, Mattina Filiberto, Mandolfino Mattia, Zimbaro Giovanni and Trimarchi Francesco. Changes in both size and cytological features of thyroid nodule after levothyroxine treatment. 59: 347-353. 2003: Thyroid.

http://dx.doi.org/10.1046/j.1365-2265.2003.01742.x

White H. D., Ahmad A. M., Guzder R., Wallace A. M., Fraser W. D. and Vora J. P. Gender variation in leptin circadian rhythm and pulsatility in adult growth hormone deficiency: effects of growth hormone replacement. 58: 482-488. 2003: Leptin/Growth Hormone.

http://dx.doi.org/10.1046/j.1365-2265.2003.01746.x

Zacharin Margaret R., Pua Joseph and Kanumakala Shankar. Bone mineral density outcomes following long-term treatment with subcutaneous testosterone pellet implants in male hypogonadism. 58: 691-695. 2003: Testosterone.

http://dx.doi.org/10.1046/j.1365-2265.2003.01808.x

Zoico Elena, Zamboni Mauro, Adami Silvano, Vettor Roberto, Mazzali Gloria, Tosoni Paolo, Bissoli Luisa and Bosello Ottavio. Relationship between leptin levels and bone mineral density in the elderly. 59: 97-103. 2003: Leptin.

http://dx.doi.org/10.1046/j.1365-2265.2003.01881.x

Allolio Bruno, Hahner Stefanie, Weismann Dirk and Fassnacht Martin. Management of adrenocortical carcinoma. 60: 273-287. 2004: Adrenal.

http://dx.doi.org/10.1111/j.1365-2265.2004.01992.x

Ayuk John, Stewart Susan E., Stewart Paul M., Sheppard Michael C. and the European Sandostatin® Lar® Group. Efficacy of Sandostatin® LAR® (long-acting somatostatin analogue) is similar in patients with untreated acromegaly and in those previously treated with surgery and/or radiotherapy. 60: 375-381. 2004: Acromegaly.

http://dx.doi.org/10.1046/j.1365-2265.2003.01949.x

Baroncelli Giampiero Igli, Bertelloni Silvano, Sodini Federica and Saggese Giuseppe. Longitudinal changes of lumbar bone mineral density (BMD) in patients with GH deficiency after discontinuation of treatment at final height; timing and peak values for lumbar BMD. 60: 175-184. 2004: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2004.02119.x

Bartalena Luigi, Wiersinga Wilmar M., Tanda Maria Laura, Bogazzi Fausto, Piantanida Eliana, Lai Adriana and Martino Enio. Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association. 61: 494-502. 2004: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2004.02021.x

Biermasz Nienke R., Hamdy Neveen A. T., Pereira Alberto M., Romijn Johannes A. and Roelfsema Ferdinand. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study. 60: 568-575. 2004: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2004.01935.x

Davidson Peter, Milne Ruairidh, Chase Deborah and Cooper Cyrus. Growth hormone replacement in adults and bone mineral density: a systematic review and meta-analysis. 60: 92-98. 2004: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2004.02000.x

Hana Vaclav, Silha Josef V., Justova Vlasta, Lacinova Zdena, Stepan Jan J. and Murphy Liam J. The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance. 60: 442-450. 2004: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2004.02032.x

He Chih-Tsueng, Hsieh An-Tsz, Pei Dee, Hung Yi-Jen, Wu Ling-Yi, Yang Tsao-Chin, Lian Wei-Cheng, Huang Wen-Sheng and Kuo Shi-Wen. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves’ hyperthyroidism. 60: 676-681. 2004: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2004.02018.x

Johannsson Gudmundur, Sunnerhagen Katharina Stibrant and Svensson Johan. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease. 60: 550-559. 2004: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2004.02037.x

Leboulleux Sophie, Baudin Eric, Travagli Jean-Paul and Schlumberger Martin. Medullary thyroid carcinoma. 61: 299-310. 2004: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2004.01929.x

Malik Iqbal A., English Patrick J., Ghatei Mohammed A., Bloom Stephen R., MacFarlane Ian A. and Wilding John P. H. The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency. 60: 137-141. 2004: Ghrelin.

http://dx.doi.org/10.1111/j.1365-2265.2004.02152.x

Metso Saara, Jaatinen Pia, Huhtala Heini, Luukkaala Tiina, Oksala Heikki and Salmi Jorma. Long-term follow-up study of radioiodine treatment of hyperthyroidism. 61: 641-648. 2004: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2004.02053.x

Murphy Elaine and Williams Graham R. The thyroid and the skeleton. 61: 285-298. 2004: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2004.02153.x

Salvatori Massimo, Perotti Germano, Rufini Vittoria, Maussier Maria Lodovica and Dottorini Massimo. Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan? 61: 704-710. 2004: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2004.02050.x

Siegmund W., Spieker K., Weike A. I., Giessmann T., Modess C., Dabers T., Kirsch G., Sänger E., Engel G., Hamm A. O., Nauck M. and Meng W. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. 60: 750-757. 2004: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2004.01989.x

Teale J. D. and Wark G. The effectiveness of different treatment options for non-islet cell tumour hypoglycaemia. 60: 457-460. 2004: Non-islet Cell Tumour.

http://dx.doi.org/10.1111/j.1365-2265.2004.02058.x

White H. D., Ahmad A. M., Syed A. A., Clewes A., Peter R., Vora J. P. and Fraser W. D. Gender variation in PTH sensitivity and rhythmicity following growth hormone replacement in adult growth hormone deficient patients. 61: 160-161. 2004: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2004.02062.x

Wong Vincent, Yan Tony, Donald Andrew and McLean Mark. Saliva and bloodspot cortisol: novel sampling methods to assess hydrocortisone replacement therapy in hypoadrenal patients. 61: 131-137. 2004: Cortisol.

http://dx.doi.org/10.1111/j.1365-2265.2004.02025.x

Woodmansee Whitney W. and Haugen Bryan R. A review of the potential uses for recombinant human TSH in patients with thyroid cancer and nodular goiter. 61: 163-173. 2004: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2004.02154.x

Zoppini Giacomo, Targher Giovanni, Venturi Cristina, Zamboni Cristina and Muggeo Michele. Relationship of nonalcoholic hepatic steatosis to overnight low-dose dexamethasone suppression test in obese individuals. 61: 711-715. 2004: Cortisol.

http://dx.doi.org/10.1111/j.1365-2265.2005.02343.x

Arwert Lucia I., Roos Jan C., Lips Paul, Twisk Jos W. R., Manoliu Radu A. and Drent Madeleine L. Effects of 10 years of growth hormone (GH) replacement therapy in adult GH-deficient men. 63: 310-316. 2005: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2005.02358.x

Brierley J., Tsang R., Panzarella T. and Bana N. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. 63: 418-427. 2005: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2005.02218.x

Ceccarelli Claudia, Bencivelli Walter, Vitti Paolo, Grasso Lucia and Pinchera Aldo. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years’ retrospective study. 62: 331-335. 2005: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2005.02351.x

Colao Annamaria, Pivonello Rosario, Cappabianca Paolo, Briganti Francesco, Tortora Fabio, Auriemma Renata S., De Martino Maria Cristina, Marzullo Paolo and Lombardi Gaetano. Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly. 63: 342-349. 2005: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2005.02216.x

Giannoulis M. G., Boroujerdi M. A., Powrie J., Dall R., Napoli R., Ehrnborg C., Pentecost C., Cittadini A., Jørgensen J. O. L. and Sonksen P. H. Gender differences in growth hormone response to exercise before and after rhGH administration and the effect of rhGH on the hormone profile of fit normal adults. 62: 315-322. 2005: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2005.02278.x

Gilbert J. A., Miell J. P., Chambers S. M., McGregor A. M. and Aylwin S. J. B. The nadir growth hormone after an octreotide test dose predicts the long-term efficacy of somatostatin analogue therapy in acromegaly. 62: 742-747. 2005: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2005.02221.x

Han Ki Ok, Choi Jong Tae, Choi Hyun Ah, Moon In Gul, Yim Chang Hoon, Park Won Keun, Yoon Hyun Koo and Han In Kwon. The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone. 62: 349-353. 2005: Osteoprotegrin.

http://dx.doi.org/10.1111/j.1365-2265.2005.02350.x

Isidori Andrea M., Giannetta Elisa, Gianfrilli Daniele, Greco Emanuela A., Bonifacio Vincenzo, Aversa Antonio, Isidori Aldo, Fabbri Andrea and Lenzi Andrea. Effects of testosterone on sexual function in men: results of a meta-analysis. 63: 381-394. 2005: Testosterone.

http://dx.doi.org/10.1111/j.1365-2265.2005.02339.x

Isidori Andrea M., Giannetta Elisa, Greco Emanuela A., Gianfrilli Daniele, Bonifacio Vincenzo, Isidori Aldo, Lenzi Andrea and Fabbri Andrea. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. 63: 280-293. 2005: Testosterone.

http://dx.doi.org/10.1111/j.1365-2265.2004.02164.x

Lange Martin, Müller Jørn, Svendsen Ole Lander, Kastrup Knud William, Juul Anders and Feldt-Rasmussen Ulla. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD. 62: 18-23. 2005: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2004.02169.x

Libè Rossella, Morpurgo Paola Silvia, Cappiello Vincenzo, Maffini Antonia, Bondioni Sara, Locatelli Marco, Zavanone Mario, Beck-Peccoz Paolo and Spada Anna. Ghrelin and adiponectin in patients with Cushing's disease before and after successful transsphenoidal surgery. 62: 30-36. 2005: Ghrelin.

http://dx.doi.org/10.1111/j.1365-2265.2004.02174.x

Mohr Beth A., Guay Andre T., O'Donnell Amy B. and McKinlay John B. Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study. 62: 64-73. 2005: Testosterone.

http://dx.doi.org/10.1111/j.1365-2265.2005.02312.x

Oh Ki Won, Lee Won Young, Rhee Eun Jung, Baek Ki Hyun, Yoon Kun Ho, Kang Moo Il, Yun Eun Joo, Park Cheol Young, Ihm Sung Hee, Choi Moon Gi, Yoo Hyung Joon and Park Sung Woo. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. 63: 131-138. 2005: Adiponectin.

http://dx.doi.org/10.1111/j.1365-2265.2005.02340.x

Resmini Eugenia, Barreca Antonina, Ferone Diego, Giusti Massimo, Sidoti Marilena and Minuto Francesco. Effect of different therapeutic modalities on spontaneous GH secretion in acromegalic patients. 63: 294-297. 2005: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2005.02318.x

Reynolds Rebecca M. and Seckl Jonathan R. Hyponatraemia for the clinical endocrinologist. 63: 366-374. 2005: Hyponatremia.

http://dx.doi.org/10.1111/j.1365-2265.2005.02283.x

Tanriverdi F., Eryol N. K., Atmaca H., Unluhizarci K., Ozdogru I., Sarikaya I., Bayram F. and Kelestimur F. The effects of 12 months of growth hormone replacement therapy on cardiac autonomic tone in adults with growth hormone deficiency. 62: 706-712. 2005: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2005.02307.x

Trepp Roman, Everts Regula, Stettler Christoph, Fischli Stefan, Allemann Sabine, Webb Susan M. and Christ Emanuel R. Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL). 63: 103-110. 2005: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2005.02249.x

Tsai Wen-Chin, Pei Dee, Wang Tso-Fu, Wu Du-An, Li Jer-Chuan, Wei Cheng Lian, Lee Chien-Hsing, Chen Sheng-Pyng and Kuo Shi-Wen. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves’ hyperthyroidism. 62: 521-524. 2005: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2006.02450.x

Caron Philippe, Cogne Muriel, Raingeard Isabelle, Bex-Bachellerie Véronique and Kuhn Jean Marc. Effectiveness and tolerability of 3-year lanreotide Autogel® treatment in patients with acromegaly. 64: 209-214. 2006: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2006.02562.x

Casanueva Felipe F., Molitch Mark E., Schlechte Janet A., Abs Roger, Bonert Vivien, Bronstein Marcello D., Brue Thierry, Cappabianca Paolo, Colao Annamaria, Fahlbusch Rudolf, Fideleff Hugo, Hadani Moshe, Kelly Paul, Kleinberg David, Laws Edward, Marek Josef, Scanlon Maurice, Sobrinho Luis G., Wass John A. H. and Giustina Andrea. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. 65: 265-273. 2006: Prolactin.

http://dx.doi.org/10.1111/j.1365-2265.2006.02613.x

Ceccarelli Claudia, Canale Domenico, Battisti Paolo, Caglieresi Carolina, Moschini Cecilia, Fiore Emilio, Grasso Lucia, Pinchera Aldo and Vitti Paolo. Testicular function after 131I therapy for hyperthyroidism. 65: 446-452. 2006: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2006.02430.x

Espinosa-de-los-Monteros Ana Laura, Sosa Ernesto, Cheng Sonia, Ochoa Raquel, Sandoval Carolina, Guinto Gerardo, Mendoza Victoria, Hernández Irma, Molina Mario and Mercado Moisés. Biochemical evaluation of disease activity after pituitary surgery in acromegaly: a critical analysis of patients who spontaneously change disease status. 64: 245-249. 2006: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2006.02667.x

Hitz Mette Friberg, Jensen Jens-Erik Beck and Eskildsen Peter C. Bone mineral density in patients with growth hormone deficiency: does a gender difference exist? 65: 783-791. 2006: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2006.02595.x

Lucas T., Astorga R. and and the Spanish–Portuguese Multicentre Autogel Study Group on Acromegaly. Efficacy of lanreotide Autogel® administered every 4–8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: a phase III trial. 65: 320-326. 2006: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2006.02451.x

Marcus-Perlman Y., Tordjman K., Greenman Y., Limor R., Shenkerman G., Osher E. and Stern N. Low-dose ACTH (1 µg) salivary test: a potential alternative to the classical blood test. 64: 215-218. 2006: Cortisol.

http://dx.doi.org/10.1111/j.1365-2265.2006.02543.x

McKenzie Joyce, Fisher B. Miles, Jaap Alan J., Stanley Adrian, Paterson Kenneth and Sattar Naveed. Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. 65: 40-44. 2006: HRT.

http://dx.doi.org/10.1111/j.1365-2265.2006.02618.x

Nieschlag Eberhard. Testosterone treatment comes of age: new options for hypogonadal men. 65: 275-281. 2006: Testosterone.

http://dx.doi.org/10.1111/j.1365-2265.2006.02574.x

Tondeur Marianne, Glinoer Daniel, Sand Alain, Verelst Jean and Ham Hamphrey. Variability of the administered radioiodine doses for the treatment of hyperthyroidism in Belgium. 65: 206-209. 2006: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2007.02937.x

Arregger Alejandro L., Contreras Liliana N., Tumilasci Omar R., Aquilano Daniel R. and Cardoso Estela M. L. Salivary testosterone: a reliable approach to the diagnosis of male hypogonadism. 67: 656-662. 2007: Testosterone.

http://dx.doi.org/10.1111/j.1365-2265.2007.02803.x

Benhadi N., Wiersinga W. M., Reitsma J. B., Vrijkotte T. G. M., Van Der Wal M. F. and Bonsel G. J. Ethnic differences in TSH but not in free T4 concentrations or TPO antibodies during pregnancy. 66: 765-770. 2007: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2006.02733.x

Catalina Pablo F., Páramo Concepción, Andrade Maria Amalia and Mallo Federico. Growth hormone distribution kinetics are markedly reduced in adults with growth hormone deficiency. 66: 341-347. 2007: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2007.02905.x

Colao Annamaria, Di Sarno Antonella, Guerra Ermelinda, Pivonello Rosario, Cappabianca Paolo, Caranci Ferdinando, Elefante Andrea, Cavallo Luigi M., Briganti Francesco, Cirillo Sossio and Lombardi Gaetano. Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy. 67: 426-433. 2007: Prolactin.

http://dx.doi.org/10.1111/j.1365-2265.2007.02809.x

Colao Annamaria, Pivonello Rosario, Di Somma Carolina, Tauchmanovà Libuse, Savastano Silvia and Lombardi Gaetano. Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome. 66: 714-722. 2007: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2007.02799.x

Gonc E. Nazli and Kandemir Nurgun. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency. 66: 672-677. 2007: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2007.02825.x

Mercado Moises, Borges Fatima, Bouterfa Hakim, Chang Tien-Chun, Chervin Alberto, Farrall Andrew J., Patocs Attila, Petersenn Stephan, Podoba Jan, Safari Mitra, Wardlaw Joanna and on behalf of the S. M. S. B. Study Group. A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR® (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly. 66: 859-868. 2007: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2007.02891.x

Paisley Angela N., Rowles Susannah V., Roberts Margaret E., Webb Susan M., Badia X., Prieto L., Shalet Stephen M. and Trainer Peter J. Treatment of acromegaly improves quality of life, measured by AcroQol. 67: 358-362. 2007: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2007.02917.x

Ronchi C. L., Boschetti M., Uberti E. C. Degli, Mariotti S., Grottoli S., Loli P., Lombardi G., Tamburrano G., Arvigo M., Angeletti G., Boscani P. F., Beck-Peccoz P., Arosio M. and for the Italian Multicenter Autogel Study Group in Acromegaly. Efficacy of a slow-release formulation of lanreotide (Autogel® 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study. 67: 512-519. 2007: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2007.02841.x

Weetman Anthony P. Radioiodine treatment for benign thyroid diseases. 66: 757-764. 2007: Thyroid.

Clinical Endocrinology

Willemsen Ruben H., Arends Nicolette J. T., Bakker-van Waarde Willie M., Jansen Maarten, Van Mil Edgar G. A. H., Mulder Jaap, Odink Roelof J., Reeser Maarten, Rongen-Westerlaken Ciska, Stokvis-Brantsma Wilhelmina H., Waelkens Johan J. J. and Hokken-Koelega Anita C. S. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial. 67: 485-492. 2007: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2007.02913.x

http://dx.doi.org/10.1111/j.1365-2265.2008.03279.x

Acharya Shamasunder H., Avenell Alison, Philip Sam, Burr Jennifer, Bevan John S. and Abraham Prakash. Radioiodine therapy (RAI) for Graves’ disease (GD) and the effect on ophthalmopathy: a systematic review*. 69: 943-950. 2008: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2007.03067.x

Andries Magdalene, Glintborg Dorte, Kvistborg Annette, Hagen Claus and Andersen Marianne. A 12-month randomized crossover study on the effects of Lanreotide Autogel and Octreotide long-acting repeatable on GH and IGF-l in patients with acromegaly. 68: 473-480. 2008: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2007.03044.x

Bevan J. S., Newell-Price J., Wass J. A. H., Atkin S. L., Bouloux P. M., Chapman J., Davis J. R. E., Howlett T. A., Randeva H. S., Stewart P. M. and Viswanath A. Home administration of lanreotide Autogel® by patients with acromegaly, or their partners, is safe and effective. 68: 343-349. 2008: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2008.03256.x

Bhatia Kunwar S. S., Ismail Mohamed M., Sahdev Anju, Rockall Andrea G., Hogarth Kieran, Canizales Ana, Avril Norbert, Monson John P., Grossman Ashley B. and Reznek Rodney H. 123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation. 69: 181-188. 2008: Adrenal.

http://dx.doi.org/10.1111/j.1365-2265.2008.03276.x

Cherk Martin H., Kalff Victor, Yap Kenneth S. K., Bailey Michael, Topliss Duncan and Kelly Michael J. Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma. 69: 957-962. 2008: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2008.03301.x

Faggiano Antongiulio, Tavares Lidice Brandao, Tauchmanova Libuse, Milone Francesco, Mansueto Gelsomina, Ramundo Valeria, Del Basso De Caro Maria Laura, Lombardi Gaetano, De Rosa Gaetano and Colao Annamaria. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients. 69: 756-762. 2008: Parathyroid.

http://dx.doi.org/10.1111/j.1365-2265.2007.03029.x

Giavoli Claudia, Bergamaschi Silvia, Ferrante Emanuele, Ronchi Cristina L., Lania Andrea G., Rusconi Roberto, Spada Anna and Beck-Peccoz Paolo. Effect of growth hormone deficiency and recombinant hGH (rhGH) replacement on the hypothalamic–pituitary–adrenal axis in children with idiopathic isolated GH deficiency. 68: 247-251. 2008: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2007.03080.x

Gouni-Berthold Ioanna, Berthold Heiner K., Chamberland John P., Krone Wilhelm and Mantzoros Christos S. Short-term treatment with ezetimibe, simvastatin or their combination does not alter circulating adiponectin, resistin or leptin levels in healthy men. 68: 536-541. 2008: Adiponectin.

http://dx.doi.org/10.1111/j.1365-2265.2008.03280.x

Handisurya Ammon, Pacini Giovanni, Tura Andrea, Gessl Alois and Kautzky-Willer Alexandra. Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH). 69: 963-969. 2008: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2007.02996.x

Jayasena C. N., Wujanto C., Donaldson M., Todd J. F. and Meeran K. Measurement of basal growth hormone (GH) is a useful test of disease activity in treated acromegalic patients. 68: 36-41. 2008: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2007.03139.x

Karavitaki N., Turner H. E., Adams C. B. T., Cudlip S., Byrne J. V., Fazal-Sanderson V., Rowlers S., Trainer P. J. and Wass J. A. H. Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide. 68: 970-975. 2008: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2007.03105.x

Koulouri Olympia and Conway Gerard S. A systematic review of commonly used medical treatments for hirsutism in women. 68: 800-805. 2008: Androgens.

http://dx.doi.org/10.1111/j.1365-2265.2008.03174.x

Lee Jeannette, Heng Derrick, Ma Stefan, Chew Suok-Kai, Hughes Kenneth and Tai E. Shyong. The metabolic syndrome and mortality: the Singapore Cardiovascular Cohort Study. 69: 225-230. 2008: Metabolic Syndrome.

http://dx.doi.org/10.1111/j.1365-2265.2008.03329.x

Mason Helen, Colao Annamaria, Blume-Peytavi Ulrike, Rice Suman, Qureshi Asjid, Pellatt Laura, Orio Francesco and Atkin Stephen L. Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review. 69: 831-844. 2008: PCOS.

http://dx.doi.org/10.1111/j.1365-2265.2008.03338.x

McGrogan Anita, Seaman Helen E., Wright John W. and De Vries Corinne S. The incidence of autoimmune thyroid disease: a systematic review of the literature. 69: 687-696. 2008: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2007.02970.x

Mihai Radu, Wass John A. H. and Sadler Gregory P. Asymptomatic hyperparathyroidism – need for multicentre studies. 68: 155-164. 2008: Prolactin.

http://dx.doi.org/10.1111/j.1365-2265.2007.03162.x

Mosekilde Leif. Primary hyperparathyroidism and the skeleton. 69: 1-19. 2008: Parathyroid.

http://dx.doi.org/10.1111/j.1365-2265.2007.03028.x

Mullan Karen R. and Atkinson A. Brew. Endocrine clinical update: Where are we in the therapeutic management of pituitary-dependent hypercortisolism? 68: 327-337. 2008: Cortisol.

http://dx.doi.org/10.1111/j.1365-2265.2007.02997.x

Schaap Laura A., Pluijm Saskia M. F., Deeg Dorly J. H., Penninx Brenda W., Nicklas Barbara J., Lips Paul, Harris Tamara B., Newman Anne B., Kritchevsky Steve B., Cauley Jane A., Goodpaster Bret H., Tylavsky Frances A., Yaffe Kristine, Visser Marjolein and for the Health A. B. C. study. Low testosterone levels and decline in physical performance and muscle strength in older men: findings from two prospective cohort studies. 68: 42-50. 2008: Testosterone.

http://dx.doi.org/10.1111/j.1365-2265.2008.03268.x

Tanda Maria Laura, Piantanida Eliana, Lai Adriana, Liparulo Luigi, Sassi Lorenza, Bogazzi Fausto, Wiersinga Wilmar M., Braverman Lewis E., Martino Enio and Bartalena Luigi. Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists*. 69: 812-818. 2008: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2007.03097.x

Vaidya Bijay, Williams Graham R., Abraham Prakash and Pearce Simon H. S. Radioiodine treatment for benign thyroid disorders: results of a nationwide survey of UK endocrinologists. 68: 814-820. 2008: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2007.03164.x

Vincent R. P. and Le Roux C. W. Changes in gut hormones after bariatric surgery. 69: 173-179. 2008: Bariatric.

http://dx.doi.org/10.1111/j.1365-2265.2008.03261.x

Yendt Edmund R., Kovacs Katherine A. and Jones Glenville. Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction. 69: 855-863. 2008: Parathyroid.

http://dx.doi.org/10.1111/j.1365-2265.2008.03509.x

Adrees M., Gibney J., El-Saeity N. and Boran G. Effects of 18 months of l-T4 replacement in women with subclinical hypothyroidism. 71: 298-303. 2009: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2008.03342.x

Anastasilakis Athanasios D., Goulis Dimirtios G., Polyzos Stergios A., Gerou Spiridon, Ballaouri Iris, Efstathiadou Zoe, Kita Marina and Avramidis Avraam. No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial. 70: 522-526. 2009: Bone.

http://dx.doi.org/10.1111/j.1365-2265.2008.03459.x

Barba Maddalena, Schünemann Holger J., Sperati Francesca, Akl Elie A., Musicco Felice, Guyatt Gordon and Muti Paola. The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis. 70: 661-670. 2009: Androgens.

http://dx.doi.org/10.1111/j.1365-2265.2008.03291.x

Boelaert K., Syed A. A., Manji N., Sheppard M. C., Holder R. L., Gough S. C. and Franklyn J. A. Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidism. 70: 129-138. 2009: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2008.03381.x

Cardoso Estela M. L., Arregger Alejandro L., Tumilasci Omar R. and Contreras Liliana N. Diagnostic value of salivary cortisol in Cushing's syndrome (CS). 70: 516-521. 2009: Cortisol.

http://dx.doi.org/10.1111/j.1365-2265.2009.03541.x

Clarke Bart L. New and emerging treatments for osteoporosis. 71: 309-321. 2009: Bone.

http://dx.doi.org/10.1111/j.1365-2265.2008.03410.x

Clausen P., Mersebach H., Nielsen B., Feldt-Rasmussen B. and Feldt-Rasmussen U. Hypothyroidism is associated with signs of endothelial dysfunction despite 1-year replacement therapy with levothyroxine. 70: 932-937. 2009: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2008.03441.x

Colao Annamaria, Cappabianca Paolo, Caron Philippe, De Menis Ernesto, Farrall Andrew J., Gadelha Monica R., Hmissi Abdel, Rees Aled, Reincke Martin, Safari Mitra, T'Sjoen Guy, Bouterfa Hakim and Cuneo Ross C. Octreotide LAR vs. surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study. 70: 757-768. 2009: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2008.03357.x

Grossmann Mathis, Panagiotopolous Sianna, Sharpe Ken, MacIsaac Richard J., Clarke Sophie, Zajac Jeffrey D., Jerums George and Thomas Merlin C. Low testosterone and anaemia in men with type 2 diabetes. 70: 547-553. 2009: Testosterone.

http://dx.doi.org/10.1111/j.1365-2265.2008.03469.x

Higham C. E., Chung T. T., Lawrance J., Drake W. M. and Trainer P. J. Long-term experience of pegvisomant therapy as a treatment for acromegaly. 71: 86-91. 2009: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2008.03472.x

Ibáñez Lourdes, López-Bermejo Abel, Díaz Marta, Enríquez Goya, Del Río Luis and De Zegher Francis. Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months. 71: 351-357. 2009: Androgens.

http://dx.doi.org/10.1111/j.1365-2265.2009.03578.x

Karavitaki N., Fernandez A., Fazal-Sanderson V. and Wass J. A. H. The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly. 71: 840-845. 2009: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2008.03515.x

Keil Margaret F., Merke Deborah P., Gandhi Roma, Wiggs Edythe A., Obunse Kathy and Stratakis Constantine A. Quality of life in children and adolescents 1-year after cure of Cushing syndrome: a prospective study. 71: 326-333. 2009: Cushings.

http://dx.doi.org/10.1111/j.1365-2265.2009.03536.x

Morris John C. How do you approach the problem of TSH elevation in a patient on high-dose thyroid hormone replacement? 70: 671-673. 2009: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2008.03324.x

Pieterman C. R. C., Schreinemakers J. M. J., Koppeschaar H. P. F., Vriens M. R., Rinkes I. H. M. Borel, Zonnenberg B. A., Van Der Luijt R. B. and Valk G. D. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome. 70: 575-581. 2009: MEN1.

http://dx.doi.org/10.1111/j.1365-2265.2009.03564.x

Pournaras Dimitrios J. and Le Roux Carel W. After bariatric surgery, what vitamins should be measured and what supplements should be given? 71: 322-325. 2009: Bariatric.

http://dx.doi.org/10.1111/j.1365-2265.2008.03490.x

Preiss David and Sattar Naveed. Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence. 70: 815-828. 2009: Lipids.

http://dx.doi.org/10.1111/j.1365-2265.2008.03364.x

Raverot Gérald, Jacob Maud, Jouanneau Emmanuel, Delemer Brigitte, Vighetto Alain, Pugeat Michel and Borson-Chazot Françoise. Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma. 70: 588-592. 2009: Prolactin.

http://dx.doi.org/10.1111/j.1365-2265.2009.03589.x

Ronchi Cristina L., Attanasio Roberto, Verrua Elisa, Cozzi Renato, Ferrante Emanuele, Loli Paola, Montefusco Laura, Motti Enrico, Ferrari Daniela I., Giugni Enrico, Beck-Peccoz Paolo and Arosio Maura. Efficacy and tolerability of gamma knife radiosurgery in acromegaly: a 10-year follow-up study. 71: 846-852. 2009: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2009.03592.x

Rubeck K. Z., Bertelsen S., Vestergaard P. and Jørgensen J. O. L. Impact of GH substitution on exercise capacity and muscle strength in GH-deficient adults: a meta-analysis of blinded, placebo-controlled trials. 71: 860-866. 2009: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2009.03585.x

Savino Francesco, Fissore Maria F., Liguori Stefania A. and Oggero Roberto. Can hormones contained in mothers’ milk account for the beneficial effect of breast-feeding on obesity in children? 71: 757-765. 2009: Obesity.

http://dx.doi.org/10.1111/j.1365-2265.2009.03540.x

Stechman Michael J., Weisters Mary, Gleeson Fergus V., Sadler Gregory P. and Mihai Radu. Parathyroidectomy is safe and improves symptoms in elderly patients with primary hyperparathyroidism (PHPT). 71: 787-791. 2009: Parathyroid.

http://dx.doi.org/10.1111/j.1365-2265.2008.03470.x

Stein E. M., Strain G., Sinha N., Ortiz D., Pomp A., Dakin G., McMahon D. J., Bockman R. and Silverberg S. J. Vitamin D insufficiency prior to bariatric surgery: risk factors and a pilot treatment study. 71: 176-183. 2009: Bariatric.

http://dx.doi.org/10.1111/j.1365-2265.2008.03496.x

Timmers Henri J. L. M., Eisenhofer Graeme, Carrasquillo Jorge A., Chen Clara C., Whatley Millie, Ling Alexander, Adams Karen T. and Pacak Karel. Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for the diagnosis and localization of non-metastatic and metastatic phaeochromocytoma (PHEO). 71: 11-17. 2009: Phaeochromocytoma.

http://dx.doi.org/10.1111/j.1365-2265.2008.03464.x

Tooze Alana, Gittoes Neil J., Jones Christopher A. and Toogood Andrew A. Neurocognitive consequences of surgery and radiotherapy for tumours of the pituitary. 70: 503-511. 2009: Pituitary.

http://dx.doi.org/10.1111/j.1365-2265.2009.03620.x

Trainer Peter J., Ezzat Shereen, D’Souza Gwyn A., Layton Gary and Strasburger Christian J. A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegaly. 71: 549-557. 2009: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2008.03398.x

Verga Uberta, Bergamaschi Silvia, Cortelazzi Donatella, Ronzoni Stefania, Marconi Anna Maria and Beck-Peccoz Paolo. Adjustment of L-T4 substitutive therapy in pregnant women with subclinical, overt or post-ablative hypothyroidism. 70: 798-802. 2009: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2008.03403.x

Yu C. K. H., Sykes L., Sethi M., Teoh T. G. and Robinson S. Vitamin D deficiency and supplementation during pregnancy. 70: 685-690. 2009: Vitamin D.

http://dx.doi.org/10.1111/j.1365-2265.2011.04087.x

Ahmed Sheba, Van Gelder Isabelle C., Wiesfeld Ans C. P., Van Veldhuisen Dirk J. and Links Thera P. Determinants and outcome of amiodarone-associated thyroid dysfunction. 75: 388-394. 2011: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2009.03631.x

Alexandraki Krystallenia I., Kaltsas Gregory A., Le Roux Carel W., Fassnacht Martin, Ajodha Sharon, Christ-Crain Mirjam, Akker Scott A., Drake William M., Edwards Ray, Allolio Bruno and Grossman Ashley B. Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study. 72: 305-311. 2011: Cortisol.

http://dx.doi.org/10.1111/j.1365-2265.2011.04033.x

Atkinson Brew and Mullan Karen R. What is the best approach to suspected cyclical Cushing syndrome? Strategies for managing Cushing’s syndrome with variable laboratory data. 75: 27-30. 2011: Cushing's.

http://dx.doi.org/10.1111/j.1365-2265.2010.03783.x

Bartalena Luigi. What to do for moderate-to-severe and active Graves’ orbitopathy if glucocorticoids fail? 73: 149-152. 2011: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2010.03815.x

Behan Lucy Ann, Monson John P. and Agha Amar. The interaction between growth hormone and the thyroid axis in hypopituitary patients. 74: 281-288. 2011: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2009.03596.x

Bleicken Benjamin, Hahner Stefanie, Loeffler Melanie, Ventz Manfred, Decker Oliver, Allolio Bruno and Quinkler Marcus. Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency. 72: 297-304. 2011: Cortisol.

http://dx.doi.org/10.1111/j.1365-2265.2009.03640.x

Boekholdt S. Matthijs, Titan Silvia M., Wiersinga Wilmar M., Chatterjee Krishna, Basart Dick C. G., Luben Robert, Wareham Nicholas J. and Khaw Kay-Tee. Initial thyroid status and cardiovascular risk factors: The EPIC-Norfolk prospective population study. 72: 404-410. 2011: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2010.03951.x

Brand Judith S., Wareham Nicholas J., Dowsett Mitch, Folkerd Elizabeth, van der Schouw Yvonne T., Luben Robert N. and Khaw Kay-Tee. Associations of endogenous testosterone and SHBG with glycated haemoglobin in middle-aged and older men. 74: 572-578. 2011: Testosterone.

http://dx.doi.org/10.1111/j.1365-2265.2010.03974.x

Chen Lili and Hu Renming. Thyroid autoimmunity and miscarriage: a meta-analysis. 74: 513-519. 2011: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2011.03994.x

Compston Juliet. Clinical Question: What is the best approach to managing glucocorticoid-induced osteoporosis? 74: 547-550. 2011: Bone.

http://dx.doi.org/10.1111/j.1365-2265.2009.03618.x

Correa-Silva Silvia R., Nascif Sérgio O., Molica Patrícia, Sá Larissa B. P. C., Vieira José G. H. and Lengyel Ana-Maria J. Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing’s disease: comparison with GH-releasing peptide-6 (GHRP-6). 72: 70-75. 2011: Ghrelin.

http://dx.doi.org/10.1111/j.1365-2265.2010.03844.x

Crabtree N. J., Bebbington N. A., Chapman D. M., Wahid Y. S., Ayuk J., Boivin C. M., Cooper M. S. and Gittoes N. J. L. Impact of UK National Guidelines based on FRAX®– comparison with current clinical practice. 73: 452-456. 2011: Bone.

http://dx.doi.org/10.1111/j.1365-2265.2011.04029.x

Duntas Leonidas H., Orgiazzi Jacques and Brabant Georg. The interface between thyroid and diabetes mellitus. 75: 1-9. 2011: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2010.03954.x

Emmelot-Vonk M. H., Verhaar H. J. J., Nakhai-Pour H. R., Grobbee D. E. and van der Schouw Y. T. Low testosterone concentrations and the symptoms of testosterone deficiency according to the Androgen Deficiency in Ageing Males (ADAM) and Ageing Males’ Symptoms rating scale (AMS) questionnaires. 74: 488-494. 2011: Testosterone.

http://dx.doi.org/10.1111/j.1365-2265.2009.03653.x

Goswami Ravinder, Goel Siya, Tomar Neeraj, Gupta Nandita, Lumb Vanshika and Sharma Yagya Dutta. Prevalence of clinical remission in patients with sporadic idiopathic hypoparathyroidism. 72: 328-333. 2011: Parathyroid.

http://dx.doi.org/10.1111/j.1365-2265.2011.04023.x

Gurnell Mark, Halsall David J. and Chatterjee V. Krishna. What should be done when thyroid function tests do not make sense? 74: 673-678. 2011: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2011.04066.x

Haddow James E., Neveux Louis M., Palomaki Glenn E., Lambert-Messerlian Geralyn, Canick Jacob A., Grenache David G. and Lu Jun. The relationship between PTH and 25-hydroxy vitamin D early in pregnancy. 75: 309-314. 2011: Parathyroid.

http://dx.doi.org/10.1111/j.1365-2265.2010.03880.x

Hattori Naoki, Ishihara Takashi, Saiki Yasuhiko and Shimatsu Akira. Macroprolactinaemia in patients with hyperprolactinaemia: composition of macroprolactin and stability during long-term follow-up. 73: 792-797. 2011: Prolactin.

http://dx.doi.org/10.1111/j.1365-2265.2009.03648.x

Havekes Bas, King Kathryn, Lai Edwin W., Romijn Johannes A., Corssmit Eleonora P. M. and Pacak Karel. New imaging approaches to phaeochromocytomas and paragangliomas. 72: 137-145. 2011: Phaeochromocytoma.

http://dx.doi.org/10.1111/j.1365-2265.2009.03688.x

Herrmann Markus and Seibel Markus J. The effects of hormonal contraceptives on bone turnover markers and bone health. 72: 571-583. 2011: Bone.

http://dx.doi.org/10.1111/j.1365-2265.2009.03686.x

Högler Wolfgang and Shaw Nick. Childhood growth hormone deficiency, bone density, structures and fractures: scrutinizing the evidence. 72: 281-289. 2011: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2009.03641.x

Joshi Devina, Van Schoor Natasja M., De Ronde Willem, Schaap Laura A., Comijs Hannie C., Beekman Aartjan T. F. and Lips Paul. Low free testosterone levels are associated with prevalence and incidence of depressive symptoms in older men. 72: 232-240. 2011: Testosterone.

http://dx.doi.org/10.1111/j.1365-2265.2009.03756.x

Jung Caroline, Alford Frank P., Topliss Duncan J., Burgess John R., Long Fiona, Gome James J., Stockigt Jim R. and Inder Warrick J. The 4-mg intravenous dexamethasone suppression test in the diagnosis of Cushing’s syndrome. 73: 78-84. 2011: Cushings.

http://dx.doi.org/10.1111/j.1365-2265.2010.03818.x

Kim Beom-Jun, Lee Seung H., Bae Sung J., Kim Hong K., Choe Jae W., Kim Ha Y., Koh Jung-Min and Kim Ghi S. ORIGINAL ARTICLE: The association between serum thyrotropin (TSH) levels and bone mineral density in healthy euthyroid men. 73: 396-403. 2011: Bone.

http://dx.doi.org/10.1111/j.1365-2265.2011.03984.x

Koulouri Olympia, Auldin Mohammed A., Agarwal Ravi, Kieffer Veronica, Robertson Carole, Falconer Smith James, Levy Miles J. and Howlett Trevor A. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine. 74: 744-749. 2011: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2011.04006.x

Lee Vivian Chi Yan and Ledger William. Aromatase inhibitors for ovulation induction and ovarian stimulation. 74: 537-546. 2011: Aromatase.

http://dx.doi.org/10.1111/j.1365-2265.2009.03701.x

Lips Paul, Bouillon Roger, Van Schoor Natasja M., Vanderschueren Dirk, Verschueren Sabine, Kuchuk Natalia, Milisen Koen and Boonen Steven. REVIEW ARTICLE: Reducing fracture risk with calcium and vitamin D. 73: 277-285. 2011: Bone.

http://dx.doi.org/10.1111/j.1365-2265.2010.03804.x

Ly Lam P., Sartorius Gideon, Hull Laura, Leung Andrew, Swerdloff Ronald S., Wang Christina and Handelsman David J. ORIGINAL ARTICLE: Accuracy of calculated free testosterone formulae in men. 73: 382-388. 2011: Testosterone.

http://dx.doi.org/10.1111/j.1365-2265.2009.03706.x

Maffei Pietro, Tamagno Gianluca, Nardelli Giovanni Battista, Videau Catherine, Menegazzo Carla, Milan Gabriella, Calcagno Alessandra, Martini Chiara, Vettor Roberto, Epelbaum Jacques and Sicolo Nicola. Effects of octreotide exposure during pregnancy in acromegaly. 72: 668-677. 2011: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2009.03716.x

Matthew Widdowson W. and Gibney James. The effect of growth hormone (GH) replacement on muscle strength in patients with GH-deficiency: a meta-analysis. 72: 787-792. 2011: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2009.03759.x

Milone F., Ramundo V., Chiofalo M. G., Severino R., Paciolla I., Pezzullo L., Lombardi G., Colao A. and Faggiano A. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels. 73: 85-88. 2011: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2010.03940.x

Mistry Dipan, Atkin Stephen, Atkinson Helen, Gunasekaran Sinnappa, Sylvester Deborah, Rigby Alan S. and England R. James. Predicting thyroxine requirements following total thyroidectomy. 74: 384-387. 2011: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2009.03694.x

Mitchell Anna L. and Pearce Simon H. S. How should we treat patients with low serum thyrotropin concentrations? 72: 292-296. 2011: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2010.03965.x

Moseley Kendall F., Dobrosielski Devon A., Stewart Kerry J., De Beur Suzanne M. Jan and Sellmeyer Deborah E. Lean mass and fat mass predict bone mineral density in middle-aged individuals with noninsulin-requiring type 2 diabetes mellitus. 74: 565-571. 2011: Bone.

http://dx.doi.org/10.1111/j.1365-2265.2010.03875.x

Murad Mohammad Hassan, Fernández-Balsells M. M., Barwise Amelia, Gallegos-Orozco Juan F., Paul Anu, Lane Melanie A., Lampropulos Julianna F., Natividad Inés, Perestelo-Pérez Lilisbeth, Ponce de León-Lovatón Paula G., Albuquerque Felipe N., Carey Jantey, Erwin Patricia J. and Montori Victor M. Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysis. 73: 777-791. 2011: Pituitary.

http://dx.doi.org/10.1111/j.1365-2265.2009.03649.x

Nakamura Akinobu, Shimizu Chikara, Nagai So, Yoshida Masahiro, Aoki Kazutaka, Kondo Takuma, Miyoshi Hideaki, Wada Norio, Tajima Toshihiro, Terauchi Yasuo, Yoshioka Narihito and Koike Takao. Problems in diagnosing atypical Gitelman’s syndrome presenting with normomagnesaemia. 72: 272-276. 2011: Gitelman's.

http://dx.doi.org/10.1111/j.1365-2265.2011.04047.x

Nivet-Antoine Valérie, Golmard Jean-Louis, Coussieu Christiane, Piette François, Cynober Luc and Bouillanne Olivier. Leptin is better than any other biological parameter for monitoring the efficacy of renutrition in hospitalized malnourished elderly patients. 75: 315-320. 2011: Leptin.

http://dx.doi.org/10.1111/j.1365-2265.2009.03623.x

Okosieme O. E., Chan D., Price S. A., Lazarus J. H. and Premawardhana L. D. K. E. The utility of radioiodine uptake and thyroid scintigraphy in the diagnosis and management of hyperthyroidism. 72: 122-127. 2011: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2010.03792.x

Reid Ian R., Bolland Mark J. and Grey Andrew. Does calcium supplementation increase cardiovascular risk? 73: 689-695. 2011: Calcium.

http://dx.doi.org/10.1111/j.1365-2265.2009.03626.x

Reid Tirissa J., Post Kalmon D., Bruce Jeffrey N., Nabi Kanibir M., Reyes-Vidal Carlos M. and Freda Pamela U. Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. 72: 203-208. 2011: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2009.03775.x

Savage Martin O., Burren Christine P. and Rosenfeld Ron G. The continuum of growth hormone–IGF-I axis defects causing short stature: diagnostic and therapeutic challenges. 72: 721-728. 2011: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2010.03908.x

Schouten Belinda J., Brownlie Bevan E. W., Frampton Chris M. and Turner John G. Subclinical thyrotoxicosis in an outpatient population – predictors of outcome. 74: 257-261. 2011: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2010.03810.x

Semple Robert K., Williams Rachel M. and Dunger David B. CLINICAL QUESTION: What is the best management strategy for patients with severe insulin resistance? 73: 286-290. 2011: Insulin Resistance.

http://dx.doi.org/10.1111/j.1365-2265.2009.03730.x

Serra-Prat Mateu, Palomera Elisabet, Roca Maria, Puig-Domingo Manel and The Mataró Ageing Study Group. Long-term effect of ghrelin on nutritional status and functional capacity in the elderly: a population-based cohort study. 73: 41-47. 2011: Ghrelin.

http://dx.doi.org/10.1111/j.1365-2265.2011.04018.x

Stephens Mark, Ludgate Marian and Rees D. Aled. Brown fat and obesity: the next big thing? 74: 661-670. 2011: Obesity.

http://dx.doi.org/10.1111/j.1365-2265.2009.03714.x

Stewart Paul M. and Allolio Bruno. Adrenal vein sampling for Primary Aldosteronism: time for a reality check. 72: 146-148. 2011: Adrenal.

http://dx.doi.org/10.1111/j.1365-2265.2010.03797.x

Stuckey B. G. A., Kent G. N., Ward L. C., Brown S. J. and Walsh J. P. ORIGINAL ARTICLE: Postpartum thyroid dysfunction and the long-term risk of hypothyroidism: results from a 12-year follow-up study of women with and without postpartum thyroid dysfunction. 73: 389-395. 2011: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2009.03745.x

Takata Kazuna, Amino Nobuyuki, Kubota Sumihisa, Sasaki Ichiro, Nishihara Eijun, Kudo Takumi, Ito Mitsuru, Fukata Shuji and Miyauchi Akira. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves’ disease. 72: 845-850. 2011: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2011.04089.x

Visser Willem Edward, de Rijke Yolanda B., van Toor Hans and Visser Theo J. Thyroid status in a large cohort of patients with mental retardation: the TOP-R (Thyroid Origin of Psychomotor Retardation) study. 75: 395-401. 2011: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2009.03606.x

Walsh Jennifer S., Henry Yvette M., Fatayerji Diana and Eastell Richard. Hormonal determinants of bone turnover before and after attainment of peak bone mass. 72: 320-327. 2011: Bone.

http://dx.doi.org/10.1111/j.1365-2265.2009.03624.x

Woerdeman Jorn, Kaufman Jean-Marc and De Ronde Willem. In young men, a moderate inhibition of testosterone synthesis capacity is only partly compensated by increased activity of the pituitary and the hypothalamus. 72: 76-80. 2011: Testosterone.

http://dx.doi.org/10.1111/j.1365-2265.2010.03910.x

Yan Yu-Qin, Dong Zuo-Liang, Dong Ling, Wang Feng-Rui, Yang Xue-Ming, Jin Xing-Yi, Lin Lai-Xiang, Sun Yi-Na and Chen Zu-Pei. Trimester- and method-specific reference intervals for thyroid tests in pregnant Chinese women: methodology, euthyroid definition and iodine status can influence the setting of reference intervals. 74: 262-269. 2011: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2009.03766.x

Yu Ning, Donnan Peter T., Flynn Robert W. V., Murphy Michael J., Smith David, Rudman Andrew and Leese Graham P. Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS). 73: 30-34. 2011: Parathyroid.

http://dx.doi.org/10.1111/j.1365-2265.2010.03958.x

Yu Ning, Donnan Peter T. and Leese Graham P. A record linkage study of outcomes in patients with mild primary hyperparathyroidism: The Parathyroid Epidemiology and Audit Research Study (PEARS). 75: 169-176. 2011: Parathyroid.

http://dx.doi.org/10.1111/j.1365-2265.2012.04477.x

Åsvold Bjørn O., Bjøro Trine, Platou Carl and Vatten Lars J. Thyroid function and the risk of coronary heart disease: 12-year follow-up of the HUNT Study in Norway. 77: 911-917. 2012: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2012.04352.x

Ekman Bertil, Bachrach-Lindström Margareta, Lindström Torbjörn, Wahlberg Jeanette, Blomgren Johan and Arnqvist Hans J. A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency. 77: 18-25. 2012: Adrenal.

http://dx.doi.org/10.1111/j.1365-2265.2011.04177.x

Graham U. M., Ellis P. K., Hunter S. J., Leslie H., Mullan K. R. and Atkinson A. B. 100 cases of primary aldosteronism: careful choice of patients for surgery using adrenal venous sampling and CT imaging results in excellent blood pressure and potassium outcomes. 76: 26-32. 2012: Adrenal.

http://dx.doi.org/10.1111/j.1365-2265.2012.04501.x

Grey Andrew. Nonsurgical management of mild primary hyperparathyroidism – a reasonable option. 77: 639-644. 2012: Parathyroid.

http://dx.doi.org/10.1111/j.1365-2265.2012.04351.x

Iglesias Pedro, Bernal Carmen, Villabona Carles, Castro José C., Arrieta Francisco and Díez Juan J. Prolactinomas in men: a multicentre and retrospective analysis of treatment outcome. 77: 281-287. 2012: Prolactin.

http://dx.doi.org/10.1111/j.1365-2265.2012.04508.x

Inder Warrick J., Dimeski Goce and Russell Anthony. Measurement of salivary cortisol in 2012 – laboratory techniques and clinical indications. 77: 645-651. 2012: Cortisol.

http://dx.doi.org/10.1111/j.1365-2265.2011.04197.x

Kahal Hassan, Aye Mo, Rigby Alan S., Sathyapalan Thozhukat, England R. J. A. and Atkin Stephen L. The effect of parathyroidectomy on neuropsychological symptoms and biochemical parameters in patients with asymptomatic primary hyperparathyroidism. 76: 196-200. 2012: Parathyroid.

http://dx.doi.org/10.1111/j.1365-2265.2011.04204.x

Kahraman Deniz, Keller Christian, Schneider Christina, Eschner Wolfgang, Sudbrock Ferdinand, Schmidt Matthias, Schicha Harald, Dietlein Markus and Kobe Carsten. Development of hypothyroidism during long-term follow-up of patients with toxic nodular goitre after radioiodine therapy. 76: 297-303. 2012: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2012.04436.x

Kaya Mehmet G., Calapkorur Bekir, Karaca Zuleyha, Yildirim Sumeyra, Celik Ahmet, Akpek Mahmut, Unluhizarci Kursad and Kelestimur Fahrettin. The effects of treatment with drospirenone/ethinyl oestradiol alone or in combination with metformin on elastic properties of aorta in women with polycystic ovary syndrome. 77: 885-892. 2012: PCOS.

http://dx.doi.org/10.1111/j.1365-2265.2012.04411.x

Kim David D. W., Goh Jovina, Panossian Zaven, Gamble Greg, Holdaway Ian and Grey Andrew. Pioglitazone in acromegaly – an open-label, prospective study. 77: 575-578. 2012: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2011.04202.x

Lau Jeshen H. G., Candy Sze W. C., Reznek Rodney H., Matson Matthew, Sahdev Anju, Carpenter Robert, Berney Daniel M., Akker Scott A., Chew Shern L., Grossman Ashley B., Monson John P. and Drake William M. A prospective evaluation of postural stimulation testing, computed tomography and adrenal vein sampling in the differential diagnosis of primary aldosteronism. 76: 182-188. 2012: Adrenal.

http://dx.doi.org/10.1111/j.1365-2265.2012.04361.x

Lin E., Wexler T. L., Nachtigall L., Tritos N., Swearingen B., Hemphill L., Loeffler J., Biller B. M. K., Klibanski A. and Miller K. K. Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly. 77: 430-438. 2012: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2011.04265.x

Lu Kuo-Cheng, Ma Wen-Ya, Yu Jyh-Cherng, Wu Chia-Chao and Chu Pauling. Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism. 76: 634-642. 2012: Parathyroid.

http://dx.doi.org/10.1111/j.1365-2265.2012.04385.x

Martin Niamh M., Patel Miraj, Nijher Gurjinder M. K., Misra Shivani, Murphy Elaine and Meeran Karim. Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease. 77: 621-627. 2012: Thyroid.

http://dx.doi.org/10.1111/j.1365-2265.2012.04356.x

McHenry Claire M., Bell Patrick M., Hunter Steven J., Thompson Christopher J., Courtney C. H., Ennis Cieran N., Sheridan Brian, McCance David R., Mullan Karen R. and Atkinson A. Brew. Effects of dehydroepiandrosterone sulphate (DHEAS) replacement on insulin action and quality of life in hypopituitary females: a double-blind, placebo-controlled study. 77: 423-429. 2012: Pituitary.

http://dx.doi.org/10.1111/j.1365-2265.2012.04346.x

Neggers S. J. C. M. M., Biermasz N. R. and van der Lely A. J. What is active acromegaly and which parameters do we have? 76: 609-614. 2012: Acromegaly.

http://dx.doi.org/10.1111/j.1365-2265.2012.04381.x

Raverot Gérald, Castinetti Frédéric, Jouanneau Emmanuel, Morange Isabelle, Figarella-Branger Dominique, Dufour Henry, Trouillas Jacqueline and Brue Thierry. Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment. 76: 769-775. 2012: Pituitary.

http://dx.doi.org/10.1111/j.1365-2265.2011.04146.x

Roemmler J., Gockel A., Otto B., Bidlingmaier M. and Schopohl J. Effects on metabolic variables after 12-month treatment with a new once-a-week sustained-release recombinant growth hormone (GH: LB03002) in patients with GH deficiency. 76: 88-95. 2012: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2011.04303.x

Sanchez-Ortiga Ruth, Klibanski Anne and Tritos Nicholas A. Effects of recombinant human growth hormone therapy in adults with Prader–Willi syndrome: a meta-analysis. 77: 86-93. 2012: Growth Hormone.

http://dx.doi.org/10.1111/j.1365-2265.2011.04253.x

Terzolo M., Pia A. and Reimondo G. Subclinical Cushing’s syndrome: definition and management. 76: 12-18. 2012: Cushing's.

http://dx.doi.org/10.1111/j.1365-2265.2012.04373.x

Whitelaw B. C., Dworakowska D., Thomas N. W., Barazi S., Riordan-Eva P., King A. P., Hampton T., Landau D. B., Lipscomb D., Buchanan C. R., Gilbert J. A. and Aylwin S. J. B. Temozolomide in the management of dopamine agonist–resistant prolactinomas. 76: 877-886. 2012: Prolactin.

http://dx.doi.org/10.1111/cen.12204

Ciresi Alessandro, Amato Marco Calogero, Guarnotta Valentina, Lo Castro Flavia and Giordano Carla. Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels. 79: 845-852. 2013: Prolactin.

http://dx.doi.org/10.1111/j.1365-2265.2012.04473.x

Downing Jennifer, Gleeson Helena K., Clayton Peter E., Davis Julian R. E., Wales Jerry K. and Callery Peter. Transition in endocrinology: the challenge of maintaining continuity. 78: 29-35. 2013: Transitional.

http://dx.doi.org/10.1111/cen.12053

Gleeson Helena, Davis Joanne, Jones Julie, O'Shea Elaine and Clayton Peter E. The challenge of delivering endocrine care and successful transition to adult services in adolescents with congenital adrenal hyperplasia: experience in a single centre over 18 years. 78: 23-28. 2013: Transitional.

http://dx.doi.org/10.1111/cen.12027

Kim Hee Kyung, Yoon Jee Hee, Kim Soo Jeong, Cho Jin Seong, Kweon Sun-Seog and Kang Ho-Cheol. Higher TSH level is a risk factor for differentiated thyroid cancer. 78: 472-477. 2013: Thyroid.

http://dx.doi.org/10.1111/cen.12191

Pamporaki Christina, Därr Roland, Bursztyn Michael, Glöckner Stephan, Bornstein Stefan R., Lenders Jacques W. M., Pacak Karel, Krinner Axel and Eisenhofer Graeme. Plasma-free vs deconjugated metanephrines for diagnosis of phaeochromocytoma. 79: 476-483. 2013: Adrenal.

http://dx.doi.org/10.1111/cen.12149

Rastogi Ashu, Bhansali Anil, Dutta Pinaki, Singh Paramjit, Vijaivergiya Rajesh, Gupta Vaishali, Sachdeva Naresh, Bhadada Sanjay Kumar and Walia Rama. A comparison between intensive and conventional cabergoline treatment of newly diagnosed patients with macroprolactinoma. 79: 409-415. 2013: Prolactin.

http://dx.doi.org/10.1111/cen.12132

Tritos Nicholas A., Hamrahian Amir H., King Donna, Greenspan Susan L., Cook David M., Jönsson Peter J., Koltowska-Häggstrom Maria and Biller Beverly M. K. Predictors of the effects of 4 years of growth hormone replacement on bone mineral density in patients with adult-onset growth hormone deficiency – a KIMS database analysis. 79: 178-184. 2013: Growth Hormone.

http://dx.doi.org/10.1111/cen.12109

Tur Juan Jesús, Escudero Antonio Jorge, Alos María Micaela, Salinas Ramón, Terés Emma, Soriano Joan B., Nicola Gabriela, Urgelés Juan Ramón, Pagán Alberto, Cortes Baltasar, González Xavier and Burguera Bartolomé. One year weight loss in the TRAMOMTANA study. A randomized controlled trial. 79: 791-799. 2013: Obesity.

Clinical Endocrinology

Appelman-Dijkstra Natasha M., Claessen Kim M. J. A., Hamdy Neveen A. T., Pereira Alberto M. and Biermasz Nienke R. Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with Growth Hormone Deficiency (GHD): The Leiden Cohort Study. 81: 727-735. 2014: Growth Hormone.

http://dx.doi.org/10.1111/cen.12493

http://dx.doi.org/10.1111/cen.12345

Gadelha Mônica R. and Vieira Neto Leonardo. Efficacy of medical treatment in Cushing's disease: a systematic review. 80: 1-12. 2014: Cushing's.

Clinical Endocrinology

Reinehr Thomas, Lindberg Anders, Koltowska-Häggström Maria and Ranke Michael. Is growth hormone treatment in children associated with weight gain? – Longitudinal analysis of KIGS data. 81: 721-726. 2014: KIGS.

http://dx.doi.org/10.1111/cen.12464

Back to Top

http://edrv.endojournals.org/content/22/4/425.abstract

Drake W. M., Howell S. J., Monson J. P. and Shalet S. M. Optimizing GH Therapy in Adults and Children. 22: 425-450. 2001: Growth Hormone.

http://edrv.endojournals.org/content/22/1/53.abstract

Le Roith Derek, Bondy Carolyn, Yakar Shoshana, Liu Jun-Li and Butler Andrew. The Somatomedin Hypothesis: 2001. 22: 53-74. 2001: Growth Hormone.

http://edrv.endojournals.org/content/22/2/240.abstract

Martino Enio, Bartalena Luigi, Bogazzi Fausto and Braverman Lewis E. The Effects of Amiodarone on the Thyroid. 22: 240-254. 2001: Thyroid.

http://edrv.endojournals.org/content/23/4/570.short

Cranney Ann, Guyatt Gordon, Griffith Lauren, Wells George, Tugwell Peter, Rosen Clifford, the Osteoporosis Methodology Group and Group and the Osteoporosis Research Advisory. IX: Summary of Meta-Analyses of Therapies for Postmenopausal Osteoporosis. 23: 570-578. 2002: Bone.

http://edrv.endojournals.org/content/23/4/517.short

Cranney Ann, Tugwell Peter, Adachi Jonathan, Weaver Bruce, Zytaruk Nicole, Papaioannou Alexandra, Robinson Vivian, Shea Beverley, Wells George, Guyatt Gordon, the Osteoporosis methodology group and Group and the Osteoporosis Research Advisory. III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis. 23: 517-523. 2002: Bone.

http://edrv.endojournals.org/content/23/4/524.short

Cranney Ann, Tugwell Peter, Zytaruk Nicole, Robinson Vivian, Weaver Bruce, Adachi Jonathan, Wells George, Shea Beverley, Guyatt Gordon, the Osteoporosis Methodology Group and Group and the Osteoporosis Research Advisory. IV. Meta-Analysis of Raloxifene for the Prevention and Treatment of Postmenopausal Osteoporosis. 23: 524-528. 2002: Bone.

http://edrv.endojournals.org/content/23/4/540.short

Cranney Ann, Tugwell Peter, Zytaruk Nicole, Robinson Vivian, Weaver Bruce, Shea Beverley, Wells George, Adachi Jonathan, Waldegger Lisa, Guyatt Gordon, the Osteoporosis Methodology Group and Group and the Osteoporosis Research Advisory. VI. Meta-Analysis of Calcitonin for the Treatment of Postmenopausal Osteoporosis. 23: 540-551. 2002: Bone.

http://edrv.endojournals.org/content/23/4/508.short

Cranney Ann, Wells George, Willan Andrew, Griffith Lauren, Zytaruk Nicole, Robinson Vivian, Black Dennis, Adachi Jonathan, Shea Beverley, Tugwell Peter, Guyatt Gordon, the Osteoporosis Methodology Group and Group and the Osteoporosis Research Advisory. II. Meta-Analysis of Alendronate for the Treatment of Postmenopausal Women. 23: 508-516. 2002: Bone.

http://edrv.endojournals.org/content/23/5/623.abstract

Kopchick J. J., Parkinson C., Stevens E. C. and Trainer P. J. Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly. 23: 623-646. 2002: Growth Hormone.

http://edrv.endojournals.org/content/23/1/16.abstract

Marcus Robert, Wong Mayme, Heath Hunter and Stock John L. Antiresorptive Treatment of Postmenopausal Osteoporosis: Comparison of Study Designs and Outcomes in Large Clinical Trials with Fracture as an Endpoint. 23: 16-37. 2002: Bone.

http://edrv.endojournals.org/content/23/4/495.short

Osteoporosis Methodology Group and Group the Osteoporosis Research Advisory. Meta-Analyses of Therapies for Postmenopausal Osteoporosis. 23: 495. 2002: Bone.

http://edrv.endojournals.org/content/23/4/560.short

Papadimitropoulos Emmanuel, Wells George, Shea Beverley, Gillespie William, Weaver Bruce, Zytaruk Nicole, Cranney Ann, Adachi Jonathan, Tugwell Peter, Josse Robert, Greenwood Carol, Guyatt Gordon, the Osteoporosis Methodology Group and Group and the Osteoporosis Research Advisory. VIII: Meta-Analysis of the Efficacy of Vitamin D Treatment in Preventing Osteoporosis in Postmenopausal Women. 23: 560-569. 2002: Bone.

http://edrv.endojournals.org/content/23/3/303.abstract

Peacock Munro, Turner Charles H., Econs Michael J. and Foroud Tatiana. Genetics of Osteoporosis. 23: 303-326. 2002: Bone.

http://edrv.endojournals.org/content/23/3/279.abstract

Riggs B. Lawrence, Khosla Sundeep and Melton L. Joseph. Sex Steroids and the Construction and Conservation of the Adult Skeleton. 23: 279-302. 2002: Bone.

http://edrv.endojournals.org/content/23/4/552.short

Shea Beverley, Wells George, Cranney Ann, Zytaruk Nicole, Robinson Vivian, Griffith Lauren, Ortiz Zulma, Peterson Joan, Adachi Jonathan, Tugwell Peter, Guyatt Gordon, the Osteoporosis Methodology Group and Group and the Osteoporosis Research Advisory. VII. Meta-Analysis of Calcium Supplementation for the Prevention of Postmenopausal Osteoporosis. 23: 552-559. 2002: Bone.

http://edrv.endojournals.org/content/23/4/496.abstract

The Osteoporosis Methodology Group and Group The Osteoporosis Research Advisory. Meta-Analyses of Therapies for Postmenopausal Osteoporosis. 23: 496-507. 2002: Bone.

http://edrv.endojournals.org/content/23/4/529.short

Wells George, Tugwell Peter, Shea Beverley, Guyatt Gordon, Peterson Joan, Zytaruk Nicole, Robinson Vivian, Henry David, O'Connell Diane, Cranney Ann, the osteoporosis methodology group and Group and the Osteoporosis Research Advisory. V. Meta-Analysis of the Efficacy of Hormone Replacement Therapy in Treating and Preventing Osteoporosis in Postmenopausal Women. 23: 529-539. 2002: Bone.

http://edrv.endojournals.org/content/24/4/539.abstract

Bravo Emmanuel L. and Tagle Rodrigo. Pheochromocytoma: State-of-the-Art and Future Prospects. 24: 539-553. 2003: Phaeochromocytoma.

http://edrv.endojournals.org/content/24/2/236.abstract

Cleare Anthony J. The Neuroendocrinology of Chronic Fatigue Syndrome. 24: 236-252. 2003: Chronic Fatihue Syndrome.

http://edrv.endojournals.org/content/24/1/102.abstract

Hegedas Laszlo, Bonnema Steen J. and Bennedbak Finn N. Management of Simple Nodular Goiter: Current Status and Future Perspectives. 24: 102-132. 2003: Thyroid.

http://edrv.endojournals.org/content/24/6/802.abstract

Prabhakar Bellur S., Bahn Rebecca S. and Smith Terry J. Current Perspective on the Pathogenesis of Gravesâ€™ Disease and Ophthalmopathy. 24: 802-835. 2003: Thyroid.

http://edrv.endojournals.org/content/25/1/102.abstract

Colao Annamaria, Ferone Diego, Marzullo Paolo and Lombardi Gaetano. Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management. 25: 102-152. 2004: Acromegaly.

http://edrv.endojournals.org/content/25/5/722.abstract

De Felice Mario and Di Lauro Roberto. Thyroid Development and Its Disorders: Genetics and Molecular Mechanisms. 25: 722-746. 2004: Thyroid.

http://edrv.endojournals.org/content/25/3/458.abstract

Kaltsas Gregory A., Besser G. Michael and Grossman Ashley B. The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors. 25: 458-511. 2004: Neuroendocrine.

http://edrv.endojournals.org/content/25/5/693.abstract

Leung Kin-Chuen, Johannsson Gudmundur, Leong Gary M. and Ho Ken K. Y. Estrogen Regulation of Growth Hormone Action. 25: 693-721. 2004: Growth Hormone.

http://edrv.endojournals.org/content/25/3/426.abstract

van der Lely Aart J., Tschop Matthias, Heiman Mark L. and Ghigo Ezio. Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin. 25: 426-457. 2004: Ghrelin.

http://edrv.endojournals.org/content/25/3/389.abstract

Vanderschueren Dirk, Vandenput Liesbeth, Boonen Steven, Lindberg Marie K., Bouillon Roger and Ohlsson Claes. Androgens and Bone. 25: 389-425. 2004: Bone.

http://edrv.endojournals.org/content/26/5/599.abstract

Caturegli Patrizio, Newschaffer Craig, Olivi Alessandro, Pomper Martin G., Burger Peter C. and Rose Noel R. Autoimmune Hypophysitis. 26: 599-614. 2005: Pituitary.

http://edrv.endojournals.org/content/26/5/688.abstract

Hodsman Anthony B., Bauer Douglas C., Dempster David W., Dian Larry, Hanley David A., Harris Steven T., Kendler David L., McClung Michael R., Miller Paul D., Olszynski Wojciech P., Orwoll Eric and Yuen Chui Kin. Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use. 26: 688-703. 2005: Bone.

http://edrv.endojournals.org/content/26/3/439.abstract

Kadowaki Takashi and Yamauchi Toshimasa. Adiponectin and Adiponectin Receptors. 26: 439-451. 2005: Adiponectin.

http://edrv.endojournals.org/content/26/5/704.abstract

Kahaly George J. and Dillmann Wolfgang H. Thyroid Hormone Action in the Heart. 26: 704-728. 2005: Thyroid.

http://edrv.endojournals.org/content/26/3/465.abstract

Koehler Konrad F., Helguero Luisa A., Haldosan Lars-Arne, Warner Margaret and Gustafsson Jan-Ã…ke. Reflections on the Discovery and Significance of Estrogen Receptor Î². 26: 465-478. 2005: Estrogen.

http://edrv.endojournals.org/content/26/1/78.abstract

Murray Timothy M., Rao Leticia G., Divieti Paola and Bringhurst F. Richard. Parathyroid Hormone Secretion and Action: Evidence for Discrete Receptors for the Carboxyl-Terminal Region and Related Biological Actions of Carboxyl- Terminal Ligands. 26: 78-113. 2005: Parathyroid.

http://edrv.endojournals.org/content/26/3/322.short

Simpson E. R., Misso M., Hewitt K. N., Hill R. A., Boon W. C., Jones M. E., Kovacic A., Zhou J. and Clyne C. D. Estrogen the Good, the Bad, and the Unexpected. 26: 322-330. 2005: Estrogen.

http://edrv.endojournals.org/content/26/3/346.abstract

Smith Roy G. Development of Growth Hormone Secretagogues. 26: 346-360. 2005: Growth Hormone.

http://edrv.endojournals.org/content/26/1/114.abstract

Veldhuis Johannes D., Roemmich James N., Richmond Erick J., Rogol Alan D., Lovejoy Jennifer C., Sheffield-Moore Melinda, Mauras Nelly and Bowers Cyril Y. Endocrine Control of Body Composition in Infancy, Childhood, and Puberty. 26: 114-146. 2005: Endocrine.

http://edrv.endojournals.org/content/27/7/736.abstract

Cone Roger D. Studies on the Physiological Functions of the Melanocortin System. 27: 736-749. 2006: Melanocortin.

http://edrv.endojournals.org/content/27/7/710.abstract

Farooqi I. Sadaf and Oâ€™Rahilly Stephen. Genetics of Obesity in Humans. 27: 710-718. 2006: Obesity.

http://edrv.endojournals.org/content/27/5/485.abstract

Gillam Mary P., Molitch Mark E., Lombardi Gaetano and Colao Annamaria. Advances in the Treatment of Prolactinomas. 27: 485-534. 2006: Prolactin.

http://edrv.endojournals.org/content/27/3/260.abstract

Hillhouse Edward W. and Grammatopoulos Dimitris K. The Molecular Mechanisms Underlying the Regulation of the Biological Activity of Corticotropin-Releasing Hormone Receptors: Implications for Physiology and Pathophysiology. 27: 260-286. 2006: Cortisol.

http://edrv.endojournals.org/content/27/1/17.abstract

Jabbour Henry N., Kelly Rodney W., Fraser Hamish M. and Critchley Hilary O. D. Endocrine Regulation of Menstruation. 27: 17-46. 2006: Estrogen Axis.

http://edrv.endojournals.org/content/27/4/371.abstract

Karavitaki Niki, Cudlip Simon, Adams Christopher B. T. and Wass John A. H. Craniopharyngiomas. 27: 371-397. 2006: Pituitary.

http://edrv.endojournals.org/content/27/7/719.abstract

Murphy Kevin G., Dhillo Waljit S. and Bloom Stephen R. Gut Peptides in the Regulation of Food Intake and Energy Homeostasis. 27: 719-727. 2006: Gut Hormones.

http://edrv.endojournals.org/content/27/1/73.abstract

Pagotto Uberto, Marsicano Giovanni, Cota Daniela, Lutz Beat and Pasquali Renato. The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance. 27: 73-100. 2006: Endocannabinoid.

http://edrv.endojournals.org/content/27/3/287.abstract

Woodhouse Linda J., Mukherjee Annice, Shalet Stephen M. and Ezzat Shereen. The Influence of Growth Hormone Status on Physical Impairments, Functional Limitations, and Health-Related Quality of Life in Adults. 27: 287-317. 2006: Growth Hormone.

http://edrv.endojournals.org/content/28/6/625.abstract

Fineberg S. Edwin, Kawabata Thomas T., Finco-Kent Deborah, Fountaine Robert J., Finch Gregory L. and Krasner Alan S. Immunological Responses to Exogenous Insulin. 28: 625-652. 2007: Insulin.

http://edrv.endojournals.org/content/28/6/603.abstract

Gibney James, Healy Marie-Louise and Sonksen Peter H. The Growth Hormone/Insulin-Like Growth Factor-I Axis in Exercise and Sport. 28: 603-624. 2007: Growth Hormone.

http://edrv.endojournals.org/content/28/6/664.abstract

Kamiji M. M. and Inui A. Neuropeptide Y Receptor Selective Ligands in the Treatment of Obesity. 28: 664-684. 2007: Obesity.

http://edrv.endojournals.org/content/28/5/463.abstract

Muniyappa Ranganath, Montagnani Monica, Koh Kwang Kon and Quon Michael J. Cardiovascular Actions of Insulin. 28: 463-491. 2007: Insulin.

http://edrv.endojournals.org/content/28/2/219.abstract

Saenger Paul, Czernichow Paul, Hughes Ieuan and Reiter Edward O. Small for Gestational Age: Short Stature and Beyond. 28: 219-251. 2007: Growth Hormone.

http://edrv.endojournals.org/content/28/1/20.abstract

Samani Amir Abbas, Yakar Shoshana, LeRoith Derek and Brodt Pnina. The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights. 28: 20-47. 2007: Growth Hormone.

http://edrv.endojournals.org/content/28/5/521.abstract

Straub Rainer H. The Complex Role of Estrogens in Inflammation. 28: 521-574. 2007: Estrogens.

http://edrv.endojournals.org/content/29/3/292.abstract

Balasubramanyam Ashok, Nalini Ramaswami, Hampe Christiane S. and Maldonado Mario. Syndromes of Ketosis-Prone Diabetes Mellitus. 29: 292-302. 2008: Diabetes.

http://edrv.endojournals.org/content/29/1/76.abstract

Biondi Bernadette and Cooper David S. The Clinical Significance of Subclinical Thyroid Dysfunction. 29: 76-131. 2008: Thyroid.

http://edrv.endojournals.org/content/29/7/777.abstract

Cornier Marc-Andre, Dabelea Dana, Hernandez Teri L., Lindstrom Rachel C., Steig Amy J., Stob Nicole R., Van Pelt Rachael E., Wang Hong and Eckel Robert H. The Metabolic Syndrome. 29: 777-822. 2008: Metabolic Syndrome.

http://edrv.endojournals.org/content/29/5/535.abstract

Giustina Andrea, Mazziotti Gherardo and Canalis Ernesto. Growth Hormone, Insulin-Like Growth Factors, and the Skeleton. 29: 535-559. 2008: Growth Hormone.

http://edrv.endojournals.org/content/29/4/441.abstract

Khosla Sundeep, Amin Shreyasee and Orwoll Eric. Osteoporosis in Men. 29: 441-464. 2008: Bone.

http://edrv.endojournals.org/content/29/7/939.abstract

Stefan Norbert, Kantartzis Konstantinos and HÃ¤ring Hans-Ulrich. Causes and Metabolic Consequences of Fatty Liver. 29: 939-960. 2008: Fatty Liver.

http://edrv.endojournals.org/content/29/3/254.abstract

Vaxillaire Martine and Froguel Philippe. Monogenic Diabetes in the Young, Pharmacogenetics and Relevance to Multifactorial Forms of Type 2 Diabetes. 29: 254-264. 2008: Diabetes.

http://edrv.endojournals.org/content/30/2/152.abstract

Moller Niels and Jorgensen Jens Otto Lunde. Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects. 30: 152-177. 2009: Growth Hormone.

http://edrv.endojournals.org/content/30/1/1.abstract

Palomba Stefano, Falbo Angela, Zullo Fulvio and Orio Francesco. Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review. 30: 1-50. 2009: PCOS.

http://edrv.endojournals.org/content/30/2/178.abstract

Saidak Zuzana, Mentaverri Romuald and Brown Edward M. The Role of the Calcium-Sensing Receptor in the Development and Progression of Cancer. 30: 178-195. 2009: Calcium.

http://edrv.endojournals.org/content/30/4/343.abstract

Santen R. J., Brodie H., Simpson E. R., Siiteri P. K. and Brodie A. History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target. 30: 343-375. 2009: Aromatase.

http://edrv.endojournals.org/content/30/4/376.abstract

Zimmermann Michael B. Iodine Deficiency. 30: 376-408. 2009: Thyroid.

http://edrv.endojournals.org/content/32/5/670.abstract

Boelen Anita, Kwakkel Joan and Fliers Eric. Beyond Low Plasma T3: Local Thyroid Hormone Metabolism during Inflammation and Infection. 32: 670-693. 2011: Thyroid.

http://edrv.endojournals.org/content/32/5/623.abstract

Brezar Vedran, Carel Jean-Claude, Boitard Christian and Mallone Roberto. Beyond the Hormone: Insulin as an Autoimmune Target in Type 1 Diabetes. 32: 623-669. 2011: Insulin.

http://edrv.endojournals.org/content/31/2/139.abstract

Cheng Sheue-Yann, Leonard Jack L. and Davis Paul J. Molecular Aspects of Thyroid Hormone Actions. 31: 139-170. 2011: Thyroid.

http://edrv.endojournals.org/content/32/2/247.abstract

Colao Annamaria, Auriemma Renata S., Lombardi Gaetano and Pivonello Rosario. Resistance to Somatostatin Analogs in Acromegaly. 32: 247-271. 2011: Acromegaly.

http://edrv.endojournals.org/content/31/1/1.abstract

Froy Oren. Metabolism and Circadian Rhythms”Implications for Obesity". 31: 1-24. 2011: Obesity.

http://edrv.endojournals.org/content/31/2/183.abstract

Grant Struan F. A., Hakonarson Hakon and Schwartz Stanley. Can the Genetics of Type 1 and Type 2 Diabetes Shed Light on the Genetics of Latent Autoimmune Diabetes in Adults? 31: 183-193. 2011: Diabetes.

http://edrv.endojournals.org/content/32/1/81.abstract

Miller Walter L. and Auchus Richard J. The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders. 32: 81-151. 2011: Cortisol.

http://edrv.endojournals.org/content/31/6/783.abstract

Petraglia Felice, Imperatore Alberto and Challis John R. G. Neuroendocrine Mechanisms in Pregnancy and Parturition. 31: 783-816. 2011: Neuroendocrine.

http://edrv.endojournals.org/content/31/5/629.abstract

Ralston Stuart H. and Uitterlinden AndraG. Genetics of Osteoporosis. 31: 629-662. 2011: Bone.

http://edrv.endojournals.org/content/32/4/498.abstract

Semple Robert K., Savage David B., Cochran Elaine K., Gorden Phillip and O'Rahilly Stephen. Genetic Syndromes of Severe Insulin Resistance. 32: 498-514. 2011: Insulin.

http://edrv.endojournals.org/content/31/3/301.abstract

Sherlock Mark, Ayuk John, Tomlinson Jeremy W., Toogood Andrew A., Aragon-Alonso Aurora, Sheppard Michael C., Bates Andrew S. and Stewart Paul M. Mortality in Patients with Pituitary Disease. 31: 301-342. 2011: Pituitary.

http://edrv.endojournals.org/content/31/2/171.abstract

Siegelaar Sarah E., Holleman Frits, Hoekstra Joost B. L. and DeVries J. Hans. Glucose Variability; Does It Matter? 31: 171-182. 2011: Diabetes.

http://edrv.endojournals.org/content/31/1/98.abstract

Vuong Cassidy, Van Uum Stan H. M., O'Dell Laura E., Lutfy Kabirullah and Friedman Theodore C. The Effects of Opioids and Opioid Analogs on Animal and Human Endocrine Systems. 31: 98-132. 2011: Opiods.

http://edrv.endojournals.org/content/33/6/920.abstract

Bonnema Steen Joop and Hegedüs Laszlo. Radioiodine Therapy in Benign Thyroid Diseases: Effects, Side Effects, and Factors Affecting Therapeutic Outcome. 33: 920-980. 2012: Thyroid.

http://edrv.endojournals.org/content/33/3/314.abstract

Giannoulis Manthos G., Martin Finbarr C., Nair K. Sreekumaran, Umpleby A. Margot and Sonksen Peter. Hormone Replacement Therapy and Physical Function in Healthy Older Men. Time to Talk Hormones? 33: 314-377. 2012: Review.

http://edrv.endojournals.org/content/33/3/456.abstract

Rosen Clifford J., Adams John S., Bikle Daniel D., Black Dennis M., Demay Marie B., Manson JoAnn E., Murad M. Hassan and Kovacs Christopher S. The Nonskeletal Effects of Vitamin D: An Endocrine Society Scientific Statement. 33: 456-492. 2012: Vitamin D.

http://edrv.endojournals.org/content/33/2/187.abstract

Ussher John R. and Drucker Daniel J. Cardiovascular Biology of the Incretin System. 33: 187-215. 2012: Incretin.

http://edrv.endojournals.org/content/34/3/439.abstract

Haugen Bryan R. and Sherman Steven I. Evolving Approaches to Patients with Advanced Differentiated Thyroid Cancer. 34: 439-455. 2013: Thyroid.

http://edrv.endojournals.org/content/34/2/171.abstract

Stanczyk Frank Z., Hapgood Janet P., Winer Sharon and Mishell Daniel R. Progestogens Used in Postmenopausal Hormone Therapy: Differences in Their Pharmacological Properties, Intracellular Actions, and Clinical Effects. 34: 171-208. 2013: HRT.

http://press.endocrine.org/doi/abs/10.1210/er.2013-1067

Alatzoglou Kyriaki S., Webb Emma Alice, Le Tissier Paul and Dattani Mehul T. Isolated Growth Hormone Deficiency (GHD) in Childhood and Adolescence: Recent Advances. 35: 376-432. 2014: Growth Hormone.

http://press.endocrine.org/doi/abs/10.1210/er.2013-1083

Biondi Bernadette and Wartofsky Leonard. Treatment With Thyroid Hormone. 35: 433-512. 2014: Thyroid.

http://www.eje-online.org/content/146/6/767.abstract

Ahmad AM, Ahmad M and Young ET. Objective estimates of the probability of developing hypothyroidism following radioactive iodine treatment of thyrotoxicosis. 146: 767-775. 2002: Thyroid.

http://www.eje-online.org/content/146/4/457.abstract

Bartalena L, Marcocci C and Pinchera A. Graves' ophthalmopathy: a preventable disease? 146: 457-461. 2002: Thyroid.

http://www.eje-online.org/content/147/4/467.abstract

Bayram F, Muderris, Guven M and Kelestimur F. Comparison of high-dose finasteride (5 mg/day) versus low-dose finasteride (2.5 mg/day) in the treatment of hirsutism. 147: 467-471. 2002: Hirsutism.

http://www.eje-online.org/content/147/1/1.abstract

Bonnema SJ, Bartalena L, Toft AD and Hegedus L. Controversies in radioiodine therapy: relation to ophthalmopathy, the possible radioprotective effect of antithyroid drugs, and use in large goitres. 147: 1-11. 2002: Thyroid.

http://www.eje-online.org/content/146/3/303.abstract

Colao A, Marzullo P and Lombardi G. Effect of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly. 146: 303-309. 2002: Acromegaly.

http://www.eje-online.org/content/147/1/65.abstract

Dall R, Kanaley J, Hansen TK, Moller N, Christiansen JS, Hosoda H, Kangawa K and Jorgensen JO. Plasma ghrelin levels during exercise in healthy subjects and in growth hormone-deficient patients. 147: 65-70. 2002: Ghrelin.

http://www.eje-online.org/content/146/1/67.abstract

Feldt-Rasmussen U, Abs R, Bengtsson BA, Bennmarker H, Bramnert M, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P and Wuster C. Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease. 146: 67-74. 2002: Growth Hormone.

http://www.eje-online.org/content/146/6/807.abstract

Hatrick AG, Boghalo P, Bingham JB, Ayres AB, Sonksen PH and Russell-Jones DL. Does GH replacement therapy in adult GH-deficient patients result in recurrence or increase in size of pituitary tumours? 146: 807-811. 2002: Growth Hormone.

http://www.eje-online.org/content/147/4/461.abstract

Lasco A, Cannavo S, Gaudio A, Morabito N, Basile G, Nicita-Mauro V and Frisina N. Effects of long-lasting raloxifene treatment on serum prolactin and gonadotropin levels in postmenopausal women. 147: 461-465. 2002: Prolactin.

http://www.eje-online.org/content/146/5/643.abstract

Lumachi F, Ermani M, Luisetto G, Nardi A, Basso SM, Camozzi V and Favia G. Relationship between serum parathyroid hormone, serum calcium and arterial blood pressure in patients with primary hyperparathyroidism: results of a multivariate analysis. 146: 643-647. 2002: Parathyroid.

http://www.eje-online.org/content/146/3/310.abstract

Maccario M, Veldhuis JD, Broglio F, Vito LD, Arvat E, Deghenghi R and Ghigo E. Impact of two or three daily subcutaneous injections of hexarelin, a synthetic growth hormone (GH) secretagogue, on 24-h GH, prolactin, adrenocorticotropin and cortisol secretion in humans. 146: 310-318. 2002: Growth Hormone.

http://www.eje-online.org/content/146/2/203.abstract

Muller AF, Lamberts SW, Janssen JA, Hofland LJ, Koetsveld PV, Bidlingmaier M, Strasburger CJ, Ghigo E and Van der Lely AJ. Ghrelin drives GH secretion during fasting in man. 146: 203-207. 2002: Ghrelin.

http://www.eje-online.org/content/146/5/635.abstract

Rejnmark L, Lauridsen AL, Vestergaard P, Heickendorff L, Andreasen F and Mosekilde L. Diurnal rhythm of plasma 1,25-dihydroxyvitamin D and vitamin D-binding protein in postmenopausal women: relationship to plasma parathyroid hormone and calcium and phosphate metabolism. 146: 635-642. 2002: Bone.

http://www.eje-online.org/content/146/3/275.abstract

Roti E and Uberti E. Post-partum thyroiditis--a clinical update. 146: 275-279. 2002: Thyroid.

http://www.eje-online.org/content/146/2/187.abstract

Sneppen SB, Hoeck HC, Kollerup G, Sorensen OH, Laurberg P and Feldt-Rasmussen U. Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults--an 18-month randomised, placebo-controlled, double blinded trial. 146: 187-195. 2002: Growth Hormone.

http://www.eje-online.org/content/147/3/339.abstract

Sugimoto T, Kaji H, Nakaoka D, Yamauchi M, Yano S, Sugishita T, Baylink DJ, Mohan S and Chihara K. Effect of low-dose of recombinant human growth hormone on bone metabolism in elderly women with osteoporosis. 147: 339-348. 2002: Growth Hormone.

http://www.eje-online.org/content/146/6/751.abstract

Terwee C, Wakelkamp I, Tan S, Dekker F, Prummel MF and Wiersinga W. Long-term effects of Graves' ophthalmopathy on health-related quality of life. 146: 751-757. 2002: Thyroid.

http://www.eje-online.org/content/147/1/85.abstract

van der Harst E, de Herder WW, de Krijger RR, Bruining HA, Bonjer HJ, Lamberts SW, van den Meiracker AH, Stijnen TH and Boomsma F. The value of plasma markers for the clinical behaviour of phaeochromocytomas. 147: 85-94. 2002: Phaeochromocytoma.

http://www.eje-online.org/content/146/3/283.abstract

Vidal-Trecan GM, Stahl JE and Durand-Zaleski I. Managing toxic thyroid adenoma: a cost-effectiveness analysis. 146: 283-294. 2002: Thyroid.

http://www.eje-online.org/content/146/3/333.abstract

Vihtamaki T, Simoni M, Tuimala R, Nieschlag E and Vihko KK. Self-adjusted postmenopausal hormone replacement therapy: effects on the biological and immunological profile of FSH and correlation to climacteric symptoms. 146: 333-338. 2002: HRT.

http://www.eje-online.org/content/148/Suppl_2/S3.abstract

Abs R. Update on the diagnosis of GH deficiency in adults. 148: S3-S8. 2003: Growth Hormone.

http://www.eje-online.org/content/148/5/571.abstract

Andreen L, Bixo M, Nyberg S, Sundstrom-Poromaa I and Backstrom T. Progesterone effects during sequential hormone replacement therapy. 148: 571-577. 2003: HRT.

http://www.eje-online.org/content/148/4/443.abstract

Attanasio R, Barausse M and Cozzi R. Raloxifene lowers IGF-I levels in acromegalic women. 148: 443-448. 2003: Acromegaly.

http://www.eje-online.org/content/149/4/273.abstract

Barzon L, Sonino N, Fallo F, Palu G and Boscaro M. Prevalence and natural history of adrenal incidentalomas. 149: 273-285. 2003: Adrenal.

http://www.eje-online.org/content/149/6/493.abstract

Boi F, Lai ML, Deias C, Piga M, Serra A, Uccheddu A, Faa G and Mariotti S. The usefulness of 99mTc-SestaMIBI scan in the diagnostic evaluation of thyroid nodules with oncocytic cytology. 149: 493-498. 2003: Thyroid.

http://www.eje-online.org/content/149/6/485.abstract

Bonnema SJ, Bennedbaek FN, Gram J, Veje A, Marving J and Hegedus L. Resumption of methimazole after 131I therapy of hyperthyroid diseases: effect on thyroid function and volume evaluated by a randomized clinical trial. 149: 485-492. 2003: Thyroid.

http://www.eje-online.org/content/148/Suppl_2/S15.abstract

Brabant G. Insulin-like growth factor-I: marker for diagnosis of acromegaly and monitoring the efficacy of treatment. 148: S15-S20. 2003: Acromegaly.

http://www.eje-online.org/content/149/3/195.abstract

Cannavo S, Almoto B, Dall'Asta C, Corsello S, Lovicu RM, De Menis E, Trimarchi F and Ambrosi B. Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas. 149: 195-200. 2003: Pituitary.

http://www.eje-online.org/content/148/1/31.abstract

Colao A, Cannavo S, Marzullo P, Pivonello R, Squadrito S, Vallone G, Almoto B, Bichisao E, Trimarchi F and Lombardi G. Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly. 148: 31-38. 2003: Acromegaly.

http://www.eje-online.org/content/148/3/325.abstract

Colao A, Sarno AD, Cappabianca P, Briganti F, Pivonello R, Somma CD, Faggiano A, Biondi B and Lombardi G. Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. 148: 325-331. 2003: Prolactin.

http://www.eje-online.org/content/149/4/247.abstract

de Vijlder JJ. Primary congenital hypothyroidism: defects in iodine pathways. 149: 247-256. 2003: Thyroid.

http://www.eje-online.org/content/148/4/413.abstract

Hedback G and Oden A. Recurrence of hyperparathyroidism; a long-term follow-up after surgery for primary hyperparathyroidism. 148: 413-421. 2003: Parathyroid.

http://www.eje-online.org/content/148/Suppl_2/S21.abstract

Kopchick JJ. Discovery and mechanism of action of pegvisomant. 148: S21-S25. 2003: Acromegaly.

http://www.eje-online.org/content/149/3/169.abstract

Lamberts SW, Romijn JA and Wiersinga WM. The future endocrine patient. Reflections on the future of clinical endocrinology. 149: 169-175. 2003: Endocrine.

http://www.eje-online.org/content/148/2/185.abstract

Lanzi R, Losa M, Villa I, Gatti E, Sirtori M, Dal Fiume C and Rubinacci A. GH replacement therapy increases plasma osteoprotegerin levels in GH-deficient adults. 148: 185-191. 2003: Growth Hormone.

http://www.eje-online.org/content/148/Suppl_2/S9.abstract

Monson JP. Long-term experience with GH replacement therapy: efficacy and safety. 148: S9-14. 2003: Growth Hormone.

http://www.eje-online.org/content/148/5/491.abstract

Prummel MF, Bakker A, Wiersinga WM, Baldeschi L, Mourits MP, Kendall-Taylor P, Perros P, Neoh C, Dickinson AJ, Lazarus JH, Lane CM, Heufelder AE, Kahaly GJ, Pitz S, Orgiazzi J, Hullo A, Pinchera A, Marcocci C, Sartini MS, Rocchi R, Nardi M, Krassas GE and Halkias A. Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience. 148: 491-495. 2003: Thyroid.

http://www.eje-online.org/content/148/5/515.abstract

Radetti G, Buzi F, Paganini C, Pilotta A and Felappi B. Treatment of GH-deficient children with two different GH doses: effect on final height and cost-benefit implications. 148: 515-518. 2003: Growth Hormone.

http://www.eje-online.org/content/149/2/91.abstract

Romijn JA, Smit JW and Lamberts SW. Intrinsic imperfections of endocrine replacement therapy. 149: 91-97. 2003: Endocrine.

http://www.eje-online.org/content/149/4/323.abstract

Sarnblad S, Kroon M and Aman J. Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity. 149: 323-329. 2003: Diabetes.

http://www.eje-online.org/content/148/Suppl_2/S27.abstract

Stewart PM. Pegvisomant: an advance in clinical efficacy in acromegaly. 148: S27-S32. 2003: Acromegaly.

http://www.eje-online.org/content/148/5/527.abstract

Valleala H, Mandelin J, Laasonen L, Koivula MK, Risteli J and Konttinen YT. Effect of cyclical intermittent etidronate therapy on circulating osteoprotegerin levels in patients with rheumatoid arthritis. 148: 527-530. 2003: Osteoprotegrin.

http://www.eje-online.org/content/148/6/589.abstract

van Tol KM, Jager PL, de Vries EG, Piers DA, Boezen HM, Sluiter WJ, Dullaart RP and Links TP. Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin. 148: 589-596. 2003: Thyroid.

http://www.eje-online.org/content/149/4/301.abstract

Yamashita H, Gao P, Cantor T, Futata T, Murakami T, Uchino S, Watanabe S, Kawamoto H, Fukagawa M and Noguchi S. Large carboxy-terminal parathyroid hormone (PTH) fragment with a relatively longer half-life than 1-84 PTH is secreted directly from the parathyroid gland in humans. 149: 301-306. 2003: Parathyroid.

http://www.eje-online.org/content/149/4/257.abstract

Zimmermann-Belsing T, Brabant G, Holst JJ and Feldt-Rasmussen U. Circulating leptin and thyroid dysfunction. 149: 257-271. 2003: Leptin.

http://www.eje-online.org/content/151/3/317.abstract

Alexopoulou O, Abrams P, Verhelst J, Poppe K, Velkeniers B, Abs R and Maiter D. Efficacy and tolerability of lanreotide Autogel therapy in acromegalic patients previously treated with octreotide LAR. 151: 317-324. 2004: Acromegaly.

http://www.eje-online.org/content/150/1/1.abstract

Alexopoulou O, Beguin C, De Nayer P and Maiter D. Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients. 150: 1-8. 2004: Thyroid.

http://www.eje-online.org/content/150/1/27.abstract

Arosio M, Ronchi CL, Gebbia C, Pizzinelli S, Conte D, Cappiello V, Epaminonda P, Cesana BM, Beck-Peccoz P and Peracchi M. Ghrelin administration affects circulating pituitary and gastro-entero-pancreatic hormones in acromegaly. 150: 27-32. 2004: Ghrelin.

http://www.eje-online.org/content/150/4/473.abstract

Ashwell SG, Bevan JS, Edwards OM, Harris MM, Holmes C, Middleton MA and James RA. The efficacy and safety of lanreotide Autogel in patients with acromegaly previously treated with octreotide LAR. 150: 473-480. 2004: Acromegaly.

http://www.eje-online.org/content/150/4/439.abstract

Bonnema SJ, Nielsen VE and Hegedus L. Long-term effects of radioiodine on thyroid function, size and patient satisfaction in non-toxic diffuse goitre. 150: 439-445. 2004: Thyroid.

http://www.eje-online.org/content/151/3/297.abstract

Boonen S, Vanderschueren D, Pelemans W and Bouillon R. Primary hyperparathyroidism: diagnosis and management in the older individual. 151: 297-304. 2004: Thyroid.

http://www.eje-online.org/content/150/6/763.abstract

Bourdelot A, Coste J, Hazebroucq V, Gaillard S, Cazabat L, Bertagna X and Bertherat J. Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly. 150: 763-771. 2004: Acromegaly.

http://www.eje-online.org/content/151/3/343.abstract

Chihara K, Koledova E, Shimatsu A, Kato Y, Kohno H, Tanaka T, Teramoto A, Bates PC and Attanasio AF. Adult GH deficiency in Japanese patients: effects of GH treatment in a randomised, placebo-controlled trial. 151: 343-350. 2004: Growth Hormone.

http://www.eje-online.org/content/150/4/481.abstract

Dimaraki EV, Symons KV and Barkan AL. Raloxifene decreases serum IGF-I in male patients with active acromegaly. 150: 481-487. 2004: Acromegaly.

European Journal of Endocrinology

Elberling TV, Rasmussen AK, Feldt-Rasmussen U, Hording M, Perrild H and Waldemar G. Impaired health-related quality of life in Graves' disease. A prospective study. 151: 549-555. 2004: Thyroid.

http://www.eje-online.org/content/151/5/549.abstract

http://www.eje-online.org/content/150/3/339.abstract

Fallo F, Scarda A, Sonino N, Paoletta A, Boscaro M, Pagano C, Federspil G and Vettor R. Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome. 150: 339-344. 2004: Cushings.

http://www.eje-online.org/content/150/4/465.abstract

Gullu S, Keles H, Delibasi T, Tonyukuk V, Kamel N and Erdogan G. Remission criteria for the follow-up of patients with acromegaly. 150: 465-471. 2004: Acromegaly.

http://www.eje-online.org/content/150/1/19.abstract

Hedback G and Oden A. Persistent disease after surgery for primary hyperparathyroidism: the long-term outcome. 150: 19-25. 2004: Parathyroid.

http://www.eje-online.org/content/150/3/351.abstract

Kelestimur F, Everest H, Unluhizarci K, Bayram F and Sahin Y. A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism. 150: 351-354. 2004: Hirsutism.

http://www.eje-online.org/content/150/4/407.abstract

Krassas GE. Treatment of juvenile Graves' disease and its ophthalmic complication: the 'European way'. 150: 407-414. 2004: Thyroid.

http://www.eje-online.org/content/150/2/105.abstract

Schlumberger M, Berg G, Cohen O, Duntas L, Jamar F, Jarzab B, Limbert E, Lind P, Pacini F, Reiners C, Sanchez Franco F, Toft A and Wiersinga WM. Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective. 150: 105-112. 2004: Thyroid.

http://www.eje-online.org/content/150/3/329.abstract

Seiler L, Rump LC, Schulte-Monting J, Slawik M, Borm K, Pavenstadt H, Beuschlein F and Reincke M. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication. 150: 329-337. 2004: Adrenal.

http://www.eje-online.org/content/150/1/65.abstract

Svartberg J, von Muhlen D, Schirmer H, Barrett-Connor E, Sundfjord J and Jorde R. Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromso Study. 150: 65-71. 2004: Testosterone.

http://www.eje-online.org/content/151/4/447.abstract

Takeno R, Okimura Y, Iguchi G, Kishimoto M, Kudo T, Takahashi K, Takahashi Y, Kaji H, Ohno M, Ikuta H, Kuroda Y, Obara T, Hosoda H, Kangawa K and Chihara K. Intravenous administration of ghrelin stimulates growth hormone secretion in vagotomized patients as well as normal subjects. 151: 447-450. 2004: Ghrelin.

http://www.eje-online.org/content/150/5/649.abstract

Taylor H, Hyer S, Vini L, Pratt B, Cook G and Harmer C. Diagnostic 131I whole body scanning after thyroidectomy and ablation for differentiated thyroid cancer. 150: 649-653. 2004: Thyroid.

http://www.eje-online.org/content/150/4/517.abstract

Unger N, Lopez Schmidt I, Pitt C, Walz MK, Philipp T, Mann K and Petersenn S. Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass. 150: 517-523. 2004: Adrenal.

http://www.eje-online.org/content/150/4/489.abstract

van Thiel SW, Romijn JA, Biermasz NR, Ballieux BE, Frolich M, Smit JW, Corssmit EP, Roelfsema F and Pereira AM. Octreotide long-acting repeatable and lanreotide Autogel are equally effective in controlling growth hormone secretion in acromegalic patients. 150: 489-495. 2004: Acromegaly.

http://www.eje-online.org/content/153/4/489.abstract

Abraham Prakash, Avenell Alison, Park Christine M, Watson Wendy A and Bevan John S. A systematic review of drug therapy for Graves hyperthyroidism. 153: 489-498. 2005: Thyroid.

http://www.eje-online.org/content/152/5/695.abstract

Azizi F, Ataie L, Hedayati M, Mehrabi Y and Sheikholeslami F. Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine. 152: 695-701. 2005: Thyroid.

http://www.eje-online.org/content/152/1/53.abstract

Biermasz Nienke R, Hamdy Neveen A T, Pereira Alberto M, Romijn Johannes A and Roelfsema Ferdinand. Long-term maintenance of the anabolic effects of GH on the skeleton in successfully treated patients with acromegaly. 152: 53-60. 2005: Growth Hormone.

http://www.eje-online.org/content/152/1/1.abstract

Biondi Bernadette, Palmieri Emiliano Antonio, Klain Michele, Schlumberger Martin, Filetti Sebastiano and Lombardi Gaetano. Subclinical hyperthyroidism: clinical features and treatment options. 152: 1-9. 2005: Thyroid.

http://www.eje-online.org/content/152/1/67.abstract

Boguszewski Cesar L, Meister Ludimyla H F, Zaninelli Daniele C T and Radominski Rosana B. One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults. 152: 67-75. 2005: Growth Hormone.

http://www.eje-online.org/content/153/3/379.abstract

Bollerslev Jens, HallÃ©n Jostein, Fougner Kristian J, JÃ¸rgensen Anders PalmstrÃ¸m, Kristo Cybele, Fagertun Hans, Gudmundsen Ola, Burman Pia and Schreiner Thomas. Low-dose GH improves exercise capacity in adults with GH deficiency: effects of a 22-month placebo-controlled, crossover trial. 153: 379-387. 2005: Growth Hormone.

http://www.eje-online.org/content/153/1/57.abstract

Chihara Kazuo, Koledova Ekaterina, Shimatsu Akira, Kato Yuzuru, Kohno Hitoshi, Tanaka Toshiaki, Teramoto Akira, Bates Peter C and Attanasio Andrea F. An individualized GH dose regimen for long-term GH treatment in Japanese patients with adult GH deficiency. 153: 57-65. 2005: Growth Hormone.

http://www.eje-online.org/content/152/2/165.abstract

Clayton P E, Cuneo R C, Juul A, Monson J P, Shalet S M and Tauber M. Consensus statement on the management of the GH-treated adolescent in the transition to adult care. 152: 165-170. 2005: Growth Hormone.

http://www.eje-online.org/content/152/1/47.abstract

Drake W M, Loureiro R A, Parkinson C, Monson J P, Besser G M and Trainer P J. Disease activity in acromegaly may be assessed 6 weeks after discontinuation of pegvisomant. 152: 47-51. 2005: Acromegaly.

http://www.eje-online.org/content/152/3/355.abstract

Gullu Sevim, Sav Hasan and Kamel Nuri. Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism. 152: 355-361. 2005: Thyroid.

http://www.eje-online.org/content/153/1/15.abstract

Jensen Berit E, Bonnema Steen J and Hegedes Laszlo. Glucocorticoids do not influence the effect of radioiodine therapy in Graves disease. 153: 15-21. 2005: Thyroid.

http://www.eje-online.org/content/152/4/557.abstract

Kendall-Taylor Pat, Jonsson Peter J, Abs Roger, Erfurth Eva Marie, Koltowska-Haggstrom Maria, Price David Anthony and Verhelst Johan. The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. 152: 557-567. 2005: Pituitary.

http://www.eje-online.org/content/153/5/651.abstract

Pacini Furio, Schlumberger Martin, Harmer Clive, Berg Gertrud G, Cohen Ohad, Duntas Leonidas, Jamar FranÃ§ois, Jarzab Barbara, Limbert Eduard, Lind Peter, Reiners Cristoph, Franco Franco Sanchez, Smit Johannes and Wiersinga Wilmar. Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report. 153: 651-659. 2005: Thyroid.

http://www.eje-online.org/content/152/2/269.abstract

Rautio K, Tapanainen J S, Ruokonen A and Morin-Papunen L C. Effects of metformin and ethinyl estradiol cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome. 152: 269-275. 2005: Obesity.

http://www.eje-online.org/content/152/6/835.abstract

Rosilio Myriam, Carel Jean-Claude, Ecosse Emmanuel, Chaussainon Jean-Louis and Group on behalf of the 0908 Lilly Study. Adult height of prepubertal short children born small for gestational age treated with GH. 152: 835-843. 2005: Growth Hormone.

http://www.eje-online.org/content/152/4/569.abstract

Selvarajah Dinesh, Webster Jonathan, Ross Richard and Newell-Price John. Effectiveness of adding dopamine agonist therapy to long-acting somatostatin analogues in the management of acromegaly. 152: 569-574. 2005: Acromegaly.

http://www.eje-online.org/content/152/1/33.abstract

Verburg Frederik A, de Keizer Bart, Lips Cornelis J M, Zelissen Pierre M J and de Klerk John M H. Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients. 152: 33-37. 2005: Thyroid.

http://www.eje-online.org/content/154/1/1.abstract

Arlt Wiebke. Androgen therapy in women. 154: 1-11. 2006: Androgen.

http://www.eje-online.org/content/154/2/187.abstract

Barlier Anne and Jaquet Philippe. Quinagolide: a valuable treatment option for hyperprolactinaemia. 154: 187-195. 2006: Prolactin.

http://www.eje-online.org/content/154/1/119.abstract

Carel Jean-Claude, Blumberg Joalle, Seymour Christine, Adamsbaum Catherine, Lahlou Najiba and Group for the Triptorelin 3-month CPP Study. Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty. 154: 119-124. 2006: Precocious Puberty.

http://www.eje-online.org/content/155/1/41.abstract

Cecconi Elisabetta, Gasperi Maurizio, Genovesi Maura, Bogazzi Fausto, Grasso Lucia, Cetani Filomena, Procopio Massimo, Marcocci Claudio, Bartalena Luigi and Martino Enio. The reduction of bone mineral density in postmenopausal women with primary hyperparathyroidism is higher in the presence of concomitant GH secretion impairment. 155: 41-45. 2006: Bone.

http://www.eje-online.org/content/154/3/467.abstract

Colao Annamaria, Pivonello Rosario, Auriemma Renata S, De Martino Maria Cristina, Bidlingmaier Martin, Briganti Francesco, Tortora Fabio, Burman Pia, Kourides Ione A, Strasburger Christian J and Lombardi Gaetano. Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance. 154: 467-477. 2006: Growth Hormone.

http://www.eje-online.org/content/154/3/483.abstract

Dekkers O M, Biermasz N R, Smit J W A, Groot L E, Roelfsema F, Romijn J A and Pereira A M. Quality of life in treated adult craniopharyngioma patients. 154: 483-489. 2006: Pituitary.

http://www.eje-online.org/content/155/5/693.abstract

Holvik Kristin, Meyer Haakon E, SÃ¸gaard Anne Johanne, Selmer Randi, Haug Egil and Falch Jan A. Biochemical markers of bone turnover and their relation to forearm bone mineral density in persons of Pakistani and Norwegian background living in Oslo, Norway: The Oslo Health Study. 155: 693-699. 2006: Bone.

http://www.eje-online.org/content/155/1/109.abstract

Koltowska-Haggstrom Maria, Mattsson Anders F, Monson John P, Kind Paul, Badia Xavier, Casanueva Felipe F, Busschbach Jan, Koppeschaar Hans P F and Johannsson Gudmundur. Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life? 155: 109-119. 2006: Growth Hormone.

http://www.eje-online.org/content/154/4/545.abstract

Koranyi Josef, Bosaeus Ingvar, Alpsten Magne, Bengtsson Bengtake and Johannsson Gudmundur. Body composition during GH replacement in adults: methodological variations with respect to gender. 154: 545-553. 2006: Growth Hormone.

http://www.eje-online.org/content/155/6/783.abstract

Laurberg Peter. Remission of Graves disease during anti-thyroid drug therapy. Time to reconsider the mechanism? 155: 783-786. 2006: Thyroid.

http://www.eje-online.org/content/154/6/787.short

Pacini Furio, Schlumberger Martin, Dralle Henning, Elisei Rossella, Smit Johannes W A, Wiersinga Wilmar and Taskforce the European Thyroid Cancer. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. 154: 787-803. 2006: Thyroid.

http://www.eje-online.org/content/154/6/763.abstract

Pasquali Renato and Gambineri Alessandra. Insulin-sensitizing agents in polycystic ovary syndrome. 154: 763-775. 2006: PCOS.

http://www.eje-online.org/content/154/5/659.abstract

Pekic S, Doknic M, Miljic D, Joksimovic M, Glodic J, Djurovic M, Dieguez C, Casanueva F and Popovic V. Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly. 154: 659-666. 2006: Ghrelin.

http://www.eje-online.org/content/154/2/267.abstract

Pokrajac Ana, Claridge Andrew G, Shakoor S K Abdul and Trainer Peter J. The octreotide test dose is not a reliable predictor of the subsequent response to somatostatin analogue therapy in patients with acromegaly. 154: 267-274. 2006: Acromegaly.

http://www.eje-online.org/content/154/2/175.abstract

Rochira V, Balestrieri A, Madeo B, Zirilli L, Granata A R M and Carani C. Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology. 154: 175-185. 2006: Bone.

http://www.eje-online.org/content/155/1/73.abstract

Steffin B, Gutt B, Bidlingmaier M, Dieterle C, Oltmann F and Schopohl J. Effects of the long-acting somatostatin analogue Lanreotide Autogel on glucose tolerance and insulin resistance in acromegaly. 155: 73-78. 2006: Acromegaly.

http://www.eje-online.org/content/155/1/1.short

Trainer Peter J, Barth Julian, Sturgeon Cathie, Wieringaon Gilbert and collaborative on behalf of the. Consensus statement on the standardisation of GH assays. 155: 1-2. 2006: Growth Hormone.

http://www.eje-online.org/content/154/3/409.abstract

Unger Nicole, Pitt Christian, Schmidt Ingo Lopez, Walz Martin K, Schmid Kurt W, Philipp Thomas, Mann Klaus and Petersenn Stephan. Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass. 154: 409-417. 2006: Phaeochromocytome.

http://www.eje-online.org/content/154/6/851.abstract

van der Klaauw A A, Pereira A M, van Thiel S W, Smit J W A, Corssmit E P M, Biermasz N R, Frolich M, Iranmanesh A, Veldhuis J D, Roelfsema F and Romijn J A. GH deficiency in patients irradiated for acromegaly: significance of GH stimulatory tests in relation to the 24 h GH secretion. 154: 851-858. 2006: Growth Hormone.

http://www.eje-online.org/content/154/4/501.abstract

Watt Torquil, Groenvold Mogens, Rasmussen Ãse Krogh, Bonnema Steen Joop, Hegedes Laszlo, Bjorner Jakob Bue and Feldt-Rasmussen Ulla. Quality of life in patients with benign thyroid disorders. A review. 154: 501-510. 2006: Thyroid.

http://www.eje-online.org/content/156/2/173.abstract

Abraham-Nordling Mirna, Wallin Goran, Lundell Goran and Torring Ove. Thyroid hormone state and quality of life at long-term follow-up after randomized treatment of Gravesâ€™ disease. 156: 173-179. 2007: Thyroid.

http://www.eje-online.org/content/156/1/13.abstract

Duntas Leonidas H and Biondi Bernadette. Short-term hypothyroidism after Levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences. 156: 13-19. 2007: Thyroid.

http://www.eje-online.org/content/156/1/55.abstract

Gotherstrom G, Bengtsson B-Ã…, Bosaeus I, Johannsson G and Svensson J. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency. 156: 55-64. 2007: Growth Hormone.

http://www.eje-online.org/content/156/3/315.abstract

Paisley A N, Hayden K, Ellis A, Anderson J, Wieringa G and Trainer P J. Pegvisomant interference in GH assays results in underestimation of GH levels. 156: 315-319. 2007: Acromegaly.

http://www.eje-online.org/content/156/1/33.abstract

Salvi Mario, Vannucchi Guia, Campi Irene, CurrÃ² Nicola, Dazzi Davide, Simonetta Simona, Bonara Paola, Rossi Stefania, Sina Clara, Guastella Claudio, Ratiglia Roberto and Beck-Peccoz Paolo. Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. 156: 33-40. 2007: Thyroid.

http://www.eje-online.org/content/156/4/439.abstract

Sathiavageeswaran Mahesh, Burman Pia, Lawrence David, Harris Alan G, Falleti Marina G, Maruff Paul and Wass John. Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo-controlled 12-month study. 156: 439-447. 2007: Growth Hormone.

http://www.eje-online.org/content/156/1/75.abstract

Schreiber I, Buchfelder M, Droste M, Forssmann K, Mann K, Saller B and Strasburger C J. Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: Safety and efficacy evaluation from the German Pegvisomant Observational Study. 156: 75-82. 2007: Acromegaly.

http://www.eje-online.org/content/156/2/225.abstract

Shimon Ilan, Benbassat Carlos and Hadani Moshe. Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men. 156: 225-231. 2007: Prolactin.

http://www.eje-online.org/content/158/3/273.short

Bartalena Luigi, Baldeschi Lelio, Dickinson Alison, Eckstein Anja, Kendall-Taylor Pat, Marcocci Claudio, Mourits Maarten, Perros Petros, Boboridis Kostas, Boschi Antonella, CurrÃ² Nicola, Daumerie Chantal, Kahaly George J, Krassas Gerasimos E, Lane Carol M, Lazarus John H, MarinÃ² Michele, Nardi Marco, Neoh Christopher, Orgiazzi Jacques, Pearce Simon, Pinchera Aldo, Pitz Susanne, Salvi Mario, Sivelli Paolo, Stahl Matthias, von Arx Georg and Wiersinga Wilmar M. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. 158: 273-285. 2008: Thyroid.

http://www.eje-online.org/content/158/2/135.abstract

Bult MariÃ«lle J F, van Dalen Thijs and Muller Alex F. Surgical treatment of obesity. 158: 135-145. 2008: Obesity.

http://www.eje-online.org/content/159/3/225.abstract

Escobar-Morreale Hector F, Botella-Carretero Jose I, Martenez-Garcia Ma Ãngeles, Luque-RamÃerez Manuel, Ãlvarez-Blasco Francisco and Millan Jose L San. Serum osteoprotegerin concentrations are decreased in women with the polycystic ovary syndrome. 159: 225-232. 2008: PCOS.

http://www.eje-online.org/content/158/3/353.abstract

GannagÃ©-Yared Marie-HÃ©lÃ¨ne, Yaghi Cesar, Habre Bassem, Khalife Simon, Noun Roger, Germanos-Haddad Myrna and Trak-Smayra Viviane. Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study. 158: 353-359. 2008: Osteoprotegrin.

http://www.eje-online.org/content/159/5/493.abstract

Gharib H, Papini E and Paschke R. Thyroid nodules: a review of current guidelines, practices, and prospects. 159: 493-505. 2008: Thyroid.

http://www.eje-online.org/content/159/2/89.abstract

Holdaway I M, Bolland M J and Gamble G D. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. 159: 89-95. 2008: Acromegaly.

http://www.eje-online.org/content/159/5/517.abstract

Jimenez Camilo, Burman Pia, Abs Roger, Clemmons David R, Drake William M, Hutson Kent R, Messig Michael, Thorner Michael O, Trainer Peter J and Gagel Robert F. Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trials. 159: 517-523. 2008: Acromegaly.

http://www.eje-online.org/content/158/4/483.abstract

Joaquin C, Aguilera E, Granada M L, Pastor M C, Salinas I, Alonso N and SanmartÃ A. Effects of GH treatment in GH-deficient adults on adiponectin, leptin and pregnancy-associated plasma protein-A. 158: 483-490. 2008: Growth Hormone.

http://www.eje-online.org/content/159/5/541.abstract

Moyes V J, Metcalfe K A and Drake W M. Clinical use of cabergoline as primary and adjunctive treatment for acromegaly. 159: 541-545. 2008: Acromegaly.

http://www.eje-online.org/content/159/5/603.abstract

Nybo Mads and Rasmussen Lars M. The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: a systematic literature review. 159: 603-608. 2008: Osteoprotegrin.

http://www.eje-online.org/content/158/4/447.abstract

Stochholm Kirstine, Laursen Torben, Green Anders, Laurberg Peter, Andersen Marianne, Kristensen Lars Ã˜stergaard, Feldt-Rasmussen Ulla, Christiansen Jens Sandahl, Frydenberg Morten and Gravholt Claus HÃ¸jbjerg. Morbidity and GH deficiency: a nationwide study. 158: 447-457. 2008: Growth Hormone.

http://www.eje-online.org/content/158/2/229.abstract

van Geest Rob J, Sasim Inna V, Koppeschaar Hans P F, Kalmann Rachel, Stravers Simone N, Bijlsma Ward R and Mourits Maarten P. Methylprednisolone pulse therapy for patients with moderately severe Graves' orbitopathy: a prospective, randomized, placebo-controlled study. 158: 229-237. 2008: Thyroid.

http://www.eje-online.org/content/161/suppl_1/S25.abstract

Brabant G, Poll E M, Jonsson P, Polydorou D and Kreitschmann-Andermahr I. Etiology, baseline characteristics, and biochemical diagnosis of GH deficiency in the adult: are there regional variations? 161: S25-S31. 2009: Growth Hormone.

http://www.eje-online.org/content/161/suppl_1/S11.abstract

Brue Thierry, Castinetti Frederic, Lundgren Frida, Koltowska-Haggstrom Maria, Petrossians Patrick and investigators on behalf of all ACROSTUDY. Which patients with acromegaly are treated with pegvisomant? An overview of methodology and baseline data in ACROSTUDY. 161: S11-S17. 2009: Acromegaly.

http://www.eje-online.org/content/161/suppl_1/S3.abstract

Buchfelder M, Schlaffer S, Droste M, Mann K, Saller B, BrÃ¼bach K, Stalla G K, Strasburger C J and Study on behalf of the investigators of the German Pegvisomant Observational. The German ACROSTUDY: past and present. 161: S3-S10. 2009: ACROSTUDY.

http://www.eje-online.org/content/161/1/27.abstract

Buchfelder M, Weigel D, Droste M, Mann K, Saller B, BrÃ¼bach K, Stalla G K, Bidlingmaier M, Strasburger C J and Study on behalf of the investigators of the German Pegvisomant Observational. Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study. 161: 27-35. 2009: Acromegaly.

http://www.eje-online.org/content/161/5/655.abstract

Butler Helen and Korbonits MÃ¡rta. Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists. 161: 655-662. 2009: Cannabinoids.

http://www.eje-online.org/content/160/6/899.abstract

Conway G S, Szarras-Czapnik M, Racz K, Keller A, Chanson P, Tauber M, Zacharin M and Group on behalf of the GHD to GHDA Transition Study. Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency. 160: 899-907. 2009: Growth Hormone.

http://www.eje-online.org/content/161/5/771.abstract

de Rooij A, Vandenbroucke J P, Smit J W A, Stokkel M P M and Dekkers O M. Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: systematic review and meta-analysis. 161: 771-777. 2009: Thyroid.

http://www.eje-online.org/content/161/suppl_1/S85.abstract

Filipsson Helena and Johannsson Gudmundur. GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies. 161: S85-S95. 2009: Growth Hormone.

http://www.eje-online.org/content/161/1/21.abstract

Higham C E, Thomas J D J, Bidlingmaier M, Drake W M and Trainer P J. Successful use of weekly pegvisomant administration in patients with acromegaly. 161: 21-25. 2009: Acromegaly.

http://www.eje-online.org/content/161/1/119.abstract

Johannsson Gudmundur, Bergthorsdottir Ragnhildur, Nilsson Anna G, Lennernas Hans, Hedner Thomas and Skrtic Stanko. Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study. 161: 119-130. 2009: Cortisol.

http://www.eje-online.org/content/161/2/213.abstract

Klefter Oliver and Feldt-Rasmussen Ulla. Is increase in bone mineral content caused by increase in skeletal muscle mass/strength in adult patients with GH-treated GH deficiency? A systematic literature analysis. 161: 213-221. 2009: Bone.

http://www.eje-online.org/content/161/suppl_1/S75.abstract

Klose M, Jonsson B, Abs R, Popovic V, Koltowska-HÃ¤ggstrom M, Saller B, Feldt-Rasmussen U and Kourides I. From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum â€“ a KIMS analysis. 161: S75-S83. 2009: Growth Hormone.

http://www.eje-online.org/content/161/suppl_1/S51.abstract

Koltowska-Haggstrom Maria, Mattsson Anders F and Shalet Stephen M. Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations. 161: S51-S64. 2009: Growth Hormone.

http://www.eje-online.org/content/160/5/821.abstract

Legros Jean-Jacques, Meuleman Eric J H, Elbers Jolanda M H, Geurts T B Paul, Kaspers Marion J G H, Bouloux Pierre M G and Investigators for the Study 43203. Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study. 160: 821-831. 2009: Testosterone.

http://www.eje-online.org/content/160/6/993.abstract

Lovas Kristian, Gjesdal Clara G, Christensen Monika, Wolff Anette B, Almas Bjorg, Svartberg Johan, Fougner Kristian J, Syversen Unni, Bollerslev Jens, Falch Jan A, Hunt Penelope J, Chatterjee V Krishna K and Husebye Eystein S. Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. 160: 993-1002. 2009: Cortisol.

http://www.eje-online.org/content/160/4/535.abstract

Marazuela Monica, Lucas TomÃ¡s, Alvarez-Escola¡ Cristina, Puig-Domingo Manel, de la Torre Nuria Garcia, de Miguel-Novoa Paz, Duran-Hervada Alejandra, Manzanares Rafael, Luque-RamÃrez Manuel, Halperin Irene, Casanueva Felipe F and Bernabeu Ignacio. Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: its efficacy in relation to gender and previous radiotherapy. 160: 535-542. 2009: Bone.

http://www.eje-online.org/content/161/suppl_1/S33.abstract

Mukherjee A and Shalet S M. The value of IGF1 estimation in adults with GH deficiency. 161: S33-S39. 2009: Growth Hormone.

http://www.eje-online.org/content/160/4/529.abstract

Neggers SJCMM, de Herder WW, Janssen JAMJL, Feelders RA and van der Lely AJ. Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patients. 160: 529-533. 2009: Acromegaly.

http://www.eje-online.org/content/160/6/883.abstract

Ohlsson Claes and Vandenput Liesbeth. The role of estrogens for male bone health. 160: 883-889. 2009: Estrogens.

http://www.eje-online.org/content/161/5/663.abstract

Olsson D S, Buchfelder M, Schlaffer S, Bengtsson B-A, Jakobsson K-E, Johannsson G and Nilsson A G. Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy. 161: 663-669. 2009: Pituitary.

http://www.eje-online.org/content/160/3/349.abstract

Peter Ferenc, Savoy Conrad, Ji Hyi-Jeong, Juhasz Mihaly, Bidlingmaier Martin and Saenger Paul. Pharmacokinetic and pharmacodynamic profile of a new sustained-release GH formulation, LB03002, in children with GH deficiency. 160: 349-355. 2009: Growth Hormone.

http://www.eje-online.org/content/160/4/543.abstract

Pokrajac Ana, Frystyk Jan, Flyvbjerg Allan and Trainer Peter J. Pituitary-independent effect of octreotide on IGF1 generation. 160: 543-548. 2009: Acromegaly.

http://www.eje-online.org/content/161/1/37.abstract

Ronchi C L, Giavoli C, Ferrante E, Verrua E, Bergamaschi S, Ferrari D I, Corbetta S, Montefusco L, Arosio M, Ambrosi B, Spada A and Beck-Peccoz P. Prevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments. 161: 37-42. 2009: Acromegaly.

http://www.eje-online.org/content/160/2/121.abstract

SeppÃ¤lÃ¤ M, Koistinen H, Koistinen R, Hautala L, Chiu P C and Yeung W S. Glycodelin in reproductive endocrinology and hormone-related cancer. 160: 121-133. 2009: Glycodelin.

http://www.eje-online.org/content/161/suppl_1/S65.abstract

Svensson Johan and Bengtsson Bengt-Ã…ke. Safety aspects of GH replacement. 161: S65-S74. 2009: Growth Hormone.

http://www.eje-online.org/content/161/suppl_1/S97.abstract

Thomas Julia D J and Monson John P. Adult GH deficiency throughout lifetime. 161: S97-S106. 2009: Growth Hormone.

http://www.eje-online.org/content/161/suppl_1/S19.abstract

Trainer Peter J. ACROSTUDY: the first 5 years. 161: S19-S24. 2009: ACROSTUDY.

http://www.eje-online.org/content/161/suppl_1/S41.abstract

Verhelst Johan and Abs Roger. Cardiovascular risk factors in hypopituitary GH-deficient adults. 161: S41-S49. 2009: Growth Hormone.

http://www.eje-online.org/content/165/2/301.abstract

Betz Matthias J, Degenhart Christoph, Fischer Evelyn, Pallauf Anna, Brand Volker, Linsenmaier Ulrich, Beuschlein Felix, Bidlingmaier Martin and Reincke Martin. Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates. 165: 301-306. 2011: Adrenal.

http://www.eje-online.org/content/165/4/491.abstract

Brandt Frans, Green Anders, Hegedüs Laszlo and Brix Thomas H. A critical review and meta-analysis of the association between overt hyperthyroidism and mortality. 165: 491-497. 2011: Thyroid.

http://www.eje-online.org/content/162/1/101.abstract

Ceral Jiri, Solar Miroslav, Krajina Antonin, Ballon Marek, Suba Petr and Cap Jan. Adrenal venous sampling in primary aldosteronism: a low dilution of adrenal venous blood is crucial for a correct interpretation of the results. 162: 101-107. 2011: Adrenal.

http://www.eje-online.org/content/165/2/217.abstract

Child Christopher J, Zimmermann Alan G, Woodmansee Whitney W, Green Daniel M, Li Jian J, Jung Heike, Erfurth Eva Marie and Robison Leslie L. Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study. 165: 217-223. 2011: Growth Hormone.

http://www.eje-online.org/content/165/5/713.abstract

Colao Annamaria, Pivonello Rosario, Grasso Ludovica Francesca Stella, Auriemma Renata Simona, Galdiero Mariano, Savastano Silvia and Lombardi Gaetano. Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study. 165: 713-721. 2011: Acromegaly.

http://www.eje-online.org/content/165/3/401.abstract

de Schepper Jean, Rasmussen Michael HÃ¸jby, Gucev Zoran, Eliakim Alon and Battelino Tadej. Long-acting pegylated human GH in children with GH deficiency: a single-dose, dose-escalation trial investigating safety, tolerability, pharmacokinetics and pharmacodynamics. 165: 401-409. 2011: Growth Hormone.

http://www.eje-online.org/content/162/2/193.abstract

Diamanti-Kandarakis Evanthia, Christakou Charikleia D, Kandaraki Eleni and Economou Frangiskos N. Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome. 162: 193-212. 2011: PCOS.

http://www.eje-online.org/content/164/1/107.abstract

Effraimidis Grigoris, Strieder Thea G A, Tijssen Jan G P and Wiersinga Wilmar M. Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: a prospective study. 164: 107-113. 2011: Thyroid.

http://www.eje-online.org/content/164/1/23.abstract

Egger A, Buehler T, Boesch C, Diem P, Stettler C and Christ E R. The effect of GH replacement therapy on different fat compartments: a whole-body magnetic resonance imaging study. 164: 23-29. 2011: Growth Hormone.

http://www.eje-online.org/content/164/5/649.abstract

Estcourt Stephanie, Quinn Anthony G and Vaidya Bijay. Quality of life in thyroid eye disease: impact of quality of care. 164: 649-655. 2011: Thyroid.

http://www.eje-online.org/content/163/5/709.abstract

Godbout Ariane, Manavela Marcos, Danilowicz Karina, Beauregard Hugues, Bruno Oscar Domingo and Lacroix Andre. Cabergoline monotherapy in the long-term treatment of Cushing's disease. 163: 709-716. 2011: Cushings.

http://www.eje-online.org/content/162/5/951.abstract

Grouzmann Eric, Drouard-Troalen Laurence, Baudin Eric, Plouin Pierre-Francois, Muller Beat, Grand Daniela and Buclin Thierry. Diagnostic accuracy of free and total metanephrines in plasma and fractionated metanephrines in urine of patients with pheochromocytoma. 162: 951-960. 2011: Phaeochromocytoma.

http://www.eje-online.org/content/162/Suppl1/S5.abstract

Hannon M J and Thompson C J. The syndrome of inappropriate antidiuretic hormone: prevalence, causes and consequences. 162: S5-S12. 2011: ADH.

http://www.eje-online.org/content/162/6/1009.abstract

Hofbauer Lorenz C, Hamann Christine and Ebeling Peter R. Approach to the patient with secondary osteoporosis. 162: 1009-1020. 2011: Bone.

http://www.eje-online.org/content/164/3/317.abstract

Karmisholt Jesper, Andersen Stig and Laurberg Peter. Variation in thyroid function in subclinical hypothyroidism: importance of clinical follow-up and therapy. 164: 317-323. 2011: Thyroid.

http://www.eje-online.org/content/165/3/365.abstract

Lentschener Claude, Gaujoux Sebastien, Tesniere Antoine and Dousset Bertrand. Point of controversy: perioperative care of patients undergoing pheochromocytoma removal-time for a reappraisal? 165: 365-373. 2011: Pheochromocytoma.

http://www.eje-online.org/content/164/4/643.abstract

Luchavova Maria, Zikan Vit, Michalska Dana, Raska Ivan, Kubena Ales A and Stepan Jan J. The effect of timing of teriparatide treatment on the circadian rhythm of bone turnover in postmenopausal osteoporosis. 164: 643-648. 2011: Bone.

http://www.eje-online.org/content/162/4/661.abstract

Mao Zhi-gang, Zhu Yong-hong, Tang Hai-liang, Wang Dao-yuan, Zhou Jing, He Dong-sheng, Lan Hai, Luo Bai-ning and Wang Hai-jun. Preoperative lanreotide treatment in acromegalic patients with macroadenomas increases short-term postoperative cure rates: a prospective, randomised trial. 162: 661-666. 2011: Acromegaly.

http://www.eje-online.org/content/165/1/1.abstract

Marie Pierre J and Kassem Moustapha. Osteoblasts in osteoporosis: past, emerging, and future anabolic targets. 165: 1-10. 2011: Bone.

http://www.eje-online.org/content/164/1/17.abstract

Ribeiro-Oliveira AntÃ´nio, Faje Alexander T and Barkan Ariel L. Limited utility of oral glucose tolerance test in biochemically active acromegaly. 164: 17-22. 2011: Acromegaly.

http://www.eje-online.org/content/163/1/1.abstract

Romero Amparo, Kirchner Henriette, Heppner Kristy, Pfluger Paul T, Tschop Matthias H and Nogueiras Ruben. GOAT: the master switch for the ghrelin system? 163: 1-8. 2011: Ghrelin.

http://www.eje-online.org/content/165/5/675.abstract

Saad Farid, Aversa Antonio, Isidori Andrea M, Zafalon Livia, Zitzmann Michael and Gooren Louis. Onset of effects of testosterone treatment and time span until maximum effects are achieved. 165: 675-685. 2011: Testosterone.

http://www.eje-online.org/content/162/Suppl1/S13.abstract

Sherlock Mark and Thompson Chris J. The syndrome of inappropriate antidiuretic hormone: current and future management options. 162: S13-S18. 2011: ADH.

http://www.eje-online.org/content/164/6/851.abstract

Terzolo M, Stigliano A, Chiodini I, Loli P, Furlani L, Arnaldi G, Reimondo G, Pia A, Toscano V, Zini M, Borretta G, Papini E, Garofalo P, Allolio B, Dupas B, Mantero F and Tabarin A. AME Position Statement on adrenal incidentaloma. 164: 851-870. 2011: Adrenal.

http://www.eje-online.org/content/165/2/171.abstract

Torres Antonio J and Rubio Miguel A. The Endocrine Society's Clinical Practice Guideline on endocrine and nutritional management of the post-bariatric surgery patient: Commentary from a European Perspective. 165: 171-176. 2011: Bariatric.

http://www.eje-online.org/content/165/3/383.abstract

Valassi Elena, Santos Alicia, Yaneva Maria, TÃ³th MiklÃ³s, Strasburger Christian J, Chanson Philippe, Wass John A H, Chabre Olivier, Pfeifer Marija, Feelders Richard A, Tsagarakis Stylianos, Trainer Peter J, Franz Holger, Zopf Kathrin, Zacharieva Sabina, Lamberts Steven W J, Tabarin Antoine and Webb Susan M. The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics. 165: 383-392. 2011: Cushing's.

http://www.eje-online.org/content/162/4/737.abstract

Vandenput Liesbeth, Mellstrom Dan, Karlsson Magnus K, Orwoll Eric, Labrie Fernand, Ljunggren Ã–sten and Ohlsson Claes. Serum estradiol is associated with lean mass in elderly Swedish men. 162: 737-745. 2011: Estrogen.

http://www.eje-online.org/content/165/1/77.abstract

Varanasi Ajay, Bellini Natalie, Rawal Deepti, Vora Mehul, Makdissi Antoine, Dhindsa Sandeep, Chaudhuri Ajay and Dandona Paresh. Liraglutide as additional treatment for type 1 diabetes. 165: 77-84. 2011: GLP-1.

http://www.eje-online.org/content/164/5/725.abstract

Verbalis Joseph G, Adler Suzanne, Schrier Robert W, Berl Tomas, Zhao Qiong, Czerwiec Frank S and Investigators for the SALT. Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion. 164: 725-732. 2011: ADH.

http://www.eje-online.org/content/165/1/39.abstract

Wade Alisha N, Baccon Jennifer, Grady M Sean, Judy Kevin D, O'Rourke Donald M and Snyder Peter J. Clinically silent somatotroph adenomas are common. 165: 39-44. 2011: Acromegaly.

http://www.eje-online.org/content/164/4/475.abstract

Wassenaar M J E, Biermasz N R, Hamdy N A T, Zillikens M C, van Meurs J B J, Rivadeneira F, Hofman A, Uitterlinden A G, Stokkel M P M, Roelfsema F, Kloppenburg M, Kroon H M, Romijn J A and Pereira A M. High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly. 164: 475-483. 2011: Bone.

http://www.eje-online.org/content/167/2/189.abstract

Arosio M, Reimondo G, Malchiodi E, Berchialla P, Borraccino A, De Marinis L, Pivonello R, Grottoli S, Losa M, Cannavò S, Minuto F, Montini M, Bondanelli M, De Menis E, Martini C, Angeletti G, Velardo A, Peri A, Faustini-Fustini M, Tita P, Pigliaru F, Borretta G, Scaroni C, Bazzoni N, Bianchi A, Appetecchia M, Cavagnini F, Lombardi G, Ghigo E, Beck-Peccoz P, Colao A, Terzolo M and Acromegaly for the Italian Study Group of. Predictors of morbidity and mortality in acromegaly: an Italian survey. 167: 189-198. 2012: Acromegaly.

http://www.eje-online.org/content/167/2/245.abstract

Awa Wendy L, Fach E, Krakow D, Welp R, Kunder J, Voll A, Zeyfang A, Wagner C, Schütt M, Boehm B, de Souza M and Holl R W. Type 2 diabetes from pediatric to geriatric age: analysis of gender and obesity among 120 183 patients from the German/Austrian DPV database. 167: 245-254. 2012: Diabetes.

http://www.eje-online.org/content/167/2/181.abstract

de Laat Joanne M, Tham Emma, Pieterman Carolina R C, Vriens Menno R, Dorresteijn Johannes A N, Bots Michiel L, Nordenskjöld Magnus, van der Luijt Rob B and Valk Gerlof D. Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors. 167: 181-187. 2012: MEN.

http://www.eje-online.org/content/167/6/817.abstract

Delemer Brigitte, Aubert Jean-Pierre, Nys Pierre, Landron Frédéric and Bouée Stéphane. An observational study of the initial management of hypothyroidism in France: the ORCHIDÉE study. 167: 817-823. 2012: Thyroid.

European Journal of Endocrinology

Elbornsson Mariam, Götherström Galina, Bosæus Ingvar, Bengtsson Bengt-Åke, Johannsson Gudmundur and Svensson Johan. Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency. 166: 787-795. 2012: Growth Hormone.

http://www.eje-online.org/content/166/5/787.abstract

http://www.eje-online.org/content/166/2/181.abstract

Elbornsson Mariam, Götherström Galina, Franco Celina, Bengtsson Bengt-Åke, Johannsson Gudmundur and Svensson Johan. Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiency. 166: 181-189. 2012: Growth Hormone.

http://www.eje-online.org/content/167/2/137.abstract

Preda Veronica A, Sen Jonathan, Karavitaki Niki and Grossman Ashley B. THERAPY IN ENDOCRINE DISEASE: Etomidate in the management of hypercortisolaemia in Cushing's syndrome: a review. 167: 137-143. 2012: Cortisol.

http://www.eje-online.org/content/166/5/779.abstract

Primeau Vanessa, Raftopoulos Christian and Maiter Dominique. Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients. 166: 779-786. 2012: Prolactin.

Schneider T C, Abdulrahman R M, Corssmit E P, Morreau H, Smit J W A and Kapiteijn E. Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial. 167: 643-650. 2012: Thyroid http://www.eje-online.org/content/167/5/643.abstract

http://www.eje-online.org/content/166/6/959.abstract

Schwetz Verena, Pieber Thomas and Obermayer-Pietsch Barbara. MECHANISMS IN ENDOCRINOLOGY: The endocrine role of the skeleton: background and clinical evidence. 166: 959-967. 2012: Review.

http://www.eje-online.org/content/167/3/343.abstract

Tritos Nicholas A, Hamrahian Amir H, King Donna, Greenspan Susan L, Cook David M, Jönsson Peter J, Wajnrajch Michael P, Koltowska-Häggstrom Maria and Biller Beverly M K. A longer interval without GH replacement and female gender are associated with lower bone mineral density in adults with childhood-onset GH deficiency: a KIMS database analysis. 167: 343-351. 2012: Growth Hormone.

http://www.eje-online.org/content/166/5/797.abstract

Wang Min, Mou Chengzhi, Jiang Meng, Han Lizhang, Fan Shengqiang, Huan Cheng, Qu Xin, Han Tao, Qu Yuanming and Xu Guangming. The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: clinical analysis of 279 cases. 166: 797-802. 2012: Acromegaly.

http://www.eje-online.org/content/168/3/297.abstract

Abs Roger, Mattsson Anders F, Thunander Maria, Verhelst Johan, Góth Miklós I, Wilton Patrick, Kołtowska-Häggström Maria and Luger Anton. Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis. 168: 297-305. 2013: Growth Hormone.

http://www.eje-online.org/content/168/5/665.abstract

Bernard Valérie, Lombard-Bohas Catherine, Taquet Marie-Caroline, Caroli-Bosc François-Xavier, Ruszniewski Philippe, Niccoli Patricia, Guimbaud Rosine, Chougnet Cécile N, Goichot Bernard, Rohmer Vincent, Borson-Chazot Françoise, Baudin Eric and Tumors for the French Group of Endocrine. Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia. 168: 665-674. 2013: Insulinoma.

http://www.eje-online.org/content/169/1/31.abstract

Ceccato Filippo, Barbot Mattia, Zilio Marialuisa, Ferasin Sergio, Occhi Gianluca, Daniele Andrea, Mazzocut Sara, Iacobone Maurizio, Betterle Corrado, Mantero Franco and Scaroni Carla. Performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiency. 169: 31-36. 2013: Cushing's.

http://www.eje-online.org/content/168/5/745.abstract

Elbornsson Mariam, Götherström Galina, Bosæus Ingvar, Bengtsson Bengt-Åke, Johannsson Gudmundur and Svensson Johan. Fifteen years of GH replacement improves body composition and cardiovascular risk factors. 168: 745-753. 2013: Growth Hormone.

http://www.eje-online.org/content/168/3/315.abstract

Manetti Luca, Rossi Giuseppe, Grasso Lucia, Raffaelli Valentina, Scattina Ilaria, Del Sarto Simone, Cosottini Mirco, Iannelli Aldo, Gasperi Maurizio, Bogazzi Fausto and Martino Enio. Usefulness of salivary cortisol in the diagnosis of hypercortisolism: comparison with serum and urinary cortisol. 168: 315-321. 2013: Cortisol.

http://www.eje-online.org/content/169/6/725.abstract

Muraleedharan Vakkat, Marsh Hazel, Kapoor Dheeraj, Channer Kevin S and Jones T Hugh. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes. 169: 725-733. 2013: Testosterone.

http://www.eje-online.org/content/169/6/795.abstract

Norenstedt Sophie, Pernow Ylva, Brismar Kerstin, Sääf Maria, Ekip Ayla, Granath Fredrik, Zedenius Jan and Nilsson Inga-Lena. Primary hyperparathyroidism and metabolic risk factors, impact of parathyroidectomy and vitamin D supplementation, and results of a randomized double-blind study. 169: 795-804. 2013: PTH.

http://www.eje-online.org/content/168/1/39.abstract

Schöfl Christof, Franz Holger, Grussendorf Martin, Honegger Jürgen, Jaursch-Hancke Cornelia, Mayr Bernhard, Schopohl Jochen and Register the participants of the German Acromegaly. Long-term outcome in patients with acromegaly: analysis of 1344 patients from the German Acromegaly Register. 168: 39-47. 2013: Acromegaly.

http://www.eje-online.org/content/169/1/99.abstract

Urbani C, Sardella C, Calevro A, Rossi G, Scattina I, Lombardi M, Lupi I, Manetti L, Martino E and Bogazzi F. Effects of medical therapies for acromegaly on glucose metabolism. 169: 99-108. 2013: Acromegaly.

http://www.eje-online.org/content/168/4/565.abstract

Woodmansee Whitney W, Zimmermann Alan G, Child Christopher J, Rong Qi, Erfurth Eva Marie, Beck-Peccoz Paolo, Blum Werner F and Robison Leslie L. Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS. 168: 565-573. 2013: Growth Hormone.

http://www.eje-online.org/content/168/5/699.abstract

Zoicas Flavius, Droste Michael, Mayr Bernhard, Buchfelder Michael and Schöfl Christof. GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases. 168: 699-706. 2013: Obesity.

http://www.eje-online.org/content/170/1/13.abstract

Blum Werner F, Deal Cheri, Zimmermann Alan G, Shavrikova Elena P, Child Christopher J, Quigley Charmian A, Drop Stenvert L S, Cutler Gordon B and Rosenfeld Ron G. Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with idiopathic isolated GH deficiency. 170: 13-21. 2014: Growth Hormone.

http://www.eje-online.org/content/171/5/571.abstract

Ragnarsson Oskar, Mattsson Anders F, Monson John P, Filipsson Nyström Helena, Åkerblad Ann-Charlotte, Kołtowska-Häggström Maria and Johannsson Gudmundur. The relationship between glucocorticoid replacement and quality of life in 2737 hypopituitary patients. 171: 571-579. 2014: Pituitary.

http://www.eje-online.org/content/171/2/151.abstract

van Bunderen Christa C, van den Dries Carline J, Heymans Martijn W, Franken Anton A M, Koppeschaar Hans P F, van der Lely Aart J and Drent Madeleine L. Effect of long-term GH replacement therapy on cardiovascular outcomes in isolated GH deficiency compared with multiple pituitary hormone deficiencies: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults. 171: 151-160. 2014: Growth Hormone.

Exp Clin Endocrinol Diabetes

Joseph F., Brabant G., Ahmad A., Fraser W. and Vora J. The effect of growth hormone replacement in adult growth hormone deficiency on the diurnal and ultradian dynamics of ghrelin, leptin, soluble leptin receptor and adiponectin. 113. 2005: Growth Hormone.

Back to Top

http://onlinelibrary.wiley.com/doi/10.1359/jbmr.070715/pdf

White H.D., Ahmad A.M., Durham B.H., Peter R., Prabhakar V.K.B., Corlett P., Vora J.P. and Fraser W.D. PTH Circadian Rhythm and PTH Target Organ Sensitivity Is Altered in Patients With Adult Growth Hormone Deficiency With Low BMD. 22: 1798-1807. 2007: Growth Hormone.

http://dx.doi.org/10.1359/jbmr.071117

Joseph Franklin, Ahmad Aftab M., Ul-Haq Mazhar, Durham Brian H., Whittingham Pauline, Fraser William D. and Vora Jiten P. Effects of Growth Hormone Administration on Bone Mineral Metabolism, PTH Sensitivity and PTH Secretory Rhythm in Postmenopausal Women With Established Osteoporosis. 23: 721-729. 2008: Growth Hormone.

Bilezikian J.P., Khan A., Potts Jr J.T., Brandi M.L., Clarke B.L., Shoback D., Jüppner H., D'Amour P., Fox J. and Rejnmark L. Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target organ involvement, treatment, and challenges for future research. 26: 2317-2337. 2011: Parathyroid.

http://dx.doi.org/10.1002/jbmr.459

Prisby Rhonda, Guignandon Alain, Vanden-Bossche Arnaud, Mac-Way Fabrice, Linossier Marie-Thérèse, Thomas Mireille, Laroche Norbert, Malaval Luc, Langer Max, Peter Zoltz-Andrei, Peyrin Françoise, Vico Laurence and Lafage-Proust Marie-Hélène. Intermittent PTH(1–84) is osteoanabolic but not osteoangiogenic and relocates bone marrow blood vessels closer to bone-forming sites. 26: 2583-2596. 2011: Parathyroid.

http://www.jbmr.org/details/journalArticle/1316855/A_single_infusion_of_zoledronic_acid_produces_sustained_remissions_in_paget_dise.html

Reid I.R., Lyles K., Su G., Brown JP, Walsh JP, del Pino Montes J., Miller PD, Fraser WD, Cafoncelli S. and Bucci Rechtweg C. A single infusion of zoledronic acid produces sustained remissions in Paget's disease–data to 6.5 years. 2011: Bone.

Sikjaer T., Rejnmark L., Rolighed L., Heickendorff L. and Mosekilde L. The effect of adding PTH (1–84) to conventional treatment of hypoparathyroidism: A randomized, placebo controlled study. 26: 2358-2370. 2011: Parathyroid.

http://dx.doi.org/10.1002/jbmr.523

Towler Dwight A. Skeletal anabolism, PTH, and the bone–vascular axis. 26: 2579-2582. 2011: Parathyroid.

http://dx.doi.org/10.1002/jbmr.1697

Barrett-Connor Elizabeth, Laughlin Gail A., Li Hong, Nielson Carrie M., Wang P. Ying, Dam Tien T., Cauley Jane A., Ensrud Kristine E., Stefanick Marcia L., Lau Edith, Hoffman Andrew R., Orwoll Eric S. and for the Osteoporotic Fractures in Men Research Group. The association of concurrent vitamin D and sex hormone deficiency with bone loss and fracture risk in older men: The osteoporotic fractures in men (MrOS) study. 27: 2306-2313. 2012: Osteoporosis.

http://dx.doi.org/10.1002/jbmr.1645

Chiang Chia-Hung, Huang Chin-Chou, Chan Wan-Leong, Huang Po-Hsun, Chen Tzeng-Ji, Chung Chia-Min, Lin Shing-Jong, Chen Jaw-Wen and Leu Hsin-Bang. Oral alendronate use and risk of cancer in postmenopausal women with osteoporosis: A nationwide study. 27: 1951-1958. 2012: Osteoporosis.

http://dx.doi.org/10.1002/jbmr.1652

FitzGerald Gordon, Boonen Steven, Compston Juliet E., Pfeilschifter Johannes, LaCroix Andrea Z., Hosmer David W., Hooven Frederick H., Gehlbach Stephen H. and for the Glow Investigators. Differing risk profiles for individual fracture sites: Evidence from the global longitudinal study of osteoporosis in women (GLOW). 27: 1907-1915. 2012: Osteoporosis.

http://dx.doi.org/10.1002/jbmr.1695

Langdahl Bente, Binkley Neil, Bone Henry, Gilchrist Nigel, Resch Heinrich, Rodriguez Portales Jose, Denker Andrew, Lombardi Antonio, Le Bailly De Tilleghem Celine, DaSilva Carolyn, Rosenberg Elizabeth and Leung Albert. Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study. 27: 2251-2258. 2012: Bone.

http://dx.doi.org/10.1002/jbmr.1870

Glüer Claus- C., Marin Fernando, Ringe Johann D., Hawkins Federico, Möricke Rüdiger, Papaioannu Nikolaos, Farahmand Parvis, Minisola Salvatore, Martínez Guillermo, Nolla Joan M., Niedhart Christopher, Guañabens Nuria, Nuti Ranuccio, Martín-Mola Emilio, Thomasius Friederike, Kapetanos Georgios, Peña Jaime, Graeff Christian, Petto Helmut, Sanz Beatriz, Reisinger Andreas and Zysset Philippe K. Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial. 28: 1355-1368. 2013: Osteoporosis.

http://dx.doi.org/10.1002/jbmr.1784

Hansen Stinus, Hauge Ellen M., Beck Jensen Jens-Erik and Brixen Kim. Differing effects of PTH 1–34, PTH 1–84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: An 18-month open-labeled observational study using HR-pQCT. 28: 736-745. 2013: Parathyroid.

http://dx.doi.org/10.1002/jbmr.1819

Hiligsmann Mickael, Sedrine Wafa Ben and Reginster Jean-Yves. Cost-effectiveness of bazedoxifene compared with raloxifene in the treatment of postmenopausal osteoporotic women. 28: 807-815. 2013: Osteoporosis.

http://dx.doi.org/10.1002/jbmr.1978

Horwitz Mara J., Augustine Marilyn, Kahn Leila, Martin Emily, Oakley Christine C., Carneiro Raquel M., Tedesco Mary Beth, Laslavic Angela, Sereika Susan M., Bisello Alessandro, Garcia-Ocaña Adolfo, Gundberg Caren M., Cauley Jane A. and Stewart Andrew F. A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: The PrOP study. 28: 2266-2276. 2013: PTH.

http://dx.doi.org/10.1002/jbmr.1828

Looker Anne C. Serum 25-hydroxyvitamin D and risk of major osteoporotic fractures in older U.S. adults. 28: 997-1006. 2013: Vitamin D.

http://dx.doi.org/10.1002/jbmr.1755

Moriwaki Kensuke, Komaba Hirotaka, Noto Shinichi, Yanagisawa Shinichiro, Takiguchi Toru, Inoue Hiroki, Toujo Takeshi, Fukagawa Masafumi and Takahashi Hideaki E. Cost-effectiveness of alendronate for the treatment of osteopenic postmenopausal women in Japan. 28: 395-403. 2013: Osteoporosis.

http://dx.doi.org/10.1002/jbmr.1964

Sikjaer Tanja, Amstrup Anne Kristine, Rolighed Lars, Kjaer Soren Geill, Mosekilde Leif and Rejnmark Lars. PTH(1-84) replacement therapy in hypoparathyroidism: A randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment. 28: 2232-2243. 2013: PTH.

http://dx.doi.org/10.1002/jbmr.2023

Díez-Pérez Adolfo, Adachi Jonathan D., Adami Silvano, Anderson Frederick A., Boonen Steven, Chapurlat Roland, Compston Juliet E., Cooper Cyrus, Gehlbach Stephen H., Greenspan Susan L., Hooven Frederick H., LaCroix Andrea Z., Nieves Jeri W., Netelenbos J. Coen, Pfeilschifter Johannes, Rossini Maurizio, Roux Christian, Saag Kenneth G., Silverman Stuart, Siris Ethel S., Wyman Allison, Rushton-Smith Sophie K., Watts Nelson B. and for the Global Longitudinal Study of Osteoporosis in Women Investigators. Risk Factors for Treatment Failure With Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW). 29: 260-267. 2014: Osteoporosis.

http://dx.doi.org/10.1002/jbmr.2011

Prieto-Alhambra Daniel, Pagès-Castellà Aina, Wallace Gemma, Javaid M. Kassim, Judge Andrew, Nogués Xavier, Arden Nigel K., Cooper Cyrus and Diez-Perez Adolfo. Predictors of Fracture While on Treatment With Oral Bisphosphonates: A Population-Based Cohort Study. 29: 268-274. 2014: Osteoporosis.

http://jcem.endojournals.org/content/82/10/3493.abstract

Abu E. O., Horner A., Kusec V., Triffitt J. T. and Compston J. E. The Localization of Androgen Receptors in Human Bone. 82: 3493-3497. 1997: Bone.

http://jcem.endojournals.org/content/82/4/1118.abstract

Al-Adsani Hana, Hoffer L. John and Silva J. Enrique. Resting Energy Expenditure is Sensitive to Small Dose Changes in Patients on Chronic Thyroid Hormone Replacement. 82: 1118-1125. 1997: Thyroid.

http://jcem.endojournals.org/content/82/8/2653.abstract

Al-Shoumer Kamal A. S., Cox Katharine H., Hughes Carol L., Richmond William and Johnston Desmond G. Fasting and Postprandial Lipid Abnormalities in Hypopituitary Women Receiving Conventional Replacement Therapy. 82: 2653-2659. 1997: Lipids.

http://jcem.endojournals.org/content/82/2/638.abstract

Andersson Bjorn, Mattsson Lars-Ãke, Hahn Lennart, Marin Per, Lapidus Leif, Holm Goran, Bengtsson Bengt-Ake and Bjorntorp Per. Estrogen Replacement Therapy Decreases Hyperandrogenicity and Improves Glucose Homeostasis and Plasma Lipids in Postmenopausal Women With Noninsulin-Dependent Diabetes Mellitus. 82: 638-643. 1997: Estrogen.

http://jcem.endojournals.org/content/82/7/2076.abstract

Argente J., Caballo N., Barrios V., Pozo J., Munoz M. T., Chowen J. A. and HernÃ¡ndez M. Multiple Endocrine Abnormalities of the Growth Hormone and Insulin-Like Growth Factor Axis in Prepubertal Children with Exogenous Obesity: Effect of Short- and Long-Term Weight Reduction. 82: 2076-2083. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/10/3213.abstract

Arslanian Silva and Suprasongsin Chittiwat. Testosterone Treatment in Adolescents with Delayed Puberty: Changes in Body Composition, Protein, Fat, and Glucose Metabolism. 82: 3213-3220. 1997: Testosterone.

http://jcem.endojournals.org/content/82/1/82.abstract

Attanasio Andrea F., Lamberts Steven W.J., Matranga Anna M.C., Birkett Martin A., Bates Peter C., Valk Nick K., Hilsted Jannik, Bengtsson Bengt-Ã…ke, Strasburger Christian J. and Group The Adult Growth Hormone Deficiency Study. Adult Growth Hormone (GH)-Deficient Patients Demonstrate Heterogeneity Between Childhood Onset and Adult Onset Before and During Human GH Treatment. 82: 82-88. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/10/3187.abstract

Barkan Ariel L., Halasz Ildiko, Dornfeld Kenneth J., Jaffe Craig A., Friberg Roberta DeMott, Chandler William F. and Sandler Howard M. Pituitary Irradiation Is Ineffective in Normalizing Plasma Insulin-Like Growth Factor I in Patients with Acromegaly. 82: 3187-3191. 1997: Acromegaly.

http://jcem.endojournals.org/content/82/9/2931.abstract

Bauer Douglas C., Nevitt Michael C., Ettinger Bruce and Stone Katie. Low Thyrotropin Levels Are Not Associated with Bone Loss in Older Women: A Prospective Study. 82: 2931-2936. 1997: Thyroid.

http://jcem.endojournals.org/content/82/8/2528.abstract

Berneis Kaspar, Ninnis Ronald, Girard Jorg, Frey Brigitte M. and Keller Ulrich. Effects of Insulin-Like Growth Factor I Combined with Growth Hormone on Glucocorticoid-Induced Whole-Body Protein Catabolism in Man. 82: 2528-2534. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/1/3.short

Bhasin Shalender and Bremner William J. Emerging Issues in Androgen Replacement Therapy. 82: 3-8. 1997: Androgen.

http://jcem.endojournals.org/content/82/9/2904.abstract

Blum Werner F., Englaro Piera, Hanitsch Sigrid, Juul Anders, Hertel Niels T., MÃ¼ller Jorn, SkakkebÃ¦k Niels E., Heiman Mark L., Birkett Martin, Attanasio Andrea M., Kiess Wieland and Rascher Wolfgang. Plasma Leptin Levels in Healthy Children and Adolescents: Dependence on Body Mass Index, Body Fat Mass, Gender, Pubertal Stage, and Testosterone. 82: 2904-2910. 1997: Leptin.

http://jcem.endojournals.org/content/82/1/265.abstract

Bone Henry G., Downs Robert W., Tucci Joseph R., Harris Steven T., Weinstein Robert S., Licata Angelo A., McClung Michael R., Kimmel Donald B., Gertz Barry J., Hale Erika, Polvino William J. and Centers for the Alendronate Elderly Osteoporosis Study. Dose-Response Relationships for Alendronate Treatment in Osteoporotic Elderly Women. 82: 265-274. 1997: Bone.

http://jcem.endojournals.org/content/82/8/2423.abstract

Boot Annemieke M., Engels Melanie A. M. J., Boerma Geert J. M., Krenning Eric P. and de Muinck Keizer-Schrama Sabine M. P. F. Changes in Bone Mineral Density, Body Composition, and Lipid Metabolism during Growth Hormone (GH) Treatment in Children with GH Deficiency. 82: 2423-2428. 1997: Bone.

http://jcem.endojournals.org/content/82/1/243.abstract

Bowes Susan B., Umpleby Margot, Cummings Michael H., Jackson Nicola C., Carroll Paul V., Lowy Clara, Sonksen Peter H. and Russell-Jones David L. The Effect of Recombinant Human Growth Hormone on Glucose and Leucine Metabolism in Cushingâ€™s Syndrome. 82: 243-246. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/6/1818.abstract

Bravenboer Nathalie, Holzmann Paulien, de Boer Hans, Roos Jan C., van der Veen Eduard A. and Lips Paul. The Effect of Growth Hormone (GH) on Histomorphometric Indices of Bone Structure and Bone Turnover in GH-Deficient Men. 82: 1818-1822. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/9/2771.short

Bray George A. and York David A. Leptin and Clinical Medicine: A New Piece in the Puzzle of Obesity. 82: 2771-2776. 1997: Obesity.

http://jcem.endojournals.org/content/82/2/550.abstract

Burman Pia, Johansson Anna G., Siegbahn Agneta, Vessby Bengt and Karlsson F. Anders. Growth Hormone (GH)-Deficient Men Are More Responsive to GH Replacement Therapy Than Women. 82: 550-555. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/2/585.abstract

Butte N. F., Hopkinson J. M. and Nicolson M. A. Leptin in Human Reproduction: Serum Leptin Levels in Pregnant and Lactating Women. 82: 585-589. 1997: Leptin.

http://jcem.endojournals.org/content/82/12/3955.abstract

Campos Hannia, Walsh Brian W., Judge Helena and Sacks Frank M. Effect of Estrogen on Very Low Density Lipoprotein and Low Density Lipoprotein Subclass Metabolism in Postmenopausal Women. 82: 3955-3963. 1997: Estrogen/Lipids.

http://jcem.endojournals.org/content/82/7/2117.abstract

Carel Jean-Claude, Tresca Jean-Pierre, Letrait Muriel, Chaussain Jean-Louis, Lebouc Yves, Job Jean-Claude and Coste Joel. Growth Hormone Testing for the Diagnosis of Growth Hormone Deficiency in Childhood: A Population Register-Based Study. 82: 2117-2121. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/1/18.abstract

Caron Philippe, Morange-Ramos Isabelle, Cogne Muriel and Jaquet Philippe. Three Year Follow-Up of Acromegalic Patients Treated with Intramuscular Slow-Release Lanreotide. 82: 18-22. 1997: Acromegaly.

http://jcem.endojournals.org/content/82/12/3989.abstract

Cassorla Fernando, Mericq Veronica, Eggers Martha, Avila Alejandra, GarcÃa Cristian, Fuentes Ariel, Rose Susan R. and Cutler Gordon B. Effects of Luteinizing Hormone-Releasing Hormone Analog-Induced Pubertal Delay in Growth Hormone (GH)-Deficient Children Treated with GH: Preliminary Results. 82: 3989-3992. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/11/3637.abstract

Chiu Alice C., Delpassand Ebrahim S. and Sherman Steven I. Prognosis and Treatment of Brain Metastases in Thyroid Carcinoma. 82: 3637-3642. 1997: Thyroid.

http://jcem.endojournals.org/content/82/2/329.short

Chopra Inder J. Euthyroid Sick Syndrome: Is It a Misnomer? 82: 329-334. 1997: Thyroid.

http://jcem.endojournals.org/content/82/9/2985.abstract

Christ E. R., Cummings M. H., Westwood N. B., Sawyer B. M., Pearson T. C., Sonksen P. H. and Russell-Jones D. L. The Importance of Growth Hormone in the Regulation of Erythropoiesis, Red Cell Mass, and Plasma Volume in Adults with Growth Hormone Deficiency. 82: 2985-2990. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/10/3308.abstract

Colao Annamaria, Ferone Diego, Cappabianca Paolo, del Basso De Caro Maria Laura, Marzullo Paolo, Monticelli Arianna, Alfieri Alessandra, Merola Bartolomeo, CalÃŒ Antonio, de Divitiis Enrico and Lombardi Gaetano. Effect of Octreotide Pretreatment on Surgical Outcome in Acromegaly. 82: 3308-3314. 1997: Acromegaly.

http://jcem.endojournals.org/content/82/9/2777.short

Colao Annamaria, Merola Bartolomeo, Ferone Diego and Lombardi Gaetano. Acromegaly. 82: 2777-2781. 1997: Acromegaly.

http://jcem.endojournals.org/content/82/9/2821.abstract

Dagogo-Jack Samuel, Al-Ali Nadia and Qurttom Mohammed. Augmentation of Bone Mineral Density in Hirsute Women. 82: 2821-2825. 1997: Hirsutism.

http://jcem.endojournals.org/content/82/9/2885.abstract

degli Uberti Ettore C., Ambrosio Maria R., Cella Silvano G., Margutti Angelo R., Trasforini Giorgio, Rigamonti Antonello E., Petrone Emilio and MÃ¼ller Eugenio E. Defective Hypothalamic Growth Hormone (GH)-Releasing Hormone Activity May Contribute to Declining GH Secretion with Age in Man. 82: 2885-2888. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/7/2182.abstract

DeRijk Roel, Michelson David, Karp Brian, Petrides John, Galliven Elise, Deuster Patty, Paciotti Giulio, Gold Philip W. and Sternberg Esther M. Exercise and Circadian Rhythm-Induced Variations in Plasma Cortisol Differentially Regulate Interleukin-1Î² (IL-1Î²), IL-6, and Tumor Necrosis Factor-Î± (TNFÎ±) Production in Humans: High Sensitivity of TNFÎ± and Resistance of IL-6. 82: 2182-2191. 1997: Cortisol.

http://jcem.endojournals.org/content/82/1/234.abstract

Deuschle Michael, Schweiger Ulrich, Weber Bettina, Gotthardt Ulrike, KÃ¶rner Andreas, Schmider Jurgen, Standhardt Harald, Lammers Claas-Hinrich and Heuser Isabella. Diurnal Activity and Pulsatility of the Hypothalamus-Pituitary-Adrenal System in Male Depressed Patients and Healthy Controls. 82: 234-238. 1997: Pituitary.

http://jcem.endojournals.org/content/82/4/1147.abstract

Ek Ingvar, Arner Peter, Bergqvist Agneta, Carlstrom Kjell and Wahrenberg Hans. Impaired Adipocyte Lipolysis in Nonobese Women with the Polycystic Ovary Syndrome: A Possible Link to Insulin Resistance? 82: 1147-1153. 1997: PCOS.

http://jcem.endojournals.org/content/82/4/1243.abstract

Elias Lucila L. K., Antunes-Rodrigues Jose, Elias Paula C. L. and Moreira Ayrton C. Effect of Plasma Osmolality on Pituitary-Adrenal Responses to Corticotropin-Releasing Hormone and Atrial Natriuretic Peptide Changes in Central Diabetes Insipidus. 82: 1243-1247. 1997: Adrenal.

http://jcem.endojournals.org/content/82/5/1549.abstract

Espeland Mark A., Stefanick Marcia L., Kritz-Silverstein Donna, Fineberg S. Edwin, Waclawiw Myron A., James Margaret K. and Greendale Gail A. Effect of Postmenopausal Hormone Therapy on Body Weight and Waist and Hip Girths. 82: 1549-1556. 1997: HRT.

http://jcem.endojournals.org/content/82/1/23.abstract

Flogstad Anette Kvistborg, Halse Johan, Bakke Soren, Lancranjan Ioana, Marbach P., Bruns Ch. and Jervell Jak. Sandostatin LAR in Acromegalic Patients: Long Term Treatment. 82: 23-28. 1997: Acromegaly.

http://jcem.endojournals.org/content/82/11/3710.abstract

Fryburg David A., Weltman Arthur, Jahn Linda A., Weltman Judy Y., Samojlik Eugene, Hintz Raymond L. and Veldhuis Johannes D. Short-Term Modulation of the Androgen Milieu Alters Pulsatile, But Not Exercise- or Growth Hormone (GH)-Releasing Hormone-Stimulated GH Secretion in Healthy Men: Impact of Gonadal Steroid and GH Secretory Changes on Metabolic Outcomes. 82: 3710-3719. 1997: Androgen.

http://jcem.endojournals.org/content/82/1/281.abstract

Fuleihan Ghada El-Hajj, Klerman Elizabeth B., Brown Emery N., Choe Yong, Brown Edward M. and Czeisler Charles A. The Parathyroid Hormone Circadian Rhythm Is Truly Endogenous-A General Clinical Research Center Study. 82: 281-286. 1997: Parathyroid.

http://jcem.endojournals.org/content/82/2/644.abstract

Fulghesu Anna Maria, Villa Paola, Pavone Virginia, Guido Maurizio, Apa Rosanna, Caruso Alessandro, Lanzone Antonio, Rossodivita Aurora and Mancuso Salvatore. The Impact of Insulin Secretion on the Ovarian Response to Exogenous Gonadotropins in Polycystic Ovary Syndrome. 82: 644-648. 1997: PCOS.

http://jcem.endojournals.org/content/82/2/414.abstract

Gambacciani M., Ciaponi M., Cappagli B., Piaggesi L., De Simone L., Orlandi R. and Genazzani A. R. Body Weight, Body Fat Distribution, and Hormonal Replacement Therapy in Early Postmenopausal Women. 82: 414-417. 1997: HRT.

http://jcem.endojournals.org/content/82/9/2849.abstract

Garcia-Mayor Ricardo V., Andrade M. Amalia, Rios Monserrat, Lage Mary, Dieguez Carlos and Casanueva Felipe F. Serum Leptin Levels in Normal Children: Relationship to Age, Gender, Body Mass Index, Pituitary-Gonadal Hormones, and Pubertal Stage. 82: 2849-2855. 1997: Leptin.

http://jcem.endojournals.org/content/82/12/3926.abstract

Girgis Rose and Winter Jeremy S.D. The Effects of Glucocorticoid Replacement Therapy on Growth, Bone Mineral Density, and Bone Turnover Markers in Children with Congenital Adrenal Hyperplasia. 82: 3926-3929. 1997: Cortisol.

http://jcem.endojournals.org/content/82/6/1960.abstract

Gittoes Neil J. L., McCabe Christopher J., Verhaeg Julie, Sheppard Michael C. and Franklyn Jayne A. Thyroid Hormone and Estrogen Receptor Expression in Normal Pituitary and Nonfunctioning Tumors of the Anterior Pituitary. 82: 1960-1967. 1997: Pituitary.

http://jcem.endojournals.org/content/82/8/2570.abstract

Gravholt Claus HÃ¸jbjerg, Naeraa Rune Weis, Fisker Sanne and Christiansen Jens Sandahl. Body Composition and Physical Fitness Are Major Determinants of the Growth Hormone-Insulin-Like Growth Factor Axis Aberrations in Adult Turnerâ€™s Syndrome, with Important Modulations by Treatment with 17Î²-Estradiol. 82: 2570-2577. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/3/870.abstract

Grebe Stefan K. G., Cooke Russell R., Ford Henry C., Fagerstrom Jocelyn N., Cordwell Diane P., Lever Nigel A., Purdie Gordon L. and Feek Colin M. Treatment of Hypothyroidism with Once Weekly Thyroxine. 82: 870-875. 1997: Thyroid.

http://jcem.endojournals.org/content/82/2/658.abstract

Guo Chun-Yuan, Jones T. Hugh and Eastell Richard. Treatment of Isolated Hypogonadotropic Hypogonadism Effect on Bone Mineral Density and Bone Turnover. 82: 658-665. 1997: Bone.

http://jcem.endojournals.org/content/82/6/1807.abstract

Haffner Steven M., Miettinen Heikki, KarhapÃ¤Ã¤ Pauli, MykkÃ¤nen Leena and Laakso Markku. Leptin Concentrations, Sex Hormones, and Cortisol in Nondiabetic Men. 82: 1807-1809. 1997: Leptin.

http://jcem.endojournals.org/content/82/4/991.abstract

Han Ki Ok, Moon In Gul, Kang Young Soon, Chung Ho Yeon, Min Hun Ki and Han In Kwon. Nonassociation of Estrogen Receptor Genotypes with Bone Mineral Density and Estrogen Responsiveness to Hormone Replacement Therapy in Korean Postmenopausal Women. 82: 991-995. 1997: Estrogen.

http://jcem.endojournals.org/content/82/10/3281.abstract

Harigaya Akira, Nagashima Kanji, Nako Yasushi and Morikawa Akihiro. Relationship between Concentration of Serum Leptin and Fetal Growth. 82: 3281-3284. 1997: Leptin.

http://jcem.endojournals.org/content/82/8/2689.abstract

Hauguel-de Mouzon S., Challier J. C., Kacemi A., CaÃ¼zac M., Malek A. and Girard J. The GLUT3 Glucose Transporter Isoform Is Differentially Expressed within Human Placental Cell Types. 82: 2689-2694. 1997: Diabetes.

http://jcem.endojournals.org/content/82/8/2476.abstract

Heikkinen Anna-Mari, Parviainen Markku, Niskanen Leo, Komulainen Marja, Tuppurainen Marjo T., Kroger Heikki and Saarikoski Seppo. Biochemical Bone Markers and Bone Mineral Density during Postmenopausal Hormone Replacement Therapy with and without Vitamin D3: A Prospective, Controlled, Randomized Study. 82: 2476-2482. 1997: Bone.

http://jcem.endojournals.org/content/82/3/900.abstract

Henry Jean G., Mitnick Maryann, Dann Pamela R. and Stewart Andrew F. Parathyroid Hormone-Related Protein-(1-36) Is Biologically Active When Administered Subcutaneously to Humans. 82: 900-906. 1997: Parathyroid.

http://jcem.endojournals.org/content/82/2/620.abstract

Hodsman A. B., Fraher L. J., Watson P. H., Ostbye T., Stitt L. W., Adachi J. D., Taves D. H. and Drost D. A Randomized Controlled Trial to Compare the Efficacy of Cyclical Parathyroid Hormone Versus Cyclical Parathyroid Hormone and Sequential Calcitonin to Improve Bone Mass in Postmenopausal Women with Osteoporosis. 82: 620-628. 1997: Parathyroid.

http://jcem.endojournals.org/content/82/4/1111.abstract

Holloway Leah, Kohlmeier Lynn, Kent Kyla and Marcus Robert. Skeletal Effects of Cyclic Recombinant Human Growth Hormone and Salmon Calcitonin in Osteopenic Postmenopausal Women. 82: 1111-1117. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/10/3285.abstract

Hwu Chii-Min, Kwok Ching Fai, Lai Tzong-Yoe, Shih Kuang-Chung, Lee Tian-Shing, Hsiao Li-Chuan, Lee Sheng-Hung, Fang Victor S. and Ho Low-Tone. Growth Hormone (GH) Replacement Reduces Total Body Fat and Normalizes Insulin Sensitivity in GH-Deficient Adults: A Report of One-Year Clinical Experience. 82: 3285-3292. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/4/1261.abstract

Iraki L., Bogdan A., Hakkou F., Amrani N., Abkari A. and Touitou Y. Ramadan Diet Restrictions Modify the Circadian Time Structure in Humans. A Study on Plasma Gastrin, Insulin, Glucose, and Calcium and on Gastric pH. 82: 1261-1273. 1997: Ramadan.

http://jcem.endojournals.org/content/82/9/2809.abstract

Janssen J. A. M. J. L., Jacobs M. L., Derkx F. H. M., Weber R. F. A., van der Lely A. J. and Lamberts S. W. J. Free and Total Insulin-Like Growth Factor I (IGF-I), IGF-Binding Protein-1 (IGFBP-1), and IGFBP-3 and Their Relationships to the Presence of Diabetic Retinopathy and Glomerular Hyperfiltration in Insulin-Dependent Diabetes Mellitus. 82: 2809-2815. 1997: Diabetes.

http://jcem.endojournals.org/content/82/1/129.abstract

Janssen Y. J. H., Frolich M. and Roelfsema F. A Low Starting Dose of Genotropin in Growth Hormone-Deficient Adults. 82: 129-135. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/6/1989.abstract

Jodar Esteban, Munz-Torres Manuel, Escobar-Jimenez Fernando, Quesada Miguel, Luna Juan D. and Olea NicolÃ¡s. Antiresorptive Therapy in Hyperthyroid Patients: Longitudinal Changes in Bone and Mineral Metabolism. 82: 1989-1994. 1997: Thyroid.

http://jcem.endojournals.org/content/82/3/727.abstract

Johannsson Gudmundur, MÃ¥rin Per, Lonn Lars, Ottosson Malin, Stenlof Kaj, Bjorntorp Per, Sjostrom Lars and Bengtsson Bengt-Ãke. Growth Hormone Treatment of Abdominally Obese Men Reduces Abdominal Fat Mass, Improves Glucose and Lipoprotein Metabolism, and Reduces Diastolic Blood Pressure. 82: 727-734. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/9/2795.abstract

Johansson Anna G., Eriksen Erik F., Lindh Erik, Langdahl Bente, Blum Werner F., Lindahl Anders, Ljunggren Ã–sten and Ljunghall Sverker. Reduced Serum Levels of the Growth Hormone-Dependent Insulin-Like Growth Factor Binding Protein and a Negative Bone Balance at the Level of Individual Remodeling Units in Idiopathic Osteoporosis in Men. 82: 2795-2798. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/8/2497.abstract

Juul Anders, Holm Kirsten, Kastrup Knud W., Pedersen Soren A., Michaelsen Kim Fleischer, Scheike Thomas, Rasmussen Susanne, MÃ¼ller JÃ¸rn and SkakkebÃ¦k Niels E. Free Insulin-Like Growth Factor I Serum Levels in 1430 Healthy Children and Adults, and Its Diagnostic Value in Patients Suspected of Growth Hormone Deficiency. 82: 2497-2502. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/12/4049.abstract

Kahaly George, Dienes Hans Peter, Beyer Jurgen and Hommel Gerhard. Randomized, Double Blind, Placebo-Controlled Trial of Low Dose Iodide in Endemic Goiter. 82: 4049-4053. 1997: Goitre.

http://jcem.endojournals.org/content/82/9/2792.short

Khosla Sundeep. Idiopathic Osteoporosis: Is the Osteoblast To Blame? 82: 2792-2794. 1997: Bone.

http://jcem.endojournals.org/content/82/5/1522.abstract

Khosla Sundeep, Atkinson Elizabeth J., Melton L. Joseph and Riggs B. Lawrence. Effects of Age and Estrogen Status on Serum Parathyroid Hormone Levels and Biochemical Markers of Bone Turnover in Women: A Population-Based Study. 82: 1522-1527. 1997: Parathyroid.

http://jcem.endojournals.org/content/82/6/1953.abstract

Kim Won Bae, Chung Hyun Kyung, Lee Hong Kyu, Kohn Leonard D., Tahara Kazuo and Cho Bo Youn. Changes in Epitopes for Thyroid-Stimulating Antibodies in Gravesâ€™ Disease Sera During Treatment of Hyperthyroidism: Therapeutic Implications. 82: 1953-1959. 1997: Thyroid.

http://jcem.endojournals.org/content/82/11/3625.abstract

King Joseph T., Justice Amy C. and Aron David C. Management of Incidental Pituitary Microadenomas: A Cost-Effectiveness Analysis. 82: 3625-3632. 1997: Pituitary.

http://jcem.endojournals.org/content/82/12/3923.short

Kleerekoper M., Schiebinger R. and Gutai J. P. Steroid Therapy for Adrenal Disorders: Getting the Dose Right. 82: 3923-3925. 1997: Adrenal.

http://jcem.endojournals.org/content/82/12/3952.short

Knopp Robert H. and Zhu Xiaodong. Multiple Beneficial Effects of Estrogen on Lipoprotein Metabolism. 82: 3952-3954. 1997: Estrogen.

http://jcem.endojournals.org/content/82/9/2799.abstract

Kurland Etah S., Rosen Clifford J., Cosman Felicia, McMahon Donald, Chan Fredriech, Shane Elizabeth, Lindsay Robert, Dempster David and Bilezikian John P. Insulin-Like Growth Factor-I in Men with Idiopathic Osteoporosis. 82: 2799-2805. 1997: Bone.

http://jcem.endojournals.org/content/82/10/3498.abstract

Labrie Fernand, Diamond Pierre, Cusan Leonello, Gomez Jose-Luis, BÃ©langer Alain and Candas Bernard. Effect of 12-Month Dehydroepiandrosterone Replacement Therapy on Bone, Vagina, and Endometrium in Postmenopausal Women. 82: 3498-3505. 1997: Bone.

http://jcem.endojournals.org/content/82/6/1692.abstract

Laughlin G. A., Morales A. J. and Yen S. S. C. Serum Leptin Levels in Women with Polycystic Ovary Syndrome: The Role of Insulin Resistance/ Hyperinsulinemia. 82: 1692-1696. 1997: Leptin.

http://jcem.endojournals.org/content/82/12/3930.short

Levine Michael A. and Ringel Matthew D. Resistance to TSH in Patients with Normal TSH Receptors-Where Do We Turn When "Sutton's Law Proves False?". 82: 3930-3932. 1997: Thyroid.

http://jcem.endojournals.org/content/82/1/151.abstract

Lin Ching-Ling, Wu Ta-Jen, Machacek Dwaine A., Jiang Nai-Siang and Kao Pai C. Urinary Free Cortisol and Cortisone Determined by High Performance Liquid Chromatography in the Diagnosis of Cushingâ€™s Syndrome. 82: 151-155. 1997: Cortisol.

http://jcem.endojournals.org/content/82/11/3553.abstract

Loh Keh-Chuan, Greenspan Francis S., Gee Lauren, Miller Theodore R. and Yeo Peter P. B. Pathological Tumor-Node-Metastasis (pTNM) Staging for Papillary and Follicular Thyroid Carcinomas: A Retrospective Analysis of 700 Patients. 82: 3553-3562. 1997: Thyroid.

http://jcem.endojournals.org/content/82/4/1047.abstract

Lopez-Velasco Rosario, Escobar-Morreale HÃ©ctor F., Vega BelÃ©n, Villa Eduardo, Sancho JosÃ© M., Moya-Mur JosÃ© Luis and GarcÃa-Robles Rafael. Cardiac Involvement in Acromegaly: Specific Myocardiopathy or Consequence of Systemic Hypertension? 82: 1047-1053. 1997: Acromegaly.

http://jcem.endojournals.org/content/82/3/765.abstract

Lovejoy Jennifer C., Smith Steven R., Bray George A., DeLany James P., Rood Jennifer C., Gouvier Drew, Windhauser Marlene, Ryan Donna H., Macchiavelli Raul and Tulley Richard. A Paradigm of Experimentally Induced Mild Hyperthyroidism: Effects on Nitrogen Balance, Body Composition, and Energy Expenditure in Healthy Young Men. 82: 765-770. 1997: Thyroid.

http://jcem.endojournals.org/content/82/6/1687.abstract

Mantzoros Christos S., Dunaif Andrea and Flier Jeffrey S. Leptin Concentrations in the Polycystic Ovary Syndrome. 82: 1687-1691. 1997: Leptin.

http://jcem.endojournals.org/content/82/8/2466.abstract

Mao Catherine S., Riegelhuth Mary Elizabeth, Van Gundy Deborah, Cortez Colleen, Melendez Sunny and Ipp Eli. An Overnight Insulin Infusion Algorithm Provides Morning Normoglycemia and Can Be Used to Predict Insulin Requirements in Noninsulin-Dependent Diabetes Mellitus. 82: 2466-2470. 1997: Diabetes.

http://jcem.endojournals.org/content/82/8/2542.abstract

Masuzaki Hiroaki, Ogawa Yoshihiro, Hosoda Kiminori, Miyawaki Takashi, Hanaoka Ikuko, Hiraoka Junko, Yasuno Akiko, Nishimura Haruo, Yoshimasa Yasunao, Nishi Shigeo and Nakao Kazuwa. Glucocorticoid Regulation of Leptin Synthesis and Secretion in Humans: Elevated Plasma Leptin Levels in Cushingâ€™s Syndrome. 82: 2542-2547. 1997: Leptin.

http://jcem.endojournals.org/content/82/10/3239.abstract

Matkovic Velimir, Ilich Jasminka Z., Skugor Mario, Badenhop Nancy E., Goel Prem, Clairmont Albert, Klisovic Dino, Nahhas Ramzi W. and Landoll John D. Leptin Is Inversely Related to Age at Menarche in Human Females. 82: 3239-3245. 1997: Leptin.

http://jcem.endojournals.org/content/82/3/777.abstract

Melegos Dimitrios N., Yu He, Ashok Mala, Wang Chun, Stanczyk Frank and Diamandis Eleftherios P. Prostate-Specific Antigen in Female Serum, a Potential New Marker of Androgen Excess. 82: 777-780. 1997: Androgen.

http://jcem.endojournals.org/content/82/9/2806.short

Merimee Thomas. The Interface Between Diabetic Retinopathy, Diabetes Management, and Insulin-Like Growth Factors. 82: 2806-2808. 1997: Diabetes.

http://jcem.endojournals.org/content/82/9/2784.abstract

Meunier P. J., Confavreux E., Tupinon I., Hardouin C., Delmas P. D. and Balena R. Prevention of Early Postmenopausal Bone Loss with Cyclical Etidronate Therapy (A Double-Blind, Placebo-Controlled Study and 1-Year Follow-Up). 82: 2784-2791. 1997: Bone.

http://jcem.endojournals.org/content/82/11/3543.abstract

Mijatovic V., Kenemans P., Netelenbos J. C., Peters-Muller E. R. A., van Kamp G. J., Voetberg G. A., van de Weijer P. H. M. and van der Mooren M. J. Oral 17Î²-Estradiol Continuously Combined with Dydrogesterone Lowers Serum Lipoprotein(a) Concentrations in Healthy Postmenopausal Women. 82: 3543-3547. 1997: Estrogen.

http://jcem.endojournals.org/content/82/11/3633.abstract

Momotani Naoko, Yoshimura Noh Jaeduk, Ishikawa Naofumi and Ito Kunihiko. Effects of Propylthiouracil and Methimazole on Fetal Thyroid Status in Mothers with Gravesâ€™ Hyperthyroidism. 82: 3633-3636. 1997: Thyroid.

http://jcem.endojournals.org/content/82/10/3315.abstract

Monzani Fabio, Caraccio Nadia, Siciliano Gabriele, Manca Laura, Murri Luigi and Ferrannini Eleuterio. Clinical and Biochemical Features of Muscle Dysfunction in Subclinical Hypothyroidism. 82: 3315-3318. 1997: Thyroid.

http://jcem.endojournals.org/content/82/9/3074.abstract

Nader Shahla, Riad-Gabriel Maggy G. and Saad Mohammed F. The Effect of a Desogestrel-Containing Oral Contraceptive on Glucose Tolerance and Leptin Concentrations in Hyperandrogenic Women. 82: 3074-3077. 1997: Leptin.

http://jcem.endojournals.org/content/82/4/989.short

Nelson Dorothy A. and Kleerekoper M.D. Michael. The Search for the Osteoporosis Gene. 82: 989-990. 1997: Bone.

http://jcem.endojournals.org/content/82/1/176.abstract

Newell-Price John, Perry Les, Medbak Sami, Monson John, Savage Martin, Besser Michael and Grossman Ashley. A Combined Test Using Desmopressin and Corticotropin-Releasing Hormone in the Differential Diagnosis of Cushing's Syndrome. 82: 176-181. 1997: Cushings.

http://jcem.endojournals.org/content/82/1/315.abstract

Nicklas Barbara J., Toth Michael J., Goldberg Andrew P. and Poehlman Eric T. Racial Differences in Plasma Leptin Concentrations in Obese Postmenopausal Women. 82: 315-317. 1997: Leptin.

http://jcem.endojournals.org/content/82/2/359.short

Norton Jeffrey A., D. M. and Wells Samuel A. The Surgical Management of Patients with Multiple Endocrine Neoplasia Type 1. 82: 359-361. 1997: MEN1.

http://jcem.endojournals.org/content/82/3/812.abstract

Nye Elisabeth J., Hockings Gregory I., Grice Jeffery E., Torpy David J., Walters Margaret M., Crosbie Georgina V., Wagenaar Monica, Cooper Michael and Jackson Richard V. Aspirin Inhibits Vasopressin-Induced Hypothalamic-Pituitary-Adrenal Activity in Normal Humans. 82: 812-817. 1997: Adrenal.

http://jcem.endojournals.org/content/82/9/2926.abstract

Nygaard Birte, Knudsen Jens Helmer, Hegedus Laszlo, Scient Annegrete Veje Cand and MÃ¸lholm Hansen Jens Erik. Thyrotropin Receptor Antibodies and Graves' Disease, a Side-Effect of 131I Treatment in Patients with Nontoxic Goiter. 82: 2926-2930. 1997: Thyroid.

http://jcem.endojournals.org/content/82/7/2177.abstract

Nyomba B. L. Gragoire, Berard Lori and Murphy Liam J. Free Insulin-Like Growth Factor I (IGF-I) in Healthy Subjects: Relationship with IGF-Binding Proteins and Insulin Sensitivity. 82: 2177-2181. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/9/2915.abstract

Okazaki Ryo, Totsuka Yasuo, Hamano Kumiko, Ajima Miho, Miura Masakazu, Hirota Yoshiko, Hata Keishi, Fukumoto Seiji and Matsumoto Toshio. Metabolic Improvement of Poorly Controlled Noninsulin-Dependent Diabetes Mellitus Decreases Bone Turnover. 82: 2915-2920. 1997: Diabetes.

http://jcem.endojournals.org/content/82/10/3303.abstract

Osella G., Terzolo M., Reimondo G., Piovesan A., Pia A., Termine A., Paccotti P. and Angeli A. Serum Markers of Bone and Collagen Turnover in Patients with Cushing's Syndrome and in Subjects with Adrenal Incidentalomas. 82: 3303-3307. 1997: Cushings.

http://jcem.endojournals.org/content/82/5/1635.abstract

Papaspyrou-Rao S., Schneider S. H., Petersen R. N. and Fried S. K. Dexamethasone Increases Leptin Expression in Humans in Vivo. 82: 1635-1637. 1997: Leptin.

http://jcem.endojournals.org/content/82/9/2836.abstract

Ramirez Luis, Braverman Lewis E., White Bernadette and Emerson Charles H. Recombinant Human Thyrotropin Is a Potent Stimulator of Thyroid Function in Normal Subjects. 82: 2836-2839. 1997: Thyroid.

http://jcem.endojournals.org/content/82/3/760.abstract

Roelen CornÃ© A. M., Koppeschaar Hans P. F., de Vries Wouter R., Snel Yvonne E. M., Doerga Manorath E., Zelissen Pierre M. J., Thijssen Jos H. H. and Blankenstein Marinus A. Visceral Adipose Tissue Is Associated with Circulating High Affinity Growth Hormone-Binding Protein. 82: 760-764. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/9/2782.short

Rosen Clifford. Evolving Toward a New Paradigm for Prevention of Osteoporosis- The Time Is Upon Us. 82: 2782-2783. 1997: Bone.

http://jcem.endojournals.org/content/82/6/1904.abstract

Rosen Clifford J., Chesnut Charles H. and Mallinak Nancy J. S. The Predictive Value of Biochemical Markers of Bone Turnover for Bone Mineral Density in Early Postmenopausal Women Treated with Hormone Replacement or Calcium Supplementation. 82: 1904-1910. 1997: Bone.

http://jcem.endojournals.org/content/82/11/3647.abstract

Rosenbaum Michael, Nicolson Margery, Hirsch Jules, Murphy Ellen, Chu Florence and Leibel Rudolph L. Effects of Weight Change on Plasma Leptin Concentrations and Energy Expenditure. 82: 3647-3654. 1997: Leptin.

http://jcem.endojournals.org/content/82/2/349.short

Rosenfeld Ron G. and D. M. Is Growth Hormone Deficiency a Viable Diagnosis? 82: 349-351. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/6/1697.abstract

Rouru Juha, Anttila Leena, Koskinen Pertti, PenttilÃ¤ Tuula-Anneli, Irjala Kerttu, Huupponen Risto and Koulu Markku. Serum Leptin Concentrations in Women with Polycystic Ovary Syndrome. 82: 1697-1700. 1997: Leptin.

http://jcem.endojournals.org/content/82/5/1325.abstract

Schipper IzaÃ¤k, Rommerts Focko F. G., ten Hacken Paulien M. and Fauser Bart C. J. M. Low Levels of Follicle-Stimulating Hormone Receptor-Activation Inhibitors in Serum and Follicular Fluid from Normal Controls and Anovulatory Patients with or without Polycystic Ovary Syndrome. 82: 1325-1331. 1997: Estrogen.

http://jcem.endojournals.org/content/82/3/717.short

Seibel Markus J. and Robins Simon P. Serum Undercarboxylated Osteocalcin and the Risk of Hip Fracture. 82: 717-718. 1997: Bone.

http://jcem.endojournals.org/content/82/6/1675.short

Shimon Ilan and Melmed Shlomo. Pituitary Tumor Pathogenesis. 82: 1675-1681. 1997: Pituitary.

http://jcem.endojournals.org/content/82/3/753.abstract

Siddiqi A., Burrin J. M., Noonan K., James I., Wood D. F., Price C. P. and Monson J. P. A Longitudinal Study of Markers of Bone Turnover in Graves' Disease and Their Value in Predicting Bone Mineral Density. 82: 753-759. 1997: Thyroid.

http://jcem.endojournals.org/content/82/6/1661.abstract

Sih Rahmawati, Morley John E., Kaiser Fran E., Perry Horace M., Patrick Ping and Ross Candie. Testosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial. 82: 1661-1667. 1997: Testosterone.

http://jcem.endojournals.org/content/82/2/682.abstract

Simon Dominique, Charles Marie-Aline, Nahoul Khalil, Orssaud Genevieve, Kremski Jacqueline, Hully Veronique, Joubert Evelyne, Papoz Laure and Eschwege Eveline. Association between Plasma Total Testosterone and Cardiovascular Risk Factors in Healthy Adult Men: The Telecom Study. 82: 682-685. 1997: Testosterone.

http://jcem.endojournals.org/content/82/9/2826.abstract

Smith Margaret L., Hua Xiao-Yun, Marsden Deborah L., Liu Dou, Kennaway Nancy G., Ngo Kim-Yen and Haas Richard H. Diabetes and Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-Like Episodes (MELAS): Radiolabeled Polymerase Chain Reaction Is Necessary for Accurate Detection of Low Percentages of Mutation. 82: 2826-2831. 1997: Diabetes.

http://jcem.endojournals.org/content/82/8/2552.abstract

Solini Anna, Bonora Enzo, Bonadonna Riccardo, Castellino Pietro and DeFronzo Ralph A. Protein Metabolism in Human Obesity: Relationship with Glucose and Lipid Metabolism and with Visceral Adipose Tissue. 82: 2552-2558. 1997: Obesity.

http://jcem.endojournals.org/content/82/7/2037.abstract

Stratakis Constantine A., Courcoutsakis Nikos A., Abati Andrea, Filie Armando, Doppman John L., Carney J. Aidan and Shawker Thomas. Thyroid Gland Abnormalities in Patients with the Syndrome of Spotty Skin Pigmentation, Myxomas, Endocrine Overactivity, and Schwannomas (Carney Complex). 82: 2037-2043. 1997: Thyroid.

http://jcem.endojournals.org/content/82/4/1181.abstract

Thrailkill Kathryn, Quattrin Teresa, Baker Lester, Litton Jean, Dwigun Karen, Rearson Melissa, Poppenheimer Mary, Kotlovker Debbie, Giltinan David, Gesundheit Neil and Martha Paul. Dual Hormonal Replacement Therapy with Insulin and Recombinant Human Insulin-Like Growth Factor (IGF)-I in Insulin-Dependent Diabetes Mellitus: Effects on the Growth Hormone/IGF/IGF-Binding Protein System. 82: 1181-1187. 1997: Growth Hormone.

Journal of Clinical Endocrinology & Metabolism

Tobiume Hitoshi, Kanzaki Susumu, Hida Shigeki, Ono Taeko, Moriwake Tadashi, Yamauchi Shigeki, Tanaka Hiroyuki and Seino Yoshiki. Serum Bone Alkaline Phosphatase Isoenzyme Levels in Normal Children and Children with Growth Hormone (GH) Deficiency: A Potential Marker for Bone Formation and Response to GH Therapy. 82: 2056-2061. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/7/2056.abstract

http://jcem.endojournals.org/content/82/5/1462.abstract

Toogood Andrew A., Adams Judith E., O'Neill Paul A. and Shalet Stephen M. Elderly Patients with Adult-Onset Growth Hormone Deficiency Are Not Osteopenic. 82: 1462-1466. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/2/357.short

Veldhuis Johannes D. An Overview: Clinical Management for MEN I Patients. 82: 357-364. 1997: MEN1.

http://jcem.endojournals.org/content/82/10/3414.abstract

Veldhuis Johannes D., Metzger Daniel L., Martha Paul M., Mauras Nelly, Kerrigan James R., Keenan Bruce, Rogol Alan D. and Pincus Steve M. Estrogen and Testosterone, But Not a Nonaromatizable Androgen, Direct Network Integration of the Hypothalamo-Somatotrope (Growth Hormone)-Insulin-Like Growth Factor I Axis in the Human: Evidence from Pubertal Pathophysiology and Sex-Steroid Hormone Replacement. 82: 3414-3420. 1997: Estrogen.

http://jcem.endojournals.org/content/82/3/719.abstract

Vergnaud P., Garnero P., Meunier P. J., Breart G., Kamihagi K. and Delmas P. D. Undercarboxylated Osteocalcin Measured with a Specific Immunoassay Predicts Hip Fracture in Elderly Women: The EPIDOS Study. 82: 719-724. 1997: Bone.

http://jcem.endojournals.org/content/82/10/3278.abstract

Vgontzas Alexandros N., Bixler Edward O., Papanicolaou Dimitris A., Kales Anthony, Stratakis Constantine A., Vela-Bueno Antonio, Gold Philip W. and Chrousos George P. Rapid Eye Movement Sleep Correlates with the Overall Activities of the Hypothalamic-Pituitary-Adrenal Axis and Sympathetic System in Healthy Humans. 82: 3278-3280. 1997: Sleep.

http://jcem.endojournals.org/content/82/5/1589.abstract

Vierhapper H., Raber W., Bieglmayer C., Kaserer K., WeinhÃ¤usl A. and Niederle B. Routine Measurement of Plasma Calcitonin in Nodular Thyroid Diseases. 82: 1589-1593. 1997: Thyroid.

http://jcem.endojournals.org/content/82/2/361.short

Vinik Aaron, Perry Roger R. and FACS. The Role of Medical Therapy in Patients with Multiple Endocrine Neoplasia Type I. 82: 361-364. 1997: MEN1.

http://jcem.endojournals.org/content/82/9/3111.abstract

Wallace Euan M., Groome Nigel P., Riley Simon C., Parker Alistair C. and Wu Frederick C. W. Effects of Chemotherapy-Induced Testicular Damage on Inhibin, Gonadotropin, and Testosterone Secretion: A Prospective Longitudinal Study. 82: 3111-3115. 1997: Testosterone.

http://jcem.endojournals.org/content/82/8/2548.abstract

Wolzt Michael, Schmetterer Leopold, Dorner Guido, Zelger Georg, Entlicher Jesusa, Kapiotis Stylianos and Eichler Hans-Georg. Hemodynamic Effects of Parathyroid Hormone-Related Peptide-(1-34) in Humans. 82: 2548-2551. 1997: Parathyroid.

http://jcem.endojournals.org/content/82/8/2492.abstract

Yang I., Park S., Woo J., Kim S., Kim J., Kim Y. and Choi Y. Growth Hormone Response to the Hypothalamic Somatostatinergic Activity in Acromegalic Patients. 82: 2492-2496. 1997: Growth Hormone.

http://jcem.endojournals.org/content/82/12/4037.abstract

Yki-Jarvinen Hannele, Ryysy Leena, Kauppila Marjut, Kujansuu Eila, Lahti Jorma, Marjanen Tapani, Niskanen Leo, Rajala Sulo, Salo Seppo, Seppala Pentti, Tulokas Timo, Viikari Jorma and Taskinen Marja-Riitta. Effect of Obesity on the Response to Insulin Therapy in Noninsulin-Dependent Diabetes Mellitus. 82: 4037-4043. 1997: Obesity.

http://jcem.endojournals.org/content/82/8/2578.abstract

Young Jacques, Couzinet Beatrice, Nahoul Khalil, Brailly Sylvie, Chanson Philippe, Baulieu Etienne Emile and Schaison Gilbert. Panhypopituitarism as a Model to Study the Metabolism of Dehydroepiandrosterone (DHEA) in Humans. 82: 2578-2585. 1997: Androgens.

http://jcem.endojournals.org/content/82/3/771.abstract

Zulewski Henryk, Muller Beat, Exer Pascale, Miserez Andre R. and Staub Jean-Jacques. Estimation of Tissue Hypothyroidism by a New Clinical Score: Evaluation of Patients with Various Grades of Hypothyroidism and Controls. 82: 771-776. 1997: Thyroid.

http://jcem.endojournals.org/content/83/11/3845.abstract

Abdelhadi Mohamed and Nordenstrom Jorgen. Bone Mineral Recovery after Parathyroidectomy in Patients with Primary and Renal Hyperparathyroidism. 83: 3845-3851. 1998: Bone.

http://jcem.endojournals.org/content/83/10/3411.abstract

Abosch Aviva, Tyrrell J. Blake, Lamborn Kathleen R., Hannegan Lisa T., Applebury Carol B. and Wilson Charles B. Transsphenoidal Microsurgery for Growth Hormone-Secreting Pituitary Adenomas: Initial Outcome and Long-Term Results. 83: 3411-3418. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/4/1056.short

Abrams Steven A. Bone Turnover during Lactation Can Calcium Supplementation Make a Difference? 83: 1056-1058. 1998: Bone.

http://jcem.endojournals.org/content/83/2/374.abstract

Abs Roger, Verhelst Johan, Maiter Dominique, Van Acker Kristien, Nobels Frank, Coolens Jean-Luc, Mahler Charles and Beckers Albert. Cabergoline in the Treatment of Acromegaly: A Study in 64 Patients. 83: 374-378. 1998: Acromegaly.

http://jcem.endojournals.org/content/83/5/1615.abstract

Aimaretti G., Corneli G., Razzore P., Bellone S., Baffoni C., Arvat E., Camanni F. and Ghigo E. Comparison between Insulin-Induced Hypoglycemia and Growth Hormone (GH)-Releasing Hormone + Arginine as Provocative Tests for the Diagnosis of GH Deficiency in Adults. 83: 1615-1618. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/6/1921.abstract

Akesson Kristina, Lau K.-H. William, Johnston Patricia, Imperio Ellen and Baylink David J. Effects of Short-Term Calcium Depletion and Repletion on Biochemical Markers of Bone Turnover in Young Adult Women. 83: 1921-1927. 1998: Calcium & Bone Markers.

http://jcem.endojournals.org/content/83/6/1911.abstract

Alemzadeh Ramin, Langley Gina, Upchurch Lori, Smith Pam and Slonim Alfred E. Beneficial Effect of Diazoxide in Obese Hyperinsulinemic Adults. 83: 1911-1915. 1998: Obesity.

http://jcem.endojournals.org/content/83/8/2824.abstract

Allen David B., Julius Joanne R., Breen Timothy J., Attie Kenneth M. and Study on behalf of the National Cooperative Growth. Treatment of Glucocorticoid-Induced Growth Suppression with Growth Hormone. 83: 2824-2829. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/2/333.abstract

Amama Ernest A., Taga Michiyoshi and Minaguchi Hiroshi. The Effect of Gonadotropin-Releasing Hormone Agonist on Type I Collagen C-Telopeptide and N-Telopeptide: the Predictive Value of Biochemical Markers of Bone Turnover. 83: 333-338. 1998: Bone.

http://jcem.endojournals.org/content/83/5/1806.abstract

Andrew Ruth, Phillips David I. W. and Walker Brian R. Obesity and Gender Influence Cortisol Secretion and Metabolism in Man. 83: 1806. 1998: Obesity.

http://jcem.endojournals.org/content/83/6/1928.abstract

Arlt Wiebke, Justl Hans-Georg, Callies Frank, Reincke Martin, Habler Doris, Oettel Michael, Ernst Michael, Schulte Heinrich Maria and Allolio Bruno. Oral Dehydroepiandrosterone for Adrenal Androgen Replacement: Pharmacokinetics and Peripheral Conversion to Androgens and Estrogens in Young Healthy Females after Dexamethasone Suppression. 83: 1928-1934. 1998: Adrenal.

http://jcem.endojournals.org/content/83/5/1467.abstract

Attia Naja, Tamborlane William V., Heptulla Rubina, Maggs David, Grozman Aida, Sherwin Robert S. and Caprio Sonia. The Metabolic Syndrome and Insulin-Like Growth Factor I Regulation in Adolescent Obesity. 83: 1467-1471. 1998: Obesity.

Bagatell C. J. and Bremner W. J. V. The Effects of Aging and Testosterone on Lipids and Cardiovascular Risk. 83: 3440-3441. 1998: Testosterone http://jcem.endojournals.org/content/83/10/3440.short

http://jcem.endojournals.org/content/83/10/3436.short

Bagatell C. J. and Bremner W. J. II. Changes in Reproductive Hormones During the Aging Process. 83: 3436. 1998: Estrogen.

http://jcem.endojournals.org/content/83/1/6.abstract

Baker Valerie L., Draper Michael, Paul Sofia, Allerheiligen Sandy, Glant Michael, Shifren Jan and Jaffe Robert B. Reproductive Endocrine and Endometrial Effects of Raloxifene Hydrochloride, a Selective Estrogen Receptor Modulator, in Women with Regular Menstrual Cycles. 83: 6-13. 1998: Estrogen.

http://jcem.endojournals.org/content/83/9/3150.abstract

Baroncelli Giampiero Igli, Bertelloni Silvano, Ceccarelli Cinzia and Saggese Giuseppe. Measurement of Volumetric Bone Mineral Density Accurately Determines Degree of Lumbar Undermineralization in Children with Growth Hormone Deficiency. 83: 3150-3154. 1998: Bone.

http://jcem.endojournals.org/content/83/9/3184.abstract

Baum Howard B. A., Katznelson Laurence, Sherman Janet C., Biller Beverly M. K., Hayden Douglas L., Schoenfeld David A., Cannistraro Kristin E. and Klibanski Anne. Effects of Physiological Growth Hormone (GH) Therapy on Cognition and Quality of Life in Patients with Adult-Onset GH Deficiency. 83: 3184-3189. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/12/4280.abstract

Bertelloni Silvano, Baroncelli Giampiero I., Ferdeghini Marco, Perri Giuseppe and Saggese Giuseppe. Normal Volumetric Bone Mineral Density and Bone Turnover in Young Men with Histories of Constitutional Delay of Puberty. 83: 4280-4283. 1998: Bone.

http://jcem.endojournals.org/content/83/4/1049.short

Betterle C., Greggio N. A. and Volpato M. Autoimmune Polyglandular Syndrome Type 1. 83: 1049-1055. 1998: Polyglandular Syndrome.

http://jcem.endojournals.org/content/83/10/3445.short

Bhasin Shalender. VIII. Conclusion ”Research Design Issues in Examining the Effects of Testosterone Supplementation in Older Men. 83: 3445-3448. 1998: Testosterone.

http://jcem.endojournals.org/content/83/10/3435.short

Bhasin Shalender. I. Introduction. 83: 3435-3436. 1998: Testosterone.

http://jcem.endojournals.org/content/83/9/3155.abstract

Bhasin Shalender, Storer Thomas W., Asbel-Sethi Nancy, Kilbourne Amy, Hays Ron, Sinha-Hikim Indrani, Shen Ruoquing, Arver Stefan and Beall Gildon. Effects of Testosterone Replacement with a Nongenital, Transdermal System, Androderm, in Human Immunodeficiency Virus-Infected Men with Low Testosterone Levels. 83: 3155-3162. 1998: Testosterone.

http://jcem.endojournals.org/content/83/4/1151.abstract

Bierwolf Claudia, Burgemeister Axel, LÃ¼thke Karen, Born Jan and Fehm Horst L. Influence of Exogenous Atrial Natriuretic Peptide on the Pituitary-Adrenal Response to Corticotropin-Releasing Hormone and Vasopressin in Healthy Men. 83: 1151-1157. 1998: Cortisol.

http://jcem.endojournals.org/content/83/12/4289.abstract

Blanc StÃ©phane, Normand Sylvie, Ritz Patrick, Pachiaudi Christiane, Vico Laurence, Gharib Claude and Gauquelin-Koch Guillemette. Energy and Water Metabolism, Body Composition, and Hormonal Changes Induced by 42 Days of Enforced Inactivity and Simulated Weightlessness. 83: 4289-4297. 1998: Obesity.

http://jcem.endojournals.org/content/83/1/63.abstract

Blevins Lewis S., Christy James H., Khajavi Masheed and Tindall George T. Outcomes of Therapy for Cushing's Disease due to Adrenocorticotropin-Secreting Pituitary Macroadenomas. 83: 63-67. 1998: Cushings.

http://jcem.endojournals.org/content/83/7/2291.abstract

Booth Gillian L., Redelmeier Donald A., Grosman Harvey, Kovacs Kalman, Smyth Harley S. and Ezzat Shereen. Improved Diagnostic Accuracy of Inferior Petrosal Sinus Sampling over Imaging for Localizing Pituitary Pathology in Patients with Cushingâ€™s Disease. 83: 2291-2295. 1998: Pituitary.

http://jcem.endojournals.org/content/83/1/280.abstract

Bornstein S.R., Licinio J., Tauchnitz R., Engelmann L., Negrao AB, Gold P. and Chrousos G.P. Plasma Leptin Levels Are Increased in Survivors of Acute Sepsis: Associated Loss of Diurnal Rhythm in Cortisol and Leptin Secretion. 83: 280-283. 1998: Leptin.

http://jcem.endojournals.org/content/83/4/1075.abstract

Buchlis John G., Irizarry Lydia, Crotzer Brian C., Shine Barbara J., Allen Laura and MacGillivray Margaret H. Comparison of Final Heights of Growth Hormone-Treated Vs. Untreated Children with Idiopathic Growth Failure. 83: 1075-1079. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/11/3920.abstract

Buckler H. M., Robertson W. R. and Wu F. C. W. Which Androgen Replacement Therapy for Women? 83: 3920-3924. 1998: Androgen.

http://jcem.endojournals.org/content/83/11/3897.abstract

Bulow Birgitta, Attewell Robyn, Hagmar Lars, Malmstrom Per, Nordstrom Carl-Henrik and Erfurth Eva Marie. Postoperative Prognosis in Craniopharyngioma with Respect to Cardiovascular Mortality, Survival, and Tumor Recurrence. 83: 3897-3904. 1998: Pituitary.

http://jcem.endojournals.org/content/83/11/3839.abstract

Cardinal H., Brossard J.-H., Roy L., Lepage R., Rousseau L. and D'Amour P. The Set Point of Parathyroid Hormone Stimulation by Calcium Is Normal in Progressive Renal Failure. 83: 3839-3844. 1998: Parathyroid.

http://jcem.endojournals.org/content/83/8/2960.abstract

Carling Tobias, Correa Pamela, Hessman Ola, Hedberg Jakob, Skogseid Britt, Lindberg Daniel, Rastad Jonas, Westin Gunnar and Ã…kerstrÃ¶m GÃ¶ran. Parathyroid MEN1 Gene Mutations in Relation to Clinical Characteristics of Nonfamilial Primary Hyperparathyroidism. 83: 2960-2963. 1998: MEN1.

http://jcem.endojournals.org/content/83/2/382.abstract

Carroll Paul V., Christ the members of Growth Hormone Research Society Scientific Committee: Emanuel R., Bengtsson B. , Carlsson L., Christiansen J. S., Clemmons D., Hintz R., Ho K., Laron Z., Sizonenko P., SÃ¶nksen P. H., Tanaka T. and Thorner M. Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review. 83: 382-395. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/9/3134.abstract

Chabre Olivier, Liakos Panagiotis, Vivier Josiane, Chaffanjon Philippe, Labat-Moleur FranÃ§oise, Martinie Monique, Bottari Serge P., Bachelot Ivan, Chambaz Edmond M., Defaye GeneviÃ¨ve and Feige Jean-Jacques. Cushing's Syndrome due to a Gastric Inhibitory Polypeptide-Dependent Adrenal Adenoma: Insights into Hormonal Control of Adrenocortical Tumorigenesis. 83: 3134-3143. 1998: Cushings.

http://jcem.endojournals.org/content/83/6/1940.abstract

Chin Daisy, Speiser Phyllis W., Imperato-McGinley Julianne, Dixit Naznin, Uli Naveen, David Raphael and Oberfield Sharon E. Study of a Kindred with Classic Congenital Adrenal Hyperplasia: Diagnostic Challenge due to Phenotypic Variance. 83: 1940-1945. 1998: Adrenal.

http://jcem.endojournals.org/content/83/6/1863.abstract

Chiodini I., Carnevale V., Torlontano M., Fusilli S., Guglielmi G., Pileri M., Modoni S., Di Giorgio A., Liuzzi A., Minisola S., Cammisa M., Trischitta V. and Scillitani A. Alterations of Bone Turnover and Bone Mass at Different Skeletal Sites due to Pure Glucocorticoid Excess: Study in Eumenorrheic Patients with Cushingâ€™s Syndrome. 83: 1863-1867. 1998: Bone.

http://jcem.endojournals.org/content/83/1/40.abstract

Chiovato L., Fiore E., Vitti P., Rocchi R., Rago T., Dokic D., Latrofa F., Mammoli C., Lippi F., Ceccarelli C. and Pinchera A. Outcome of Thyroid Function in Graves' Patients Treated with Radioiodine: Role of Thyroid-Stimulating and Thyrotropin-Blocking Antibodies and of Radioiodine-Induced Thyroid Damage. 83: 40-46. 1998: Thyroid.

http://jcem.endojournals.org/content/83/10/3450.abstract

Christin-Maitre Sophie, RongiÃ¨res-Bertrand Catherine, Kottler Marie-Laure, Lahlou Najiba, Frydman RenÃ©, Touraine Philippe and Bouchard Philippe. A Spontaneous and Severe Hyperstimulation of the Ovaries Revealing a Gonadotroph Adenoma. 83: 3450-3453. 1998: Estrogen.

http://jcem.endojournals.org/content/83/4/1100.short

Clark Orlo H. and Ituarte Philip. Ambulatory Thyroid Surgery; Unnecessary and Dangerous. 83: 1100-1103. 1998: Thyroid.

http://jcem.endojournals.org/content/83/3/775.abstract

Colao Annamaria, Marzullo Paolo, Ferone Diego, Spiezia Stefano, Cerbone Gaetana, MarinÃ² Valeria, Di Sarno Antonella, Merola Bartolomeo and Lombardi Gaetano. Prostatic Hyperplasia: An Unknown Feature of Acromegaly. 83: 775-779. 1998: Acromegaly.

http://jcem.endojournals.org/content/83/4/1083.abstract

Collins Michael T., Skarulis Monica C., Bilezikian John P., Silverberg Shonni J., Spiegel Allen M. and Marx Stephen J. Treatment of Hypercalcemia Secondary to Parathyroid Carcinoma with a Novel Calcimimetic Agent. 83: 1083-1088. 1998: Parathyroid.

http://jcem.endojournals.org/content/83/6/1993.short

Conference Sponsors: The Hormone Foundation The Susan G. Komen Breast Cancer Foundation, the Canadian Breast Cancer Research Initiative, the National Cancer Institute of Canada, The Endocrine Society,, Center the University of Virginia Cancer and Place Womanâ€™s. Treatment of Estrogen Deficiency Symptoms in Women Surviving Breast Cancer. 83: 1993-2000. 1998: Estrogen.

http://jcem.endojournals.org/content/83/3/788.abstract

Cosman Felicia, Nieves Jeri, Woelfert Lillian, Gordon Susan, Shen Victor and Lindsay Robert. Parathyroid Responsivity in Postmenopausal Women with Osteoporosis During Treatment with Parathyroid Hormone. 83: 788-790. 1998: Bone.

http://jcem.endojournals.org/content/83/4/1070.abstract

Coutant RÃ©gis, Carel Jean-Claude, Letrait Muriel, Bouvattier Claire, Chatelain Pierre, Coste JoÃ«l and Chaussain Jean-Louis. Short Stature Associated with Intrauterine Growth Retardation: Final Height of Untreated and Growth Hormone-Treated Children. 83: 1070-1074. 1998: Short Stature.

http://jcem.endojournals.org/content/83/6/1976.abstract

Cronin L., Guyatt G., Griffith L., Wong E., Azziz R., Futterweit W., Cook D. and Dunaif A. Development of a Health-Related Quality-of-Life Questionnaire (PCOSQ) for Women with Polycystic Ovary Syndrome (PCOS). 83: 1976-1987. 1998: PCOS.

http://jcem.endojournals.org/content/83/1/107.abstract

Cuneo Ross C., Judd Steve, Wallace Jennifer D., Perry-Keene Don, Burger Henry, Lim-Tio Sylvia, Strauss Boyd, Stockigt Jan, Topliss Duncan, Alford Frank, Hew L., Bode Hans, Conway Ann, Handelsman David, Dunn Stewart, Boyages Steve, Cheung N. Wah and Hurley David. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults. 83: 107-116. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/11/3777.short

Davies Terry F. Thyroid-Stimulating Antibodies Predict Hyperthyroidisma. 83: 3777-3781. 1998: Thyroid.

http://jcem.endojournals.org/content/83/3/807.abstract

Di Somma Carolina, Colao Annamaria, Di Sarno Antonella, Klain Michele, Landi Maria Luisa, Facciolli Giuseppina, Pivonello Rosario, Panza Nicola, Salvatore Marco and Lombardi Gaetano. Bone Marker and Bone Density Responses to Dopamine Agonist Therapy in Hyperprolactinemic Males. 83: 807-813. 1998: Bone.

http://jcem.endojournals.org/content/83/12/4420.abstract

Diamond Michael P., Grainger David, Diamond Meredith C., Sherwin Robert S. and DeFronzo Ralph A. Effects of Methyltestosterone on Insulin Secretion and Sensitivity In Women. 83: 4420-4425. 1998: Testosterone.

http://jcem.endojournals.org/content/83/8/2742.abstract

Dimai H.-P., Porta S., Wirnsberger G., Lindschinger M., Pamperl I., Dobnig H., Wilders-Truschnig M. and Lau K.-H. W. Daily Oral Magnesium Supplementation Suppresses Bone Turnover in Young Adult Males. 83: 2742-2748. 1998: Bone.

http://jcem.endojournals.org/content/83/11/3913.abstract

Drake W. M., Coyte D., Camacho-HÃ¼bner C., Jivanji N. M., Kaltsas G., Wood D. F., Trainer P. J., Grossman A. B., Besser G. M. and Monson J. P. Optimizing Growth Hormone Replacement Therapy by Dose Titration in Hypopituitary Adults. 83: 3913-3919. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/3/791.abstract

Eckert Elke D., Pomeroy Claire, Raymond Nancy, Kohler Peter F., Thuras Paul and Bowers Cyril Y. Leptin in Anorexia Nervosa. 83: 791-795. 1998: Leptin.

http://jcem.endojournals.org/content/83/7/2239.abstract

Ettinger Bruce, Pressman Alice, Sklarin Peter, Bauer Douglas C., Cauley Jane A. and Cummings Steven R. Associations between Low Levels of Serum Estradiol, Bone Density, and Fractures among Elderly Women: The Study of Osteoporotic Fractures. 83: 2239-2243. 1998: Bone.

http://jcem.endojournals.org/content/83/1/135.abstract

Fall Caroline, Hindmarsh Peter, Dennison Elaine, Kellingray Samantha, Barker David and Cooper Cyrus. Programming of Growth Hormone Secretion and Bone Mineral Density in Elderly Men: A Hypothesis. 83: 135-139. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/8/2627.abstract

Farnebo Filip, Teh Bin Tean, Kytoa Soili, Svensson Ann, Phelan Catherine, Sandelin Kerstin, Thompson Norman W., Hoog Anders, Weber Gunther, Farnebo Lars-Ove and Larsson Catharina. Alterations of the MEN1 Gene in Sporadic Parathyroid Tumors. 83: 2627-2630. 1998: MEN1.

http://jcem.endojournals.org/content/83/3/719.short

Fitzpatrick Lorraine A. and D. M. Coronary Artery Disease in Women: an Equal Opportunity Killer. 83: 719-720. 1998: CVD.

http://jcem.endojournals.org/content/83/5/1407.short

Flier Jeffrey S. What's in a Name? In Search of Leptin's Physiologic Role. 83: 1407-1413. 1998: Leptin.

http://jcem.endojournals.org/content/83/11/3808.abstract

Freda Pamela U., Post Kalmon D., Powell Jeffrey S. and Wardlaw Sharon L. Evaluation of Disease Status with Sensitive Measures of Growth Hormone Secretion in 60 Postoperative Patients with Acromegaly. 83: 3808-3816. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/9/3031.short

Freda Pamela U. and Wardlaw Sharon L. Primary Medical Therapy for Acromegaly. 83: 3031-3033. 1998: Acromegaly.

http://jcem.endojournals.org/content/83/4/1097.short

Gerfo Paul Lo. Outpatient Thyroid Surgery. 83: 1097-1100. 1998: Thyroid.

http://jcem.endojournals.org/content/83/8/2765.abstract

Goodman William G., Veldhuis Johannes D., Belin Thomas R., Van Herle Andre J., Juppner Harald and Salusky Isidro B. Calcium-Sensing by Parathyroid Glands in Secondary Hyperparathyroidism. 83: 2765-2772. 1998: Parathyroid.

http://jcem.endojournals.org/content/83/12/4251.abstract

Grinspoon Steven, Corcoran Colleen, Stanley Takara, Katznelson Laurence and Klibanski Anne. Effects of Androgen Administration on the Growth Hormone-Insulin-Like Growth Factor I Axis in Men with Acquired Immunodeficiency Syndrome Wasting. 83: 4251-4256. 1998: Androgen.

http://jcem.endojournals.org/content/83/8/2621.abstract

group: Mutation analysis, Teh B. T., Kytoa S., Farnebo F., Bergman L., Wong F. K., Weber G., Hayward N., Larsson C., group: Clinical diagnosis, Skogseid B., Beckers A., Phelan C., Edwards M., Epstein M., Alford F., Hurley D., Grimmond S., Silins G., Walters M., Stewart C., Cardinal J., Khodaei S., Parente F., TranebjÃ¦rg L., Jorde R., Menon J., Khir A., Tan T. T., Chan S. P., Zaini A., Khalid B. A. K., Sandelin K., Thompson N., Brandi M.-L., Warth M., Stock J., Leisti J., Cameron D., Shepherd J. J., Ã–berg K., NordenskjÃ¶ld M. and Salmela P. Mutation Analysis of the MEN1 Gene in Multiple Endocrine Neoplasia Type 1, Familial Acromegaly and Familial Isolated Hyperparathyroidism. 83: 2621-2626. 1998: MEN1.

http://jcem.endojournals.org/content/83/9/3258.abstract

Gundberg Caren M., Nieman Sherril D., Abrams Steven and Rosen Harold. Vitamin K Status and Bone Health: An Analysis of Methods for Determination of Undercarboxylated Osteocalcin. 83: 3258-3266. 1998: Bone.

http://jcem.endojournals.org/content/83/12/4189.short

Haber Richard S. The Diagnosis of Recurrent Thyroid Cancer-A New Approach. 83: 4189-4190. 1998: Thyroid.

http://jcem.endojournals.org/content/83/10/3578.abstract

Hanew Kunihiko, Utsumi Atushi, Tanaka Aki, Ikeda Hidetoshi and Yokogoshi Yutaka. Secretory Mechanisms of Growth Hormone (GH)-Releasing Peptide-, GH-Releasing Hormone-, and Thyrotropin-Releasing Hormone-Induced GH Release in Patients with Acromegaly. 83: 3578-3583. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/3/736.abstract

Hangaard J., Andersen M., Grodum E., KoldkjÃ¦r O. and Hagen C. Pulsatile Luteinizing Hormone Secretion in Patients with Addison's Disease. Impact of Glucocorticoid Substitution. 83: 736-743. 1998: Adrenal.

http://jcem.endojournals.org/content/83/11/3832.abstract

Haug Charlotte J., Aukrust PÃ¥l, Haug Egil, MÃ¸rkrid Lars, MÃ¼ller Fredrik and FrÃ¸land Stig S. Severe Deficiency of 1,25-Dihydroxyvitamin D3 in Human Immunodeficiency Virus Infection: Association with Immunological Hyperactivity and Only Minor Changes in Calcium Homeostasis. 83: 3832-3838. 1998: Vitamin D.

http://jcem.endojournals.org/content/83/6/1835.short

Hayes Frances J., Hall Janet E., Boepple Paul A. and Crowley William F. Differential Control of Gonadotropin Secretion in the Human: Endocrine Role of Inhibin. 83: 1835-1841. 1998: Inhibin.

http://jcem.endojournals.org/content/83/3/727.short

Herman-Bonert Vivien, Seliverstov Maria and Melmed Shlomo. Pregnancy in Acromegaly: Successful Therapeutic Outcome. 83: 727-731. 1998: Acromegaly.

http://jcem.endojournals.org/content/83/6/1916.abstract

Heshmati Hassan M., Khosla Sundeep, Burritt Mary F., O'Fallon W. Michael and Riggs B. Lawrence. A Defect in Renal Calcium Conservation May Contribute to the Pathogenesis of Postmenopausal Osteoporosis. 83: 1916-1920. 1998: Bone.

http://jcem.endojournals.org/content/83/3/751.abstract

Heshmati Hassan M., Riggs B. Lawrence, Burritt Mary F., McAlister Carol A., Wollan Peter C. and Khosla Sundeep. Effects of the Circadian Variation in Serum Cortisol on Markers of Bone Turnover and Calcium Homeostasis in Normal Postmenopausal Women. 83: 751-756. 1998: Cortisol.

http://jcem.endojournals.org/content/83/9/3130.abstract

Heuser Isabella, Deuschle Michael, Luppa Peter, Schweiger Ulrich, Standhardt Harald and Weber Bettina. Increased Diurnal Plasma Concentrations of Dehydroepiandrosterone in Depressed Patients. 83: 3130-3133. 1998: Androgens.

http://jcem.endojournals.org/content/83/7/2384.abstract

Hines Oscar Joe and Gordon H. Earl. Secondary Hyperparathyroidism in a Patient with Eight Parathyroid Glands. 83: 2384-2386. 1998: Parathyroid.

http://jcem.endojournals.org/content/83/2/339.abstract

Hoeldtke Robert D., Horvath Gabriella G., Bryner Kimberly D. and Hobbs Gerald R. Treatment of Orthostatic Hypotension with Midodrine and Octreotide. 83: 339-343. 1998: Hypotension.

http://jcem.endojournals.org/content/83/6/1946.abstract

Hogikyan Robert V., Galecki Andrzej T., Pitt Bertram, Halter Jeffrey B., Greene Douglas A. and Supiano Mark A. Specific Impairment of Endothelium-Dependent Vasodilation in Subjects with Type 2 Diabetes Independent of Obesity. 83: 1946-1952. 1998: Diabetes.

http://jcem.endojournals.org/content/83/4/1143.abstract

Holte Jan, Gennarelli Gianluca, Wide Leif, Lithell Hans and Berne Christian. High Prevalence of Polycystic Ovaries and Associated Clinical, Endocrine, and Metabolic Features in Women with Previous Gestational Diabetes Mellitus. 83: 1143-1150. 1998: PCOS.

http://jcem.endojournals.org/content/83/12/4239.abstract

Hong Yuling, Rice Treva, Gagnon Jacques, DesprÃ©s Jean-Pierre, Nadeau Andre, PÃ©russe Louis, Bouchard Claude, Leon Arthur S., Skinner James S., Wilmore Jack H. and Rao D. C. Familial Clustering of Insulin and Abdominal Visceral Fat: The HERITAGE Family Study. 83: 4239-4245. 1998: HERITAGE Study.

http://jcem.endojournals.org/content/83/3/744.abstract

Hovorka Roman, Chassin Ludovic, Luzio Stephen D., Playle Rebecca and Owens David R. Pancreatic Î²-Cell Responsiveness during Meal Tolerance Test: Model Assessment in Normal Subjects and Subjects with Newly Diagnosed Noninsulin-Dependent Diabetes Mellitus. 83: 744-750. 1998: Diabetes.

http://jcem.endojournals.org/content/83/5/1633.abstract

Hozumi Yasuo, Kawano Mikihiko, Saito Tsuyoshi and Miyata Michio. Effect of Tamoxifen on Serum Lipid Metabolism. 83: 1633-1635. 1998: Lipid.

http://jcem.endojournals.org/content/83/8/2653.abstract

Iguchi Haruo, Miyagi Chisato, Tomita Kichinobu, Kawauchi Shigeto, Nozuka Yoko, Tsuneyoshi Masazumi and Wakasugi Hideyuki. Hypercalcemia Caused by Ectopic Production of Parathyroid Hormone in a Patient with Papillary Adenocarcinoma of the Thyroid Gland. 83: 2653-2657. 1998: Parathyroid.

http://jcem.endojournals.org/content/83/2/685.abstract

Imseis Raed E., Vanmiddlesworth L., Massie James D., Bush Andrew J. and Vanmiddlesworth N. R. Pretreatment with Propylthiouracil But Not Methimazole Reduces the Therapeutic Efficacy of Iodine-131 in Hyperthyroidism. 83: 685-687. 1998: Thyroid.

http://jcem.endojournals.org/content/83/12/4274.abstract

Jones G. and Dwyer T. Bone Mass in Prepubertal Children: Gender Differences and the Role of Physical Activity and Sunlight Exposure. 83: 4274-4279. 1998: Bone.

http://jcem.endojournals.org/content/83/12/4233.abstract

Kaltsas G. A., Mukherjee J. J., Plowman P. N., Monson J. P., Grossman A. B. and Besser G. M. The Role of Cytotoxic Chemotherapy in the Management of Aggressive and Malignant Pituitary Tumors. 83: 4233-4238. 1998: Pituitary.

http://jcem.endojournals.org/content/83/10/3449.short

Kazer Ralph R. Androgen Excess Disorders in Women. 83: 3449. 1998: Androgen.

http://jcem.endojournals.org/content/83/3/1013.abstract

Kennaway D. J. and Voultsios A. Circadian Rhythm of Free Melatonin in Human Plasma. 83: 1013-1015. 1998: Melatonin.

http://jcem.endojournals.org/content/83/7/2266.abstract

Khosla Sundeep, Melton L. Joseph, Atkinson Elizabeth J., O'Fallon W. M., Klee George G. and Riggs B. Lawrence. Relationship of Serum Sex Steroid Levels and Bone Turnover Markers with Bone Mineral Density in Men and Women: A Key Role for Bioavailable Estrogen. 83: 2266-2274. 1998: Bone.

http://jcem.endojournals.org/content/83/8/2964.abstract

Kilby M. D., Verhaeg J., Gittoes N., Somerset D. A., Clark P. M. S. and Franklyn J. A. Circulating Thyroid Hormone Concentrations and Placental Thyroid Hormone Receptor Expression in Normal Human Pregnancy and Pregnancy Complicated by Intrauterine Growth Restriction (IUGR). 83: 2964-2971. 1998: Thyroid.

http://jcem.endojournals.org/content/83/1/21.abstract

Klein Gordon L., Wolf Steven E., Langman Craig B., Rosen Clifford J., Mohan Subburaman, Keenan Bruce S., Matin Sina, Steffen Christopher, Nicolai Marc, Sailer Dawn E. and Herndon David N. Effect of Therapy with Recombinant Human Growth Hormone on Insulin-Like Growth Factor System Components and Serum Levels of Biochemical Markers of Bone Formation in Children After Severe Burn Injury. 83: 21-24. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/10/3469.abstract

Klein Karen Oerter, Larmore Kimberly A., de Lancey Elizabeth, Brown Jaquelyn M., Considine Robert V. and Hassink Sandra G. Effect of Obesity on Estradiol Level, and Its Relationship to Leptin, Bone Maturation, and Bone Mineral Density in Children. 83: 3469-3475. 1998: Obesity.

http://jcem.endojournals.org/content/83/9/3078.abstract

Knochenhauer E. S., Key T. J., Kahsar-Miller M., Waggoner W., Boots L. R. and Azziz R. Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study. 83: 3078-3082. 1998: PCOS.

http://jcem.endojournals.org/content/83/10/3441.short

Korenman Stanley G. VI. A Pragmatic Approach to Androgen Replacement in Older Men: Risks vs. Benefits. 83: 3441-3443. 1998: Androgen.

http://jcem.endojournals.org/content/83/8/2735.abstract

Kristram B., Carlsson B., Rosberg S., Carlsson L. M. S., Albertsson-Wikland K. and Treatment on behalf of the Swedish Study Group for Growth Hormone. Short-Term Changes in Serum Leptin Levels Provide a Strong Metabolic Marker for the Growth Response to Growth Hormone Treatment in Children. 83: 2735-2741. 1998: Leptin.

http://jcem.endojournals.org/content/83/3/732.short

Kulak Carolina A. Moreira, Bandeira Cristina, Voss Dora, Sobieszczyk Sylwester M., Silverberg Shonni J., Bandeira Francisco and Bilezikian John P. Marked Improvement in Bone Mass after Parathyroidectomy in Osteitis Fibrosa Cystica. 83: 732-735. 1998: Parathyroid.

http://jcem.endojournals.org/content/83/2/514.abstract

Kung A. W. C. and Jones B. M. A Change from Stimulatory to Blocking Antibody Activity in Graves' Disease during Pregnancy. 83: 514-518. 1998: Thyroid.

http://jcem.endojournals.org/content/83/11/3890.abstract

Kuromaru R., Kohno H., Ueyama N., Hassan H. M. S., Honda S. and Hara T. Long-Term Prospective Study of Body Composition and Lipid Profiles during and after Growth Hormone (GH) Treatment in Children with GH Deficiency: Gender-Specific Metabolic Effects. 83: 3890-3896. 1998: Lipid.

http://jcem.endojournals.org/content/83/9/3083.abstract

Lado-Abeal J., Rodriguez-Arnao J., Newell-Price J. D. C., Perry L. A., Grossman A. B., Besser G. M. and Trainer P. J. Menstrual Abnormalities in Women with Cushing's Disease Are Correlated with Hypercortisolemia Rather Than Raised Circulating Androgen Levels. 83: 3083-3088. 1998: Cushings.

http://jcem.endojournals.org/content/83/5/1706.abstract

Langendonk Janneke G., Pijl Hanno, Toornvliet Arnoud C., Burggraaf Jacobus, Frolich Marijke, Schoemaker Rik C., Doornbos Joost, Cohen Adam F. and Meinders A. Edo. Circadian Rhythm of Plasma Leptin Levels in Upper and Lower Body Obese Women: Influence of Body Fat Distribution and Weight Loss. 83: 1706-1712. 1998: Leptin.

http://jcem.endojournals.org/content/83/12/4269.abstract

Lann Lars, Stenlaf Kaj, Ottosson Malin, Lindroos Anna-Karin, Nystram Ernst and Sjastram Lars. Body Weight and Body Composition Changes after Treatment of Hyperthyroidism. 83: 4269-4273. 1998: Thyroid.

http://jcem.endojournals.org/content/83/11/3786.abstract

Leibowitz J., Pertsemlidis D. and Gabrilove J. L. Recurrent Cushing's Syndrome Due to Recurrent Adrenocortical Tumorâ€”Fragmentation or Tumor in Ectopic Adrenal Tissue? 83: 3786-3789. 1998: Cushings.

http://jcem.endojournals.org/content/83/11/3795.abstract

Lippuner Kurt, Casez Jean-Paul, Horber Fritz F. and Jaeger Philippe. Effects of Deflazacort Versus Prednisone on Bone Mass, Body Composition, and Lipid Profile: A Randomized, Double Blind Study in Kidney Transplant Patients. 83: 3795-3802. 1998: Bone.

http://jcem.endojournals.org/content/83/2/353.abstract

Lucidi Paola, Lauteri Marco, Laureti Stefano, Celleno Roberta, Santoni Stefania, Volpi Elena, Angeletti Gabriella, Santeusanio Fausto and De Feo Pierpaolo. A Dose-Response Study of Growth Hormone (GH) Replacement on Whole Body Protein and Lipid Kinetics in GH-Deficient Adults. 83: 353-357. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/11/3852.abstract

Maier G. W., Kreis M. E., Renn W., Pereira P. L., HÃ¤ring H. U. and Becker H. D. Parathyroid Hormone after Adenectomy for Primary Hyperparathyroidism. A Study of Peptide Hormone Elimination Kinetics in Humans. 83: 3852-3856. 1998: Parathyroid.

http://jcem.endojournals.org/content/83/11/3857.abstract

Mak Tony W. L., Shek Chi-Chung, Chow Chun-Chung, Wing Yun-Kwok and Lee Sing. Effects of Lithium Therapy on Bone Mineral Metabolism: A Two-Year Prospective Longitudinal Study. 83: 3857-3859. 1998: Bone.

http://jcem.endojournals.org/content/83/4/1158.abstract

Marttunen Merja B., Hietanen PÃ¤ivi, Tiitinen Aila and Ylikorkala Olavi. Comparison of Effects of Tamoxifen and Toremifene on Bone Biochemistry and Bone Mineral Density in Postmenopausal Breast Cancer Patients. 83: 1158-1162. 1998: Bone.

http://jcem.endojournals.org/content/83/6/1886.abstract

Mauras Nelly, Hayes Valerie, Welch Susan, Rini Annie, Helgeson Kevin, Dokler Maryanne, Veldhuis Johannes D. and Urban Randall J. Testosterone Deficiency in Young Men: Marked Alterations in Whole Body Protein Kinetics, Strength, and Adiposity. 83: 1886-1892. 1998: Testosterone.

http://jcem.endojournals.org/content/83/6/1900.abstract

Mauras Nelly, Welch Susan, Rini Annie and Haymond Morey W. Ovarian Hyperandrogenism Is Associated with Insulin Resistance to Both Peripheral Carbohydrate and Whole-Body Protein Metabolism in Postpubertal Young Females: A Metabolic Study. 83: 1900-1905. 1998: Androgen.

http://jcem.endojournals.org/content/83/5/1548.abstract

McCanlies Erin, Oâ€™Leary Leslie A., Foley Thomas P., Kramer M. Kaye, Burke James P., Libman Astrid, Swan Jennifer S., Steenkiste Ann R., McCarthy Bridget J., Trucco Massimo and Dorman Janice S. Hashimoto's Thyroiditis and Insulin-Dependent Diabetes Mellitus: Differences among Individuals with and without Abnormal Thyroid Function. 83: 1548-1551. 1998: Thyroid.

http://jcem.endojournals.org/content/83/10/3409.short

Melmed Shlomo. Tight Control of Growth Hormone: An Attainable Outcome for Acromegaly Treatment. 83: 3409-3410. 1998: Acromegaly.

http://jcem.endojournals.org/content/83/8/2646.abstract

Melmed Shlomo, Jackson Ivor, Kleinberg David and Klibanski Anne. Current Treatment Guidelines for Acromegaly. 83: 2646-2652. 1998: Acromegaly.

http://jcem.endojournals.org/content/83/2/682.abstract

Mericq M. Veronica and Cutler Gordon B. High Fluid Intake Increases Urine Free Cortisol Excretion in Normal Subjects. 83: 682-684. 1998: Cortisol.

http://jcem.endojournals.org/content/83/9/3046.short

Merke Deborah P. The Role of Laparoscopic Surgery in Adrenal Disease: A Pediatric Perspective. 83: 3046-3048. 1998: Adrenal.

http://jcem.endojournals.org/content/83/7/2569.abstract

Micic Dragan, Popovic Vera, Doknic Mirjana, Macut Djuro, Dieguez Carlos and Casanueva Felipe F. Preserved Growth Hormone (GH) Secretion in Aged and Very Old Subjects after Testing with the Combined Stimulus GH-Releasing Hormone plus GH-Releasing Hexapeptide-6. 83: 2569-2572. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/10/3476.abstract

Miyakawa Megumi, Tsushima Toshio, Murakami Hitomi, Isozaki Osamu, Demura Hiroshi and Tanaka Toshiaki. Effect of Growth Hormone (GH) on Serum Concentrations of Leptin: Study in Patients with Acromegaly and GH Deficiency. 83: 3476-3479. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/7/2566.abstract

Morin-Papunen Laure C., Koivunen Riitta M., TomÃ¡s Candido, Ruokonen Aimo and Martikainen Hannu K. Decreased Serum Leptin Concentrations during Metformin Therapy in Obese Women with Polycystic Ovary Syndrome. 83: 2566-2568. 1998: Leptin.

http://jcem.endojournals.org/content/83/2/396.abstract

Mortensen Lene, Charles Peder, Bekker Pirow J., Digennaro Joseph and Johnston C. Conrad. Risedronate Increases Bone Mass in an Early Postmenopausal Population: Two Years of Treatment Plus One Year of Follow-Up. 83: 396-402. 1998: Bone.

http://jcem.endojournals.org/content/83/3/824.abstract

Namnoum Anne B., Merriam George R., Moses Arnold M. and Levine Michael A. Reproductive Dysfunction in Women with Albright's Hereditary Osteodystrophy. 83: 824-829. 1998: Bone.

http://jcem.endojournals.org/content/83/9/3034.abstract

Newman Connie B., Melmed Shlomo, George Ajax, Torigian Drew, Duhaney Michael, Snyder Peter, Young William, Klibanski Anne, Molitch Mark E., Gagel Robert, Sheeler Leslie, Cook David, Malarkey William, Jackson Ivor, Vance Mary Lee, Barkan Ariel, Frohman Lawrence and Kleinberg David L. Octreotide as Primary Therapy for Acromegaly. 83: 3034-3040. 1998: Acromegaly.

http://jcem.endojournals.org/content/83/10/3443.short

Nieschlag Eberhard. VII. If Testosterone, Which Testosterone? Which Androgen Regimen Should be Used for Supplementation in Older Men? Formulation, Dosing, and Monitoring Issues. 83: 3443-3445. 1998: Testosterone.

http://jcem.endojournals.org/content/83/1/195.abstract

Nishimura Masato, Nakano Koji, Ushiyama Masaji, Nanbu Akira, Ohtsuka Ken, Takahashi Hakuo and Yoshimura Manabu. Increased Serum Concentrations of Human Hepatocyte Growth Factor in Proliferative Diabetic Retinopathy. 83: 195-198. 1998: Diabetes.

http://jcem.endojournals.org/content/83/9/3048.short

Norton Jeffrey A. Laparoscopic versus Open Adrenalectomy. 83: 3048-3049. 1998: Adrenal.

http://jcem.endojournals.org/content/83/8/2730.abstract

Orme Stephen M., McNally Richard J. Q., Cartwright Ray A., Belchetz Paul E. and Group for the United Kingdom Acromegaly Study. Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study. 83: 2730-2734. 1998: Acromegaly.

http://jcem.endojournals.org/content/83/11/3803.abstract

Ortiz Robert, Hupart Kenneth H., DeFesi Charles R. and Surks Martin I. Effect of Early Referral to an Endocrinologist on Efficiency and Cost of Evaluation and Development of Treatment Plan in Patients with Thyroid Nodules. 83: 3803-3807. 1998: Bone.

http://jcem.endojournals.org/content/83/11/3930.abstract

Orwoll Eric S., Bell Norman H., Nanes Mark S., Flessland Karen A., Pettinger Mary B., Mallinak Nancy J. S. and Cain Daniel F. Collagen N-Telopeptide Excretion in Men: The Effects of Age and Intrasubject Variability. 83: 3930-3935. 1998: Bone.

http://jcem.endojournals.org/content/83/4/1080.short

Ott Susan M. Calcimimetics-New Drugs with the Potential To Control Hyperparathyroidism. 83: 1080-1082. 1998: Parathyroid.

Journal of Clinical Endocrinology & Metabolism

Pandya Naushira, DeMott-Friberg Roberta, Bowers Cyril Y., Barkan Ariel L. and Jaffe Craig A. Growth Hormone (GH)-Releasing Peptide-6 Requires Endogenous Hypothalamic GH-Releasing Hormone for Maximal GH Stimulation. 83: 1186-1189. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/4/1186.abstract

http://jcem.endojournals.org/content/83/4/1163.abstract

Papanicolaou Dimitris A., Yanovski Jack A., Cutler Gordon B., Chrousos George P. and Nieman Lynnette K. A Single Midnight Serum Cortisol Measurement Distinguishes Cushing's Syndrome from Pseudo-Cushing States. 83: 1163-1167. 1998: Cushings.

http://jcem.endojournals.org/content/83/3/780.abstract

Papini E., Petrucci L., Guglielmi R., Panunzi C., Rinaldi R., Bacci V., Crescenzi A., Nardi F., Fabbrini R. and Pacella C. M. Long-Term Changes in Nodular Goiter: A 5-Year Prospective Randomized Trial of Levothyroxine Suppressive Therapy for Benign Cold Thyroid Nodules. 83: 780-783. 1998: Thyroid.

http://jcem.endojournals.org/content/83/3/801.abstract

Pearce Georgina, Tabensky D. Aaron, Delmas Pierre D., Baker H. W. Gordon and Seeman Ego. Corticosteroid-Induced Bone Loss in Men. 83: 801-806. 1998: Bone.

http://jcem.endojournals.org/content/83/8/2805.abstract

Pellegriti Gabriella, Belfiore Antonino, Giuffrida Dario, Lupo Lorenzo and Vigneri Riccardo. Outcome of Differentiated Thyroid Cancer in Graves' Patients. 83: 2805-2809. 1998: Thyroid.

http://jcem.endojournals.org/content/83/3/757.abstract

Phillips D. I. W., Barker D. J. P., Fall C. H. D., Seckl J. R., Whorwood C. B., Wood P. J. and Walker B. R. Elevated Plasma Cortisol Concentrations: A Link between Low Birth Weight and the Insulin Resistance Syndrome? 83: 757-760. 1998: Cortisol.

http://jcem.endojournals.org/content/83/4/1168.abstract

Pihoker Catherine, Kearns Gregory L., French Daniel and Bowers Cyril Y. Pharmacokinetics and Pharmacodynamics of Growth Hormone-Releasing Peptide-2: A Phase I Study in Children. 83: 1168-1172. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/7/2275.abstract

Pivonello Rosario, Colao Annamaria, Di Somma Carolina, Facciolli Giuseppina, Klain Michele, Faggiano Antongiulio, Salvatore Marco and Lombardi Gaetano. Impairment of Bone Status in Patients with Central Diabetes Insipidus*. 83: 2275-2280. 1998: Bone.

http://jcem.endojournals.org/content/83/8/2786.abstract

Plotkin Horacio, Gundberg Caren, Mitnick Maryann and Stewart Andrew F. Dissociation of Bone Formation from Resorption during 2-Week Treatment with Human Parathyroid Hormone-Related Peptide-(1â€“36) in Humans: Potential as an Anabolic Therapy for Osteoporosis. 83: 2786-2791. 1998: Bone.

http://jcem.endojournals.org/content/83/10/3436-a.short

Plymate S. R. III. Which Testosterone Assay Should Be Used In Older Men?1. 83: 3436-a-3438. 1998: Testosterone.

http://jcem.endojournals.org/content/83/4/1059.abstract

Prentice Ann, Jarjou Landing M. A., Stirling Dorothy M., Buffenstein Rochelle and Fairweather-Tait Susan. Biochemical Markers of Calcium and Bone Metabolism during 18 Months of Lactation in Gambian Women Accustomed to a Low Calcium Intake and in Those Consuming a Calcium Supplement. 83: 1059-1066. 1998: Bone.

http://jcem.endojournals.org/content/83/8/2681.abstract

Raff Hershel, Raff Jonathan L. and Findling James W. Late-Night Salivary Cortisol as a Screening Test for Cushing's Syndrome. 83: 2681-2686. 1998: Cushings.

http://jcem.endojournals.org/content/83/6/1860.short

Reid Ian R. Glucocorticoid Effects on Bone. 83: 1860-1862. 1998: Bone.

http://jcem.endojournals.org/content/83/3/814.abstract

Rittmaster Roger S., Abbott E. Carl, Douglas Robert, Givner Morris L., Lehmann Lea, Reddy Sethu, Salisbury Sonia R., Shlossberg Allan H., Tan Meng H. and York Samuel E. Effect of Methimazole, with or without l-Thyroxine, on Remission Rates in Graves' Disease. 83: 814-818. 1998: Thyroid.

http://jcem.endojournals.org/content/83/11/3767.short

Rivkees Scott A., Sklar Charles and Freemark Michael. The Management of Graves' Disease in Children, with Special Emphasis on Radioiodine Treatment. 83: 3767-3776. 1998: Thyroid.

http://jcem.endojournals.org/content/83/6/1868.short

Robertson R. Paul, Holohan Thomas V. and Genuth Saul. Pancreas Transplantation for Type 1 Diabetes- A Summation. 83: 1868-1874. 1998: Diabetes.

http://jcem.endojournals.org/content/83/4/1089.short

Rogol Alan D. Leptin and Puberty. 83: 1089-1090. 1998: Leptin.

http://jcem.endojournals.org/content/83/8/2792.abstract

Ronnemaa Tapani, Marniemi Jukka, Savolainen Markku J., Kesaniemi Y. Antero, Ehnholm Christian, Bouchard Claude and Koskenvuo Markku. Serum Lipids, Lipoproteins, and Lipid Metabolizing Enzymes in Identical Twins Discordant for Obesity. 83: 2792-2799. 1998: Lipids.

http://jcem.endojournals.org/content/83/4/1067.short

Root Allen W. Does Growth Hormone Have a Role in the Management of Children with Nongrowth Hormone Deficient Short Stature and Intrauterine Growth Retardation? 83: 1067-1069. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/7/2324.abstract

Rosen Harold N., Moses Alan C., Garber Jeffrey, Ross Douglas S., Lee Stephanie L., Ferguson Lauren, Chen Vicki, Lee Kevin and Greenspan Susan L. Randomized Trial of Pamidronate in Patients with Thyroid Cancer: Bone Density Is Not Reduced by Suppressive Doses of Thyroxine, But Is Increased by Cyclic Intravenous Pamidronate. 83: 2324-2330. 1998: Thyroid.

http://jcem.endojournals.org/content/83/11/3781.short

Roti Elio, Braverman Lewis E. and DeGroot Leslie J. TSH Receptor Antibody Measurement in the Diagnosis and Management of Gravesâ€™ Disease Is Rarely Necessaryb. 83: 3781-3784. 1998: Thyroid.

http://jcem.endojournals.org/content/83/5/1502.abstract

Roubenoff Ronenn, Rall Laura C., Veldhuis Johannes D., Kehayias Joseph J., Rosen Clifford, Nicolson Margery, Lundgren Nancy and Reichlin Seymour. The Relationship between Growth Hormone Kinetics and Sarcopenia in Postmenopausal Women: The Role of Fat Mass and Leptin. 83: 1502-1506. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/4/1128.abstract

Roux Christian, Oriente Pasquale, Laan Roland, Hughes Rodney Andrey, Ittner Jochen, Goemaere Stefan, Di Munno Ombretta, PouillÃ¨s Jean Michel, Horlait StÃ©phane and Cortet for the ciblos study group Bernard. Randomized Trial of Effect of Cyclical Etidronate in the Prevention of Corticosteroid-Induced Bone Loss. 83: 1128-1133. 1998: Bone.

http://jcem.endojournals.org/content/83/10/3463.abstract

Russell-Aulet Mary, Shapiro Brahm, Jaffe Craig A., Gross Milton D. and Barkan Ariel L. Peak Bone Mass in Young Healthy Men Is Correlated with the Magnitude of Endogenous Growth Hormone Secretion. 83: 3463-3468. 1998: Bone.

Saad Mohammed F., Riad-Gabriel Maggy G., Khan Arshad, Sharma Alok, Michael Ragui, Jinagouda Sujata D., Boyadjian Rima and Steil Garry M. Diurnal and Ultradian Rhythmicity of Plasma Leptin: Effects of Gender and Adiposity. 83: 453-459. 1998: Leptin http://jcem.endojournals.org/content/83/2/453.abstract

http://jcem.endojournals.org/content/83/4/1134.abstract

Sandberg David E., MacGillivray Margaret H., Clopper Richard R., Fung Caroline, LeRoux Linda and Alliger Dana E. Quality of Life among Formerly Treated Childhood-Onset Growth Hormone-Deficient Adults: A Comparison with Unaffected Siblings. 83: 1134-1142. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/12/4201.short

Schlumberger Martin. Use of Radioactive Iodine in Patients with Papillary and Follicular Thyroid Cancer: Towards A Selective Approach. 83: 4201-4203. 1998: Thyroid.

http://jcem.endojournals.org/content/83/5/1414.short

Seeman Ego and D. M. Growth in Bone Mass and Size-Are Racial and Gender Differences in Bone Mineral Density More Apparent than Real? 83: 1414-1419. 1998: Bone.

http://jcem.endojournals.org/content/83/6/1988.abstract

Seippel Lena and Backstrom Torbjorn. Luteal-Phase Estradiol Relates to Symptom Severity in Patients with Premenstrual Syndrome. 83: 1988-1992. 1998: Estrogen.

http://jcem.endojournals.org/content/83/12/4199.short

Sherman Steven I. and Gopal Jayashree. Thyroglobulin Positive, RAI Negative Thyroid Cancers: The Role of Conservative Management. 83: 4199-4200. 1998: Thyroid.

http://jcem.endojournals.org/content/83/6/1893.abstract

Simon C., Gronfier C., Schlienger J. L. and Brandenberger G. Circadian and Ultradian Variations of Leptin in Normal Man under Continuous Enteral Nutrition: Relationship to Sleep and Body Temperature. 83: 1893-1899. 1998: Leptin.

http://jcem.endojournals.org/content/83/6/1906.abstract

Singer Frederick R., Clemens Thomas L., Eusebio Rachelle A. and Bekker Pirow J. Risedronate, a Highly Effective Oral Agent in the Treatment of Patients with Severe Paget's Disease. 83: 1906-1910. 1998: Bone.

http://jcem.endojournals.org/content/83/4/1106.abstract

Slyper Arnold H., Zvereva Svetlana, Schectman Gordon, Hoffmann Raymond G., Pleuss Joan and Walker John A. Normal Postprandial Lipemia and Chylomicron Clearance in Offspring of Parents with Early Coronary Artery Disease. 83: 1106-1113. 1998: Lipids.

http://jcem.endojournals.org/content/83/2/379.short

Society Growth Hormone. Consensus Guidelines for the Diagnosis and Treatment of Adults with Growth Hormone Deficiency: Summary Statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. 83: 379-381. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/8/2658.abstract

Sosa Julie Ann, Powe Neil R., Levine Michael A., Udelsman Robert and Zeiger Martha A. Thresholds for Surgery and Surgical Outcomes for Patients with Primary Hyperparathyroidism: A National Survey of Endocrine Surgeons. 83: 2658-2665. 1998: Parathyroid.

http://jcem.endojournals.org/content/83/4/1121.abstract

Spencer C. A., Takeuchi M., Kazarosyan M., Wang C. C., Guttler R. B., Singer P. A., Fatemi S., LoPresti J. S. and Nicoloff J. T. Serum Thyroglobulin Autoantibodies: Prevalence, Influence on Serum Thyroglobulin Measurement, and Prognostic Significance in Patients with Differentiated Thyroid Carcinoma. 83: 1121-1127. 1998: Thyroid.

http://jcem.endojournals.org/content/83/11/3817.abstract

Storm Deborah, Porter REBEKAH ESLIN Eileen Smith, Musgrave Katherine, Vereault Donald, Patton Christine, Kessenich Cathy, Mohan Subburaman, Chen Tai, Holick Michael F. and Rosen Clifford J. Calcium Supplementation Prevents Seasonal Bone Loss and Changes in Biochemical Markers of Bone Turnover in Elderly New England Women: A Randomized Placebo-Controlled Trial. 83: 3817-3825. 1998: Bone.

http://jcem.endojournals.org/content/83/4/1114.abstract

Streeten David H. P., Anderson Gunnar H., Brennan Suzanne and Jones Carol. Suppressibility of Plasma Adrenocorticotropin by Hydrocortisone: Potential Usefulness in the Diagnosis of Cushing's Disease. 83: 1114-1120. 1998: Cushings.

http://jcem.endojournals.org/content/83/2/362.abstract

Svensson J., Lonn L., Jansson J.-O., Murphy G., Wyss D., Krupa D., Cerchio K., Polvino W., Gertz B., Boseaus I., Sjostrom L. and Bengtsson B.-Ãke. Two-Month Treatment of Obese Subjects with the Oral Growth Hormone (GH) Secretagogue MK-677 Increases GH Secretion, Fat-Free Mass, and Energy Expenditure. 83: 362-369. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/10/3419.abstract

Swearingen Brooke, Barker Fred G., Katznelson Laurence, Biller Beverly M. K., Grinspoon Steven, Klibanski Anne, Moayeri Nicole, Black Peter McL. and Zervas Nicholas T. Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly. 83: 3419-3426. 1998: Acromegaly.

http://jcem.endojournals.org/content/83/10/3439.short

Tenover J. Lisa. IV. Can Replacement Doses of Testosterone Produce Clinically Meaningful Changes in Body Composition in Older Men? 83: 3439-3440. 1998: Testosterone.

http://jcem.endojournals.org/content/83/8/2617.short

Thakker Rajesh V. Multiple Endocrine Neoplasia-Syndromes of the Twentieth Century. 83: 2617-2620. 1998: MEN.

http://jcem.endojournals.org/content/83/8/2726.abstract

Thaler Leonard M. and Blevins Lewis S. The Low Dose (1-Î¼g) Adrenocorticotropin Stimulation Test in the Evaluation of Patients with Suspected Central Adrenal Insufficiency. 83: 2726-2729. 1998: Adrenal.

http://jcem.endojournals.org/content/83/2/403.abstract

Touati G., Prieur A. M., Ruiz J. C., Noel M. and Czernichow P. Beneficial Effects of One-Year Growth Hormone Administration to Children with Juvenile Chronic Arthritis on Chronic Steroid Therapy. I. Effects on Growth Velocity and Body Composition. 83: 403-409. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/5/1611.abstract

Trainer P. J., Woods R. J., Korbonits M., Popovic V., Stewart P. M., Lowry P. J. and Grossman A. B. The Pathophysiology of Circulating Corticotropin-Releasing Hormone-Binding Protein Levels in the Human. 83: 1611-1614. 1998: Cortisol.

http://jcem.endojournals.org/content/83/8/2675.abstract

Travagli J. P., Cailleux A. F., Ricard M., Baudin E., Caillou B., Parmentier C. and Schlumberger M. Combination of Radioiodine (131I) and Probe-Guided Surgery for Persistent or Recurrent Thyroid Carcinoma. 83: 2675-2680. 1998: Thyroid.

http://jcem.endojournals.org/content/83/9/3025.short

Tritos Nicholas A. and Mantzoros Christos S. Syndromes of Severe Insulin Resistance. 83: 3025-3030. 1998: Insulin.

http://jcem.endojournals.org/content/83/2/309.abstract

Van den Berghe Greet, de Zegher Francis, Baxter Robert C., Veldhuis Johannes D., Wouters Pieter, Schetz Miet, Verwaest Charles, Van der Vorst Erik, Lauwers Peter, Bouillon Roger and Bowers Cyril Y. Neuroendocrinology of Prolonged Critical Illness: Effects of Exogenous Thyrotropin-Releasing Hormone and Its Combination with Growth Hormone Secretagogues. 83: 309-319. 1998: Thyroid.

http://jcem.endojournals.org/content/83/6/1827.short

Van den Berghe Greet, de Zegher Francis and Bouillon Roger. Acute and Prolonged Critical Illness as Different Neuroendocrine Paradigms. 83: 1827-1834. 1998: Neuroendocrine.

http://jcem.endojournals.org/content/83/3/870.abstract

Wang Christina, Berman Nancy G., Veldhuis Johannes D., Der Tina, McDonald Veronica, Steiner Barbara and Swerdloff Ronald S. Graded Testosterone Infusions Distinguish Gonadotropin Negative-Feedback Responsiveness in Asian and White Menâ€”A Clinical Research Center Study. 83: 870-876. 1998: Testosterone.

http://jcem.endojournals.org/content/83/12/4195.short

Wartofsky Leonard. Management of Patients with Scan Negative, Thyroglobulin Positive Differentiated Thyroid Carcinoma. 83: 4195-4199. 1998: Thyroid.

http://jcem.endojournals.org/content/83/9/3041.short

Wells Samuel A. The Role of Laparoscopic Surgery in Adrenal Disease. 83: 3041-3043. 1998: Adrenal.

http://jcem.endojournals.org/content/83/10/3480.abstract

Winer Karen K., Yanovski Jack A., Sarani Babak and Cutler Jr. Gordon B. A Randomized, Cross-Over Trial of Once-Daily Versus Twice-Daily Parathyroid Hormone 1â€“34 in Treatment of Hypoparathyroidism. 83: 3480-3486. 1998: Parathyroid.

http://jcem.endojournals.org/content/83/1/68.abstract

Woitge Henning W., Scheidt-Nave Christa, Kissling Christian, Leidig-Bruckner Gudrun, Meyer Kristina, Grauer Andreas, Scharla Stephan H., Ziegler Reinhard and Seibel Markus J. Seasonal Variation of Biochemical Indexes of Bone Turnover: Results of a Population-Based Study. 83: 68-75. 1998: Bone.

http://jcem.endojournals.org/content/83/10/3493.abstract

Wyatt David T., Gesundheit Neil and Sherman Barry. Changes in Thyroid Hormone Levels during Growth Hormone Therapy in Initially Euthyroid Patients: Lack of Need for Thyroxine Supplementation. 83: 3493-3497. 1998: Growth Hormone.

http://jcem.endojournals.org/content/83/2/348.abstract

Yanovski Jack A., Cutler Gordon B., Chrousos George P. and Nieman Lynnette K. The Dexamethasone-Suppressed Corticotropin-Releasing Hormone Stimulation Test Differentiates Mild Cushing's Disease from Normal Physiology. 83: 348-352. 1998: Cushings.

http://jcem.endojournals.org/content/83/8/2773.abstract

Yip Jeannie, Facchini Francesco S. and Reaven Gerald M. Resistance to Insulin-Mediated Glucose Disposal as a Predictor of Cardiovascular Disease. 83: 2773-2776. 1998: Insulin.

http://jcem.endojournals.org/content/83/9/3339.abstract

Young Elizabeth A., Lopez Juan F., Murphy-Weinberg Virginia, Watson Stanley J. and Akil Huda. The Role of Mineralocorticoid Receptors in Hypothalamic-Pituitary-Adrenal Axis Regulation in Humans. 83: 3339-3345. 1998: Pituitary.

http://jcem.endojournals.org/content/83/11/3905.abstract

Zingrillo Matteo, Collura Daniela, Ghiggi Maria Rosaria, Nirchio Vincenzo and Trischitta Vincenzo. Treatment of Large Cold Benign Thyroid Nodules Not Eligible for Surgery with Percutaneous Ethanol Injection. 83: 3905-3907. 1998: Thyroid.

http://jcem.endojournals.org/content/84/9/3013.abstract

Alexandersen Peter, Riis Bente Juel and Christiansen Claus. Monofluorophosphate Combined with Hormone Replacement Therapy Induces a Synergistic Effect on Bone Mass by Dissociating Bone Formation and Resorption in Postmenopausal Women: A Randomized Study. 84: 3013-3020. 1999: HRT.

http://jcem.endojournals.org/content/84/11/4012.abstract

Andrade Venia A., Gross Jorge L. and Maia Ana Luiza. Effect of Methimazole Pretreatment on Serum Thyroid Hormone Levels after Radioactive Treatment in Gravesâ€™ Hyperthyroidism. 84: 4012-4016. 1999: Thyroid.

http://jcem.endojournals.org/content/84/1/7.short

Aronne Louis J. Drug Therapy for Obesity: A Therapeutic Option? 84: 7-10. 1999: Obesity.

http://jcem.endojournals.org/content/84/8/2611.abstract

Arvat Emanuela, Maccagno Barbara, Ramunni Josefina, Di Vito Lidia, Giordano Roberta, Gianotti Laura, Broglio Fabio, Camanni Franco and Ghigo Ezio. The Inhibitory Effect of Alprazolam, a Benzodiazepine, Overrides the Stimulatory Effect of Metyrapone-Induced Lack of Negative Cortisol Feedback on Corticotroph Secretion in Humans. 84: 2611-2615. 1999: Cortisol.

http://jcem.endojournals.org/content/84/2/573.abstract

Barrett-Connor Elizabeth, von Mehlen Denise G. and Kritz-Silverstein Donna. Bioavailable Testosterone and Depressed Mood in Older Men: The Rancho Bernardo Study. 84: 573-577. 1999: Testosterone.

http://jcem.endojournals.org/content/84/11/3929.abstract

Bengtsson Bengt-Ã…ke, Abs Roger, Bennmarker Helge, Monson John P., Feldt-Rasmussen Ulla, Hernberg-StÃ¥hl Elizabeth, Westberg BjÃ¶rn, Wilton Patrick, WÃ¼ster Christian and Board on behalf of the Kims Study Group the Kims International. The Effects of Treatment and the Individual Responsiveness to Growth Hormone (GH) Replacement Therapy in 665 GH-Deficient Adults. 84: 3929-3935. 1999: Growth Hormone.

http://jcem.endojournals.org/content/84/10/3551.abstract

Biermasz N. R., van Dulken H. and Roelfsema F. Direct Postoperative and Follow-Up Results of Transsphenoidal Surgery in 19 Acromegalic Patients Pretreated with Octreotide Compared to Those in Untreated Matched Controls. 84: 3551-3555. 1999: Acromegaly.

http://jcem.endojournals.org/content/84/2/499.abstract

Bogazzi Fausto, Bartalena Luigi, Brogioni Sandra, Scarcello Giovanna, Burelli Alessandro, Campomori Alberto, Manetti Luca, Rossi Giuseppe, Pinchera Aldo and Martino Enio. Comparison of Radioiodine with Radioiodine plus Lithium in the Treatment of Graves Hyperthyroidism. 84: 499-503. 1999: Thyroid.

http://jcem.endojournals.org/content/84/7/2458.abstract

Bondanelli Marta, Ambrosio Maria Rosaria, Franceschetti Paola, Margutti Angelo, Trasforini Giorgio and degli Uberti Ettore C. Diurnal Rhythm of Plasma Catecholamines in Acromegaly. 84: 2458-2467. 1999: Acromegaly.

http://jcem.endojournals.org/content/84/7/2278.short

Bone Henry G. Who Needs Parathyroid Surgery? The Case for Parathyroidectomy in Nonclassical Primary Hyperparathyroidismb. 84: 2278-2282. 1999: Parathyroid.

http://jcem.endojournals.org/content/84/1/10.short

Bray George A. Overweight Is Risking Fate. 84: 10-12. 1999: Obesity.

http://jcem.endojournals.org/content/84/5/1664.abstract

Carlsen Elisabeth, Olsson Claus, Petersen Jorgen Holm, Andersson Anna-Maria and Skakkebek Niels E. Diurnal Rhythm in Serum Levels of Inhibin B in Normal Men: Relation to Testicular Steroids and Gonadotropins. 84: 1664-1669. 1999: Inhibin.

http://jcem.endojournals.org/content/84/6/1802.short

Cauley Jane A. and Zmuda Joseph. Hormonal Replacement; Effect on Bone Density. 84: 1802-1803. 1999: Bone.

http://jcem.endojournals.org/content/84/6/1919.abstract

Colao Annamaria, Di Somma Carolina, Pivonello Rosario, Loche Sandro, Aimaretti Gianluca, Cerbone Gaetana, Faggiano Antongiulio, Corneli Ginevra, Ghigo Ezio and Lombardi Gaetano. Bone Loss Is Correlated to the Severity of Growth Hormone Deficiency in Adult Patients with Hypopituitarism. 84: 1919-1924. 1999: Growth Hormone.

http://jcem.endojournals.org/content/84/8/2664.abstract

Colao Annamaria, Pivonello Rosario, Spiezia Stefano, Faggiano Antongiulio, Ferone Diego, Filippella Mariagiovanna, Marzullo Paolo, Cerbone Gaetana, Siciliani Marcello and Lombardi Gaetano. Persistence of Increased Cardiovascular Risk in Patients with Cushingâ€™s Disease after Five Years of Successful Cure. 84: 2664-2672. 1999: Cushings.

http://jcem.endojournals.org/content/84/4/1184.short

de Herder Wouter W. and Lamberts Steven W.J. Tumor Localization: The Ectopic ACTH Syndrome. 84: 1184-1185. 1999: Adrenal.

http://jcem.endojournals.org/content/84/5/1558.abstract

de Zegher Francis, Du Caju Marc V. L., Heinrichs Claudine, Maes Marc, De Schepper Jean, Craen Margareta, Vanweser Karin, Malvaux Paul and Rosenfeld Ron G. Early, Discontinuous, High Dose Growth Hormone Treatment to Normalize Height and Weight of Short Children Born Small for Gestational Age: Results Over 6 Years. 84: 1558-1561. 1999: Growth Hormone.

http://jcem.endojournals.org/content/84/5/1562.abstract

Dempster D. W., Parisien M., Silverberg S. J., Liang X.-G., Schnitzer M., Shen V., Shane E., Kimmel D. B., Recker R., Lindsay R. and Bilezikian J. P. On the Mechanism of Cancellous Bone Preservation in Postmenopausal Women with Mild Primary Hyperparathyroidism. 84: 1562-1566. 1999: Bone.

http://jcem.endojournals.org/content/84/8/2739.abstract

Fraher L. J., Avram R., Watson P. H., Hendy G. N., Henderson J. E., Chong K. L., Goltzman D., Morley P., Willick G. E., Whitfield J. F. and Hodsman A. B. Comparison of the Biochemical Responses to Human Parathyroid Hormone-(1-31)NH2 and hPTH-(1-34) in Healthy Humans. 84: 2739-2743. 1999: Parathyroid.

http://jcem.endojournals.org/content/84/11/3859.short

Freda Pamela U. and Wardlaw Sharon L. Diagnosis and Treatment of Pituitary Tumors. 84: 3859-3866. 1999: Pituitary.

http://jcem.endojournals.org/content/84/9/3041.abstract

Fruehwald-Schultes Bernd, Kern Werner, Bong Wolfgang, Wellhoener Peter, Kerner Wolfgang, Born Jan, Fehm Horst L. and Peters Achim. Supraphysiological Hyperinsulinemia Acutely Increases Hypothalamic-Pituitary-Adrenal Secretory Activity in Humans. 84: 3041-3046. 1999: Pituitary.

http://jcem.endojournals.org/content/84/8/2633.abstract

Gasperi M., Aimaretti G., Scarcello G., Corneli G., Cosci C., Arvat E., Martino E. and Ghigo E. Low Dose Hexarelin and Growth Hormone (GH)-Releasing Hormone as a Diagnostic Tool for the Diagnosis of GH Deficiency in Adults: Comparison with Insulin-Induced Hypoglycemia Test. 84: 2633-2637. 1999: Growth Hormone.

http://jcem.endojournals.org/content/84/1/285.abstract

Ghigo E., Gianotti L., Arvat E., Ramunni J., Valetto M. R., Broglio F., Rolla M., Cavagnini F. and MÃ¼ller E. E. Effects of Recombinant Human Insulin-Like Growth Factor I Administration on Growth Hormone (GH) Secretion, Both Spontaneous and Stimulated by GH-Releasing Hormone or Hexarelin, a Peptidyl GH Secretagogue, in Humans. 84: 285-290. 1999: Growth Hormone.

http://jcem.endojournals.org/content/84/8/2596.abstract

Gibney J., Wallace J. D., Spinks T., Schnorr L., Ranicar A., Cuneo R. C., Lockhart S., Burnand K. G., Salomon F., Sonksen P. H. and Russell-Jones D. The Effects of 10 Years of Recombinant Human Growth Hormone (GH) in Adult GH-Deficient Patients. 84: 2596-2602. 1999: Growth Hormone.

http://jcem.endojournals.org/content/84/8/2686.abstract

Gronfier Claude, Simon Chantal, Piquard FranÃ§ois, Ehrhart Jean and Brandenberger Gabrielle. Neuroendocrine Processes Underlying Ultradian Sleep Regulation in Man. 84: 2686-2690. 1999: Neuroendocrine.

http://jcem.endojournals.org/content/84/12/4307.short

Guyda Harvey J. Four Decades of Growth Hormone Therapy for Short Children: What Have We Achieved? 84: 4307-4316. 1999: Growth Hormone.

http://jcem.endojournals.org/content/84/2/440.abstract

Invitti Cecilia, Giraldi Francesca Pecori, De Martin Martina, Cavagnini Francesco and Axis The Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal. Diagnosis and Management of Cushing's Syndrome: Results of an Italian Multicentre Study. 84: 440-448. 1999: Cushings.

http://jcem.endojournals.org/content/84/6/1979.abstract

Irwin Michael, Thompson John, Miller Claudine, Gillin J. Christian and Ziegler Michael. Effects of Sleep and Sleep Deprivation on Catecholamine And Interleukin-2 Levels in Humans: Clinical Implications. 84: 1979-1985. 1999: Sleep Studies.

http://jcem.endojournals.org/content/84/10/3673.abstract

Isidori Andrea M., Caprio Massimiliano, Strollo Felice, Moretti Costanzo, Frajese Gaetano, Isidori Aldo and Fabbri Andrea. Leptin and Androgens in Male Obesity: Evidence for Leptin Contribution to Reduced Androgen Levels. 84: 3673-3680. 1999: Obesity.

http://jcem.endojournals.org/content/84/1/279.abstract

Janssen Y. J. H., Doornbos J. and Roelfsema F. Changes in Muscle Volume, Strength, and Bioenergetics during Recombinant Human Growth Hormone (GH) Therapy in Adults with GH Deficiency. 84: 279-284. 1999: Growth Hormone.

http://jcem.endojournals.org/content/84/12/4516.abstract

Johannsson Gudmundur, Albertsson-Wikland Kerstin, Children on behalf of the Swedish Study Group for Growth Hormone Treatment in and Bengtsson Bengt-Ã…ke. Discontinuation of Growth Hormone (GH) Treatment: Metabolic Effects in GH-Deficient and GH-Sufficient Adolescent Patients Compared with Control Subjects. 84: 4516-4524. 1999: Growth Hormone.

http://jcem.endojournals.org/content/84/1/165.abstract

Legro Richard S., Kunselman Allen R., Dodson William C. and Dunaif Andrea. Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women. 84: 165-169. 1999: Diabetes.

http://jcem.endojournals.org/content/84/9/3076.abstract

Lindsay Robert, Cosman Felicia, Lobo Rogerio A., Walsh Brian W., Harris Steven T., Reagan Jane E., Liss Charles L., Melton Mary E. and Byrnes Christine A. Addition of Alendronate to Ongoing Hormone Replacement Therapy in the Treatment of Osteoporosis: A Randomized, Controlled Clinical Trial. 84: 3076-3081. 1999: HRT.

http://jcem.endojournals.org/content/84/1/29.abstract

Mitamura Ryo, Yano Koichi, Suzuki Naoki, Ito Yoshiya, Makita Yoshio and Okuno Akimasa. Diurnal Rhythms of Luteinizing Hormone, Follicle-Stimulating Hormone, and Testosterone Secretion before the Onset of Male Puberty. 84: 29-37. 1999: Testosterone.

http://jcem.endojournals.org/content/84/6/1872.short

Orwoll Eric S. and Nelson Heidi D. Does Estrogen Adequately Protect Postmenopausal Women Against Osteoporosis: An Iconoclastic Perspective. 84: 1872-1874. 1999: Estrogen.

http://jcem.endojournals.org/content/84/12/4480.abstract

Palmert Mark R., Mansfield M. Joan, Crowley William F., Crigler John F., Crawford John D. and Boepple Paul A. Is Obesity an Outcome of Gonadotropin-Releasing Hormone Agonist Administration? Analysis of Growth and Body Composition in 110 Patients with Central Precocious Puberty. 84: 4480-4488. 1999: Obesity.

http://jcem.endojournals.org/content/84/1/3.short

Pi-Sunyer F-Xavier and LaferrÃ¨re Blandine. Metabolic Abnormalities and the Role of Leptin in Human Obesity. 84: 3-7. 1999: Leptin.

http://jcem.endojournals.org/content/84/1/179.abstract

Prestwood K. M., Thompson D. L., Kenny A. M., Seibel M. J., Pilbeam C. C. and Raisz L. G. Low Dose Estrogen and Calcium Have an Additive Effect on Bone Resorption in Older Women. 84: 179-183. 1999: Estrogen.

http://jcem.endojournals.org/content/84/7/2267.short

Reichlin Seymour. Is Leptin a Secretion of the Brain? 84: 2267-2269. 1999: Leptin.

http://jcem.endojournals.org/content/84/4/1172.short

Rosenbloom Arlan L. A Mathematical Model for Predicting Growth Response to Growth Hormone Replacement Therapyâ€”A Useful Clinical Tool or an Intellectual Exercise? 84: 1172-1173. 1999: Growth Hormone.

http://jcem.endojournals.org/content/84/9/3064.abstract

Sas Theo, de Waal Wouter, Mulder Paul, Houdijk Mieke, Jansen Maarten, Reeser Maarten and Hokken-Koelega Anita. Growth Hormone Treatment in Children with Short Stature Born Small for Gestational Age: 5-Year Results of a Randomized, Double-Blind, Dose-Response Trial. 84: 3064-3070. 1999: Growth Hormone.

http://jcem.endojournals.org/content/84/7/2275.short

Silverberg Shonni J., Bilezikian John P., Bone Henry G., Talpos Gary B., Horwitz Mara J. and Stewart Andrew F. To Treat or Not To Treat: Conclusions from the NIH Consensus Conferencea. 84: 2275-2278. 1999: Parathyroid.

http://jcem.endojournals.org/content/84/6/1966.abstract

Snyder Peter J., Peachey Helen, Hannoush Peter, Berlin Jesse A., Loh Louise, Holmes John H., Dlewati Abdallah, Staley Janet, Santanna Jill, Kapoor Shiv C., Attie Maurice F., Haddad John G. and Strom Brian L. Effect of Testosterone Treatment on Bone Mineral Density in Men Over 65 Years of Age. 84: 1966-1972. 1999: Testosterone.

http://jcem.endojournals.org/content/84/9/3025.abstract

Thorsen Kim, Nordstrom Peter, Lorentzon Ronny and Dahlen Gosta H. The Relation between Bone Mineral Density, Insulin-Like Growth Factor I, Lipoprotein (a), Body Composition, and Muscle Strength in Adolescent Males. 84: 3025-3029. 1999: Bone.

http://jcem.endojournals.org/content/84/7/2518.abstract

Verhelst Johan, Abs Roger, Maiter Dominique, van den Bruel Annick, Vandeweghe Mark, Velkeniers Brigitte, Mockel Jean, Lamberigts Gerard, Petrossians Patrick, Coremans Peter, Mahler Charles, Stevenaert Achille, Verlooy Jan, Raftopoulos Christian and Beckers Albert. Cabergoline in the Treatment of Hyperprolactinemia: A Study in 455 Patients. 84: 2518-2522. 1999: Prolactin.

http://jcem.endojournals.org/content/84/7/2286.abstract

Vestergaard Peter, Hermann Anne Pernille, Ã˜rskov Hans, Mosekilde Leif and Study the Danish Osteoporosis Prevention. Effect of Sex Hormone Replacement on the Insulin-Like Growth Factor System and Bone Mineral: A Cross-Sectional and Longitudinal Study in 595 Perimenopausal Women Participating in the Danish Osteoporosis Prevention Study. 84: 2286-2290. 1999: Bone.

http://jcem.endojournals.org/content/84/12/4549.abstract

Wang Pei-Wen, Wang Shan-Tair, Liu Rue-Tsuan, Chien Wen-Yen, Tung Shih-Chen, Lu Yung-Chuan, Chen Hue-Yong and Lee Chiang-Hsuan. Levothyroxine Suppression of Thyroglobulin in Patients with Differentiated Thyroid Carcinoma. 84: 4549-4553. 1999: Thyroid.

http://jcem.endojournals.org/content/84/7/2532.abstract

Weintraub Moshe, Grosskopf Itamar, Trostanesky Yana, Charach Gideon, Rubinstein Ardon and Stern Naftali. Thyroxine Replacement Therapy Enhances Clearance of Chylomicron Remnants in Patients with Hypothyroidism. 84: 2532-2536. 1999: Thyroid.

http://jcem.endojournals.org/content/84/2/401.short

Weiss Roy E. and Refetoff Samuel. Treatment of Resistance to Thyroid Hormone-Primum Non Nocere. 84: 401-404. 1999: Thyroid.

http://jcem.endojournals.org/content/84/7/2270.abstract

Wiesner Glen, Vaz Mario, Collier Greg, Seals Douglas, Kaye David, Jennings Gary, Lambert Gavin, Wilkinson Dominic and Esler Murray. Leptin Is Released from the Human Brain: Influence of Adiposity and Gender. 84: 2270-2274. 1999: Leptin.

http://jcem.endojournals.org/content/84/8/2696.abstract

Young Jacques, Rey Rodolfo, Couzinet Beatrice, Chanson Philippe, Josso Nathalie and Schaison Gilbert. Antimallerian Hormone in Patients with Hypogonadotropic Hypogonadism. 84: 2696-2699. 1999: Testosterone.

http://jcem.endojournals.org/content/85/3/1038.abstract

Allahabadia Amit, Daykin Jacquie, Holder Roger L., Sheppard Michael C., Gough Stephen C. L. and Franklyn Jayne A. Age and Gender Predict the Outcome of Treatment for Graves Hyperthyroidism. 85: 1038-1042. 2000: Thyroid.

http://jcem.endojournals.org/content/85/10/3779.abstract

Barrande Gaelle, Pittino-Lungo Myriam, Coste Joel, Ponvert Dominique, Bertagna Xavier, Luton Jean Pierre and Bertherat JÃ©rÃ´me. Hormonal and Metabolic Effects of Radiotherapy in Acromegaly: Long-Term Results in 128 Patients Followed in a Single Center. 85: 3779-3785. 2000: Acromegaly.

http://jcem.endojournals.org/content/85/1/219.abstract

Barrett-Connor Elizabeth, Mueller Judith E., von Mehlen Denise G., Laughlin Gail A., Schneider Diane L. and Sartoris David J. Low Levels of Estradiol Are Associated with Vertebral Fractures in Older Men, But Not Women: The Rancho Bernardo Study. 85: 219-223. 2000: Estrogens.

http://jcem.endojournals.org/content/85/3/933.short

Bengtsson Bengt-Ã…ke and Johannsson Gudmundur. The Treatment of Growth Hormone Deficiency in Adults. 85: 933-937. 2000: Growth Hormone.

http://jcem.endojournals.org/content/85/7/2476.abstract

Biermasz Nienke R., van Dulken Hans and Roelfsema Ferdinand. Long-Term Follow-Up Results of Postoperative Radiotherapy in 36 Patients with Acromegaly. 85: 2476-2482. 2000: Acromegaly.

http://jcem.endojournals.org/content/85/3/970.abstract

Biller Beverly M. K., Sesmilo Gemma, Baum Howard B. A., Hayden Douglas, Schoenfeld David and Klibanski Anne. Withdrawal of Long-Term Physiological Growth Hormone (GH) Administration: Differential Effects on Bone Density and Body Composition in Men with Adult-Onset GH Deficiency. 85: 970-976. 2000: Growth Hormone.

http://jcem.endojournals.org/content/85/2/720.abstract

Bone Henry G., Greenspan Susan L., McKeever Clark, Bell Norman, Davidson Michael, Downs Robert W., Emkey Ronald, Meunier Pierre J., Miller Sam S., Mulloy Anthony L., Recker Robert R., Weiss Stuart R., Heyden Norman, Musliner Thomas, Suryawanshi Shailaja, Yates A. John, Lombardi Antonio and group for the alendronate/estrogen study. Alendronate and Estrogen Effects in Postmenopausal Women with Low Bone Mineral Density. 85: 720-726. 2000: Bone.

http://jcem.endojournals.org/content/85/2/574.abstract

Bulow Birgitta, Hagmar Lars, Eskilsson Jan and Erfurth Eva Marie. Hypopituitary Females Have a High Incidence of Cardiovascular Morbidity and an Increased Prevalence of Cardiovascular Risk Factors. 85: 574-584. 2000: Obesity.

http://jcem.endojournals.org/content/85/1/76.abstract

Carlsson AsaLinda, Sundkvist Goran, Groop Leif and Tuomi Tiinamaija. Insulin and Glucagon Secretion in Patients with Slowly Progressing Autoimmune Diabetes (LADA). 85: 76-80. 2000: Diabetes.

http://jcem.endojournals.org/content/85/10/3762.abstract

Chrisoulidou Alexandra, Beshyah Salem A., Rutherford Olga, Spinks Terry J., Mayet Jamil, Kyd Patricia, Anyaoku Victor, Haida Abel, Ariff Ben, Murphy Margaret, Thomas Elizabeth, Robinson Stephen, Foale Rodney and Johnston Desmond G. Effects of 7 Years of Growth Hormone Replacement Therapy in Hypopituitary Adults. 85: 3762-3769. 2000: Growth Hormone.

http://jcem.endojournals.org/content/85/5/1783.abstract

Downs Jr. Robert W., Bell Norman H., Ettinger Mark P., Walsh Brian W., Favus Murray J., Mako Barbara, Wang Lixia, Smith Mary E., Gormley Glenn J. and Melton Mary E. Comparison of Alendronate and Intranasal Calcitonin for Treatment of Osteoporosis in Postmenopausal Women. 85: 1783-1788. 2000: Bone.

http://jcem.endojournals.org/content/85/5/1755.short

Eng Charis. Familial Papillary Thyroid Cancerâ€”Many Syndromes, Too Many Genes? 85: 1755-1757. 2000: Thyroid.

http://jcem.endojournals.org/content/85/5/1895.abstract

Fogelman Ignac, Ribot Claude, Smith Roger, Ethgen Dominique, Sod Earl and Reginster for the bmd-mn Study Group Jean-Yves. Risedronate Reverses Bone Loss in Postmenopausal Women with Low Bone Mass: Results From a Multinational, Double-Blind, Placebo-Controlled Trial. 85: 1895-1900. 2000: Bone.

http://jcem.endojournals.org/content/85/1/8.short

Freda Pamela U., Andreadis Charalambos I., Khandji Alexander G., Khoury Maha, Bruce Jeffrey N., Jacobs Thomas P. and Wardlaw Sharon L. Long-Term Treatment of Prolactin-Secreting Macroadenomas with Pergolide. 85: 8-13. 2000: Prolactin.

http://jcem.endojournals.org/content/85/2/526.abstract

Giustina Andrea, Barkan Ariel, Casanueva Felipe F., Cavagnini Franco, Frohman Lawrence, Ho Ken, Veldhuis Johannes, Wass John, von Werder Klaus and Melmed Shlomo. Criteria for Cure of Acromegaly: A Consensus Statement. 85: 526-529. 2000: Acromegaly.

http://jcem.endojournals.org/content/85/10/3537.abstract

Greenspan Susan L., Rosen Harold N. and Parker Robert A. Early Changes in Serum N-Telopeptide and C-Telopeptide Cross-Linked Collagen Type 1 Predict Long-Term Response to Alendronate Therapy in Elderly Women. 85: 3537-3540. 2000: Bone.

http://jcem.endojournals.org/content/85/5/1794.abstract

Hall Janet E., Lavoie Helene B., Marsh Erica E. and Martin Kathryn A. Decrease in Gonadotropin-Releasing Hormone (GnRH) Pulse Frequency with Aging in Postmenopausal Women. 85: 1794-1800. 2000: Estrogen.

http://jcem.endojournals.org/content/85/4/1498.abstract

Hickner R. C., Racette S. B., Binder E. F., Fisher J. S. and Kohrt W. M. Effects of 10 Days of Endurance Exercise Training on the Suppression of Whole Body and Regional Lipolysis by Insulin. 85: 1498-1504. 2000: Exercise.

http://jcem.endojournals.org/content/85/4/1412.abstract

Kamel Ashraf, Norgren Svante, Elimam Amira, Danielsson Pernilla and Marcus Claude. Effects of Growth Hormone Treatment in Obese Prepubertal Boys. 85: 1412-1419. 2000: Growth Hormone.

http://jcem.endojournals.org/content/85/4/1487.abstract

Kuhn J. M., Arlot S., Lefebvre H., Caron P., Cortet-Rudelli C., Archambaud F., Chanson P., Tabarin A., Goth Mi, Blumberg J., Catus F., Ispas S. and Beck-Peccoz P. Evaluation of the Treatment of Thyrotropin-Secreting Pituitary Adenomas with a Slow Release Formulation of the Somatostatin Analog Lanreotide. 85: 1487-1491. 2000: Thyroid.

http://jcem.endojournals.org/content/85/9/3069.abstract

Kurland Etah S., Cosman Felicia, McMahon Donald J., Rosen Clifford J., Lindsay Robert and Bilezikian John P. Parathyroid Hormone as a Therapy for Idiopathic Osteoporosis in Men: Effects on Bone Mineral Density and Bone Markers. 85: 3069-3076. 2000: Parathyroid.

http://jcem.endojournals.org/content/85/4/1505.abstract

Longobardi S., Keay N., Ehrnborg C., Cittadini A., Rosen T., Dall R., Boroujerdi M. A., Bassett E. E., Healy M. L., Pentecost C., Wallace J. D., Powrie J., JÃ¸rgensen J. O., SaccÃ L. and group on behalf of the gh- study. Growth Hormone (GH) Effects on Bone and Collagen Turnover in Healthy Adults and Its Potential as a Marker of GH Abuse in Sports: A Double Blind, Placebo-Controlled Study. 85: 1505-1512. 2000: Growth Hormone.

http://jcem.endojournals.org/content/85/4/1473.abstract

Mahajan Tripti and Lightman Stafford L. A Simple Test for Growth Hormone Deficiency in Adults. 85: 1473-1476. 2000: Growth Hormone.

http://jcem.endojournals.org/content/85/10/3653.abstract

Mauras Nelly, Attie Kenneth M., Reiter Edward O., Saenger Paul and Baptista the Genentech Inc. Cooperative Study Group Joyce. High Dose Recombinant Human Growth Hormone (GH) Treatment of GH-Deficient Patients in Puberty Increases Near-Final Height: A Randomized, Multicenter Trial. 85: 3653-3660. 2000: Growth Hormone.

http://jcem.endojournals.org/content/85/1/48.abstract

Parker C. Richard, Slayden Scott M., Azziz Ricardo, Crabbe S. Lolita, Hines Gene A., Boots Larry R. and Bae Sejong. Effects of Aging on Adrenal Function in the Human: Responsiveness and Sensitivity of Adrenal Androgens and Cortisol to Adrenocorticotropin in Premenopausal and Postmenopausal Women. 85: 48-54. 2000: Adrenal.

http://jcem.endojournals.org/content/85/9/3053.abstract

Pinzone Joseph J., Katznelson Laurence, Danila Daniel C., Pauler Donna K., Miller Caleb S. and Klibanski Anne. Primary Medical Therapy of Micro- and Macroprolactinomas in Men. 85: 3053-3057. 2000: Prolactin.

http://jcem.endojournals.org/content/85/3/943.abstract

Pop-Busui Rodica, Chey William and Stevens Martin J. Severe Hypertension Induced by the Long-Acting Somatostatin Analogue Sandostatin LAR in a Patient with Diabetic Autonomic Neuropathy. 85: 943-946. 2000: Diabetes.

http://jcem.endojournals.org/content/85/5/2068.abstract

Powell Jeffrey S., Wardlaw Sharon L., Post Kalmon D. and Freda Pamela U. Outcome of Radiotherapy for Acromegaly Using Normalization of Insulin-Like Growth Factor I to Define Cure. 85: 2068-2071. 2000: Acromegaly.

http://jcem.endojournals.org/content/85/6/2197.abstract

Prestwood Karen M., Gunness Michele, Muchmore Douglas B., Lu Yili, Wong Mayme and Raisz Lawrence G. A Comparison of the Effects of Raloxifene and Estrogen on Bone in Postmenopausal Women. 85: 2197-2202. 2000: Estrogen.

Journal of Clinical Endocrinology & Metabolism

Ravn Pernille, Weiss Stuart R., Rodriguez-Portales Jose A., McClung Michael R., Wasnich Richard D., Gilchrist Nigel L., Sambrook Philip, Fogelman Ignac, Krupa David, Yates A. John, Daifotis Anastasia, Fuleihan Ghada El-Hajj and group for the alendronate osteoporosis prevention study. Alendronate in Early Postmenopausal Women: Effects on Bone Mass during Long-Term Treatment and after Withdrawal. 85: 1492-1497. 2000: Bone.

http://jcem.endojournals.org/content/85/4/1492.abstract

http://jcem.endojournals.org/content/85/6/2129.abstract

Rittmaster Roger S., Bolognese Michael, Ettinger Mark P., Hanley David A., Hodsman Anthony B., Kendler David L. and Rosen Clifford J. Enhancement of Bone Mass in Osteoporotic Women with Parathyroid Hormone followed by Alendronate. 85: 2129-2134. 2000: Bone.

http://jcem.endojournals.org/content/85/4/1440.abstract

Rossi R., Tauchmanova L., Luciano A., Di Martino M., Battista C., Del Viscovo L., Nuzzo V. and Lombardi G. Subclinical Cushing's Syndrome in Patients with Adrenal Incidentaloma: Clinical and Biochemical Features. 85: 1440-1448. 2000: Cushings.

http://jcem.endojournals.org/content/85/10/3786.abstract

Sas Theo, Mulder Paul and Hokken-Koelega Anita. Body Composition, Blood Pressure, and Lipid Metabolism before and during Long-Term Growth Hormone (GH) Treatment in Children with Short Stature Born Small for Gestational Age Either with or without GH Deficiency. 85: 3786-3792. 2000: Lipids.

http://jcem.endojournals.org/content/85/3/937.short

Shalet Stephen M. Growth Hormone (GH) Replacement Is Not Justified for All Adults with GH Deficiency. 85: 937-939. 2000: Growth Hormone.

http://jcem.endojournals.org/content/85/3/939.short

Simpson Helen and Sonksen Peter. Treatment of Growth Hormone Deficiency in Adults. 85: 939-942. 2000: Growth Hormone.

http://jcem.endojournals.org/content/85/3/989.abstract

Smit Jan W. A., Vielvoye G. Jan and Goslings Bernard M. Embolization for Vertebral Metastases of Follicular Thyroid Carcinoma. 85: 989-994. 2000: Thyroid.

http://jcem.endojournals.org/content/85/8/2670.abstract

Snyder Peter J., Peachey Helen, Berlin Jesse A., Hannoush Peter, Haddad Ghada, Dlewati Abdallah, Santanna Jill, Loh Louise, Lenrow David A., Holmes John H., Kapoor Shiv C., Atkinson Linda E. and Strom Brian L. Effects of Testosterone Replacement in Hypogonadal Men. 85: 2670-2677. 2000: Testosterone.

http://jcem.endojournals.org/content/85/9/3109.abstract

Tonino Richard P., Meunier Pierre J., Emkey Ronald, Rodriguez-Portales Jose A., Menkes Charles-Joel, Wasnich Richard D., Bone Henry G., Santora Arthur C., Wu Mei, Desai Rena, Ross Philip D. and Group for the Phase iii Osteoporosis Treatment Study. Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women. 85: 3109-3115. 2000: Bone.

http://jcem.endojournals.org/content/85/3/983.abstract

Vitale Giovanni, Tagliaferri Pierosandro, Caraglia Michele, Rampone Erminia, Ciccarelli Antonio, Bianco Angelo Raffaele, Abbruzzese Alberto and Lupoli Giovanni. Slow Release Lanreotide in Combination with Interferon-Î±2b in the Treatment of Symptomatic Advanced Medullary Thyroid Carcinoma. 85: 983-988. 2000: Thyroid.

http://jcem.endojournals.org/content/85/1/124.abstract

Wallace Jennifer D., Cuneo Ross C., Lundberg Per Arne, Rosen Thord, JÃ¸rgensen Jens Otto Lunde, Longobardi Salvatore, Keay Nicola, Sacca Luigi, Christiansen Jens Sandahl, Bengtsson Bengt-Ãke and Sonksen Peter H. Responses of Markers of Bone and Collagen Turnover to Exercise, Growth Hormone (GH) Administration, and GH Withdrawal in Trained Adult Males. 85: 124-133. 2000: Bone.

http://jcem.endojournals.org/content/85/1/214.abstract

Walsh Brian W., Paul Sofia, Wild Robert A., Dean Robert A., Tracy Russell P., Cox David A. and Anderson Pamela W. The Effects of Hormone Replacement Therapy and Raloxifene on C-Reactive Protein and Homocysteine in Healthy Postmenopausal Women: A Randomized, Controlled Trial. 85: 214-218. 2000: HRT.

http://jcem.endojournals.org/content/85/1/66.abstract

Yesilova Zeki, Ozata Metin, Kocar Ismail H., Turan Mustafa, Pekel Aysel, Sengul Ali and OzdemÃr I. Caglayan. The Effects of Gonadotropin Treatment on the Immunological Features of Male Patients with Idiopathic Hypogonadotropic Hypogonadism. 85: 66-70. 2000: Testosterone.

http://jcem.endojournals.org/content/86/8/3499.abstract

Ahmad Aftab M., Guzder Rustom, Wallace A. Michael, Thomas Joegi, Fraser William D. and Vora Jiten P. Circadian and Ultradian Rhythm and Leptin Pulsatility in Adult GH Deficiency: Effects of GH Replacement. 86: 3499-3506. 2001: Growth Hormone.

http://jcem.endojournals.org/content/86/8/3611.abstract

Allahabadia Amit, Daykin Jacquie, Sheppard Michael C., Gough Stephen C. L. and Franklyn Jayne A. Radioiodine Treatment of Hyperthyroidism Prognostic Factors for Outcome. 86: 3611-3617. 2001: Thyroid.

http://jcem.endojournals.org/content/86/8/3488.abstract

Andrade Venia A., Gross Jorge L. and Maia Ana Luiza. The Effect of Methimazole Pretreatment on the Efficacy of Radioactive Iodine Therapy in Gravesâ€™ Hyperthyroidism: One-Year Follow-Up of a Prospective, Randomized Study. 86: 3488-3493. 2001: Thyroid.

http://jcem.endojournals.org/content/86/4/1504.abstract

Backeljauw Philippe F., Underwood Louis E. and Group The GHIS Collaborative. Therapy for 6.5-7.5 Years with Recombinant Insulin-Like Growth Factor I in Children with Growth Hormone Insensitivity Syndrome: A Clinical Research Center Study. 86: 1504-1510. 2001: Growth Hormone.

http://jcem.endojournals.org/content/86/5/1905.abstract

Barkan Ariel L. The "Quality of Life-Assessment of Growth Hormone Deficiency in Adults" Questionnaire: Can It Be Used to Assess Quality of Life in Hypopituitarism? 86: 1905-1907. 2001: Growth Hormone.

http://jcem.endojournals.org/content/86/7/3079.abstract

Biermasz Nienke R., Hamdy Neveen A. T., Janssen Yvonne J. H. and Roelfsema Ferdinand. Additional Beneficial Effects of Alendronate in Growth Hormone (GH)-Deficient Adults with Osteoporosis Receiving Long-Term Recombinant Human GH Replacement Therapy: A Randomized Controlled Trial. 86: 3079-3085. 2001: Growth Hormone.

http://jcem.endojournals.org/content/86/12/5658.abstract

Brandi Maria Luisa, Gagel Robert F., Angeli Alberto, Bilezikian John P., Beck-Peccoz Paolo, Bordi Cesare, Conte-Devolx Bernard, Falchetti Alberto, Gheri Riccardo Gionata, Libroia Alfonso, Lips Cornelius J. M., Lombardi Gaetano, Mannelli Massimo, Pacini Furio, Ponder Bruce A. J., Raue Frank, Skogseid Britt, Tamburrano Guido, Thakker Rajesh V., Thompson Norman W., Tomassetti Paola, Tonelli Francesco, Wells Samuel A. and Marx Stephen J. CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2. 86: 5658-5671. 2001: MEN 1 & 2.

http://jcem.endojournals.org/content/86/10/5083.abstract

Broglio Fabio, Arvat Emanuela, Benso Andrea, Gottero Cristina, Muccioli Giampiero, Papotti Mauro, Lely Aart Jan van der, Deghenghi Romano and Ghigo Ezio. Ghrelin, a Natural GH Secretagogue Produced by the Stomach, Induces Hyperglycemia and Reduces Insulin Secretion in Humans. 86: 5083. 2001: Ghrelin.

http://jcem.endojournals.org/content/86/7/3016.abstract

Burch H. B., Solomon B. L., Cooper D. S., Ferguson P., Walpert N. and Howard R. The Effect of Antithyroid Drug Pretreatment on Acute Changes in Thyroid Hormone Levels after 131I Ablation for Gravesâ€™ Disease. 86: 3016-3021. 2001: Thyroid.

http://jcem.endojournals.org/content/86/7/3070.abstract

Cabrera Monina S., Vogiatzi Maria G. and New Maria I. Long Term Outcome in Adult Males with Classic Congenital Adrenal Hyperplasia. 86: 3070-3078. 2001: Adrenal.

http://jcem.endojournals.org/content/86/6/2849.abstract

Caron Philippe, Arlot Sylvie, Bauters Catherine, Chanson Philippe, Kuhn Jean-Marc, Pugeat Michel, Marechaud Richard, Teutsch Caline, Vidal Elisabeth and Sassano Paolo. Efficacy of the Long-Acting Octreotide Formulation (Octreotide-Lar) in Patients with Thyrotropin-Secreting Pituitary Adenomas. 86: 2849-2853. 2001: Acromegaly.

http://jcem.endojournals.org/content/86/12/5700.abstract

Cauley Jane A., Zmuda Joseph M., Ensrud Kristine E., Bauer Douglas C., Ettinger Bruce and Group for the Study of Osteoporotic Fractures Research. Timing of Estrogen Replacement Therapy for Optimal Osteoporosis Prevention. 86: 5700-5705. 2001: Bone.

http://jcem.endojournals.org/content/86/8/3512.abstract

Ceccarelli Claudia, Bencivelli Walter, Morciano Donata, Pinchera Aldo and Pacini Furio. 131I Therapy for Differentiated Thyroid Cancer Leads to an Earlier Onset of Menopause: Results of a Retrospective Study. 86: 3512-3515. 2001: Thyroid.

http://jcem.endojournals.org/content/86/7/3009.abstract

Chanson Philippe, Daujat France, Young Jacques, Bellucci Angela, Kujas MichÃ¨le, Doyon Dominique and Schaison Gilbert. Normal Pituitary Hypertrophy as a Frequent Cause of Pituitary Incidentaloma: A Follow-Up Study. 86: 3009-3015. 2001: Pituitary.

http://jcem.endojournals.org/content/86/6/2701.abstract

Charmandari Evangelia, Hindmarsh Peter C., Johnston Atholl and Brook Charles G. D. Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency: Alterations in Cortisol Pharmacokinetics at Puberty. 86: 2701-2708. 2001: Adrenal.

http://jcem.endojournals.org/content/86/5/1913.abstract

Chu Leung-Wing, Lam Karen S. L., Tam Sidney C. F., Hu Wayne J. H. C., Hui Sau-Lan, Chiu Anna, Chiu Ka-Chun and Ng Pauline. A Randomized Controlled Trial of Low-Dose Recombinant Human Growth Hormone in the Treatment of Malnourished Elderly Medical Patients. 86: 1913-1920. 2001: Growth Hormone.

http://jcem.endojournals.org/content/86/6/2391.short

Cohan Pejman and Korenman Stanley G. Erectile Dysfunction. 86: 2391-2394. 2001: ED.

http://jcem.endojournals.org/content/86/5/1874.abstract

Colao Annamaria, di Somma Carolina, Cuocolo Alberto, Spinelli Letizia, Tedesco Nicolina, Pivonello Rosario, Bonaduce Domenico, Salvatore Marco and Lombardi Gaetano. Improved Cardiovascular Risk Factors and Cardiac Performance after 12 Months of Growth Hormone (GH) Replacement in Young Adult Patients with GH Deficiency. 86: 1874-1881. 2001: Growth Hormone.

http://jcem.endojournals.org/content/86/6/2779.abstract

Colao Annamaria, Ferone Diego, Marzullo Paolo, Cappabianca Paolo, Cirillo Sossio, Boerlin Viktor, Lancranjan Ioana and Lombardi Gaetano. Long-Term Effects of Depot Long-Acting Somatostatin Analog Octreotide on Hormone Levels and Tumor Mass in Acromegaly. 86: 2779-2786. 2001: Acromegaly.

http://jcem.endojournals.org/content/86/10/4644.abstract

Corrias A., Einaudi S., Chiorboli E., Weber G., CrinÃ² A., Andreo M., Cesaretti G., de Sanctis L., Messina M. F., Segni M., Cicchetti M., Vigone M., Pasquino A. M., Spera S., de Luca F., Mussa G. C. and Bona G. Accuracy of Fine Needle Aspiration Biopsy of Thyroid Nodules in Detecting Malignancy in Childhood: Comparison with Conventional Clinical, Laboratory, and Imaging Approaches. 86: 4644-4648. 2001: Thyroid.

http://jcem.endojournals.org/content/86/10/4649.abstract

Coutant Regis, Rouleau Staphanie, Despert Fracois, Magontier Nathalie, Loisel Didier and Limal Jean-Marie. Growth and Adult Height in GH-Treated Children with Nonacquired GH Deficiency and Idiopathic Short Stature: The Influence of Pituitary Magnetic Resonance Imaging Findings. 86: 4649-4654. 2001: Growth Hormone.

http://jcem.endojournals.org/content/86/1/3.short

Daniels Gilbert H. Amiodarone-Induced Thyrotoxicosis. 86: 3-8. 2001: Thyroid.

http://jcem.endojournals.org/content/86/9/4098.abstract

Ebeling Peter R., Wark John D., Yeung Stella, Poon Cathy, Salehi Nouria, Nicholson Geoffrey C. and Kotowicz Mark A. Effects of Calcitriol or Calcium on Bone Mineral Density, Bone Turnover, and Fractures in Men with Primary Osteoporosis: A Two-Year Randomized, Double Blind, Double Placebo Study. 86: 4098-4103. 2001: Bone.

http://jcem.endojournals.org/content/86/4/1496.abstract

Friedlander Anne L., Butterfield Gail E., Moynihan Sharon, Grillo Jeanine, Pollack Margaret, Holloway Leah, Friedman Leah, Yesavage Jerome, Matthias Dwight, Lee Scott, Marcus Robert and Hoffman Andrew R. One Year of Insulin-Like Growth Factor I Treatment Does Not Affect Bone Density, Body Composition, or Psychological Measures in Postmenopausal Women. 86: 1496-1503. 2001: Bone.

http://jcem.endojournals.org/content/86/8/3618.abstract

Gallagher J. C., Fowler S. E., Detter J. R. and Sherman S. S. Combination Treatment with Estrogen and Calcitriol in the Prevention of Age-Related Bone Loss. 86: 3618-3628. 2001: Estrogen.

http://jcem.endojournals.org/content/86/10/4657.abstract

Gatherstram G., Svensson J., Koranyi J., Alpsten M., Bosaus I., Bengtsson B.-Ã…. and Johannsson G. A Prospective Study of 5 Years of GH Replacement Therapy in GH-Deficient Adults: Sustained Effects on Body Composition, Bone Mass, and Metabolic Indices. 86: 4657-4665. 2001: Growth Hormone.

http://jcem.endojournals.org/content/86/3/965.short

Goldberg Ira J. Diabetic Dyslipidemia: Causes and Consequences. 86: 965-971. 2001: Lipids.

http://jcem.endojournals.org/content/86/5/1890.abstract

Harris Steven T., Eriksen Erik F., Davidson Michael, Ettinger Mark P., Moffett Jr. Alfred H., Baylink David J., Crusan Claudia E. and Chines Arkadi A. Effect of Combined Risedronate and Hormone Replacement Therapies on Bone Mineral Density in Postmenopausal Women. 86: 1890-1897. 2001: Bone.

http://jcem.endojournals.org/content/86/7/2969.abstract

Kamp G. A., Mul D., Waelkens J. J. J., Jansen M., Delemarre-van de Waal H. A., Verhoeven-Wind L., Frolich M., Oostdijk W. and Wit J. M. A Randomized Controlled Trial of Three Years Growth Hormone and Gonadotropin-Releasing Hormone Agonist Treatment in Children with Idiopathic Short Stature and Intrauterine Growth Retardation. 86: 2969-2975. 2001: Growth Hormone.

http://jcem.endojournals.org/content/86/1/289.abstract

Khastgir Gautam, Studd John, Holland Nigel, Alaghband-Zadeh Jamshid, Fox Simon and Chow Jade. Anabolic Effect of Estrogen Replacement on Bone in Postmenopausal Women with Osteoporosis: Histomorphometric Evidence in a Longitudinal Study. 86: 289-295. 2001: Estrogen.

http://jcem.endojournals.org/content/86/10/4693.abstract

Koranyi J., Svensson J., Gotherstrom G., Sunnerhagen K. S., Bengtsson B.-Ãke and Johannsson G. Baseline Characteristics and the Effects of Five Years of GH Replacement Therapy in Adults with GH Deficiency of Childhood or Adulthood Onset: A Comparative, Prospective Study. 86: 4693-4699. 2001: Growth Hormone.

http://jcem.endojournals.org/content/86/7/2958.abstract

Kovacs Jozsef, Votava Felix, Heinze Georg, Selyom Jenos, Lebl Jan, Pribilincove Zuzana, Frisch Herwig, Battelino Tadej, Waldhauser Franz and Group for the Middle European Workshop on Paediatric Endocrinology Congenital Adrenal Hyperplasia Study. Lessons From 30 Years of Clinical Diagnosis and Treatment of Congenital Adrenal Hyperplasia in Five Middle European Countries. 86: 2958-2964. 2001: Adrenal.

http://jcem.endojournals.org/content/86/8/3629.abstract

Luyer M. D. P., Khosla S., Owen W. G. and Miller V. M. Prospective Randomized Study of Effects of Unopposed Estrogen Replacement Therapy on Markers of Coagulation and Inflammation in Postmenopausal Women. 86: 3629-3634. 2001: Estrogen.

http://jcem.endojournals.org/content/86/6/2354.short

Mandel Susan J. and Cooper David S. The Use of Antithyroid Drugs in Pregnancy and Lactation. 86: 2354-2359. 2001: Thyroid.

http://jcem.endojournals.org/content/86/7/3001.abstract

Marzullo Paolo, Di Somma Carolina, Pratt Katherine L., Khosravi Javad, Diamandis Anastasia, Lombardi Gaetano, Colao Annamaria and Rosenfeld Ron G. Usefulness of Different Biochemical Markers of the Insulin-Like Growth Factor (IGF) Family in Diagnosing Growth Hormone Excess and Deficiency in Adults. 86: 3001-3008. 2001: Growth Hormone.

http://jcem.endojournals.org/content/86/4/1447.short

Mazzaferri Ernest L. and Kloos Richard T. Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer. 86: 1447-1463. 2001: Thyroid.

http://jcem.endojournals.org/content/86/11/5342.abstract

McConnell E. M., Atkinson A. B., Ennis C., Hadden D. R., McCance D. R., Sheridan B. and Bell P. M. The Effects on Insulin Action in Adult Hypopituitarism of Recombinant Human GH Therapy Individually Titrated for Six Months. 86: 5342-5347. 2001: Growth Hormone.

http://jcem.endojournals.org/content/86/6/2395.abstract

Miller Karen K. Androgen Deficiency in Women. 86: 2395-2401. 2001: Androgen.

http://jcem.endojournals.org/content/86/5/1884.abstract

Pasco Julie A., Henry Margaret J., Kotowicz Mark A., Collier Gregory R., Ball Madeleine J., Ugoni Antony M. and Nicholson Geoffrey C. Serum Leptin Levels Are Associated with Bone Mass in Nonobese Women. 86: 1884-1887. 2001: Leptin.

http://jcem.endojournals.org/content/86/10/4700.abstract

Reiter Edward O., Attie Kenneth M., Moshang Thomas, Silverman Bernard L., Kemp Stephen F., Neuwirth Rachel B., Ford Kathleen M., Saenger Paul and Group) for the Genentech Inc.-Alkermes Inc. Collaborative Study. A Multicenter Study of the Efficacy and Safety of Sustained Release GH in the Treatment of Naive Pediatric Patients with GH Deficiency. 86: 4700-4706. 2001: Growth Hormone.

http://jcem.endojournals.org/content/86/11/5252.abstract

Ringe J. D., Faber H. and Dorst A. Alendronate Treatment of Established Primary Osteoporosis in Men: Results of a 2-Year Prospective Study. 86: 5252-5255. 2001: Bone.

http://jcem.endojournals.org/content/86/3/957.abstract

Rosen Clifford J. and Bilezikian John P. Anabolic Therapy for Osteoporosis. 86: 957-964. 2001: Bone.

http://jcem.endojournals.org/content/86/5/1900.abstract

Saggese Giuseppe, Federico Giovanni, Barsanti Stefania and Fiore Lisa. The Effect of Administering Gonadotropin-Releasing Hormone Agonist with Recombinant-Human Growth Hormone (GH) on the Final Height of Girls with Isolated GH Deficiency: Results from a Controlled Study. 86: 1900-1904. 2001: Growth Hormone.

http://jcem.endojournals.org/content/86/1/16.short

Santen Richard J., Pinkerton JoAnn, McCartney Christopher and Petroni Gina R. Risk of Breast Cancer with Progestins in Combination with Estrogen as Hormone Replacement Therapy. 86: 16-23. 2001: Estrogen.

http://jcem.endojournals.org/content/86/11/5273.abstract

Sato Mayumi, Takeda Noriyuki, Sarui Hiroshi, Takami Rieko, Takami Kazuhisa, Hayashi Makoto, Sasaki Akihiko, Kawachi Shinnichi, Yoshino Koji and Yasuda Keigo. Association between Serum Leptin Concentrations and Bone Mineral Density, and Biochemical Markers of Bone Turnover in Adult Men. 86: 5273-5276. 2001: Leptin.

http://jcem.endojournals.org/content/86/6/2369.short

Snyder Peter J. Effects of Age on Testicular Function and Consequences of Testosterone Treatment. 86: 2369-2372. 2001: Testosterone.

http://jcem.endojournals.org/content/86/6/2787.abstract

Stoch S. Aubrey, Parker Robert A., Chen Liping, Bubley Glenn, Ko Yoo-Joung, Vincelette Aimee and Greenspan Susan L. Bone Loss in Men with Prostate Cancer Treated with Gonadotropin-Releasing Hormone Agonists. 86: 2787-2791. 2001: Bone.

http://jcem.endojournals.org/content/86/6/2607.abstract

The European Recombinant LH Study Group and Group The European Recombinant LH Study. Human Recombinant Luteinizing Hormone Is as Effective as, But Safer Than, Urinary Human Chorionic Gonadotropin in Inducing Final Follicular Maturation and Ovulation in in Vitro Fertilization Procedures: Results of a Multicenter Double-Blind Study. 86: 2607-2618. 2001: Estrogen.

http://jcem.endojournals.org/content/86/5/1871.short

Thomas Asha M. and Berglund Lars. Growth Hormone and Cardiovascular Disease: An Area in Rapid Growth. 86: 1871-1873. 2001: Growth Hormone.

http://jcem.endojournals.org/content/86/5/1908.abstract

Tiosano Dov, Weisman Yosef and Hochberg Ze'ev. The Role of the Vitamin D Receptor in Regulating Vitamin D Metabolism: A Study of Vitamin D-Dependent Rickets, Type II. 86: 1908-1912. 2001: Vitamin D.

http://jcem.endojournals.org/content/86/7/2989.abstract

Trainer P. J., Drake W. M., Perry L. A., Taylor N. F., Besser G. M. and Monson J. P. Modulation of Cortisol Metabolism by the Growth Hormone Receptor Antagonist Pegvisomant in Patients with Acromegaly. 86: 2989-2992. 2001: Cortisol.

http://jcem.endojournals.org/content/86/6/2380.short

Vermeulen A. Androgen Replacement Therapy in the Aging Maleâ-A Critical Evaluation. 86: 2380-2390. 2001: Androgen.

http://jcem.endojournals.org/content/86/2/517.abstract

Vgontzas Alexandros N., Legro Richard S., Bixler Edward O., Grayev Allison, Kales Anthony and Chrousos George P. Polycystic Ovary Syndrome Is Associated with Obstructive Sleep Apnea and Daytime Sleepiness: Role of Insulin Resistance. 86: 517-520. 2001: PCOS.

http://jcem.endojournals.org/content/86/6/2531.abstract

Welt Corrine K., Smith Zachary A., Pauler Donna K. and Hall Janet E. Differential Regulation of Inhibin A and Inhibin B by Luteinizing Hormone, Follicle-Stimulating Hormone, and Stage of Follicle Development. 86: 2531-2537. 2001: Inhibin.

http://jcem.endojournals.org/content/86/3/998.abstract

Wesche Maria F. T., Tiel-v Buul Monique M. C., Lips Paul, Smits Nico J. and Wiersinga Wilmar M. A Randomized Trial Comparing Levothyroxine with Radioactive Iodine in the Treatment of Sporadic Nontoxic Goiter. 86: 998-1005. 2001: Thyroid.

http://jcem.endojournals.org/content/86/2/501.short

Wiersinga W. M. and Prummel M. F. Pathogenesis of Graves' Ophthalmopathy-Current Understanding. 86: 501-503. 2001: Thyroid.

http://jcem.endojournals.org/content/86/8/3494.abstract

Wiren Lena, Johannsson Gudmundur and Bengtsson Bengt-Ãke. A Prospective Investigation of Quality of Life and Psychological Well-Being after the Discontinuation of GH Treatment in Adolescent Patients Who Had GH Deficiency during Childhood. 86: 3494-3498. 2001: Growth Hormone.

http://jcem.endojournals.org/content/86/10/4727.abstract

Zhdanova Irina V., Wurtman Richard J., Regan Meredith M., Taylor Judith A., Shi Jian Ping and Leclair Ojingwa U. Melatonin Treatment for Age-Related Insomnia. 86: 4727-4730. 2001: Melatonin.

http://jcem.endojournals.org/content/87/1/122.abstract

Andersson Bjorn, Johannsson Gudmundur, Holm Goran, Bengtsson Bengt-Ake, Sashegyi Andreas, Pavo Imre, Mason Timothy and Anderson Pamela W. Raloxifene Does Not Affect Insulin Sensitivity or Glycemic Control in Postmenopausal Women with Type 2 Diabetes Mellitus: A Randomized Clinical Trial. 87: 122-128. 2002: Bone.

http://jcem.endojournals.org/content/87/1/99.abstract

Caron Ph., Beckers A., Cullen D. R., Goth M. I., Gutt B., Laurberg P., Pico A. M., Valimaki M. and Zgliczynski W. Efficacy of the New Long-Acting Formulation of Lanreotide (Lanreotide Autogel) in the Management of Acromegaly. 87: 99-104. 2002: Acromegaly.

http://jcem.endojournals.org/content/87/1/90.abstract

Cohen Pinchas, Bright George M., Rogol Alan D., Kappelgaard Anne-Marie, Rosenfeld Ron G. and Group on behalf of the American Norditropin Clinical Trials. Effects of Dose and Gender on the Growth and Growth Factor Response to GH in GH-Deficient Children: Implications for Efficacy and Safety. 87: 90-98. 2002: Growth Hormone.

http://jcem.endojournals.org/content/87/1/84.abstract

Mericq VerÃ³nica, Gajardo HÃ©ctor, Eggers Martha, Avila Alejandra and Cassorla Fernando. Effects of Treatment with GH Alone or in Combination with LHRH Analog on Bone Mineral Density in Pubertal GH-Deficient Patients. 87: 84-89. 2002: Growth Hormone.

http://jcem.endojournals.org/content/87/1/16.short

Modelska Katharina and Cummings Steven. Tibolone for Postmenopausal Women: Systematic Review of Randomized Trials. 87: 16-23. 2002: Tibolone.

http://jcem.endojournals.org/content/87/1/129.abstract

Murray R. D., Darzy K. H., Gleeson H. K. and Shalet S. M. GH-Deficient Survivors of Childhood Cancer: GH Replacement during Adult Life. 87: 129-135. 2002: Growth Hormone.

http://jcem.endojournals.org/content/87/1/213.abstract

Song Soon H., Kjems Lise, Ritzel Robert, McIntyre Susan M., Johnson Michael L., Veldhuis Johannes D. and Butler Peter C. Pulsatile Insulin Secretion by Human Pancreatic Islets. 87: 213-221. 2002: Insulin.

http://jcem.endojournals.org/content/88/6/2860.abstract

Ahmad Aftab M., Thomas Joegi, Clewes Adrian, Hopkins Marion T., Guzder Rostem, Ibrahim Hisham, Durham Brian H., Vora Jiten P. and Fraser William D. Effects of Growth Hormone Replacement on Parathyroid Hormone Sensitivity and Bone Mineral Metabolism. 88: 2860-2868. 2003: Growth Hormone.

http://jcem.endojournals.org/content/88/7/3015.abstract

Allendorf John, Kim Lucy, Chabot John, DiGiorgi Mary, Spanknebel Katherine and LoGerfo Paul. The Impact of Sestamibi Scanning on the Outcome of Parathyroid Surgery. 88: 3015-3018. 2003: Parathyroid.

http://jcem.endojournals.org/content/88/12/5593.abstract

Arnaldi G., Angeli A., Atkinson A. B., Bertagna X., Cavagnini F., Chrousos G. P., Fava G. A., Findling J. W., Gaillard R. C., Grossman A. B., Kola B., Lacroix A., Mancini T., Mantero F., Newell-Price J., Nieman L. K., Sonino N., Vance M. L., Giustina A. and Boscaro M. Diagnosis and Complications of Cushing's Syndrome: A Consensus Statement. 88: 5593-5602. 2003: Cushing's.

http://jcem.endojournals.org/content/88/2/701.abstract

Arosio Maura, Ronchi Cristina L., Gebbia Carlotta, Cappiello Vincenzo, Beck-Peccoz Paolo and Peracchi Maddalena. Stimulatory Effects of Ghrelin on Circulating Somatostatin and Pancreatic Polypeptide Levels. 88: 701-704. 2003: Ghrelin.

http://jcem.endojournals.org/content/88/11/5258.abstract

Attanasio Roberto, Baldelli Roberto, Pivonello Rosario, Grottoli Silvia, Bocca Liliana, Gasco Valentina, Giusti Massimo, Tamburrano Guido, Colao Annamaria and Cozzi Renato. Lanreotide 60 mg, a New Long-Acting Formulation: Effectiveness in the Chronic Treatment of Acromegaly. 88: 5258-5265. 2003: Acromegaly.

http://jcem.endojournals.org/content/88/7/3105.abstract

Attanasio Roberto, Epaminonda Paolo, Motti Enrico, Giugni Enrico, Ventrella Laura, Cozzi Renato, Farabola Mario, Loli Paola, Beck-Peccoz Paolo and Arosio Maura. Gamma-Knife Radiosurgery in Acromegaly: A 4-Year Follow-Up Study. 88: 3105-3112. 2003: Acromegaly.

http://jcem.endojournals.org/content/88/9/4110.abstract

Barbaro Daniele, Boni Giuseppe, Meucci Giuseppe, Simi Umberto, Lapi Paola, Orsini Paola, Pasquini Cristina, Piazza Francesca, Caciagli Marco and Mariani Giuliano. Radioiodine Treatment with 30 mCi after Recombinant Human Thyrotropin Stimulation in Thyroid Cancer: Effectiveness for Postsurgical Remnants Ablation and Possible Role of Iodine Content in l-Thyroxine in the Outcome of Ablation. 88: 4110-4115. 2003: Thyroid.

http://jcem.endojournals.org/content/88/9/4055.short

Bastepe Murat and Joppner Harald. Pseudohypoparathyroidism and Mechanisms of Resistance toward Multiple Hormones: Molecular Evidence to Clinical Presentation. 88: 4055-4058. 2003: Parathyroid.

http://jcem.endojournals.org/content/88/3/963.short

Ben-Shlomo Anat and Melmed Shlomo. The Role of Pharmacotherapy in Perioperative Management of Patients with Acromegaly. 88: 963-968. 2003: Acromegaly.

http://jcem.endojournals.org/content/88/8/3664.abstract

Besson AmÃ©lie, Salemi Souzan, Gallati Sabina, Jenal Arthur, Horn Rudolf, Mullis Pia S. and Mullis Primus E. Reduced Longevity in Untreated Patients with Isolated Growth Hormone Deficiency. 88: 3664-3667. 2003: Growth Hormone.

http://jcem.endojournals.org/content/88/9/4158.abstract

Blum Werner F., Shavrikova Elena P., Edwards David J., Rosilio Myriam, Hartman Mark L., MarÃn Fernando, Valle Domenico, van der Lely Aart Jan, Attanasio Andrea F., Strasburger Christian J., Henrich Gerhard and Herschbach Peter. Decreased Quality of Life in Adult Patients with Growth Hormone Deficiency Compared with General Populations Using the New, Validated, Self-Weighted Questionnaire, Questions on Life Satisfaction Hypopituitarism Module. 88: 4158-4167. 2003: Growth Hormone.

http://jcem.endojournals.org/content/88/5/1999.abstract

Bogazzi Fausto, Bartalena Luigi, Cosci Chiara, Brogioni Sandra, Dellâ€™Unto Enrica, Grasso Lucia, Aghini-Lombardi Fabrizio, Rossi Giuseppe, Pinchera Aldo, Braverman Lewis E. and Martino Enio. Treatment of Type II Amiodarone-Induced Thyrotoxicosis by Either Iopanoic Acid or Glucocorticoids: A Prospective, Randomized Study. 88: 1999-2002. 2003: Thyroid.

http://jcem.endojournals.org/content/88/5/1947.abstract

Braga-Basaria Milena and Ringel Matthew D. Beyond Radioiodine: A Review of Potential New Therapeutic Approaches for Thyroid Cancer. 88: 1947-1960. 2003: Thyroid.

http://jcem.endojournals.org/content/88/11/5287.abstract

Brenta G., Schnitman M., Fretes O., Facco E., Gurfinkel M., Damilano S., Pacenza N., Blanco A., Gonzalez E. and Pisarev M. A. Comparative Efficacy and Side Effects of the Treatment of Euthyroid Goiter with Levo-Thyroxine or Triiodothyroacetic Acid. 88: 5287-5292. 2003: Thyroid.

http://jcem.endojournals.org/content/88/9/4268.abstract

Broglio F., Gottero C., Benso A., Prodam F., Destefanis S., Gauna C., Maccario M., Deghenghi R., van der Lely A. J. and Ghigo E. Effects of Ghrelin on the Insulin and Glycemic Responses to Glucose, Arginine, or Free Fatty Acids Load in Humans. 88: 4268-4272. 2003: Ghrelin.

http://jcem.endojournals.org/content/88/4/1537.abstract

Broglio Fabio, Benso Andrea, Castiglioni Carlotta, Gottero Cristina, Prodam Flavia, Destefanis Silvia, Gauna Carlotta, van der Lely Aart Jan, Deghenghi Romano, Bo Mario, Arvat Emanuela and Ghigo Ezio. The Endocrine Response to Ghrelin as a Function of Gender in Humans in Young and Elderly Subjects. 88: 1537-1542. 2003: Ghrelin.

http://jcem.endojournals.org/content/88/4/1587.abstract

Carel Jean-Claude, Chatelain Pierre, Rochiccioli Pierre and Chaussain Jean-Louis. Improvement in Adult Height after Growth Hormone Treatment in Adolescents with Short Stature Born Small for Gestational Age: Results of a Randomized Controlled Study. 88: 1587-1593. 2003: Growth Hormone.

http://jcem.endojournals.org/content/88/7/3155.abstract

Chan Fredriech K. W., Tiu Sau-Cheung, Choi Kin-Lam, Choi Cheung-Hei, Kong Alice P. S. and Shek Chi-Chung. Increased Bone Mineral Density in Patients with Chronic Hypoparathyroidism. 88: 3155-3159. 2003: Bone.

http://jcem.endojournals.org/content/88/2/581.abstract

Chow C. C., Chan W. B., Li June K. Y., Chan Norman N., Chan Michael H. M., Ko Gary T. C., Lo K. W. and Cockram Clive S. Oral Alendronate Increases Bone Mineral Density in Postmenopausal Women with Primary Hyperparathyroidism. 88: 581-587. 2003: Bone.

http://jcem.endojournals.org/content/88/7/3011.short

Clark Orlo H. How Should Patients with Primary Hyperparathyroidism Be Treated? 88: 3011-3014. 2003: Parathyroid.

http://jcem.endojournals.org/content/88/1/88.abstract

Colao Annamaria, Di Somma Carolina, Spiezia Stefano, Filippella Mariagiovanna, Pivonello Rosario and Lombardi Gaetano. Effect of Growth Hormone (GH) and/or Testosterone Replacement on the Prostate in GH-Deficient Adult Patients. 88: 88-94. 2003: Growth Hormone.

http://jcem.endojournals.org/content/88/10/4609.abstract

Cooper Cyrus, Emkey Ronald D., McDonald Robert H., Hawker Gillian, Bianchi Gerolamo, Wilson Katie and Schimmer Ralph C. Efficacy and Safety of Oral Weekly Ibandronate in the Treatment of Postmenopausal Osteoporosis. 88: 4609-4615. 2003: Bone.

http://jcem.endojournals.org/content/88/8/3474.short

Cooper David S. Antithyroid Drugs in the Management of Patients with Graves' Disease: An Evidence-Based Approach to Therapeutic Controversies. 88: 3474-3481. 2003: Thyroid.

http://jcem.endojournals.org/content/88/7/3090.abstract

Cozzi Renato, Attanasio Roberto, Montini Marcella, Pagani Giorgio, Lasio Giovanni, Lodrini Sandro, Barausse Michela, Albizzi Mascia, Dallabonzana Daniela and Pedroncelli Alberto M. Four-Year Treatment with Octreotide-Long-Acting Repeatable in 110 Acromegalic Patients: Predictive Value of Short-Term Results? 88: 3090-3098. 2003: Acromegaly.

http://jcem.endojournals.org/content/88/7/3167.abstract

Crawford Bronwyn A. L., Liu Peter Y., Kean Mary T., Bleasel Jane F. and Handelsman David J. Randomized Placebo-Controlled Trial of Androgen Effects on Muscle and Bone in Men Requiring Long-Term Systemic Glucocorticoid Treatment. 88: 3167-3176. 2003: Androgen.

http://jcem.endojournals.org/content/88/1/95.abstract

Darzy K. H., Aimaretti G., Wieringa G., Gattamaneni H. Rao, Ghigo E. and Shalet S. M. The Usefulness of the Combined Growth Hormone (GH)-Releasing Hormone and Arginine Stimulation Test in the Diagnosis of Radiation-Induced GH Deficiency Is Dependent on the Post-Irradiation Time Interval. 88: 95-102. 2003: Growth Hormone.

http://jcem.endojournals.org/content/88/7/2983.abstract

Dittmar Manuela and Kahaly George J. Polyglandular Autoimmune Syndromes: Immunogenetics and Long-Term Follow-Up. 88: 2983-2992. 2003: Polyglandular.

http://jcem.endojournals.org/content/88/2/550.short

Eisenhofer Graeme. Biochemical Diagnosis of Pheochromocytoma: Is it Time to Switch to Plasma-Free Metanephrines? 88: 550-552. 2003: Phaeochromocytoma.

http://jcem.endojournals.org/content/88/11/5193.abstract

Engstram Britt Eden, Burman Pia, Holdstock Camilla and Karlsson F. Anders. Effects of Growth Hormone (GH) on Ghrelin, Leptin, and Adiponectin in GH-Deficient Patients. 88: 5193-5198. 2003: Growth Hormone.

http://jcem.endojournals.org/content/88/6/2714.abstract

Fernandez-Real Jose Manuel, Lopez-Bermejo Abel, Casamitjana Roser and Ricart Wifredo. Novel Interactions of Adiponectin with the Endocrine System and Inflammatory Parameters. 88: 2714-2718. 2003: Adiponectin.

http://jcem.endojournals.org/content/88/5/2037.abstract

Freda Pamela U., Reyes Carlos M., Conwell Irene M., Sundeen Robert E. and Wardlaw Sharon L. Serum Ghrelin Levels in Acromegaly: Effects of Surgical and Long-Acting Octreotide Therapy. 88: 2037-2044. 2003: Ghrelin.

http://jcem.endojournals.org/content/88/6/2838.abstract

Gavrila Alina, Peng C.-K., Chan Jean L., Mietus Joseph E., Goldberger Ary L. and Mantzoros Christos S. Diurnal and Ultradian Dynamics of Serum Adiponectin in Healthy Men: Comparison with Leptin, Circulating Soluble Leptin Receptor, and Cortisol Patterns. 88: 2838-2843. 2003: Adiponectin.

http://jcem.endojournals.org/content/88/9/4059.abstract

Germain-Lee Emily L., Groman Joshua, Crane Janet L., Jan de Beur Suzanne M. and Levine Michael A. Growth Hormone Deficiency in Pseudohypoparathyroidism Type 1a: Another Manifestation of Multihormone Resistance. 88: 4059-4069. 2003: Growth Hormone.

http://jcem.endojournals.org/content/88/2/562.abstract

Gu Yi-Qun, Wang Xing-Hai, Xu Dwo, Peng Lin, Cheng Li-Fa, Huang Ming-Kong, Huang Zhen-Jia and Zhang Gui-Yuan. A Multicenter Contraceptive Efficacy Study of Injectable Testosterone Undecanoate in Healthy Chinese Men. 88: 562-568. 2003: Testosterone.

http://jcem.endojournals.org/content/88/7/3177.abstract

Holdstock Camilla, Engstrom Britt Eden, Ãhrvall Margareta, Lind Lars, Sundbom Magnus and Karlsson F. Anders. Ghrelin and Adipose Tissue Regulatory Peptides: Effect of Gastric Bypass Surgery in Obese Humans. 88: 3177-3183. 2003: Ghrelin.

http://jcem.endojournals.org/content/88/8/3499.short

Holick Michael F. The Parathyroid Hormone D-Lema. 88: 3499-3500. 2003: Parathyroid.

http://jcem.endojournals.org/content/88/2/569.abstract

Horwitz Mara J., Tedesco Mary Beth, Gundberg Caren, Garcia-Ocana Adolfo and Stewart Andrew F. Short-Term, High-Dose Parathyroid Hormone-Related Protein as a Skeletal Anabolic Agent for the Treatment of Postmenopausal Osteoporosis. 88: 569-575. 2003: Parathyroid.

http://jcem.endojournals.org/content/88/9/4130.abstract

Huang Kuo-Chin, Chen Chi-Ling, Chuang Lee-Ming, Ho Shiuh-Rong, Tai Tong-Yuan and Yang Wei-Shiung. Plasma Adiponectin Levels and Blood Pressures in Nondiabetic Adolescent Females. 88: 4130-4134. 2003: Adiponectin.

http://jcem.endojournals.org/content/88/3/975.short

Kalinyak Judith E. and McDougall I. Ross. How Should the Dose of Iodine-131 Be Determined in the Treatment of Graves' Hyperthyroidism? 88: 975-977. 2003: Thyroid.

http://jcem.endojournals.org/content/88/10/4540.short

Kaplan Michael M., Sarne David H. and Schneider Arthur B. In Search of the Impossible Dream? Thyroid Hormone Replacement Therapy That Treats All Symptoms in All Hypothyroid Patients. 88: 4540-4542. 2003: Thyroid.

http://jcem.endojournals.org/content/88/6/2445.short

Kreisberg Robert A. and Oberman Albert. Medical Management of Hyperlipidemia/Dyslipidemia. 88: 2445-2461. 2003: Lipids.

http://jcem.endojournals.org/content/88/7/3130.abstract

Kung Annie W. C., Chao Hsiang-Tai, Huang Ko-En, Need Allan G., Taechakraichana Nimit, Loh Foo-Hoe, Gonzaga Florante, Sriram Usha, Ismail Nik Mohd Nasri, Farooqi Abid, Rachman Ichramsjah Azim, Crans Gerald G., Wong Mayme and Thiebaud Daniel. Efficacy and Safety of Raloxifene 60 Milligrams/Day in Postmenopausal Asian Women. 88: 3130-3136. 2003: Bone.

http://jcem.endojournals.org/content/88/5/2045.abstract

le Roux C. W., Chapman G. A., Kong W. M., Dhillo W. S., Jones J. and Alaghband-Zadeh J. Free Cortisol Index Is Better Than Serum Total Cortisol in Determining Hypothalamic-Pituitary-Adrenal Status in Patients Undergoing Surgery. 88: 2045-2048. 2003: Cortisol.

http://jcem.endojournals.org/content/88/3/978.abstract

Leslie William D., Ward Linda, Salamon Elizabeth A., Ludwig Sora, Rowe Richard C. and Cowden Elizabeth A. A Randomized Comparison of Radioiodine Doses in Graves' Hyperthyroidism. 88: 978-983. 2003: Thyroid.

http://jcem.endojournals.org/content/88/6/2586.abstract

Lustig Robert H., Hinds Pamela S., Ringwald-Smith Karen, Christensen Robbin K., Kaste Sue C., Schreiber Randi E., Rai Shesh N., Lensing Shelly Y., Wu Shengjie and Xiong Xiaoping. Octreotide Therapy of Pediatric Hypothalamic Obesity: A Double-Blind, Placebo-Controlled Trial. 88: 2586-2592. 2003: Obesity.

http://jcem.endojournals.org/content/88/9/4070.abstract

Mantovani Giovanna, Maghnie Mohamad, Weber Giovanna, De Menis Ernesto, Brunelli Valeria, Cappa Marco, Loli Paola, Beck-Peccoz Paolo and Spada Anna. Growth Hormone-Releasing Hormone Resistance in Pseudohypoparathyroidism Type Ia: New Evidence for Imprinting of the GsÎ± Gene. 88: 4070-4074. 2003: Parathyroid.

http://jcem.endojournals.org/content/88/8/3561.abstract

Marcocci Claudio, Bartalena Luigi, Rocchi Roberto, MarinÃ² Michele, Menconi Francesca, Morabito Eugenia, Mazzi Barbara, Mazzeo Salvatore, Sartini Maria Sole, Nardi Marco, Cartei Francesco, Cionini Luca and Pinchera Aldo. Long-Term Safety of Orbital Radiotherapy for Graves' Ophthalmopathy. 88: 3561-3566. 2003: Thyroid.

http://jcem.endojournals.org/content/88/12/5603.short

Mariash Cary N. Thyroid Hormone and the Adipocyte. 88: 5603-5604. 2003: Thyroid.

http://jcem.endojournals.org/content/88/4/1433.abstract

Mazzaferri E. L., Robbins R. J., Spencer C. A., Braverman L. E., Pacini F., Wartofsky L., Haugen B. R., Sherman S. I., Cooper D. S., Braunstein G. D., Lee S., Davies T. F., Arafah B. M., Ladenson P. W. and Pinchera A. A Consensus Report of the Role of Serum Thyroglobulin as a Monitoring Method for Low-Risk Patients with Papillary Thyroid Carcinoma. 88: 1433-1441. 2003: Thyroid.

http://jcem.endojournals.org/content/88/8/3467.abstract

Moore Eva, Wisniewski Amy and Dobs Adrian. Endocrine Treatment of Transsexual People: A Review of Treatment Regimens, Outcomes, and Adverse Effects. 88: 3467-3473. 2003: Transsexual.

http://jcem.endojournals.org/content/88/3/1157.abstract

Munoz Julian and Gower Barbara A. Relationship between Serum Leptin Concentration and Low-Density Muscle in Postmenopausal Women. 88: 1157-1161. 2003: Leptin.

http://jcem.endojournals.org/content/88/7/3121.abstract

Nieuwlaat Willy-Anne, Huysmans Dyde A., van den Bosch Harrie C., Sweep C. G., Ross H. Alec, Corstens Frans H. and Hermus Ad R. Pretreatment with a Single, Low Dose of Recombinant Human Thyrotropin Allows Dose Reduction of Radioiodine Therapy in Patients with Nodular Goiter. 88: 3121-3129. 2003: Thyroid.

http://jcem.endojournals.org/content/88/8/3668.abstract

Pacini F., Molinaro E., Castagna M. G., Agate L., Elisei R., Ceccarelli C., Lippi F., Taddei D., Grasso L. and Pinchera A. Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin Combined with Neck Ultrasonography Has the Highest Sensitivity in Monitoring Differentiated Thyroid Carcinoma. 88: 3668-3673. 2003: Thyroid.

http://jcem.endojournals.org/content/88/9/4139.abstract

Pagotto Uberto, Gambineri Alessandra, Pelusi Carla, Genghini Silvia, Cacciari Mauro, Otto Baerbel, Castaneda Tamara, Tschop Matthias and Pasquali Renato. Testosterone Replacement Therapy Restores Normal Ghrelin in Hypogonadal Men. 88: 4139-4143. 2003: Testosterone.

http://jcem.endojournals.org/content/88/3/986.abstract

Rauch Frank, Plotkin Horacio, Travers Rose, Zeitlin Leonid and Glorieux Francis H. Osteogenesis Imperfecta Types I, III, and IV: Effect of Pamidronate Therapy on Bone and Mineral Metabolism. 88: 986-992. 2003: Bone.

http://jcem.endojournals.org/content/88/5/1933.short

Robbins Richard J. and Robbins Anne K. Recombinant Human Thyrotropin and Thyroid Cancer Management. 88: 1933-1938. 2003: Thyroid.

http://jcem.endojournals.org/content/88/3/1174.abstract

Rubin Mishaela R., Lee Kristen H., McMahon Donald J. and Silverberg Shonni J. Raloxifene Lowers Serum Calcium and Markers of Bone Turnover in Postmenopausal Women with Primary Hyperparathyroidism. 88: 1174-1178. 2003: Bone.

http://jcem.endojournals.org/content/88/10/4551.abstract

Sawka A. M., Gerstein H. C., Marriott M. J., MacQueen G. M. and Joffe R. T. Does a Combination Regimen of Thyroxine (T4) and 3,5,3-Triiodothyronine Improve Depressive Symptoms Better Than T4 Alone in Patients with Hypothyroidism? Results of a Double-Blind, Randomized, Controlled Trial. 88: 4551-4555. 2003: Thyroid.

http://jcem.endojournals.org/content/88/2/553.abstract

Sawka Anna M., Jaeschke Roman, Singh Ravinder J. and Young William F. A Comparison of Biochemical Tests for Pheochromocytoma: Measurement of Fractionated Plasma Metanephrines Compared with the Combination of 24-Hour Urinary Metanephrines and Catecholamines. 88: 553-558. 2003: Phaeochromocytoma.

http://jcem.endojournals.org/content/88/11/5266.abstract

Schweizer R., Martin D. D., Schwarze C. P., Binder G., Georgiadou A., Ihle J. and Ranke M. B. Cortical Bone Density Is Normal in Prepubertal Children with Growth Hormone (GH) Deficiency, but Initially Decreases during GH Replacement due to Early Bone Remodeling. 88: 5266-5272. 2003: Growth Hormone.

Journal of Clinical Endocrinology & Metabolism

Shalet Stephen M., Shavrikova Elena, Cromer Morris, Child Christopher J., Keller Eberhard, ZapletalovÃ¡ Jirina, Moshang Thomas, Blum Werner F., Chipman John J., Quigley Charmian A. and Attanasio Andrea F. Effect of Growth Hormone (GH) Treatment on Bone in Postpubertal GH-Deficient Patients: A 2-Year Randomized, Controlled, Dose-Ranging Study. 88: 4124-4129. 2003: Growth Hormone.

http://jcem.endojournals.org/content/88/9/4124.abstract

http://jcem.endojournals.org/content/88/9/4095.abstract

Shulman Dorothy I., Root Allen W., Diamond Frank B., Bercu Barry B., Martinez Richard and Boucek Robert J. Effects of One Year of Recombinant Human Growth Hormone (GH) Therapy on Cardiac Mass and Function in Children with Classical GH Deficiency. 88: 4095-4099. 2003: Growth Hormone.

http://jcem.endojournals.org/content/88/10/4682.abstract

Silfen Miriam E., Denburg Michelle R., Manibo Alexandra M., Lobo Rogerio A., Jaffe Richard, Ferin Michel, Levine Lenore S. and Oberfield Sharon E. Early Endocrine, Metabolic, and Sonographic Characteristics of Polycystic Ovary Syndrome (PCOS): Comparison between Nonobese and Obese Adolescents. 88: 4682-4688. 2003: PCOS.

http://jcem.endojournals.org/content/88/8/3501.abstract

Souberbielle Jean-Claude, Lawson-Body Ethel, Hammadi Boualem, Sarfati Emile, Kahan AndrÃ¨ and Cormier Catherine. The Use in Clinical Practice of Parathyroid Hormone Normative Values Established in Vitamin D-Sufficient Subjects. 88: 3501-3504. 2003: Parathyroid.

http://jcem.endojournals.org/content/88/7/3099.abstract

Svartberg Johan, Jorde Rolf, Sundsfjord Johan, BÃ¸naa Kaare H. and Barrett-Connor Elizabeth. Seasonal Variation of Testosterone and Waist to Hip Ratio in Men: The TromsÃ¸ Study. 88: 3099-3104. 2003: Testosterone.

http://jcem.endojournals.org/content/88/5/2061.abstract

Svensson Johan, Stibrant Sunnerhagen Katharina and Johannsson Gudmundur. Five Years of Growth Hormone Replacement Therapy in Adults: Age- and Gender-Related Changes in Isometric and Isokinetic Muscle Strength. 88: 2061-2069. 2003: Growth Hormone.

http://jcem.endojournals.org/content/88/6/2489.abstract

Tanabe Akiyo, Naruse Mitsuhide, Takagi Sachiko, Tsuchiya Ken, Imaki Toshihiro and Takano Kazue. Variability in the Renin/Aldosterone Profile under Random and Standardized Sampling Conditions in Primary Aldosteronism. 88: 2489-2494. 2003: Adrenal.

http://jcem.endojournals.org/content/88/11/5478.abstract

Tassone F., Broglio F., Destefanis S., Rovere S., Benso A., Gottero C., Prodam F., Rossetto R., Gauna C., van der Lely A. J., Ghigo E. and Maccario M. Neuroendocrine and Metabolic Effects of Acute Ghrelin Administration in Human Obesity. 88: 5478-5483. 2003: Ghrelin.

http://jcem.endojournals.org/content/88/3/1179.abstract

Tauber M., Berro B., Delagnes V., Lounis N., Jouret B., Pienkowski C., Oliver I. and Rochiccioli P. Can Some Growth Hormone (GH)-Deficient Children Benefit from Combined Therapy with Gonadotropin-Releasing Hormone Analogs and GH? Results of a Retrospective Study. 88: 1179-1183. 2003: Growth Hormone.

http://jcem.endojournals.org/content/88/10/4689.abstract

Tozawa Takuma, Mishima Kazuo, Satoh Kohtoku, Echizenya Masaru, Shimizu Tetsuo and Hishikawa Yasuo. Stability of Sleep Timing against the Melatonin Secretion Rhythm with Advancing Age: Clinical Implications. 88: 4689-4695. 2003: Melatonin.

http://jcem.endojournals.org/content/88/11/5273.abstract

Underwood Louis E., Attie Kenneth M., Baptista Joyce and Group the Genentech Collaborative Study. Growth Hormone (GH) Dose-Response in Young Adults with Childhood-Onset GH Deficiency: A Two-Year, Multicenter, Multiple-Dose, Placebo-Controlled Study. 88: 5273-5280. 2003: Growth Hormone.

http://jcem.endojournals.org/content/88/2/588.abstract

Vihma Veera, Vehkavaara Satu, Yki-Jarvinen Hannele, Hohtari Hannele and Tikkanen Matti J. Differential Effects of Oral and Transdermal Estradiol Treatment on Circulating Estradiol Fatty Acid Ester Concentrations in Postmenopausal Women. 88: 588-593. 2003: Estrogen.

http://jcem.endojournals.org/content/88/10/4543.abstract

Walsh John P., Shiels Lauren, Lim Ee Mun, Bhagat Chotoo I., Ward Lynley C., Stuckey Bronwyn G. A., Dhaliwal Satvinder S., Chew Gerard T., Bhagat Minoti C. and Cussons Andrea J. Combined Thyroxine/Liothyronine Treatment Does Not Improve Well-Being, Quality of Life, or Cognitive Function Compared to Thyroxine Alone: A Randomized Controlled Trial in Patients with Primary Hypothyroidism. 88: 4543-4550. 2003: Thyroid.

http://jcem.endojournals.org/content/88/2/542.abstract

Watts Nelson B., Josse Robert G., Hamdy Ronald C., Hughes Rodney A., Manhart Michael D., Barton Ian, Calligeros Danny and Felsenberg Dieter. Risedronate Prevents New Vertebral Fractures in Postmenopausal Women at High Risk. 88: 542-549. 2003: Bone.

http://jcem.endojournals.org/content/88/6/2462.short

Weigle David S. Pharmacological Therapy of Obesity: Past, Present, and Future. 88: 2462-2469. 2003: Obesity.

http://jcem.endojournals.org/content/88/4/1577.abstract

Weigle David S., Cummings David E., Newby Patricia D., Breen Patricia A., Frayo R. Scott, Matthys Colleen C., Callahan Holly S. and Purnell Jonathan Q. Roles of Leptin and Ghrelin in the Loss of Body Weight Caused by a Low Fat, High Carbohydrate Diet. 88: 1577-1586. 2003: Ghrelin.

http://jcem.endojournals.org/content/89/2/695.abstract

Albert Stewart G. and Mooradian Arshag D. Low-Dose Recombinant Human Growth Hormone as Adjuvant Therapy to Lifestyle Modifications in the Management of Obesity. 89: 695-701. 2004: Growth Hormone.

http://jcem.endojournals.org/content/89/2/503.abstract

Amory John K., Watts Nelson B., Easley Kirk A., Sutton Paul R., Anawalt Bradley D., Matsumoto Alvin M., Bremner William J. and Tenover J. Lisa. Exogenous Testosterone or Testosterone with Finasteride Increases Bone Mineral Density in Older Men with Low Serum Testosterone. 89: 503-510. 2004: Testosterone.

http://jcem.endojournals.org/content/89/2/453.abstract

Azziz R., Sanchez L. A., Knochenhauer E. S., Moran C., Lazenby J., Stephens K. C., Taylor K. and Boots L. R. Androgen Excess in Women: Experience with Over 1000 Consecutive Patients. 89: 453-462. 2004: Androgen.

http://jcem.endojournals.org/content/89/3/1213.abstract

Cecconi Elisabetta, Gasperi Maurizio, Bogazzi Fausto, Grasso Lucia, Genovesi Maura, Marcocci Claudio, Pinchera Aldo, Procopio Massimo, Bartalena Luigi and Martino Enio. Improvement of Growth Hormone Deficiency in Patients with Primary Hyperparathyroidism after Parathyroidectomy: Results of a Prospective Study. 89: 1213-1216. 2004: Growth Hormone.

http://jcem.endojournals.org/content/89/4/1801.abstract

Christ E. R., Cummings M. H., Jackson N., Stolinski M., Lumb P. J., Wierzbicki A. S., Sonksen P. H., Russell-Jones D. L. and Umpleby A. M. Effects of Growth Hormone (GH) Replacement Therapy on Low-Density Lipoprotein Apolipoprotein B100 Kinetics in Adult Patients with GH Deficiency: A Stable Isotope Study. 89: 1801-1807. 2004: Growth Hormone.

http://jcem.endojournals.org/content/89/11/5289.short

Clemmons David R. and Strasburger Christian. Monitoring the Response to Treatment in Acromegaly. 89: 5289-5291. 2004: Acromegaly.

http://jcem.endojournals.org/content/89/3/1117.abstract

Clowes Jackie A., Peel Nicola F. A. and Eastell Richard. The Impact of Monitoring on Adherence and Persistence with Antiresorptive Treatment for Postmenopausal Osteoporosis: A Randomized Controlled Trial. 89: 1117-1123. 2004: Bone.

http://jcem.endojournals.org/content/89/3/1160.abstract

Dal Maso Luigino, Augustin Livia S. A., Karalis Aspasia, Talamini Renato, Franceschi Silvia, Trichopoulos Dimitrios, Mantzoros Christos S. and La Vecchia Carlo. Circulating Adiponectin and Endometrial Cancer Risk. 89: 1160-1163. 2004: Adiponectin.

http://jcem.endojournals.org/content/89/1/174.abstract

De Marinis L., Bianchi A., Mancini A., Gentilella R., Perrelli M., Giampietro A., Porcelli T., Tilaro L., Fusco A., Valle D. and Tacchino R. M. Growth Hormone Secretion and Leptin in Morbid Obesity before and after Biliopancreatic Diversion: Relationships with Insulin and Body Composition. 89: 174-180. 2004: Obesity.

http://jcem.endojournals.org/content/89/1/163.abstract

Elisei Rossella, Bottici Valeria, Luchetti Fabiana, Di Coscio Giancarlo, Romei Cristina, Grasso Lucia, Miccoli Paolo, Iacconi Pietro, Basolo Fulvio, Pinchera Aldo and Pacini Furio. Impact of Routine Measurement of Serum Calcitonin on the Diagnosis and Outcome of Medullary Thyroid Cancer: Experience in 10,864 Patients with Nodular Thyroid Disorders. 89: 163-168. 2004: Thyroid.

http://jcem.endojournals.org/content/89/2/626.abstract

Evio Sirpa, Tiitinen Aila, Laitinen Kalevi, Ylikorkala Olavi and Valimaki Matti J. Effects of Alendronate and Hormone Replacement Therapy, Alone and in Combination, on Bone Mass and Markers of Bone Turnover in Elderly Women with Osteoporosis. 89: 626-631. 2004: Bone.

http://jcem.endojournals.org/content/89/11/5397.abstract

Giavoli Claudia, Libe Rossella, Corbetta Sabrina, Ferrante Emanuele, Lania Andrea, Arosio Maura, Spada Anna and Beck-Peccoz Paolo. Effect of Recombinant Human Growth Hormone (GH) Replacement on the Hypothalamic-Pituitary-Adrenal Axis in Adult GH-Deficient Patients. 89: 5397-5401. 2004: Growth Hormone.

http://jcem.endojournals.org/content/89/8/3665.short

Haugen Bryan R. Patients with Differentiated Thyroid Carcinoma Benefit from Radioiodine Remnant Ablation. 89: 3665-3667. 2004: Thyroid.

http://jcem.endojournals.org/content/89/2/479.short

Ilias Ioannis and Pacak Karel. Current Approaches and Recommended Algorithm for the Diagnostic Localization of Pheochromocytoma. 89: 479-491. 2004: Phaeochromocytoma.

http://jcem.endojournals.org/content/89/4/1618.abstract

Kirwan Lori D., MacLusky Neil J., Shapiro Heather M., Abramson Beth L., Thomas Scott G. and Goodman Jack M. Acute and Chronic Effects of Hormone Replacement Therapy on the Cardiovascular System in Healthy Postmenopausal Women. 89: 1618-1629. 2004: HRT.

http://jcem.endojournals.org/content/89/2/681.abstract

Mayo A., Macintyre H., Wallace A. M. and Ahmed S. F. Transdermal Testosterone Application: Pharmacokinetics and Effects on Pubertal Status, Short-Term Growth, and Bone Turnover. 89: 681-687. 2004: Testosterone.

http://jcem.endojournals.org/content/89/3/1207.abstract

Nikander Eini, MetsÃ¤-HeikkilÃ¤ Merja, Ylikorkala Olavi and Tiitinen Aila. Effects of Phytoestrogens on Bone Turnover in Postmenopausal Women with a History of Breast Cancer. 89: 1207-1212. 2004: Bone.

http://jcem.endojournals.org/content/89/8/3696.abstract

Orio Francesco, Palomba Stefano, Spinelli Letizia, Cascella Teresa, TauchmanovÃ Libuse, Zullo Fulvio, Lombardi Gaetano and Colao Annamaria. The Cardiovascular Risk of Young Women with Polycystic Ovary Syndrome: An Observational, Analytical, Prospective Case-Control Study. 89: 3696-3701. 2004: PCOS.

http://jcem.endojournals.org/content/89/8/3710.short

Pearce Elizabeth N. and Braverman Lewis E. Papillary Thyroid Microcarcinoma Outcomes and Implications for Treatment. 89: 3710-3712. 2004: Thyroid.

http://jcem.endojournals.org/content/89/7/3326.abstract

Racine Michael S., Symons Kathy V., Foster Carol M. and Barkan Ariel L. Augmentation of Growth Hormone Secretion after Testosterone Treatment in Boys with Constitutional Delay of Growth and Adolescence: Evidence against an Increase in Hypothalamic Secretion of Growth Hormone-Releasing Hormone. 89: 3326-3331. 2004: Growth Hormone.

http://jcem.endojournals.org/content/89/8/3668.abstract

Sawka Anna M., Thephamongkhol Kullathorn, Brouwers Melissa, Thabane Lehana, Browman George and Gerstein Hertzel C. A Systematic Review and Metaanalysis of the Effectiveness of Radioactive Iodine Remnant Ablation for Well-Differentiated Thyroid Cancer. 89: 3668-3676. 2004: Thyroid.

http://jcem.endojournals.org/content/89/2/632.abstract

Shapses Sue A., Heshka Stanley and Heymsfield Steven B. Effect of Calcium Supplementation on Weight and Fat Loss in Women. 89: 632-637. 2004: Obesity.

http://jcem.endojournals.org/content/89/8/3677.short

Stewart Paul M. Adrenal Replacement Therapy: Time for an Inward Look to the Medulla? 89: 3677-3678. 2004: Adrenal.

http://jcem.endojournals.org/content/89/3/1285.abstract

Veldhuis Johannes D., Evans William S., Iranmanesh Ali, Weltman Arthur L. and Bowers Cyril Y. Short-Term Testosterone Supplementation Relieves Growth Hormone Autonegative Feedback in Men. 89: 1285-1290. 2004: Testosterone.

http://jcem.endojournals.org/content/89/1/87.abstract

Yamamoto Yukihiro, Hirose Hiroshi, Saito Ikuo, Nishikai Kanako and Saruta Takao. Adiponectin, an Adipocyte-Derived Protein, Predicts Future Insulin Resistance: Two-Year Follow-Up Study in Japanese Population. 89: 87-90. 2004: Adiponectin.

http://jcem.endojournals.org/content/89/4/1739.abstract

You Tongjian, Berman Dora M., Ryan Alice S. and Nicklas Barbara J. Effects of Hypocaloric Diet and Exercise Training on Inflammation and Adipocyte Lipolysis in Obese Postmenopausal Women. 89: 1739-1746. 2004: Adiponectin.

http://jcem.endojournals.org/content/90/5/2775.abstract

Albino C. C., Mesa C. O., Olandoski M., Ueda C. E., Woellner L. C., Goedert C. A., Souza A. M. and Graf H. Recombinant Human Thyrotropin as Adjuvant in the Treatment of Multinodular Goiters with Radioiodine. 90: 2775-2780. 2005: Thyroid.

http://jcem.endojournals.org/content/90/8/4525.abstract

Attanasio Andrea F., Shavrikova Elena P., Blum Werner F. and Shalet Stephen M. Quality of Life in Childhood Onset Growth Hormone-Deficient Patients in the Transition Phase from Childhood to Adulthood. 90: 4525-4529. 2005: Growth Hormone.

http://jcem.endojournals.org/content/90/7/3863.abstract

Baillargeon Jean-Patrice, McClish Donna K., Essah Paulina A. and Nestler John E. Association between the Current Use of Low-Dose Oral Contraceptives and Cardiovascular Arterial Disease: A Meta-Analysis. 90: 3863-3870. 2005: HRT.

http://jcem.endojournals.org/content/90/12/6370.abstract

Boudou Philippe, Ibrahim Fidaa, Cormier Catherine, Chabas AlmÃ©cinda, Sarfati Emile and Souberbielle Jean-Claude. Third- or Second-Generation Parathyroid Hormone Assays: A Remaining Debate in the Diagnosis of Primary Hyperparathyroidism. 90: 6370-6372. 2005: Parathyroid.

http://jcem.endojournals.org/content/90/7/4057.abstract

Caraccio Nadia, Natali Andrea, Sironi Annamaria, Baldi Simona, Frascerra Silvia, Dardano Angela, Monzani Fabio and Ferrannini Ele. Muscle Metabolism and Exercise Tolerance in Subclinical Hypothyroidism: A Controlled Trial of Levothyroxine. 90: 4057-4062. 2005: Thyroid.

http://jcem.endojournals.org/content/90/7/4047.abstract

Castagna Maria Grazia, Pinchera Aldo, Marsili Alessandro, Giannetti Monica, Molinaro Eleonora, Fierabracci Paola, Grasso Lucia, Pacini Furio, Santini Ferruccio and Elisei Rossella. Influence of Human Body Composition on Serum Peak Thyrotropin (TSH) after Recombinant Human TSH Administration in Patients with Differentiated Thyroid Carcinoma. 90: 4047-4050. 2005: Thyroid.

http://jcem.endojournals.org/content/90/7/3933.abstract

Chan Carina C. W., Ng Ernest H. Y., Tang O. S., Yeung William S. B., Lau Estella Y. L. and Ho P. C. A Prospective, Randomized, Double-Blind Study to Compare Two Doses of Recombinant Human Chorionic Gonadotropin in Inducing Final Oocyte Maturity and the Hormonal Profile during the Luteal Phase. 90: 3933-3938. 2005: Growth Hormone.

http://jcem.endojournals.org/content/90/4/2056.abstract

Colao Annamaria, Di Somma Carolina, Rota Francesca, Pivonello Rosario, Savanelli Maria Cristina, Spiezia Stefano and Lombardi Gaetano. Short-Term Effects of Growth Hormone (GH) Treatment or Deprivation on Cardiovascular Risk Parameters and Intima-Media Thickness at Carotid Arteries in Patients with Severe GH Deficiency. 90: 2056-2062. 2005: Growth Hormone.

http://jcem.endojournals.org/content/90/12/6364.abstract

Escobar-Morreale Hector F., Botella-Carretero Jose I., Ãlvarez-Blasco Francisco, Sancho Jose and San MillÃ¡n Jose L. The Polycystic Ovary Syndrome Associated with Morbid Obesity May Resolve after Weight Loss Induced by Bariatric Surgery. 90: 6364-6369. 2005: PCOS.

http://jcem.endojournals.org/content/90/8/4465.abstract

Freda Pamela U., Katznelson Laurence, van der Lely Aart Jan, Reyes Carlos M., Zhao Shouhao and Rabinowitz Daniel. Long-Acting Somatostatin Analog Therapy of Acromegaly: A Meta-Analysis. 90: 4465-4473. 2005: Acromegaly.

http://jcem.endojournals.org/content/90/6/3209.abstract

Fuleihan Ghada El-Hajj, Salamoun Mariana, Mourad Yasser Abou, Chehal Aref, Salem Ziad, Mahfoud Ziyad and Shamseddine Ali. Pamidronate in the Prevention of Chemotherapy-Induced Bone Loss in Premenopausal Women with Breast Cancer: A Randomized Controlled Trial. 90: 3209-3214. 2005: Bone.

http://jcem.endojournals.org/content/90/7/3854.abstract

Gambineri Alessandra, Patton Laura, De Iasio Rosaria, Cantelli Barbara, Cognini Graciela Estela, Filicori Marco, Barreca Antonina, Diamanti-Kandarakis Evanthia, Pagotto Uberto and Pasquali Renato. Efficacy of Octreotide-LAR in Dieting Women with Abdominal Obesity and Polycystic Ovary Syndrome. 90: 3854-3862. 2005: PCOS.

http://jcem.endojournals.org/content/90/7/3927.abstract

Gibney J., Smith T. P. and McKenna T. J. The Impact on Clinical Practice of Routine Screening for Macroprolactin. 90: 3927-3932. 2005: Prolactin.

http://jcem.endojournals.org/content/90/7/3897.abstract

Gibney James, Johannsson Gudmundur, Leung Kin-Chuen and Ho Ken K. Y. Comparison of the Metabolic Effects of Raloxifene and Oral Estrogen in Postmenopausal and Growth Hormone-Deficient Women. 90: 3897-3903. 2005: Estrogen.

http://jcem.endojournals.org/content/90/7/3838.abstract

Gray Peter B., Singh Atam B., Woodhouse Linda J., Storer Thomas W., Casaburi Richard, Dzekov Jeanne, Dzekov Connie, Sinha-Hikim Indrani and Bhasin Shalender. Dose-Dependent Effects of Testosterone on Sexual Function, Mood, and Visuospatial Cognition in Older Men. 90: 3838-3846. 2005: Testosterone.

http://jcem.endojournals.org/content/90/5/2762.abstract

Greenspan Susan L., Resnick Neil M. and Parker Robert A. Early Changes in Biochemical Markers of Bone Turnover Are Associated with Long-Term Changes in Bone Mineral Density in Elderly Women on Alendronate, Hormone Replacement Therapy, or Combination Therapy: A Three-Year, Double-Blind, Placebo-Controlled, Randomized Clinical Trial. 90: 2762-2767. 2005: Bone.

http://jcem.endojournals.org/content/90/10/5765.abstract

Guang-da Xiang, Hui-ling Sun, Zhi-song Cheng and Lin-shuang Zhao. Changes in Plasma Concentrations of Osteoprotegerin before and after Levothyroxine Replacement Therapy in Hypothyroid Patients. 90: 5765-5768. 2005: Osteoprotegrin.

http://jcem.endojournals.org/content/90/8/4593.abstract

Harborne Lyndal R., Sattar Naveed, Norman Jane E. and Fleming Richard. Metformin and Weight Loss in Obese Women with Polycystic Ovary Syndrome: Comparison of Doses. 90: 4593-4598. 2005: PCOS.

http://jcem.endojournals.org/content/90/4/2042.abstract

Hay Cathy J., Brady Brian M., Zitzmann Michael, Osmanagaoglu Kaan, Pollanen Pasi, Apter Dan, Wu Frederick C. W., Anderson Richard A., Nieschlag Eberhard, Devroey Paul, Huhtaniemi Ilpo and Kersemaekers Wendy M. A Multicenter Phase IIb Study of a Novel Combination of Intramuscular Androgen (Testosterone Decanoate) and Oral Progestogen (Etonogestrel) for Male Hormonal Contraception. 90: 2042-2049. 2005: Androgen.

http://jcem.endojournals.org/content/90/12/6431.abstract

Hoffman Andrew R., Biller Beverly M. K., Cook David, Baptista Joyce, Silverman Bernard L., Dao Le, Attie Kenneth M., Fielder Paul, Maneatis Thomas, Lippe Barbara and Group for the Genentech Adult Growth Hormone Deficiency Study. Efficacy of a Long-Acting Growth Hormone (GH) Preparation in Patients with Adult GH Deficiency. 90: 6431-6440. 2005: Growth Hormone.

http://jcem.endojournals.org/content/90/2/729.abstract

Jayagopal V., Kilpatrick E. S., Holding S., Jennings P. E. and Atkin S. L. Orlistat Is as Beneficial as Metformin in the Treatment of Polycystic Ovarian Syndrome. 90: 729-733. 2005: PCOS.

http://jcem.endojournals.org/content/90/7/3989.abstract

Johannsson Gudmundur, Gibney James, Wolthers Troels, Leung Kin-Chuen and Ho Ken K. Y. Independent and Combined Effects of Testosterone and Growth Hormone on Extracellular Water in Hypopituitary Men. 90: 3989-3994. 2005: Growth Hormone.

http://jcem.endojournals.org/content/90/7/4081.abstract

Kauppinen-MÃ¤kelin Ritva, Sane Timo, Reunanen Antti, Valimaki Matti J., Niskanen Leo, Markkanen Helene, Loyttyniemi Eliisa, Ebeling Tapani, Jaatinen Pia, Laine Hanna, Nuutila Pirjo, Salmela Pasi, Salmi Jorma, Stenman Ulf-HÃ¥kan, Viikari Jorma and Voutilainen Erkki. A Nationwide Survey of Mortality in Acromegaly. 90: 4081-4086. 2005: Acromegaly.

http://jcem.endojournals.org/content/90/12/6448.abstract

Langenberg Claudia, Bergstrom Jaclyn, Laughlin Gail A. and Barrett-Connor Elizabeth. Ghrelin and the Metabolic Syndrome in Older Adults. 90: 6448-6453. 2005: Ghrelin.

http://jcem.endojournals.org/content/90/8/4521.abstract

le Roux C. W., Neary N. M., Halsey T. J., Small C. J., Martinez-Isla A. M., Ghatei M. A., Theodorou N. A. and Bloom S. R. Ghrelin Does Not Stimulate Food Intake in Patients with Surgical Procedures Involving Vagotomy. 90: 4521-4524. 2005: Ghrelin.

http://jcem.endojournals.org/content/90/11/5964.abstract

Mah P. M., Webster J., Jonsson P., Feldt-Rasmussen U., Koltowska-Haggstrom M. and Ross R. J. M. Estrogen Replacement in Women of Fertile Years with Hypopituitarism. 90: 5964-5969. 2005: Estrogen.

http://jcem.endojournals.org/content/90/7/3946.abstract

Mauras Nelly, Pescovitz Ora Hirsch, Allada Vivek, Messig Michael, Wajnrajch Michael P., Lippe Barbara and Group on behalf of the Transition Study. Limited Efficacy of Growth Hormone (GH) during Transition of GH-Deficient Patients from Adolescence to Adulthood: A Phase III Multicenter, Double-Blind, Randomized Two-Year Trial. 90: 3946-3955. 2005: Growth Hormone.

http://jcem.endojournals.org/content/90/7/4068.abstract

Palomba Stefano, Orio Francesco, Falbo Angela, Manguso Francesco, Russo Tiziana, Cascella Teresa, Tolino Achille, Carmina Enrico, Colao Annamaria and Zullo Fulvio. Prospective Parallel Randomized, Double-Blind, Double-Dummy Controlled Clinical Trial Comparing Clomiphene Citrate and Metformin as the First-Line Treatment for Ovulation Induction in Nonobese Anovulatory Women with Polycystic Ovary Syndrome. 90: 4068-4074. 2005: PCOS.

http://jcem.endojournals.org/content/90/9/5321.abstract

Perros Petros, Kendall-Taylor Pat, Neoh Chris, Frewin Sarah and Dickinson Jane. A Prospective Study of the Effects of Radioiodine Therapy for Hyperthyroidism in Patients with Minimally Active Gravesâ€™ Ophthalmopathy. 90: 5321-5323. 2005: Thyroid.

http://jcem.endojournals.org/content/90/6/3153.abstract

Prentice Ann, Ginty Fiona, Stear Samantha J., Jones Sarah C., Laskey M. Ann and Cole Tim J. Calcium Supplementation Increases Stature and Bone Mineral Mass of 16- to 18-Year-Old Boys. 90: 3153-3161. 2005: Bone.

http://jcem.endojournals.org/content/90/9/5018.abstract

Reginster Jean-Yves, Wilson Katie M., Dumont Etienne, Bonvoisin Bernard and Barrett Joanne. Monthly Oral Ibandronate Is Well Tolerated and Efficacious in Postmenopausal Women: Results from the Monthly Oral Pilot Study. 90: 5018-5024. 2005: Bone.

http://jcem.endojournals.org/content/90/7/3824.abstract

Reid Ian R., Horne Anne, Mason Barbara, Ames Ruth, Bava Usha and Gamble Gregory D. Effects of Calcium Supplementation on Body Weight and Blood Pressure in Normal Older Women: A Randomized Controlled Trial. 90: 3824-3829. 2005: Calcium.

http://jcem.endojournals.org/content/90/10/5588.abstract

Reinehr Thomas, de Sousa Gideon, Roth Christian Ludwig and Andler Werner. Androgens before and after Weight Loss in Obese Children. 90: 5588-5595. 2005: Androgen.

http://jcem.endojournals.org/content/90/6/3337.abstract

Rowles Susannah V., Prieto L., Badia X., Shalet Steven M., Webb Susan M. and Trainer Peter J. Quality of Life (QOL) in Patients with Acromegaly Is Severely Impaired: Use of a Novel Measure of QOL: Acromegaly Quality of Life Questionnaire. 90: 3337-3341. 2005: Acromegaly.

http://jcem.endojournals.org/content/90/5/2701.abstract

Sites Cynthia K., L'Hommedieu Georgia D., Toth Michael J., Brochu Martin, Cooper Brian C. and Fairhurst Penny A. The Effect of Hormone Replacement Therapy on Body Composition, Body Fat Distribution, and Insulin Sensitivity in Menopausal Women: A Randomized, Double-Blind, Placebo-Controlled Trial. 90: 2701-2707. 2005: Growth Hormone.

http://jcem.endojournals.org/content/90/10/5566.abstract

Spencer C. A., Bergoglio L. M., Kazarosyan M., Fatemi S. and LoPresti J. S. Clinical Impact of Thyroglobulin (Tg) and Tg Autoantibody Method Differences on the Management of Patients with Differentiated Thyroid Carcinomas. 90: 5566-5575. 2005: Thyroid.

http://jcem.endojournals.org/content/90/6/3371.abstract

White H. D., Ahmad A. M., Durham B. H., Patwala A., Whittingham P., Fraser W. D. and Vora J. P. Growth Hormone Replacement Is Important for the Restoration of Parathyroid Hormone Sensitivity and Improvement in Bone Metabolism in Older Adult Growth Hormone-Deficient Patients. 90: 3371-3380. 2005: Growth Hormone.

http://jcem.endojournals.org/content/91/6/1995.abstract

Bhasin Shalender, Cunningham Glenn R., Hayes Frances J., Matsumoto Alvin M., Snyder Peter J., Swerdloff Ronald S. and Montori Victor M. Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline. 91: 1995-2010. 2006: Testosterone.

http://jcem.endojournals.org/content/91/11/4295.abstract

Boelaert K., Horacek J., Holder R. L., Watkinson J. C., Sheppard M. C. and Franklyn J. A. Serum Thyrotropin Concentration as a Novel Predictor of Malignancy in Thyroid Nodules Investigated by Fine-Needle Aspiration. 91: 4295-4301. 2006: Thyroid.

http://jcem.endojournals.org/content/91/9/3404.abstract

Bonds Denise E., Larson Joseph C., Schwartz Ann V., Strotmeyer Elsa S., Robbins John, Rodriguez Beatriz L., Johnson Karen C. and Margolis Karen L. Risk of Fracture in Women with Type 2 Diabetes: the Women's Health Initiative Observational Study. 91: 3404-3410. 2006: Bone.

http://jcem.endojournals.org/content/91/8/2946.abstract

Bonnema Steen Joop, BennedbÃ¦k Finn Noe, Veje Annegrete, Marving Jens and HegedÃ¼s Laszlo. Continuous Methimazole Therapy and Its Effect on the Cure Rate of Hyperthyroidism Using Radioactive Iodine: An Evaluation by a Randomized Trial. 91: 2946-2951. 2006: Thyroid.

http://jcem.endojournals.org/content/91/10/3773.abstract

Brooke Antonia M., Kalingag Leonila A., Miraki-Moud Farideh, Camacho-Habner Cecilia, Maher Katharine T., Walker Dorothy M., Hinson Joy P. and Monson John P. Dehydroepiandrosterone Improves Psychological Well-Being in Male and Female Hypopituitary Patients on Maintenance Growth Hormone Replacement. 91: 3773-3779. 2006: Pituitary.

http://jcem.endojournals.org/content/91/5/1698.abstract

Buemann B., Astrup A., Pedersen O., Black E., Holst C., Toubro S., Echwald S., Holst J. J., Rasmussen C. and SÃ¸rensen T. I. A. Possible Role of Adiponectin and Insulin Sensitivity in Mediating the Favorable Effects of Lower Body Fat Mass on Blood Lipids. 91: 1698-1704. 2006: Adiponectin.

http://jcem.endojournals.org/content/91/5/1748.abstract

Charopoulos Ioannis, Tournis Symeon, Trovas George, Raptou Panagiota, Kaldrymides Philippos, Skarandavos Gregory, Katsalira Katerina and Lyritis George P. Effect of Primary Hyperparathyroidism on Volumetric Bone Mineral Density and Bone Geometry Assessed by Peripheral Quantitative Computed Tomography in Postmenopausal Women. 91: 1748-1753. 2006: Bone.

http://jcem.endojournals.org/content/91/6/2250.abstract

Codner Ethel, Soto Nestor, Lopez Patricia, Trejo Lean, Ãvila Alejandra, Eyzaguirre Francisca C., Ãniguez GermÃ¡n and Cassorla Fernando. Diagnostic Criteria for Polycystic Ovary Syndrome and Ovarian Morphology in Women with Type 1 Diabetes Mellitus. 91: 2250-2256. 2006: PCOS.

http://jcem.endojournals.org/content/91/9/3364.abstract

Dekkers O. M., van der Klaauw A. A., Pereira A. M., Biermasz N. R., Honkoop P. J., Roelfsema F., Smit J. W. A. and Romijn J. A. Quality of Life Is Decreased after Treatment for Nonfunctioning Pituitary Macroadenoma. 91: 3364-3369. 2006: Pituitary.

http://jcem.endojournals.org/content/91/6/2185.abstract

Dimaraki Eleni V., Chandler William F., Brown Morton B., Jaffe Craig A., Kim Soo Y., Taussig Ronald, Padmanabhan Vasantha and Barkan Ariel L. The Role of Endogenous Growth Hormone-Releasing Hormone in Acromegaly. 91: 2185-2190. 2006: Growth Hormone.

http://jcem.endojournals.org/content/91/8/2892.abstract

Durante C., Haddy N., Baudin E., Leboulleux S., Hartl D., Travagli J. P., Caillou B., Ricard M., Lumbroso J. D., De Vathaire F. and Schlumberger M. Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy. 91: 2892-2899. 2006: Thyroid.

http://jcem.endojournals.org/content/91/8/2882.abstract

Finkelstein Joel S., Leder Benjamin Z., Burnett Sherri-Ann M., Wyland Jason J., Lee Hang, de la Paz Amanda Victoria, Gibson Kate and Neer Robert M. Effects of Teriparatide, Alendronate, or Both on Bone Turnover in Osteoporotic Men. 91: 2882-2887. 2006: Bone.

http://jcem.endojournals.org/content/91/1/25.short

Fonseca Vivian, Jawa Ali and Asnani Sunil. The PROactive Study: The Glass Is Half Full. 91: 25-27. 2006: PROactive.

http://jcem.endojournals.org/content/91/2/477.abstract

Giannoulis Manthos G., Sonksen Peter H., Umpleby Margot, Breen Louise, Pentecost Claire, Whyte Martin, McMillan Carolyn V., Bradley Clare and Martin Finbarr C. The Effects of Growth Hormone and/or Testosterone in Healthy Elderly Men: A Randomized Controlled Trial. 91: 477-484. 2006: Growth Hormone.

http://jcem.endojournals.org/content/91/2/383.abstract

Ginsberg Henry N. REVIEW: Efficacy and Mechanisms of Action of Statins in the Treatment of Diabetic Dyslipidemia. 91: 383-392. 2006: Lipids.

http://jcem.endojournals.org/content/91/10/3780.abstract

Grewal Jagteshwar, Sowers MaryFran R., Randolph John F., Harlow Sioban D. and Lin Xihong. Low Bone Mineral Density in the Early Menopausal Transition: Role for Ovulatory Function. 91: 3780-3785. 2006: Bone.

http://jcem.endojournals.org/content/91/7/2592.abstract

Grozinsky-Glasberg Simona, Fraser Abigail, Nahshoni Ethan, Weizman Abraham and Leibovici Leonard. Thyroxine-Triiodothyronine Combination Therapy Versus Thyroxine Monotherapy for Clinical Hypothyroidism: Meta-Analysis of Randomized Controlled Trials. 91: 2592-2599. 2006: Thyroid.

http://jcem.endojournals.org/content/91/8/2986.abstract

Jankowski Catherine M., Gozansky Wendolyn S., Schwartz Robert S., Dahl Daniel J., Kittelson John M., Scott Stephen M., Van Pelt Rachael E. and Kohrt Wendy M. Effects of Dehydroepiandrosterone Replacement Therapy on Bone Mineral Density in Older Adults: A Randomized, Controlled Trial. 91: 2986-2993. 2006: Bone.

http://jcem.endojournals.org/content/91/10/3891.abstract

Kauppinen-MÃ¤kelin Ritva, Sane Timo, Sintonen Harri, Markkanen Helene, Valimaki Matti J., Loyttyniemi Eliisa, Niskanen Leo, Reunanen Antti, Stenman Ulf-HÃ¥kan and Group and the Finnish Acromegaly Study. Quality of Life in Treated Patients with Acromegaly. 91: 3891-3896. 2006: Acromegaly.

http://jcem.endojournals.org/content/91/7/2490.abstract

Kung Annie W. C. Thyrotoxic Periodic Paralysis: A Diagnostic Challenge. 91: 2490-2495. 2006: Thyroid.

http://jcem.endojournals.org/content/91/9/3296.abstract

Levin F., Edholm T., Schmidt P. T., Gryback P., Jacobsson H., Degerblad M., Haybye C., Holst J. J., Rehfeld J. F., Hellstram P. M. and Naslund E. Ghrelin Stimulates Gastric Emptying and Hunger in Normal-Weight Humans. 91: 3296-3302. 2006: Ghrelin.

http://jcem.endojournals.org/content/91/8/2900.abstract

Maghnie Mohamad, Ambrosini Linda, Cappa Marco, Pozzobon Gabriella, Ghizzoni Lucia, Ubertini Maria Grazia, di Iorgi Natascia, Tinelli Carmine, Pilia Sabrina, Chiumello Giuseppe, Lorini Renata and Loche Sandro. Adult Height in Patients with Permanent Growth Hormone Deficiency with and without Multiple Pituitary Hormone Deficiencies. 91: 2900-2905. 2006: Growth Hormone.

http://jcem.endojournals.org/content/91/3/870.abstract

MichalskÃ¡ Dana, Stepan Jan J., Basson Bruce R. and Pavo Imre. The Effect of Raloxifene after Discontinuation of Long-Term Alendronate Treatment of Postmenopausal Osteoporosis. 91: 870-877. 2006: Bone.

http://jcem.endojournals.org/content/91/5/1683.abstract

Miller K. K., Biller B. M. K., Beauregard C., Lipman J. G., Jones J., Schoenfeld D., Sherman J. C., Swearingen B., Loeffler J. and Klibanski A. Effects of Testosterone Replacement in Androgen-Deficient Women with Hypopituitarism: A Randomized, Double-Blind, Placebo-Controlled Study. 91: 1683-1690. 2006: Testosterone.

http://jcem.endojournals.org/content/91/5/1621.abstract

Molitch Mark E., Clemmons David R., Malozowski Saul, Merriam George R., Shalet Stephen M., Vance Mary Lee and Subcommittee for The Endocrine Societyâ€™s Clinical Guidelines. Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline. 91: 1621-1634. 2006: Growth Hormone.

http://jcem.endojournals.org/content/91/6/2201.abstract

Mrozek Ewa, Kloos Richard T., Ringel Matthew D., Kresty Laura, Snider Paulette, Arbogast Daria, Kies Merrill, Munden Reginald, Busaidy Naifa, Klein Mary Jean, Sherman Steven I. and Shah Manisha H. Phase II Study of Celecoxib in Metastatic Differentiated Thyroid Carcinoma. 91: 2201-2204. 2006: Thyroid.

http://jcem.endojournals.org/content/91/11/4205.abstract

New Maria I. Nonclassical 21-Hydroxylase Deficiency. 91: 4205-4214. 2006: Cortisol.

http://jcem.endojournals.org/content/91/2/425.abstract

O'Donnell Amy B., Travison Thomas G., Harris Susan S., Tenover J. Lisa and McKinlay John B. Testosterone, Dehydroepiandrosterone, and Physical Performance in Older Men: Results from the Massachusetts Male Aging Study. 91: 425-431. 2006: Testosterone.

http://jcem.endojournals.org/content/91/6/2047.abstract

Reiter Edward O., Price David A., Wilton Patrick, Albertsson-Wikland Kerstin and Ranke Michael B. Effect of Growth Hormone (GH) Treatment on the Near-Final Height of 1258 Patients with Idiopathic GH Deficiency: Analysis of a Large International Database. 91: 2047-2054. 2006: Growth Hormone.

http://jcem.endojournals.org/content/91/11/4223.abstract

Shah Meena, Simha Vinaya and Garg Abhimanyu. Long-Term Impact of Bariatric Surgery on Body Weight, Comorbidities, and Nutritional Status. 91: 4223-4231. 2006: Bariatric.

http://jcem.endojournals.org/content/91/6/2074.abstract

Srinivasan Shubha, Ambler Geoffrey R., Baur Louise A., Garnett Sarah P., Tepsa Mirijana, Yap Fabian, Ward Glenn M. and Cowell Christopher T. Randomized, Controlled Trial of Metformin for Obesity and Insulin Resistance in Children and Adolescents: Improvement in Body Composition and Fasting Insulin. 91: 2074-2080. 2006: Obesity.

http://jcem.endojournals.org/content/91/12/4817.abstract

Stan Marius N., Garrity James A., Bradley Elizabeth A., Woog John J., Bahn Mark M., Brennan Michael D., Bryant Sandra C., Achenbach Sara J. and Bahn Rebecca S. Randomized, Double-Blind, Placebo-Controlled Trial of Long-Acting Release Octreotide for Treatment of Graves' Ophthalmopathy. 91: 4817-4824. 2006: Thyroid.

http://jcem.endojournals.org/content/91/5/1729.abstract

Svensson Johan, Ericsson Ulla-Britt, Nilsson Paul, Olsson Catherine, Jonsson BjÃ¶rn, Lindberg Bengt and Ivarsson Sten-A. Levothyroxine Treatment Reduces Thyroid Size in Children and Adolescents with Chronic Autoimmune Thyroiditis. 91: 1729-1734. 2006: Thyroid.

http://jcem.endojournals.org/content/91/11/4497.abstract

Tajiri Junichi. Radioactive Iodine Therapy for Goitrous Hashimoto's Thyroiditis. 91: 4497-4500. 2006: Thyroid.

http://jcem.endojournals.org/content/91/6/2011.abstract

Tracz Michal J., Sideras Kostandinos, Bolona Enrique R., Haddad Rudy M., Kennedy Cassie C., Uraga Maria V., Caples Sean M., Erwin Patricia J. and Montori Victor M. Testosterone Use in Men and Its Effects on Bone Health. A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. 91: 2011-2016. 2006: Testosterone.

http://jcem.endojournals.org/content/91/7/2509.abstract

Travison Thomas G., Morley John E., Araujo Andre B., O'Donnell Amy B. and McKinlay John B. The Relationship between Libido and Testosterone Levels in Aging Men. 91: 2509-2513. 2006: Testosterone.

http://jcem.endojournals.org/content/91/3/913.abstract

White H. D., Ahmad A. M., Durham B. H., Chandran S., Patwala A., Fraser W. D. and Vora J. P. Effect of Active Acromegaly and Its Treatment on Parathyroid Circadian Rhythmicity and Parathyroid Target-Organ Sensitivity. 91: 913-919. 2006: Parathyroid.

http://jcem.endojournals.org/content/91/10/3697.abstract

Wierman Margaret E., Basson Rosemary, Davis Susan R., Khosla Sundeep, Miller Karen K., Rosner William and Santoro Nanette. Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline. 91: 3697-3710. 2006: Androgen.

http://jcem.endojournals.org/content/91/11/4271.abstract

Zucchini Stefano, Pirazzoli Piero, Baronio Federico, Gennari Monia, Bal Milva Orquidea, Balsamo Antonio, Gualandi Stefano and Cicognani Alessandro. Effect on Adult Height of Pubertal Growth Hormone Retesting and Withdrawal of Therapy in Patients with Previously Diagnosed Growth Hormone Deficiency. 91: 4271-4276. 2006: Growth Hormone.

http://jcem.endojournals.org/content/92/3/942.abstract

Antoniucci Diana M., Sellmeyer Deborah E., Bilezikian John P., Palermo Lisa, Ensrud Kristine E., Greenspan Susan L. and Black Dennis M. Elevations in Serum and Urinary Calcium with Parathyroid Hormone (1-84) with and without Alendronate for Osteoporosis. 92: 942-947. 2007: Parathyroid.

http://jcem.endojournals.org/content/92/3/911.abstract

Archer David F., Hendrix Susan, Gallagher J. Chris, Rymer Janice, Skouby Sven, Ferenczy Alex, den Hollander Wil, Stathopoulos Victoria, Helmond Frans A., Endometrium for the Tibolone Histology of the and Group Breast Endpoints Study. Endometrial Effects of Tibolone. 92: 911-918. 2007: Tibolone.

http://jcem.endojournals.org/content/92/8/3095.abstract

Argente JesÃºs, Gracia Ricardo, Ibanez Lourdes, Oliver Antonio, Borrajo Emilio, Vela Amaya, LÃ³pez-Siguero Juan Pedro, Moreno M. Llanos, RodrÃguez-Hierro Francisco and Group on behalf of the Spanish SGA Working. Improvement in Growth after Two Years of Growth Hormone Therapy in Very Young Children Born Small for Gestational Age and without Spontaneous Catch-Up Growth: Results of a Multicenter, Controlled, Randomized, Open Clinical Trial. 92: 3095-3101. 2007: Growth Hormone.

http://jcem.endojournals.org/content/92/1/219.abstract

Blum Werner F., Crowe Brenda J., Quigley Charmian A., Jung Heike, Cao Dachuang, Ross Judith L., Braun LeeAnn, Rappold Gudrun and Group for the SHOX Study. Growth Hormone Is Effective in Treatment of Short Stature Associated with Short Stature Homeobox-Containing Gene Deficiency: Two-Year Results of a Randomized, Controlled, Multicenter Trial. 92: 219-228. 2007: Growth Hormone.

http://jcem.endojournals.org/content/92/3/902.abstract

Chernausek Steven D., Backeljauw Philippe F., Frane James, Kuntze Joyce, Underwood Louis E. and Group for the GH Insensitivity Syndrome Collaborative. Long-Term Treatment with Recombinant Insulin-Like Growth Factor (IGF)-I in Children with Severe IGF-I Deficiency due to Growth Hormone Insensitivity. 92: 902-910. 2007: Growth Hormone.

http://jcem.endojournals.org/content/92/3/804.abstract

Clayton P. E., Cianfarani S., Czernichow P., Johannsson G., Rapaport R. and Rogol A. Management of the Child Born Small for Gestational Age through to Adulthood: A Consensus Statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. 92: 804-810. 2007: Short Stature.

http://jcem.endojournals.org/content/92/1/3.abstract

Cooper David S. Approach to the Patient with Subclinical Hyperthyroidism. 92: 3-9. 2007: Thyroid.

http://jcem.endojournals.org/content/92/5/1666.abstract

Darzy Ken H., Pezzoli Suzan S., Thorner Michael O. and Shalet Stephen M. Cranial Irradiation and Growth Hormone Neurosecretory Dysfunction: A Critical Appraisal. 92: 1666-1672. 2007: Growth Hormone.

http://jcem.endojournals.org/content/92/9/3466.abstract

de Groot J. W. B., Zonnenberg B. A., van Ufford-Mannesse P. Quarles, de Vries M. M., Links T. P., Lips C. J. M. and Voest E. E. A Phase II Trial of Imatinib Therapy for Metastatic Medullary Thyroid Carcinoma. 92: 3466-3469. 2007: Thyroid.

http://jcem.endojournals.org/content/92/4/1296.abstract

Delmas Pierre D., Vrijens Bernard, Eastell Richard, Roux Christian, Pols Huibert A. P., Ringe Johann D., Grauer Andreas, Cahall David, Watts Nelson B. and Investigators on behalf of the Improving Measurements of Persistence on Actonel Treatment. Effect of Monitoring Bone Turnover Markers on Persistence with Risedronate Treatment of Postmenopausal Osteoporosis. 92: 1296-1304. 2007: Bone.

http://jcem.endojournals.org/content/92/7/2644.abstract

Franco Celina, Andersson Bjorn, Lonn Lars, Bengtsson Bengt-Ake, Svensson Johan and Johannsson Gudmundur. Growth Hormone Reduces Inflammation in Postmenopausal Women with Abdominal Obesity: A 12-Month, Randomized, Placebo-Controlled Trial. 92: 2644-2647. 2007: Growth Hormone.

http://jcem.endojournals.org/content/92/4/1442.abstract

Gatherstram G., Bengtsson B.-Ãke, Bosaus I., Johannsson G. and Svensson J. A 10-Year, Prospective Study of the Metabolic Effects of Growth Hormone Replacement in Adults. 92: 1442-1445. 2007: Growth Hormone.

http://jcem.endojournals.org/content/92/4/1226.short

Goldstein Barry J. Clinical Translation of "A Diabetes Outcome Progression Trial". ADOPT Appropriate Combination Oral Therapies in Type 2 Diabetes. 92: 1226-1228. 2007: ADOPT.

http://jcem.endojournals.org/content/92/1/28.abstract

Hackshaw Allan, Harmer Clive, Mallick Ujjal, Haq Masud and Franklyn Jayne A. 131I Activity for Remnant Ablation in Patients with Differentiated Thyroid Cancer: A Systematic Review. 92: 28-38. 2007: Thyroid.

http://jcem.endojournals.org/content/92/12/4505.abstract

Handelsman David J. Update in Andrology. 92: 4505-4511. 2007: Androgen.

http://jcem.endojournals.org/content/92/8/3033.abstract

Hannon Tamara S., Danadian Kapriel, Suprasongsin Chittiwat and Arslanian Silva A. Growth Hormone Treatment in Adolescent Males with Idiopathic Short Stature: Changes in Body Composition, Protein, Fat, and Glucose Metabolism. 92: 3033-3039. 2007: Growth Hormone.

http://jcem.endojournals.org/content/92/8/3230.abstract

Joseph F., Chan B. Y., Durham B. H., Ahmad A. M., Vinjamuri S., Gallagher J. A., Vora J. P. and Fraser W. D. The Circadian Rhythm of Osteoprotegerin and Its Association with Parathyroid Hormone Secretion. 92: 3230-3238. 2007: Osteoprotegrin.

http://jcem.endojournals.org/content/92/12/4529.abstract

Kaplan Solomon A. and Cohen Pinchas. REVIEW: The Somatomedin Hypothesis 2007: 50 Years Later. 92: 4529-4535. 2007: Growth Hormone.

http://jcem.endojournals.org/content/92/3/801.short

Lee James A., Grumbach Melvin M. and Clark Orlo H. The Optimal Treatment for Pediatric Graves' Disease Is Surgery. 92: 801-803. 2007: Thyroid.

http://jcem.endojournals.org/content/92/1/77.abstract

Leslie William D., Tsang James F., Caetano Patricia A., Lix Lisa M. and Program for the Manitoba Bone Density. Effectiveness of Bone Density Measurement for Predicting Osteoporotic Fractures in Clinical Practice. 92: 77-81. 2007: Bone.

http://jcem.endojournals.org/content/92/5/1743.abstract

Maison Patrick, Tropeano Anne-Isabelle, Macquin-Mavier Isabelle, Giustina Andrea and Chanson Philippe. Impact of Somatostatin Analogs on the Heart in Acromegaly: A Metaanalysis. 92: 1743-1747. 2007: Acromegaly.

http://jcem.endojournals.org/content/92/5/1653.abstract

Menconi Francesca, MarinÃ² Michele, Pinchera Aldo, Rocchi Roberto, Mazzi Barbara, Nardi Marco, Bartalena Luigi and Marcocci Claudio. Effects of Total Thyroid Ablation Versus Near-Total Thyroidectomy Alone on Mild to Moderate Gravesâ€™ Orbitopathy Treated with Intravenous Glucocorticoids. 92: 1653-1658. 2007: Thyroid.

http://jcem.endojournals.org/content/92/11/4069.abstract

Pacak Karel. Preoperative Management of the Pheochromocytoma Patient. 92: 4069-4079. 2007: Phaeochromocytoma.

http://jcem.endojournals.org/content/92/5/1814.abstract

Piccoli Franziska, Degen Lukas, MacLean Carol, Peter Shajan, Baselgia Luisa, Larsen Finn, Beglinger Christoph and Drewe JÃ¼rgen. Pharmacokinetics and Pharmacodynamic Effects of an Oral Ghrelin Agonist in Healthy Subjects. 92: 1814-1820. 2007: Ghrelin.

http://jcem.endojournals.org/content/92/6/2017.abstract

Pittas Anastassios G., Lau Joseph, Hu Frank B. and Dawson-Hughes Bess. The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis. 92: 2017-2029. 2007: Diabetes.

http://jcem.endojournals.org/content/92/4/1195.abstract

Radovick Sally and DiVall Sara. Approach to the Growth Hormone-Deficient Child during Transition to Adulthood. 92: 1195-1200. 2007: Growth Hormone.

http://jcem.endojournals.org/content/92/3/797.abstract

Rivkees Scott A. and Dinauer Catherine. An Optimal Treatment for Pediatric Graves' Disease Is Radioiodine. 92: 797-800. 2007: Thyroid.

http://jcem.endojournals.org/content/92/8/2861.abstract

Schlechte Janet A. Long-Term Management of Prolactinomas. 92: 2861-2865. 2007: Prolactin.

http://jcem.endojournals.org/content/92/4/1217.abstract

Scholz Tim, Eisenhofer Graeme, Pacak Karel, Dralle Henning and Lehnert Hendrik. Current Treatment of Malignant Pheochromocytoma. 92: 1217-1225. 2007: Phaeochromocytoma.

Journal of Clinical Endocrinology & Metabolism

Shoback Dolores. Update in Osteoporosis and Metabolic Bone Disorders. 92: 747-753. 2007: Bone.

http://jcem.endojournals.org/content/92/3/747.abstract

http://jcem.endojournals.org/content/92/7/2567.abstract

Simon Dominique, Prieur Anne-Marie, Quartier Pierre, Charles Ruiz Jean and Czernichow Paul. Early Recombinant Human Growth Hormone Treatment in Glucocorticoid-Treated Children with Juvenile Idiopathic Arthritis: A 3-Year Randomized Study. 92: 2567-2573. 2007: Growth Hormone.

http://jcem.endojournals.org/content/92/11/4115.abstract

Slawik Marc, Klawitter Bjorn, Meiser Edith, Schories Marcus, Zwermann Oliver, Borm Katrin, Peper Martin, Lubrich Beate, Hug Martin J., Nauck Markus, Olschewski Manfred, Beuschlein Felix and Reincke Martin. Thyroid Hormone Replacement for Central Hypothyroidism: A Randomized Controlled Trial Comparing Two Doses of Thyroxine (T4) with a Combination of T4 and Triiodothyronine. 92: 4115-4122. 2007: Thyroid.

http://jcem.endojournals.org/content/92/12/4514.abstract

Vega Damaris, Maalouf Naim M. and Sakhaee Khashayar. The Role of Receptor Activator of Nuclear Factor-ÎºB (RANK)/RANK Ligand/Osteoprotegerin: Clinical Implications. 92: 4514-4521. 2007: Osteoprotegrin.

http://jcem.endojournals.org/content/92/5/1640.abstract

Zhao Lan-Juan, Liu Yong-Jun, Liu Peng-Yuan, Hamilton James, Recker Robert R. and Deng Hong-Wen. Relationship of Obesity with Osteoporosis. 92: 1640-1646. 2007: Obesity.

http://jcem.endojournals.org/content/93/11/4175.abstract

Alexander Erik K. Approach to the Patient with a Cytologically Indeterminate Thyroid Nodule. 93: 4175-4182. 2008: Thyroid.

http://jcem.endojournals.org/content/93/10/3663.abstract

Anderson Mark S. Update in Endocrine Autoimmunity. 93: 3663-3670. 2008: Endocrine.

http://jcem.endojournals.org/content/93/12/4576.abstract

August Gilbert P., Caprio Sonia, Fennoy Ilene, Freemark Michael, Kaufman Francine R., Lustig Robert H., Silverstein Janet H., Speiser Phyllis W., Styne Dennis M. and Montori Victor M. Prevention and Treatment of Pediatric Obesity: An Endocrine Society Clinical Practice Guideline Based on Expert Opinion. 93: 4576-4599. 2008: Obesity.

http://jcem.endojournals.org/content/93/6/2063.abstract

Beauregard Catherine, Utz Andrea L., Schaub Amber E., Nachtigall Lisa, Biller Beverly M. K., Miller Karen K. and Klibanski Anne. Growth Hormone Decreases Visceral Fat and Improves Cardiovascular Risk Markers in Women with Hypopituitarism: A Randomized, Placebo-Controlled Study. 93: 2063-2071. 2008: Growth Hormone.

http://jcem.endojournals.org/content/93/6/2027.abstract

Bessesen Daniel H. Update on Obesity. 93: 2027-2034. 2008: Obesity.

http://jcem.endojournals.org/content/93/12/4656.abstract

Bikman Benjamin T., Zheng Donghai, Pories Walter J., Chapman William, Pender John R., Bowden Rita C., Reed Melissa A., Cortright Ronald N., Tapscott Edward B., Houmard Joseph A., Tanner Charles J., Lee Jihyun and Dohm G. Lynis. Mechanism for Improved Insulin Sensitivity after Gastric Bypass Surgery. 93: 4656-4663. 2008: Bariatric.

http://jcem.endojournals.org/content/93/7/2454.abstract

Biller B. M. K., Grossman A. B., Stewart P. M., Melmed S., Bertagna X., Bertherat J., Buchfelder M., Colao A., Hermus A. R., Hofland L. J., Klibanski A., Lacroix A., Lindsay J. R., Newell-Price J., Nieman L. K., Petersenn S., Sonino N., Stalla G. K., Swearingen B., Vance M. L., Wass J. A. H. and Boscaro M. Treatment of Adrenocorticotropin-Dependent Cushing's Syndrome: A Consensus Statement. 93: 2454-2462. 2008: Cushings.

http://jcem.endojournals.org/content/93/6/2166.abstract

Black Dennis M., Bouxsein Mary L., Palermo Lisa, McGowan Joan A., Newitt David C., Rosen Eyal, Majumdar Sharmila, Rosen Clifford J. and Group for the PTH Once-Weekly Research. Randomized Trial of Once-Weekly Parathyroid Hormone (1-84) on Bone Mineral Density and Remodeling. 93: 2166-2172. 2008: Bone.

http://jcem.endojournals.org/content/93/6/2149.abstract

Bone Henry G., Bolognese Michael A., Yuen Chui Kin, Kendler David L., Wang Huei, Liu Yu and San Martin Javier. Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women. 93: 2149-2157. 2008: Bone.

http://jcem.endojournals.org/content/93/8/2984.abstract

Carlsen Sven M., Lund-Johansen Morten, Schreiner Thomas, Aanderud Sylvi, Johannesen Ãlvind, Svartberg Johan, Cooper John G., Hald John K., Fougner Stine L., Bollerslev Jens and group on behalf of the Preoperative Octreotide Treatment of Acromegaly study. Preoperative Octreotide Treatment in Newly Diagnosed Acromegalic Patients with Macroadenomas Increases Cure Short-Term Postoperative Rates: A Prospective, Randomized Trial. 93: 2984-2990. 2008: Acromegaly.

http://jcem.endojournals.org/content/93/1/76.abstract

Castagna M. G., Brilli L., Pilli T., Montanaro A., Cipri C., Fioravanti C., Sestini F., Capezzone M. and Pacini F. Limited Value of Repeat Recombinant Human Thyrotropin (rhTSH)-Stimulated Thyroglobulin Testing in Differentiated Thyroid Carcinoma Patients with Previous Negative rhTSH-Stimulated Thyroglobulin and Undetectable Basal Serum Thyroglobulin Levels. 93: 76-81. 2008: Thyroid.

http://jcem.endojournals.org/content/93/11/4210.abstract

Cohen P., Rogol A. D., Deal C. L., Saenger P., Reiter E. O., Ross J. L., Chernausek S. D., Savage M. O., Wit J. M. and participants on behalf of the ISS Consensus Workshop. Consensus Statement on the Diagnosis and Treatment of Children with Idiopathic Short Stature: A Summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. 93: 4210-4217. 2008: Short Stature.

http://jcem.endojournals.org/content/93/7/2639.abstract

Colao Annamaria, Pivonello Rosario, Galderisi Maurizio, Cappabianca Paolo, Auriemma Renata S., Galdiero Mariano, Cavallo Luigi M., Esposito Felice and Lombardi Gaetano. Impact of Treating Acromegaly First with Surgery or Somatostatin Analogs on Cardiomyopathy. 93: 2639-2646. 2008: Acromegaly.

http://jcem.endojournals.org/content/93/7/2463.short

Dawson-Hughes Bess and Committee on behalf of the National Osteoporosis Foundation Guide. A Revised Clinician's Guide to the Prevention and Treatment of Osteoporosis. 93: 2463-2465. 2008: Bone.

http://jcem.endojournals.org/content/93/2/477.abstract

de Ridder Maria A. J., Stijnen Theo and Hokken-Koelega Anita C. S. Prediction Model for Adult Height of Small for Gestational Age Children at the Start of Growth Hormone Treatment. 93: 477-483. 2008: Short Stature.

http://jcem.endojournals.org/content/93/1/61.abstract

Dekkers O. M., Biermasz N. R., Pereira A. M., Romijn J. A. and Vandenbroucke J. P. Mortality in Acromegaly: A Metaanalysis. 93: 61-67. 2008: Acromegaly.

http://jcem.endojournals.org/content/93/5/1553.abstract

Elamin Mohamed B., Murad M. Hassan, Mullan Rebecca, Erickson Dana, Harris Katherine, Nadeem Sarah, Ennis Robert, Erwin Patricia J. and Montori Victor M. Accuracy of Diagnostic Tests for Cushing's Syndrome: A Systematic Review and Metaanalyses. 93: 1553-1562. 2008: Cushings.

http://jcem.endojournals.org/content/93/10/3735.abstract

Fleischer J., Stein E. M., Bessler M., Badia M. Della, Restuccia N., Olivero-Rivera L., McMahon D. J. and Silverberg S. J. The Decline in Hip Bone Density after Gastric Bypass Surgery Is Associated with Extent of Weight Loss. 93: 3735-3740. 2008: Bariatric.

http://jcem.endojournals.org/content/93/9/3266.abstract

Funder John W., Carey Robert M., Fardella Carlos, Gomez-Sanchez Celso E., Mantero Franco, Stowasser Michael, Young William F. and Montori Victor M. Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline. 93: 3266-3281. 2008: Adrenal.

http://jcem.endojournals.org/content/93/6/2277.abstract

Gjedde Signe, Vestergaard Esben Thyssen, Gormsen Lars Christian, Riis Anne Lene DalkjÃ¦r, Rungby JÃ¸rgen, MÃ¸ller Niels, Weeke JÃ¸rgen and JÃ¸rgensen Jens Otto Lunde. Serum Ghrelin Levels Are Increased in Hypothyroid Patients and Become Normalized by l-Thyroxine Treatment. 93: 2277-2280. 2008: Ghrelin.

http://jcem.endojournals.org/content/93/1/2.abstract

Greenspan Susan L. Approach to the Prostate Cancer Patient with Bone Disease. 93: 2-7. 2008: Bone.

http://jcem.endojournals.org/content/93/1/125.abstract

Hartman Mark L., Weltman Arthur, Zagar Anthony, Qualy Rebecca L., Hoffman Andrew R. and Merriam George R. Growth Hormone Replacement Therapy in Adults with Growth Hormone Deficiency Improves Maximal Oxygen Consumption Independently of Dosing Regimen or Physical Activity. 93: 125-130. 2008: Growth Hormone.

http://jcem.endojournals.org/content/93/3/809.abstract

Haymart Megan Rist, Repplinger Daniel John, Leverson Glen E., Elson Diane F., Sippel Rebecca S., Jaume Juan Carlos and Chen Herbert. Higher Serum Thyroid Stimulating Hormone Level in Thyroid Nodule Patients Is Associated with Greater Risks of Differentiated Thyroid Cancer and Advanced Tumor Stage. 93: 809-814. 2008: Thyroid.

http://jcem.endojournals.org/content/93/5/1519.abstract

Kloos Richard T. Approach to the Patient with a Positive Serum Thyroglobulin and a Negative Radioiodine Scan after Initial Therapy for Differentiated Thyroid Cancer. 93: 1519-1525. 2008: Thyroid.

http://jcem.endojournals.org/content/93/7/2479.abstract

LaferrÃ¨re Blandine, Teixeira Julio, McGinty James, Tran Hao, Egger Joseph R., Colarusso Antonia, Kovack Betty, Bawa Baani, Koshy Ninan, Lee Hongchan, Yapp Kimberly and Olivan Blanca. Effect of Weight Loss by Gastric Bypass Surgery Versus Hypocaloric Diet on Glucose and Incretin Levels in Patients with Type 2 Diabetes. 93: 2479-2485. 2008: Bariatric.

http://jcem.endojournals.org/content/93/1/68.abstract

Laughlin Gail A., Barrett-Connor Elizabeth and Bergstrom Jaclyn. Low Serum Testosterone and Mortality in Older Men. 93: 68-75. 2008: Testosterone.

http://jcem.endojournals.org/content/93/4/1105.abstract

Martin Kathryn A., Chang R. Jeffrey, Ehrmann David A., Ibanez Lourdes, Lobo Rogerio A., Rosenfield Robert L., Shapiro Jerry, Montori Victor M. and Swiglo Brian A. Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. 93: 1105-1120. 2008: Hirsutism.

http://jcem.endojournals.org/content/93/12/4649.abstract

Mazziotti Gherardo, Bianchi Antonio, Bonadonna Stefania, Cimino Vincenzo, Patelli Ilaria, Fusco Alessandra, Pontecorvi Alfredo, De Marinis Laura and Giustina Andrea. Prevalence of Vertebral Fractures in Men with Acromegaly. 93: 4649-4655. 2008: Acromegaly.

http://jcem.endojournals.org/content/93/12/4600.abstract

McGovern Lauren, Johnson Jonathan N., Paulo Remberto, Hettinger Allison, Singhal Vibha, Kamath Celia, Erwin Patricia J. and Montori Victor M. Treatment of Pediatric Obesity: A Systematic Review and Meta-Analysis of Randomized Trials. 93: 4600-4605. 2008: Obesity.

http://jcem.endojournals.org/content/93/2/331.abstract

Melmed Shlomo. Update in Pituitary Disease. 93: 331-338. 2008: Pituitary.

http://jcem.endojournals.org/content/93/3/653.abstract

Merke Deborah P. Approach to the Adult with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. 93: 653-660. 2008: Adrrenal.

http://jcem.endojournals.org/content/93/8/2957.abstract

Murray Robert D. and Melmed Shlomo. A Critical Analysis of Clinically Available Somatostatin Analog Formulations for Therapy of Acromegaly. 93: 2957-2968. 2008: Acromegaly.

http://jcem.endojournals.org/content/93/6/2035.abstract

Nachtigall Lisa, Delgado Adriano, Swearingen Brooke, Lee Hang, Zerikly Rahfa and Klibanski Anne. Changing Patterns in Diagnosis and Therapy of Acromegaly over Two Decades. 93: 2035-2041. 2008: Acromegaly.

http://jcem.endojournals.org/content/93/10/3853.abstract

Neggers S. J. C. M. M., van Aken M. O., de Herder W. W., Feelders R. A., Janssen J. A. M. J. L., Badia X., Webb S. M. and van der Lely A. J. Quality of Life in Acromegalic Patients during Long-Term Somatostatin Analog Treatment with and without Pegvisomant. 93: 3853-3859. 2008: Acromegaly.

http://jcem.endojournals.org/content/93/5/1526.abstract

Nieman Lynnette K., Biller Beverly M. K., Findling James W., Newell-Price John, Savage Martin O., Stewart Paul M. and Montori Victor M. The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. 93: 1526-1540. 2008: Cushings.

http://jcem.endojournals.org/content/93/7/2531.abstract

Norrman Lise-Lott, Johannsson Gudmundur, Sunnerhagen Katharina S. and Svensson Johan. Baseline Characteristics and the Effects of Two Years of Growth Hormone (GH) Replacement Therapy in Adults with GH Deficiency Previously Treated for Acromegaly. 93: 2531-2538. 2008: Growth Hormone.

http://jcem.endojournals.org/content/93/12/4721.abstract

Ono Masami, Miki Nobuhiro, Kawamata Takakazu, Makino Rena, Amano Kosaku, Seki Toshiro, Kubo Osami, Hori Tomokatsu and Takano Kazue. Prospective Study of High-Dose Cabergoline Treatment of Prolactinomas in 150 Patients. 93: 4721-4727. 2008: Prolactin.

http://jcem.endojournals.org/content/93/2/372.short

Riddle Matthew C. Starting and Advancing Insulin for Type 2 Diabetes: Algorithms and Individualized Methods Are Both Necessary. 93: 372-374. 2008: Diabetes.

http://jcem.endojournals.org/content/93/6/2300.abstract

Russell W., Harrison R. F., Smith N., Darzy K., Shalet S., Weetman A. P. and Ross R. J. Free Triiodothyronine Has a Distinct Circadian Rhythm That Is Delayed but Parallels Thyrotropin Levels. 93: 2300-2306. 2008: Thyroid.

http://jcem.endojournals.org/content/93/7/2486.abstract

Salerno Mariacarolina, Oliviero Ugo, Lettiero Teresa, Guardasole Vincenzo, Mattiacci Dario Maria, Saldamarco Lavinia, Capalbo Donatella, Lucariello Antonio, SaccÃ Luigi and Cittadini Antonio. Long-Term Cardiovascular Effects of Levothyroxine Therapy in Young Adults with Congenital Hypothyroidism. 93: 2486-2491. 2008: Thyroid.

http://jcem.endojournals.org/content/93/5/1789.abstract

Samelson Elizabeth J., Broe Kerry E., Demissie Serkalem, Beck Thomas J., Karasik David, Kathiresan Sekar and Kiel Douglas P. Increased Plasma Osteoprotegerin Concentrations Are Associated with Indices of Bone Strength of the Hip. 93: 1789-1795. 2008: Osteoprotegrin.

http://jcem.endojournals.org/content/93/8/2978.abstract

Schweizer Roland, Martin David D., Schonau Eckhard and Ranke Michael B. Muscle Function Improves during Growth Hormone Therapy in Short Children Born Small for Gestational Age: Results of a Peripheral Quantitative Computed Tomography Study on Body Composition. 93: 2978-2983. 2008: Growth Hormone.

http://jcem.endojournals.org/content/93/4/1153.abstract

Swiglo Brian A., Cosma Mihaela, Flynn David N., Kurtz David M., LaBella Matthew L., Mullan Rebecca J., Erwin Patricia J. and Montori Victor M. Antiandrogens for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials. 93: 1153-1160. 2008: Androgens.

http://jcem.endojournals.org/content/93/6/2181.abstract

Villareal Dennis T., Shah Krupa, Banks Marian R., Sinacore David R. and Klein Samuel. Effect of Weight Loss and Exercise Therapy on Bone Metabolism and Mass in Obese Older Adults: A One-Year Randomized Controlled Trial. 93: 2181-2187. 2008: Bone.

http://jcem.endojournals.org/content/94/2/400.abstract

Bachrach Laura K. and Ward Leanne M. Clinical Review: Bisphosphonate Use in Childhood Osteoporosis. 94: 400-409. 2009: Bone.

http://jcem.endojournals.org/content/94/11/4224.abstract

Bhasin Shalender, He E. Jiaxiu, Kawakubo Miwa, Schroeder E. Todd, Yarasheski Kevin, Opiteck Gregory J., Reicin Alise, Chen Fabian, Lam Raymond, Tsou Jeffrey A., Castaneda-Sceppa Carmen, Binder Ellen F., Azen Stanley P. and Sattler Fred R. N-Terminal Propeptide of Type III Procollagen as a Biomarker of Anabolic Response to Recombinant Human GH and Testosterone. 94: 4224-4233. 2009: Bone.

http://jcem.endojournals.org/content/94/2/335.abstract

Bilezikian John P., Khan Aliya A., Potts John T. and Hyperthyroidism on behalf of the Third International Workshop on the Management of Asymptomatic Primary. Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop. 94: 335-339. 2009: Parathyroid.

http://jcem.endojournals.org/content/94/7/2284.abstract

Bolognese M., Krege J. H., Utian W. H., Feldman R., Broy S., Meats D. L., Alam J., Lakshmanan M. and Omizo M. Effects of Arzoxifene on Bone Mineral Density and Endometrium in Postmenopausal Women with Normal or Low Bone Mass. 94: 2284-2289. 2009: Bone.

http://jcem.endojournals.org/content/94/9/3121.abstract

Boscaro Marco and Arnaldi Giorgio. Approach to the Patient with Possible Cushing's Syndrome. 94: 3121-3131. 2009: Cushings.

http://jcem.endojournals.org/content/94/4/1097.abstract

Burnett-Bowie Sherri-Ann M., Saag Kenneth, Sebba Anthony, de Papp Anne E., Chen Erluo, Rosenberg Elizabeth and Greenspan Susan L. Prediction of Changes in Bone Mineral Density in Postmenopausal Women Treated with Once-Weekly Bisphosphonates. 94: 1097-1103. 2009: Bone.

http://jcem.endojournals.org/content/94/9/3207.abstract

Chiodini Iacopo, Morelli Valentina, Masserini Benedetta, Salcuni Antonio Stefano, Eller-Vainicher Cristina, Viti Raffaella, Coletti Francesca, Guglielmi Giuseppe, Battista Claudia, Carnevale Vincenzo, Iorio Laura, Beck-Peccoz Paolo, Arosio Maura, Ambrosi Bruno and Scillitani Alfredo. Bone Mineral Density, Prevalence of Vertebral Fractures, and Bone Quality in Patients with Adrenal Incidentalomas with and without Subclinical Hypercortisolism: An Italian Multicenter Study. 94: 3207-3214. 2009: Bone.

http://jcem.endojournals.org/content/94/11/4351.abstract

Cohen Adi, Liu X. Sherry, Stein Emily M., McMahon Donald J., Rogers Halley F., LeMaster Jeanette, Recker Robert R., Lappe Joan M., Guo X. Edward and Shane Elizabeth. Bone Microarchitecture and Stiffness in Premenopausal Women with Idiopathic Osteoporosis. 94: 4351-4360. 2009: Bone.

http://jcem.endojournals.org/content/94/10/3746.abstract

Colao Annamaria, Auriemma Renata S., Galdiero Mariano, Lombardi Gaetano and Pivonello Rosario. Effects of Initial Therapy for Five Years with Somatostatin Analogs for Acromegaly on Growth Hormone and Insulin-Like Growth Factor-I Levels, Tumor Shrinkage, and Cardiovascular Disease: A Prospective Study. 94: 3746-3756. 2009: Acromegaly.

http://jcem.endojournals.org/content/94/10/3772.abstract

Cosman Felicia, Wermers Robert A., Recknor Christopher, Mauck Karen F., Xie Li, Glass Emmett V. and Krege John H. Effects of Teriparatide in Postmenopausal Women with Osteoporosis on Prior Alendronate or Raloxifene: Differences between Stopping and Continuing the Antiresorptive Agent. 94: 3772-3780. 2009: Bone.

http://jcem.endojournals.org/content/94/3/709.abstract

Cryer Philip E., Axelrod Lloyd, Grossman Ashley B., Heller Simon R., Montori Victor M., Seaquist Elizabeth R. and Service F. John. Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline. 94: 709-728. 2009: Hypoglycaemia.

http://jcem.endojournals.org/content/94/2/340.abstract

Eastell R., Arnold A., Brandi M. L., Brown E. M., D'Amour P., Hanley D. A., Rao D. Sudhaker, Rubin M. R., Goltzman D., Silverberg S. J., Marx S. J., Peacock M., Mosekilde L., Bouillon R. and Lewiecki E. M. Diagnosis of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop. 94: 340-350. 2009: Parathyroid.

http://jcem.endojournals.org/content/94/3/729.abstract

Fatourechi Mitra M., Kudva Yogish C., Murad M. Hassan, Elamin Mohamed B., Tabini Claudia C. and Montori Victor M. Hypoglycemia with Intensive Insulin Therapy: A Systematic Review and Meta-Analyses of Randomized Trials of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections. 94: 729-740. 2009: Diabetes.

http://jcem.endojournals.org/content/94/7/2495.abstract

Finkelstein Joel S., Wyland Jason J., Leder Benjamin Z., Burnett-Bowie Sherri-Ann M., Lee Hang, Juppner Harald and Neer Robert M. Effects of Teriparatide Retreatment in Osteoporotic Men and Women. 94: 2495-2501. 2009: Bone.

http://jcem.endojournals.org/content/94/2/538.abstract

Grey Andrew, Bolland Mark J., Wattie Diana, Horne Anne, Gamble Greg and Reid Ian R. The Antiresorptive Effects of a Single Dose of Zoledronate Persist for Two Years: A Randomized, Placebo-Controlled Trial in Osteopenic Postmenopausal Women. 94: 538-544. 2009: Bone.

http://jcem.endojournals.org/content/94/9/3132.abstract

Hembree Wylie C., Cohen-Kettenis Peggy, Delemarre-van de Waal Henriette A., Gooren Louis J., Meyer Walter J., Spack Norman P., Tangpricha Vin and Montori Victor M. Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline. 94: 3132-3154. 2009: Transsexual.

http://jcem.endojournals.org/content/94/7/2459.abstract

Higham C. E., Rowles S., Russell-Jones D., Umpleby A. M. and Trainer P. J. Pegvisomant Improves Insulin Sensitivity and Reduces Overnight Free Fatty Acid Concentrations in Patients with Acromegaly. 94: 2459-2463. 2009: Acromegaly.

http://jcem.endojournals.org/content/94/2/333.short

Khan Aliya A., Bilezikian John P., Potts John T. and Hyperparathyroidism Guest Editors for the Third International Workshop on Asymptomatic Primary. The Diagnosis and Management of Asymptomatic Primary Hyperparathyroidism Revisited. 94: 333-334. 2009: Parathyroid.

http://jcem.endojournals.org/content/94/2/373.abstract

Khan Aliya, Grey Andrew and Shoback Dolores. Medical Management of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop. 94: 373-381. 2009: Parathyroid.

http://jcem.endojournals.org/content/94/7/2428.abstract

Kharlip J., Salvatori R., Yenokyan G. and Wand G. S. Recurrence of Hyperprolactinemia after Withdrawal of Long-Term Cabergoline Therapy. 94: 2428-2436. 2009: Prolactin.

http://jcem.endojournals.org/content/94/5/1644.abstract

Konopko-Zubrzycka M., Baniukiewicz A., Wroblewski E., Kowalska I., Zarzycki W., Gerska M. and Dabrowski A. The Effect of Intragastric Balloon on Plasma Ghrelin, Leptin, and Adiponectin Levels in Patients with Morbid Obesity. 94: 1644-1649. 2009: Ghrelin.

http://jcem.endojournals.org/content/94/5/1678.abstract

Lazar Liora, Frumkin Rachel Ben-David, Battat Erez, Lebenthal Yael, Phillip Moshe and Meyerovitch Joseph. Natural History of Thyroid Function Tests over 5 Years in a Large Pediatric Cohort. 94: 1678-1682. 2009: Thyroid.

http://jcem.endojournals.org/content/94/5/1500.abstract

Mazziotti Gherardo, Floriani Irene, Bonadonna Stefania, Torri Valter, Chanson Philippe and Giustina Andrea. Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies. 94: 1500-1508. 2009: Acromegaly.

http://jcem.endojournals.org/content/94/1/130.abstract

Mekala Kavya C. and Tritos Nicholas A. Effects of Recombinant Human Growth Hormone Therapy in Obesity in Adults: A Metaanalysis. 94: 130-137. 2009: Growth Hormone.

http://jcem.endojournals.org/content/94/5/1509.abstract

Melmed S., Colao A., Barkan A., Molitch M., Grossman A. B., Kleinberg D., Clemmons D., Chanson P., Laws E., Schlechte J., Vance M. L., Ho K. and Giustina A. Guidelines for Acromegaly Management: An Update. 94: 1509-1517. 2009: Acromegaly.

http://jcem.endojournals.org/content/94/3/741.abstract

Murad M. Hassan, Coto-Yglesias Fernando, Wang Amy T., Sheidaee Nasim, Mullan Rebecca J., Elamin Mohamed B., Erwin Patricia J. and Montori Victor M. Drug-Induced Hypoglycemia: A Systematic Review. 94: 741-745. 2009: Hypoglycaemia.

http://jcem.endojournals.org/content/94/12/4635.abstract

Naik Ramachandra G., Brooks-Worrell Barbara M. and Palmer Jerry P. Latent Autoimmune Diabetes in Adults. 94: 4635-4644. 2009: Diabetes.

http://jcem.endojournals.org/content/94/1/223.abstract

Pivonello Rosario, De Martino Maria Cristina, Cappabianca Paolo, De Leo Monica, Faggiano Antongiulio, Lombardi Gaetano, Hofland Leo J., Lamberts Steven W. J. and Colao Annamaria. The Medical Treatment of Cushing's Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery. 94: 223-230. 2009: Cushings.

http://jcem.endojournals.org/content/94/1/103.abstract

Sathyapalan Thozhukat, Kilpatrick Eric S., Coady Anne-Marie and Atkin Stephen L. The Effect of Atorvastatin in Patients with Polycystic Ovary Syndrome: A Randomized Double-Blind Placebo-Controlled Study. 94: 103-108. 2009: PCOS.

http://jcem.endojournals.org/content/94/3/817.abstract

Savastano Silvia, Di Somma Carolina, Angrisani Luigi, Orio Francesco, Longobardi Salvatore, Lombardi Gaetano and Colao Annamaria. Growth Hormone Treatment Prevents Loss of Lean Mass after Bariatric Surgery in Morbidly Obese Patients: Results of a Pilot, Open, Prospective, Randomized, Controlled Study. 94: 817-826. 2009: Growth Hormone.

http://jcem.endojournals.org/content/94/4/1255.abstract

Sherlock M., Fernandez-Rodriguez E., Alonso A. Aragon, Reulen R. C., Ayuk J., Clayton R. N., Holder G., Sheppard M. C., Bates A. and Stewart P. M. Medical Therapy in Patients with Acromegaly: Predictors of Response and Comparison of Efficacy of Dopamine Agonists and Somatostatin Analogues. 94: 1255-1263. 2009: Acromegaly.

http://jcem.endojournals.org/content/94/11/4216.abstract

Sherlock M., Reulen R. C., Alonso A. Aragon, Ayuk J., Clayton R. N., Sheppard M. C., Hawkins M. M., Bates A. S. and Stewart P. M. ACTH Deficiency, Higher Doses of Hydrocortisone Replacement, and Radiotherapy Are Independent Predictors of Mortality in Patients with Acromegaly. 94: 4216-4223. 2009: Cortisol.

http://jcem.endojournals.org/content/94/2/351.abstract

Silverberg Shonni J., Lewiecki E. Michael, Mosekilde Leif, Peacock Munro and Rubin Mishaela R. Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop. 94: 351-365. 2009: Parathyroid.

http://jcem.endojournals.org/content/94/8/2708.abstract

Stiebel-Kalish Hadas, Robenshtok Eyal, Hasanreisoglu Murat, Ezrachi David, Shimon Ilan and Leibovici Leonard. Treatment Modalities for Graves' Ophthalmopathy: Systematic Review and Metaanalysis. 94: 2708-2716. 2009: Thyroid.

http://jcem.endojournals.org/content/94/7/2437.abstract

Sukor Norlela, Gordon Richard D., Ku Yee Kim, Jones Mark and Stowasser Michael. Role of Unilateral Adrenalectomy in Bilateral Primary Aldosteronism: A 22-Year Single Center Experience. 94: 2437-2445. 2009: Adrenal.

http://jcem.endojournals.org/content/94/10/3700.abstract

Treisk Frank, Tallstedt Leif, Abraham-Nordling Mirna, Andersson Tommy, Berg Gertrud, Calissendorff Jan, Hallengren Bengt, Hedner Pavo, Lantz Mikael, NystrÃ¶m Ernst, Ponjavic Vesna, Taube Adam, Tarring Ove, Wallin GÃ¶ran, Ã…sman Peter, Lundell Garan and 96 the Thyroid Study Group of TT. Thyroid-Associated Ophthalmopathy after Treatment for Graves' Hyperthyroidism with Antithyroid Drugs or Iodine-131. 94: 3700-3707. 2009: Thyroid.

http://jcem.endojournals.org/content/94/2/366.abstract

Udelsman Robert, Pasieka Janice L., Sturgeon Cord, Young J. E. M. and Clark Orlo H. Surgery for Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop. 94: 366-372. 2009: Parathyroid.

http://jcem.endojournals.org/content/94/4/1198.abstract

White Heidi K., Petrie Charles D., Landschulz William, MacLean David, Taylor Ann, Lyles Kenneth, Wei Jeanne Y., Hoffman Andrew R., Salvatori Roberto, Ettinger Mark P., Morey Miriam C., Blackman Marc R., Merriam George R. and Group for the Capromorelin Study. Effects of an Oral Growth Hormone Secretagogue in Older Adults. 94: 1198-1206. 2009: Growth Hormone.

http://jcem.endojournals.org/content/96/8/2596.abstract

Abdul-Ghani Muhammad A., Abdul-Ghani Tamam, Meller Gabriele, Bergmann Antje, Fischer Sabine, Bornstein Stefan, DeFronzo Ralph A. and Schwarz Peter. Role of Glycated Hemoglobin in the Prediction of Future Risk of T2DM. 96: 2596-2600. 2011: Diabetes.

http://jcem.endojournals.org/content/95/2/471.abstract

Adams John S. and Hewison Martin. Update in Vitamin D. 95: 471-478. 2011: Vitamin D.

http://jcem.endojournals.org/content/96/5/1237.abstract

Ahmed Shabina R. and Ball Douglas W. Incidentally Discovered Medullary Thyroid Cancer: Diagnostic Strategies and Treatment. 96: 1237-1245. 2011: Thyroid.

http://jcem.endojournals.org/content/96/10/3007.abstract

Araujo Andre B., Dixon Julia M., Suarez Elizabeth A., Murad M. Hassan, Guey Lin T. and Wittert Gary A. Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis. 96: 3007-3019. 2011: Testosterone.

http://jcem.endojournals.org/content/96/5/1202.abstract

Bahn Rebecca S. and Castro M. Regina. Approach to the Patient with Nontoxic Multinodular Goiter. 96: 1202-1212. 2011: Thyroid.

http://jcem.endojournals.org/content/96/11/3493.abstract

Banaszewska Beata, Pawelczyk Leszek, Spaczynski Robert Z. and Duleba Antoni J. Effects of Simvastatin and Metformin on Polycystic Ovary Syndrome after Six Months of Treatment. 96: 3493-3501. 2011: PCOS.

http://jcem.endojournals.org/content/95/7/3189.abstract

Barkoff Marla S., Kocherginsky Masha, Anselmo Joao, Weiss Roy E. and Refetoff Samuel. Autoimmunity in Patients with Resistance to Thyroid Hormone. 95: 3189-3193. 2011: Thyroid.

http://jcem.endojournals.org/content/96/3/592.abstract

Bartalena Luigi. The Dilemma of How to Manage Graves' Hyperthyroidism in Patients with Associated Orbitopathy. 96: 592-599. 2011: Thyroid.

http://jcem.endojournals.org/content/95/1/167.abstract

Bell J., Parker K. L., Swinford R. D., Hoffman A. R., Maneatis T. and Lippe B. Long-Term Safety of Recombinant Human Growth Hormone in Children. 95: 167-177. 2011: Growth Hormone.

http://jcem.endojournals.org/content/95/8/3586.abstract

Bernet Victor. Approach to the Patient with Incidental Papillary Microcarcinoma. 95: 3586-3592. 2011: Thyroid.

http://jcem.endojournals.org/content/95/6/2536.abstract

Bhasin Shalender, Cunningham Glenn R., Hayes Frances J., Matsumoto Alvin M., Snyder Peter J., Swerdloff Ronald S. and Montori Victor M. Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline. 95: 2536-2559. 2011: Testosterone.

http://jcem.endojournals.org/content/96/6/1718.abstract

Biller Beverly M. K., Ji Hyi-Jeong, Ahn Hyunji, Savoy Conrad, Siepl E. Christine, Popovic Vera, Coculescu Mihail, Roemmler Josefine, Gavrila Catalin, Cook David M. and Strasburger Christian J. Effects of Once-Weekly Sustained-Release Growth Hormone: A Double-Blind, Placebo-Controlled Study in Adult Growth Hormone Deficiency. 96: 1718-1726. 2011: Growth Hormone.

http://jcem.endojournals.org/content/96/4/981.abstract

Binkley N., Gemar D., Engelke J., Gangnon R., Ramamurthy R., Krueger D. and Drezner M. K. Evaluation of Ergocalciferol or Cholecalciferol Dosing, 1,600 IU Daily or 50,000 IU Monthly in Older Adults. 96: 981-988. 2011: Vitamin D.

http://jcem.endojournals.org/content/95/5/2099.abstract

Birzniece Vita, Meinhardt Udo, Gibney James, Johannsson Gudmundur, Baxter Robert C., Seibel Markus J. and Ho Ken K. Y. Modulatory Effect of Raloxifene and Estrogen on the Metabolic Action of Growth Hormone in Hypopituitary Women. 95: 2099-2106. 2011: Growth Hormone.

http://jcem.endojournals.org/content/96/5/1301.abstract

Blevins Thomas, Pullman John, Malloy Jaret, Yan Ping, Taylor Kristin, Schulteis Christine, Trautmann Michael and Porter Lisa. DURATION-5: Exenatide Once Weekly Resulted in Greater Improvements in Glycemic Control Compared with Exenatide Twice Daily in Patients with Type 2 Diabetes. 96: 1301-1310. 2011: DURATION-5.

http://jcem.endojournals.org/content/95/9/4124.abstract

Bliziotes Michael. Update in Serotonin and Bone. 95: 4124-4132. 2011: Bone.

http://jcem.endojournals.org/content/95/6/2529.abstract

Bogazzi Fausto, Bartalena Luigi and Martino Enio. Approach to the Patient with Amiodarone-Induced Thyrotoxicosis. 95: 2529-2535. 2011: Thyroid.

http://jcem.endojournals.org/content/96/11/3374.abstract

Bogazzi Fausto, Bartalena Luigi, Tomisti Luca, Rossi Giuseppe, Brogioni Sandra and Martino Enio. Continuation of Amiodarone Delays Restoration of Euthyroidism in Patients with Type 2 Amiodarone-Induced Thyrotoxicosis Treated with Prednisone: A Pilot Study. 96: 3374-3380. 2011: Thyroid.

http://jcem.endojournals.org/content/95/4/1856.abstract

Bolland Mark J. and Grey Andrew. Disparate Outcomes from Applying U.K. and U.S. Osteoporosis Treatment Guidelines. 95: 1856-1860. 2011: Bone.

http://jcem.endojournals.org/content/95/3/1174.abstract

Bolland Mark J., Grey Andrew B., Gamble Greg D. and Reid Ian R. Effect of Osteoporosis Treatment on Mortality: A Meta-Analysis. 95: 1174-1181. 2011: Bone.

http://jcem.endojournals.org/content/96/4/972.abstract

Bone Henry G., Bolognese Michael A., Yuen Chui Kin, Kendler David L., Miller Paul D., Yang Yu-Ching, Grazette Luanda, San Martin Javier and Gallagher J. Christopher. Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass. 96: 972-980. 2011: Bone.

http://jcem.endojournals.org/content/96/6/1727.abstract

Boonen S., Adachi J. D., Man Z., Cummings S. R., Lippuner K., Tarring O., Gallagher J. C., Farrerons J., Wang A., Franchimont N., San Martin J., Grauer A. and McClung M. Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk. 96: 1727-1736. 2011: Bone.

http://jcem.endojournals.org/content/95/6/2607.abstract

Bosi Emanuele. Time for Testing Incretin Therapies in Early Type 1 Diabetes? 95: 2607-2609. 2011: Diabetes.

http://jcem.endojournals.org/content/96/5/1352.abstract

Brassard M., Borget I., Edet-Sanson A., Giraudet A.-L., Mundler O., Toubeau M., Bonichon F., Borson-Chazot F., Leenhardt L., Schvartz C., Dejax C., Brenot-Rossi I., Toubert M.-E., Torlontano M., Benhamou E., Schlumberger M. and Group THYRDIAG Working. Long-Term Follow-Up of Patients with Papillary and Follicular Thyroid Cancer: A Prospective Study on 715 Patients. 96: 1352-1359. 2011: Thyroid.

http://jcem.endojournals.org/content/96/5/1246.abstract

Brewer H. Bryan. The Evolving Role of HDL in the Treatment of High-Risk Patients with Cardiovascular Disease. 96: 1246-1257. 2011: Lipids.

http://jcem.endojournals.org/content/96/6/1695.abstract

Buse John B., Garber Alan, Rosenstock Julio, Schmidt Wolfgang E., Brett Jason H., VidebÃ¦k Nicoline, Holst Jens and Nauck Michael. Liraglutide Treatment Is Associated with a Low Frequency and Magnitude of Antibody Formation with No Apparent Impact on Glycemic Response or Increased Frequency of Adverse Events: Results from the Liraglutide Effect and Action in Diabetes (LEAD) Trials. 96: 1695-1702. 2011: Diabetes.

http://jcem.endojournals.org/content/95/4/1496.abstract

Canalis Ernesto. Update in New Anabolic Therapies for Osteoporosis. 95: 1496-1504. 2011: Bone.

http://jcem.endojournals.org/content/96/1/15.abstract

Carlson Harold E. Approach to the Patient with Gynecomastia. 96: 15-21. 2011: Gynaecomastia.

http://jcem.endojournals.org/content/95/10/4625.abstract

Cawthon Peggy M., Parimi Neeta, Barrett-Connor Elizabeth, Laughlin Gail A., Ensrud Kristine E., Hoffman Andrew R., Shikany James M., Cauley Jane A., Lane Nancy E., Bauer Douglas C., Orwoll Eric S., Cummings Steven R. and Group for the Osteoporotic Fractures in Men Research. Serum 25-Hydroxyvitamin D, Parathyroid Hormone, and Mortality in Older Men. 95: 4625-4634. 2011: Parathyroid.

http://jcem.endojournals.org/content/96/5/1223.abstract

Chiodini Iacopo. Diagnosis and Treatment of Subclinical Hypercortisolism. 96: 1223-1236. 2011: Cortisol.

http://jcem.endojournals.org/content/96/3/632.abstract

Clayton R. N., Raskauskiene D., Reulen R. C. and Jones P. W. Mortality and Morbidity in Cushing's Disease over 50 Years in Stoke-on-Trent, UK: Audit and Meta-Analysis of Literature. 96: 632-642. 2011: Cushings.

http://jcem.endojournals.org/content/96/3/573.abstract

Collett-Solberg Paulo Ferrez. Update in Growth Hormone Therapy of Children. 96: 573-579. 2011: Growth Hormone.

http://jcem.endojournals.org/content/95/1/151.abstract

Cosman Felicia, Lane Nancy E., Bolognese Michael A., Zanchetta Jose R., Garcia-Hernandez Pedro A., Sees Karen, Matriano James A., Gaumer Kim and Daddona Peter E. Effect of Transdermal Teriparatide Administration on Bone Mineral Density in Postmenopausal Women. 95: 151-158. 2011: Bone.

http://jcem.endojournals.org/content/96/7/2089.abstract

Cruz-Topete Diana, Jorgensen Jens Otto L., Christensen Britt, Sackmann-Sala Lucila, Krusenstjerna-HafstrÃ¸m Thomas, Jara Adam, Okada Shigeru and Kopchick John J. Identification of New Biomarkers of Low-Dose GH Replacement Therapy in GH-Deficient Patients. 96: 2089-2097. 2011: Growth Hormone.

http://jcem.endojournals.org/content/96/1/38.abstract

Cunningham Glenn R. and Toma Shivani M. Why Is Androgen Replacement in Males Controversial? 96: 38-52. 2011: Androgen.

http://jcem.endojournals.org/content/95/7/3149.abstract

Cuttler Leona and Silvers J. B. Growth Hormone and Health Policy. 95: 3149-3153. 2011: Growth Hormone.

http://jcem.endojournals.org/content/96/6/1642.abstract

Davis Susan R., Panjari Mary and Stanczyk Frank Z. DHEA Replacement for Postmenopausal Women. 96: 1642-1653. 2011: HRT.

http://jcem.endojournals.org/content/96/8/2354.abstract

DeFronzo Ralph A. and Abdul-Ghani Muhammad A. Preservation of Î²-Cell Function: The Key to Diabetes Prevention. 96: 2354-2366. 2011: Diabetes.

http://jcem.endojournals.org/content/96/8/2422.abstract

DeladoÃ«y Johnny, Ruel Jean, GiguÃ¨re Yves and Van Vliet Guy. Is the Incidence of Congenital Hypothyroidism Really Increasing? A 20-Year Retrospective Population-Based Study in QuÃ©bec. 96: 2422-2429. 2011: Thyroid.

http://jcem.endojournals.org/content/95/11/5056.abstract

Drake Matthew T., Srinivasan Bhuma, Modder Ulrike I., Peterson James M., McCready Louise K., Riggs B. Lawrence, Dwyer Denise, Stolina Marina, Kostenuik Paul and Khosla Sundeep. Effects of Parathyroid Hormone Treatment on Circulating Sclerostin Levels in Postmenopausal Women. 95: 5056-5062. 2011: Parathyroid.

http://jcem.endojournals.org/content/95/9/4235.abstract

Dwyer Andrew A., Hayes Frances J., Plummer Lacey, Pitteloud Nelly and Crowley William F. The Long-Term Clinical Follow-Up and Natural History of Men with Adult-Onset Idiopathic Hypogonadotropic Hypogonadism. 95: 4235-4243. 2011: Testosterone.

http://jcem.endojournals.org/content/96/11/3367.abstract

Eastell Richard, Hannon Rosemary A., Wenderoth Dietrich, Rodriguez-Moreno Jesus and Sawicki Andrzej. Effect of Stopping Risedronate after Long-Term Treatment on Bone Turnover. 96: 3367-3373. 2011: Bone.

http://jcem.endojournals.org/content/95/11/4864.short

Ebeling Peter R. What Is the Missing Hormonal Factor Controlling Menopausal Bone Resorption? 95: 4864-4866. 2011: Bone.

http://jcem.endojournals.org/content/96/6/1654.abstract

Eckel Robert H., Kahn Steven E., Ferrannini Ele, Goldfine Allison B., Nathan David M., Schwartz Michael W., Smith Robert J. and Smith Steven R. Obesity and Type 2 Diabetes: What Can Be Unified and What Needs to Be Individualized? 96: 1654-1663. 2011: Obesity.

http://jcem.endojournals.org/content/96/7/1931.abstract

Elamin Mohamed B., Abu Elnour Nisrin O., Elamin Khalid B., Fatourechi Mitra M., Alkatib Aziz A., Almandoz Jaime P., Liu Hau, Lane Melanie A., Mullan Rebecca J., Hazem Ahmad, Erwin Patricia J., Hensrud Donald D., Murad Mohammad Hassan and Montori Victor M. Vitamin D and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. 96: 1931-1942. 2011: Vitamin D.

http://jcem.endojournals.org/content/96/4/905.abstract

Fernandez-Balsells M. Merca¨, Murad Mohammad Hassan, Barwise Amelia, Gallegos-Orozco Juan F., Paul Anu, Lane Melanie A., Lampropulos Julianna F., Natividad Inas, Perestelo-Parez Lilisbeth, Ponce de Lean-Lovatan Paula G., Erwin Patricia J., Carey Jantey and Montori Victor M. Natural History of Nonfunctioning Pituitary Adenomas and Incidentalomas: A Systematic Review and Metaanalysis. 96: 905-912. 2011: Pituitary.

http://jcem.endojournals.org/content/95/6/2560.abstract

Fernandez-Balsells M. Merca¨, Murad Mohammad Hassan, Lane Melanie, Lampropulos Juliana F., Albuquerque Felipe, Mullan Rebecca J., Agrwal Neera, Elamin Mohamed B., Gallegos-Orozco Juan F., Wang Amy T., Erwin Patricia J., Bhasin Shalender and Montori Victor M. Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis. 95: 2560-2575. 2011: Testosterone.

http://jcem.endojournals.org/content/96/10/3067.abstract

Fidler Meredith C., Sanchez Matilde, Raether Brian, Weissman Neil J., Smith Steven R., Shanahan William R. and Anderson Christen M. A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial. 96: 3067-3077. 2011: Blossom Trial.

http://jcem.endojournals.org/content/96/8/2441.abstract

Fitzpatrick Lorraine A., Dabrowski Christine E., Cicconetti Gregory, Gordon David N., Papapoulos Socrates, Bone Henry G. and Bilezikian John P. The Effects of Ronacaleret, a Calcium-Sensing Receptor Antagonist, on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Women with Low Bone Mineral Density. 96: 2441-2449. 2011: Bone.

http://jcem.endojournals.org/content/96/2/E243.abstract

Ghayee Hans K., Rege Juilee, Watumull Lori M., Nwariaku Fiemu E., Carrick Kelley S., Rainey William E., Miller Walter L. and Auchus Richard J. Clinical, Biochemical, and Molecular Characterization of Macronodular Adrenocortical Hyperplasia of the Zona Reticularis: A New Syndrome. 96: E243-E250. 2011: Adrenal.

http://jcem.endojournals.org/content/95/7/3141.abstract

Giustina A., Chanson P., Bronstein M. D., Klibanski A., Lamberts S., Casanueva F. F., Trainer P., Ghigo E., Ho K. and Melmed S. A Consensus on Criteria for Cure of Acromegaly. 95: 3141-3148. 2011: Acromegaly.

http://jcem.endojournals.org/content/96/8/2341.abstract

Grossmann Mathis. Low Testosterone in Men with Type 2 Diabetes: Significance and Treatment. 96: 2341-2353. 2011: Testosterone.

http://jcem.endojournals.org/content/95/10/4518.abstract

Grynberg Michael, Salenave Sylvie, Young Jacques and Chanson Philippe. Female Gonadal Function before and after Treatment of Acromegaly. 95: 4518-4525. 2011: Acromegaly.

http://jcem.endojournals.org/content/95/3/1034.abstract

Halban Philippe A., German Michael S., Kahn Steven E. and Weir Gordon C. Current Status of Islet Cell Replacement and Regeneration Therapy. 95: 1034-1043. 2011: Islet Cell.

http://jcem.endojournals.org/content/95/11/4823.abstract

Heber David, Greenway Frank L., Kaplan Lee M., Livingston Edward, Salvador Javier and Still Christopher. Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: An Endocrine Society Clinical Practice Guideline. 95: 4823-4843. 2011: Bariatric.

http://jcem.endojournals.org/content/96/10/3031.abstract

Hennessey James V. Riedel's Thyroiditis: A Clinical Review. 96: 3031-3041. 2011: Thyroid.

Journal of Clinical Endocrinology & Metabolism

Hershman Jerome M., Cheng Sheue-yann and Gianoukakis Andrew G. Update in Thyroidology 2010. 96: 9-14. 2011: Thyroid.

http://jcem.endojournals.org/content/96/1/9.abstract

http://jcem.endojournals.org/content/96/7/1911.abstract

Holick Michael F., Binkley Neil C., Bischoff-Ferrari Heike A., Gordon Catherine M., Hanley David A., Heaney Robert P., Murad M. Hassan and Weaver Connie M. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. 96: 1911-1930. 2011: Vitamin D.

http://jcem.endojournals.org/content/95/8/3578.abstract

Hone Jennifer and JovanoviÄ Lois. Approach to the Patient with Diabetes during Pregnancy. 95: 3578-3585. 2011: Diabetes.

http://jcem.endojournals.org/content/95/7/3165.abstract

Hyde Zoe, Flicker Leon, Almeida Osvaldo P., Hankey Graeme J., McCaul Kieran A., Chubb S. A. Paul and Yeap Bu B. Low Free Testosterone Predicts Frailty in Older Men: The Health in Men Study. 95: 3165-3172. 2011: Testosterone.

http://jcem.endojournals.org/content/95/6/2596.abstract

Jacobson Arnold F., Deng Hsiaowei, Lombard John, Lessig Harry J. and Black Richard R. 123I-Meta-Iodobenzylguanidine Scintigraphy for the Detection of Neuroblastoma and Pheochromocytoma: Results of a Meta-Analysis. 95: 2596-2606. 2011: Phaeochromocytoma.

http://jcem.endojournals.org/content/95/10/4526.abstract

Kaptein Elaine M., Sanchez Andrea, Beale Elizabeth and Chan Linda S. Thyroid Hormone Therapy for Postoperative Nonthyroidal Illnesses: A Systematic Review and Synthesis. 95: 4526-4534. 2011: Thyroid.

http://jcem.endojournals.org/content/95/9/4114.abstract

Katznelson Laurence. Approach to the Patient with Persistent Acromegaly after Pituitary Surgery. 95: 4114-4123. 2011: Acromegaly.

http://jcem.endojournals.org/content/96/10/2968.abstract

Klonoff David C., Buckingham Bruce, Christiansen Jens S., Montori Victor M., Tamborlane William V., Vigersky Robert A. and Wolpert Howard. Continuous Glucose Monitoring: An Endocrine Society Clinical Practice Guideline. 96: 2968-2979. 2011: Glucose.

http://jcem.endojournals.org/content/95/11/4812.abstract

Lacroix Andre. Approach to the Patient with Adrenocortical Carcinoma. 95: 4812-4822. 2011: Adrenal.

http://jcem.endojournals.org/content/96/8/2450.abstract

Lee Paul, Zhao Jing Ting, Swarbrick Michael M., Gracie Gary, Bova Ron, Greenfield Jerry R., Freund Judith and Ho Ken K. Y. High Prevalence of Brown Adipose Tissue in Adult Humans. 96: 2450-2455. 2011: Obesity.

http://jcem.endojournals.org/content/96/6/1710.abstract

Lin-Su Karen, Harbison Madeleine D., Lekarev Oksana, Vogiatzi Maria G. and New Maria I. Final Adult Height in Children with Congenital Adrenal Hyperplasia Treated with Growth Hormone. 96: 1710-1717. 2011: Adrenal.

http://jcem.endojournals.org/content/96/7/1992.abstract

Loeffler Jay S. and Shih Helen A. Radiation Therapy in the Management of Pituitary Adenomas. 96: 1992-2003. 2011: Pituitary.

http://jcem.endojournals.org/content/95/1/109.abstract

Magiakou Maria Alexandra, Manousaki Despoina, Papadaki Marina, Hadjidakis Dimitrios, Levidou Georgia, Vakaki Marina, Papaefstathiou Athanassios, Lalioti Niki, Kanaka-Gantenbein Christina, Piaditis George, Chrousos George P. and Dacou-Voutetakis Catherine. The Efficacy and Safety of Gonadotropin-Releasing Hormone Analog Treatment in Childhood and Adolescence: A Single Center, Long-Term Follow-Up Study. 95: 109-117. 2011: Estrogen.

http://jcem.endojournals.org/content/96/10/3020.abstract

Mantovani Giovanna. Pseudohypoparathyroidism: Diagnosis and Treatment. 96: 3020-3030. 2011: Parathyroid.

http://jcem.endojournals.org/content/96/2/265.abstract

Mazzaferri Ernest L. Approach to the Pregnant Patient with Thyroid Cancer. 96: 265-272. 2011: Thyroid.

http://jcem.endojournals.org/content/96/2/273.abstract

Melmed Shlomo, Casanueva Felipe F., Hoffman Andrew R., Kleinberg David L., Montori Victor M., Schlechte Janet A. and Wass John A. H. Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline. 96: 273-288. 2011: Prolactin.

http://jcem.endojournals.org/content/96/11/3337.abstract

Meneghini L. F., Orozco-Beltran D., Khunti K., Caputo S., Damçi T., Liebl A. and Ross S. A. Weight Beneficial Treatments for Type 2 Diabetes. 96: 3337-3353. 2011: Obesity.

http://jcem.endojournals.org/content/96/7/2081.abstract

Miller Karen K., Meenaghan Erinne, Lawson Elizabeth A., Misra Madhusmita, Gleysteen Suzanne, Schoenfeld David, Herzog David and Klibanski Anne. Effects of Risedronate and Low-Dose Transdermal Testosterone on Bone Mineral Density in Women with Anorexia Nervosa: A Randomized, Placebo-Controlled Study. 96: 2081-2088. 2011: Testosterone.

http://jcem.endojournals.org/content/96/6/1587.abstract

Molitch Mark E., Clemmons David R., Malozowski Saul, Merriam George R. and Vance Mary Lee. Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline. 96: 1587-1609. 2011: Growth Hormone.

http://jcem.endojournals.org/content/96/5/1213.abstract

More Julie, Young Jacques, Reznik Yves, Raverot Gerald, Borson-Chazot FranÃ§oise, Rohmer Vincent, Baudin Eric, Coutant Regis, Tabarin Antoine and Endocrines the Groupe FranÃ§ais des Tumeurs. Ectopic ACTH Syndrome in Children and Adolescents. 96: 1213-1222. 2011: Cortisol.

http://jcem.endojournals.org/content/95/9/4406.abstract

Ohlsson Claes, Labrie Fernand, Barrett-Connor Elizabeth, Karlsson Magnus K., Ljunggren Ã–sten, Vandenput Liesbeth, Mellstrom Dan and Tivesten Ã…sa. Low Serum Levels of Dehydroepiandrosterone Sulfate Predict All-Cause and Cardiovascular Mortality in Elderly Swedish Men. 95: 4406-4414. 2011: Androgen.

http://jcem.endojournals.org/content/95/8/3623.abstract

Parle J., Roberts L., Wilson S., Pattison H., Roalfe A., Haque M. S., Heath C., Sheppard M., Franklyn J. and Hobbs F. D. R. A Randomized Controlled Trial of the Effect of Thyroxine Replacement on Cognitive Function in Community-Living Elderly Subjects with Subclinical Hypothyroidism: The Birmingham Elderly Thyroid Study. 95: 3623-3632. 2011: Thyroid.

http://jcem.endojournals.org/content/96/10/3078.abstract

Qiu Zhong-Ling, Song Hong-Jun, Xu Yan-Hong and Luo Quan-Yong. Efficacy and Survival Analysis of 131I Therapy for Bone Metastases from Differentiated Thyroid Cancer. 96: 3078-3086. 2011: Thyroid.

http://jcem.endojournals.org/content/95/3/1229.abstract

Ranke Michael B., Lindberg Anders and Board on behalf of the KIGS International. Observed and Predicted Growth Responses in Prepubertal Children with Growth Disorders: Guidance of Growth Hormone Treatment by Empirical Variables. 95: 1229-1237. 2011: Growth Hormone.

http://jcem.endojournals.org/content/95/10/4592.abstract

Raverot GÃ©rald, Sturm Nathalie, de Fraipont Florence, Muller Marie, Salenave Sylvie, Caron Philippe, Chabre Olivier, Chanson Philippe, Cortet-Rudelli Christine, Assaker Richard, Dufour Henry, Gaillard Stephan, FranÃ§ois Patrick, Jouanneau Emmanuel, Passagia Jean-Guy, Bernier MichÃ¨le, CornÃ©lius AurÃ©lie, Figarella-Branger Dominique, Trouillas Jacqueline, Borson-Chazot FranÃ§oise and Brue Thierry. Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience. 95: 4592-4599. 2011: Pituitary.

http://jcem.endojournals.org/content/96/5/1327.abstract

Sandret Laure, Maison Patrick and Chanson Philippe. Place of Cabergoline in Acromegaly: A Meta-Analysis. 96: 1327-1335. 2011: Acromegaly.

http://jcem.endojournals.org/content/96/1/1.abstract

Schlechte Janet A. Update in Pituitary 2010. 96: 1-8. 2011: Pituitary.

http://jcem.endojournals.org/content/96/7/2074.abstract

Schneider Harald J., Kosilek Robert P., Gunther Manuel, Roemmler Josefine, Stalla Gunter K., Sievers Caroline, Reincke Martin, Schopohl Jochen and WÃ¼rtz Rolf P. A Novel Approach to the Detection of Acromegaly: Accuracy of Diagnosis by Automatic Face Classification. 96: 2074-2080. 2011: Acromegaly.

http://jcem.endojournals.org/content/96/11/3448.abstract

Sone Hirohito, Tanaka Sachiko, Tanaka Shiro, Iimuro Satoshi, Oida Koji, Yamasaki Yoshimitsu, Oikawa Shinichi, Ishibashi Shun, Katayama Shigehiro, Ohashi Yasuo, Akanuma Yasuo, Yamada Nobuhiro and Group for the Japan Diabetes Complications Study. Serum Level of Triglycerides Is a Potent Risk Factor Comparable to LDL Cholesterol for Coronary Heart Disease in Japanese Patients with Type 2 Diabetes: Subanalysis of the Japan Diabetes Complications Study (JDCS). 96: 3448-3456. 2011: Lipids.

http://jcem.endojournals.org/content/95/9/4133.abstract

Speiser Phyllis W., Azziz Ricardo, Baskin Laurence S., Ghizzoni Lucia, Hensle Terry W., Merke Deborah P., Meyer-Bahlburg Heino F. L., Miller Walter L., Montori Victor M., Oberfield Sharon E., Ritzen Martin and White Perrin C. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. 95: 4133-4160. 2011: Adrenal.

http://jcem.endojournals.org/content/96/2/35A.short

Taylor Hugh S. and Manson JoAnn E. Patient Guide to Hyperprolactinemia Diagnosis and Treatment

Update in Hormone Therapy Use in Menopause. 96: 35A-36A. 2011: Prolactin.

http://jcem.endojournals.org/content/96/2/255.abstract

http://jcem.endojournals.org/content/96/10/2950.abstract

Udelsman Robert. Approach to the Patient with Persistent or Recurrent Primary Hyperparathyroidism. 96: 2950-2958. 2011: Parathyroid.

http://jcem.endojournals.org/content/96/10/3151.abstract

van Bunderen Christa C., van Nieuwpoort I. Caroline, Arwert Lucia I., Heymans Martijn W., Franken Anton A. M., Koppeschaar Hans P. F., van der Lely Aart J. and Drent Madeleine L. Does Growth Hormone Replacement Therapy Reduce Mortality in Adults with Growth Hormone Deficiency? Data from the Dutch National Registry of Growth Hormone Treatment in Adults. 96: 3151-3159. 2011: Growth Hormone.

http://jcem.endojournals.org/content/96/1/E83.abstract

Verrua E., Filopanti M., Ronchi C. L., Olgiati L., Ferrante E., Giavoli C., Sala E., Mantovani G., Arosio M., Beck-Peccoz P., Lania A. G. and Spada A. GH Response to Oral Glucose Tolerance Test: A Comparison between Patients with Acromegaly and Other Pituitary Disorders. 96: E83-E88. 2011: Growth Hormone.

http://jcem.endojournals.org/content/95/11/4802.abstract

Vinik Aaron. The Approach to the Management of the Patient with Neuropathic Pain. 95: 4802-4811. 2011: Neuropathy.

http://jcem.endojournals.org/content/95/7/3268.abstract

Wallace I. R., Satti N., Courtney C. H., Leslie H., Bell P. M., Hunter S. J., McCance D. R., Sheridan B. and Atkinson A. B. Ten-Year Clinical Follow-Up of a Cohort of 51 Patients with Macroprolactinemia Establishes It as a Benign Variant. 95: 3268-3271. 2011: Prolactin.

http://jcem.endojournals.org/content/95/4/1555.abstract

Watts Nelson B. and Diab Dima L. Long-Term Use of Bisphosphonates in Osteoporosis. 95: 1555-1565. 2011: Bone.

http://jcem.endojournals.org/content/96/3/726.abstract

White H. D., Ahmad A. M., Durham B. H., Joshi A. A., Fraser W. D. and Vora J. P. Effect of Oral Phosphate and Alendronate on Bone Mineral Density When Given as Adjunctive Therapy to Growth Hormone Replacement in Adult Growth Hormone Deficiency. 96: 726-736. 2011: Growth Hormone.

Yassa Leila, Marqusee Ellen, Fawcett Rachael and Alexander Erik K. Thyroid Hormone Early Adjustment in Pregnancy (The THERAPY) Trial. 95: 3234-3241. 2011: Thyroid http://jcem.endojournals.org/content/95/7/3234.abstract

http://jcem.endojournals.org/content/96/2/320.abstract

Zang S., Ponto K. A. and Kahaly G. J. Intravenous Glucocorticoids for Graves' Orbitopathy: Efficacy and Morbidity. 96: 320-332. 2011: Thyroid.

http://jcem.endojournals.org/content/96/6/1873.abstract

Zhang Yiyi, Post Wendy S., Dalal Darshan, Bansal Sandeep, Blasco-Colmenares Elena, Jan De Beur Suzanne, Alonso Alvaro, Soliman Elsayed Z., Whitsel Eric A., Brugada RamÃ³n, Tomaselli Gordon F. and Guallar Eliseo. Serum 25-Hydroxyvitamin D, Calcium, Phosphorus, and Electrocardiographic QT Interval Duration: Findings from NHANES III and ARIC. 96: 1873-1882. 2011: Vitamin D.

http://jcem.endojournals.org/content/97/1/93.abstract

Åsvold Bjørn O., Vatten Lars J., Midthjell Kristian and Bjøro Trine. Serum TSH within the Reference Range as a Predictor of Future Hypothyroidism and Hyperthyroidism: 11-Year Follow-Up of the HUNT Study in Norway. 97: 93-99. 2012: HUNT study.

http://jcem.endojournals.org/content/97/2/311.abstract

Baron Roland and Hesse Eric. Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives. 97: 311-325. 2012: Osteoporosis.

http://jcem.endojournals.org/content/97/9/2969.abstract

Berglund Lars, Brunzell John D., Goldberg Anne C., Goldberg Ira J., Sacks Frank, Murad Mohammad Hassan and Stalenhoef Anton F. H. Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline. 97: 2969-2989. 2012: Lipids.

http://jcem.endojournals.org/content/97/9/3179.abstract

Bible Keith C., Suman Vera J., Menefee Michael E., Smallridge Robert C., Molina Julian R., Maples William J., Karlin Nina J., Traynor Anne M., Kumar Priya, Goh Boon Cher, Lim Wan-Teck, Bossou Ayoko R., Isham Crescent R., Webster Kevin P., Kukla Andrea K., Bieber Carolyn, Burton Jill K., Harris Pamela, Erlichman Charles, Consortium the Mayo Phase 2 and Group Mayo Clinic Endocrine Malignances Disease Oriented. A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer. 97: 3179-3184. 2012: Thyroid.

http://jcem.endojournals.org/content/97/2/416.abstract

Carel Jean-Claude, Ecosse Emmanuel, Landier Fabienne, Meguellati-Hakkas Djamila, Kaguelidou Florentia, Rey Grégoire and Coste Joël. Long-Term Mortality after Recombinant Growth Hormone Treatment for Isolated Growth Hormone Deficiency or Childhood Short Stature: Preliminary Report of the French SAGhE Study. 97: 416-425. 2012: Growth Hormone.

http://jcem.endojournals.org/content/97/3/738.abstract

Davidson Zoe E., Walker Karen Z. and Truby Helen. Do Glucocorticosteroids Alter Vitamin D Status? A Systematic Review with Meta-Analyses of Observational Studies. 97: 738-744. 2012: Vitamin D.

http://jcem.endojournals.org/content/97/10/3426.abstract

Fenske Wiebke and Allolio Bruno. Current State and Future Perspectives in the Diagnosis of Diabetes Insipidus: A Clinical Review. 97: 3426-3437. 2012: Pituitary.

http://jcem.endojournals.org/content/97/9/3185.abstract

Filipsson Nyström Helena, Barbosa Edna J. L., Nilsson Anna G., Norrman Lise-Lott, Ragnarsson Oskar and Johannsson Gudmundur. Discontinuing Long-Term GH Replacement Therapy—A Randomized, Placebo-Controlled Crossover Trial in Adult GH Deficiency. 97: 3185-3195. 2012: Growth Hormone.

http://jcem.endojournals.org/content/97/2/E165.abstract

Filopanti M., Olgiati L., Mantovani G., Corbetta S., Arosio M., Gasco V., De Marinis L., Martini C., Bogazzi F., Cannavò S., Colao A., Ferone D., Arnaldi G., Pigliaru F., Peri A., Angeletti G., Jaffrain-Rea M. L., Lania A. G. and Spada A. Growth Hormone Receptor Variants and Response to Pegvisomant in Monotherapy or in Combination with Somatostatin Analogs in Acromegalic Patients: A Multicenter Study. 97: E165-E172. 2012: Acromegaly.

http://jcem.endojournals.org/content/97/4/1134.abstract

Fiore Emilio and Vitti Paolo. Serum TSH and Risk of Papillary Thyroid Cancer in Nodular Thyroid Disease. 97: 1134-1145. 2012: Thyroid.

http://jcem.endojournals.org/content/97/6/2039.abstract

Fleseriu Maria, Biller Beverly M. K., Findling James W., Molitch Mark E., Schteingart David E., Gross Coleman and Investigators on behalf of the SEISMIC Study. Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome. 97: 2039-2049. 2012: SEISMIC.

http://jcem.endojournals.org/content/97/4/1258.abstract

Gautier Alain, Godbout Ariane, Grosheny Catherine, Tejedor Isabelle, Coudert Mathieu, Courtillot Carine, Jublanc Christel, De Kerdanet Marc, Poirier Jean-Yves, Riffaud Laurent, Sainte-Rose Christian, Van Effenterre Remy, Brassier Gilles, Bonnet Fabrice, Touraine Philippe, Prs. on behalf of the Craniopharyngioma Study Group:, Drs. Anne Bachelot Anne-Laure Boch, Raja Brauner, Jean-Claude Carel, Anne Colobert, Hélène Crosnier, Vonny Derennes, Pierre Doyard, Françoise Getin, Isabelle Guilhem, Muriel Hoang, Claire Josseaume, Julianne Leger, Sylvie Nivot, Christian Pauwels, Graziella Pinto, Michel Polak, Raphaël Rappaport, Dinane Samara, Sylvie Sauvion, Caroline Thalassinos, and Thibaud Elisabeth. Markers of Recurrence and Long-Term Morbidity in Craniopharyngioma: A Systematic Analysis of 171 Patients. 97: 1258-1267. 2012: Craniopharyngioma.

http://jcem.endojournals.org/content/97/11/3983.abstract

Giavoli Claudia, Profka Eriselda, Verrua Elisa, Ronchi Cristina L., Ferrante Emanuele, Bergamaschi Silvia, Sala Elisa, Malchiodi Elena, Lania Andrea G., Arosio Maura, Ambrosi Bruno, Spada Anna and Beck-Peccoz Paolo. GH Replacement Improves Quality of Life and Metabolic Parameters in Cured Acromegalic Patients with Growth Hormone Deficiency. 97: 3983-3988. 2012: Acromegaly.

http://jcem.endojournals.org/content/97/4/1194.abstract

Hassan-Smith Zaki K., Sherlock Mark, Reulen Raoul C., Arlt Wiebke, Ayuk John, Toogood Andrew A., Cooper Mark S., Johnson Alan P. and Stewart Paul M. Outcome of Cushing's Disease following Transsphenoidal Surgery in a Single Center over 20 Years. 97: 1194-1201. 2012: Cushing's.

http://jcem.endojournals.org/content/97/4/1187.abstract

Higham C. E., Atkinson A. B., Aylwin S., Bidlingmaier M., Drake W. M., Lewis A., Martin N. M., Moyes V., Newell-Price J. and Trainer P. J. Effective Combination Treatment with Cabergoline and Low-Dose Pegvisomant in Active Acromegaly: A Prospective Clinical Trial. 97: 1187-1193. 2012: Acromegaly.

http://jcem.endojournals.org/content/97/6/E878.abstract

Jonklaas J., Nogueras-Gonzalez G., Munsell M., Litofsky D., Ain K. B., Bigos S. T., Brierley J. D., Cooper D. S., Haugen B. R., Ladenson P. W., Magner J., Robbins J., Ross D. S., Skarulis M. C., Steward D. L., Maxon H. R., Sherman S. I. and Group from the National Thyroid Cancer Treatment Cooperative Study. The Impact of Age and Gender on Papillary Thyroid Cancer Survival. 97: E878-E887. 2012: Thyroid.

http://jcem.endojournals.org/content/97/6/2124.abstract

Kamenický Peter, Blanchard Anne, Gauci Cédric, Salenave Sylvie, Letierce Alexia, Lombès Marc, Brailly-Tabard Sylvie, Azizi Michel, Prié Dominique, Souberbielle Jean-Claude and Chanson Philippe. Pathophysiology of Renal Calcium Handling in Acromegaly: What Lies behind Hypercalciuria? 97: 2124-2133. 2012: Acromegaly.

http://jcem.endojournals.org/content/97/3/E448.abstract

Kluge Michael, Schüssler Petra, Schmidt Doreen, Uhr Manfred and Steiger Axel. Ghrelin Suppresses Secretion of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) in Women. 97: E448-E451. 2012: Ghrelin.

http://jcem.endojournals.org/content/97/1/85.abstract

Koetz K. R., Ventz M., Diederich S. and Quinkler M. Bone Mineral Density Is Not Significantly Reduced in Adult Patients on Low-Dose Glucocorticoid Replacement Therapy. 97: 85-92. 2012: Bone.

http://jcem.endojournals.org/content/97/11/4156.abstract

Kritchevsky Stephen B., Tooze Janet A., Neiberg Rebecca H., Schwartz Gary G., Hausman Dorothy B., Johnson Mary Ann, Bauer Douglas C., Cauley Jane A., Shea M. Kyla, Cawthon Peggy M., Harris Tamara B., Rubin Susan M., Tylavsky Francis A. and Houston Denise K. 25-Hydroxyvitamin D, Parathyroid Hormone, and Mortality in Black and White Older Adults: The Health ABC Study. 97: 4156-4165. 2012: Parathyroid.

http://jcem.endojournals.org/content/97/10/3530.abstract

Küpers Elselien M., Amar Laurence, Raynaud Alain, Plouin Pierre-François and Steichen Olivier. A Clinical Prediction Score to Diagnose Unilateral Primary Aldosteronism. 97: 3530-3537. 2012: Adrenal.

http://jcem.endojournals.org/content/97/9/2957.abstract

Loriaux D. Lynn. An Approach to the Patient with Hirsutism. 97: 2957-2968. 2012: Hirsutism.

http://jcem.endojournals.org/content/97/12/4507.abstract

Mitchell Deborah M., Regan Susan, Cooley Michael R., Lauter Kelly B., Vrla Michael C., Becker Carolyn B., Burnett-Bowie Sherri-Ann M. and Mannstadt Michael. Long-Term Follow-Up of Patients with Hypoparathyroidism. 97: 4507-4514. 2012: Thyroid.

http://jcem.endojournals.org/content/97/5/1688.abstract

Nanba Kazutaka, Tamanaha Tamiko, Nakao Kanako, Kawashima Sachiko-Tsukamoto, Usui Takeshi, Tagami Tetsuya, Okuno Hiroshi, Shimatsu Akira, Suzuki Tomoko and Naruse Mitsuhide. Confirmatory Testing in Primary Aldosteronism. 97: 1688-1694. 2012: Adrenal.

http://jcem.endojournals.org/content/97/2/400.abstract

Péter Ferenc, Bidlingmaier Martin, Savoy Conrad, Ji Hyi-Jeong and Saenger Paul H. Three-Year Efficacy and Safety of LB03002, a Once-Weekly Sustained-Release Growth Hormone (GH) Preparation, in Prepubertal Children with GH Deficiency (GHD). 97: 400-407. 2012: Growth Hormone.

http://jcem.endojournals.org/content/97/2/E213.abstract

Sävendahl Lars, Maes Marc, Albertsson-Wikland Kerstin, Borgström Birgit, Carel Jean-Claude, Henrard Séverine, Speybroeck Niko, Thomas Muriel, Zandwijken Gladys and Hokken-Koelega Anita. Long-Term Mortality and Causes of Death in Isolated GHD, ISS, and SGA Patients Treated with Recombinant Growth Hormone during Childhood in Belgium, The Netherlands, and Sweden: Preliminary Report of 3 Countries Participating in the EU SAGhE Study. 97: E213-E217. 2012: Growth Hormone.

http://jcem.endojournals.org/content/97/11/3926.abstract

Schneider Rita, Schneider Mara, Reiners Christoph and Schneider Peter. Effects of Levothyroxine on Bone Mineral Density, Muscle Force, and Bone Turnover Markers: A Cohort Study. 97: 3926-3934. 2012: Thyroid.

http://jcem.endojournals.org/content/97/5/1526.abstract

Schvartz Claire, Bonnetain Franck, Dabakuyo Sandrine, Gauthier Mélanie, Cueff Adèle, Fieffé Sandrine, Pochart Jean-Marie, Cochet Inna, Crevisy Elodie, Dalac Audrey, Papathanassiou Dimitri and Toubeau Michel. Impact on Overall Survival of Radioactive Iodine in Low-Risk Differentiated Thyroid Cancer Patients. 97: 1526-1535. 2012: Thyroid.

http://jcem.endojournals.org/content/97/6/2050.abstract

Shores Molly M., Smith Nicholas L., Forsberg Christopher W., Anawalt Bradley D. and Matsumoto Alvin M. Testosterone Treatment and Mortality in Men with Low Testosterone Levels. 97: 2050-2058. 2012: Testosterone.

http://jcem.endojournals.org/content/97/9/2990.abstract

Thakker Rajesh V., Newey Paul J., Walls Gerard V., Bilezikian John, Dralle Henning, Ebeling Peter R., Melmed Shlomo, Sakurai Akihiro, Tonelli Francesco and Brandi Maria Luisa. Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1). 97: 2990-3011. 2012: MEN.

http://jcem.endojournals.org/content/97/10/3515.abstract

Tomisti Luca, Materazzi Gabriele, Bartalena Luigi, Rossi Giuseppe, Marchello Angelica, Moretti Manuela, De Napoli Luigi, Mariotti Rita, Miccoli Paolo, Martino Enio and Bogazzi Fausto. Total Thyroidectomy in Patients with Amiodarone-Induced Thyrotoxicosis and Severe Left Ventricular Systolic Dysfunction. 97: 3515-3521. 2012: Thyroid.

http://jcem.endojournals.org/content/97/3/862.abstract

Waring Avantika C., Harrison Stephanie, Samuels Mary H., Ensrud Kristine E., LeBlanc Erin S., Hoffman Andrew R., Orwoll Eric, Fink Howard A., Barrett-Connor Elizabeth, Bauer Douglas C. and Study for the Osteoporotic Fractures in Men. Thyroid Function and Mortality in Older Men: A Prospective Study. 97: 862-870. 2012: Thyroid.

http://jcem.endojournals.org/content/97/6/1802.abstract

Watts Nelson B., Adler Robert A., Bilezikian John P., Drake Matthew T., Eastell Richard, Orwoll Eric S. and Finkelstein Joel S. Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline. 97: 1802-1822. 2012: Osteoporosis.

http://jcem.endojournals.org/content/97/4/1277.abstract

Yamamoto Masahiro, Yamaguchi Toru, Nawata Kiyoko, Yamauchi Mika and Sugimoto Toshitsugu. Decreased PTH Levels Accompanied by Low Bone Formation Are Associated with Vertebral Fractures in Postmenopausal Women with Type 2 Diabetes. 97: 1277-1284. 2012: Parathyroid.

http://jcem.endojournals.org/content/98/6/2277.abstract

Dekkers Olaf M., Horváth-Puhó Erzsébet, Jørgensen Jens Otto L., Cannegieter Suzanne C., Ehrenstein Vera, Vandenbroucke Jan P., Pereira Alberto M. and Sørensen Henrik Toft. Multisystem Morbidity and Mortality in Cushing's Syndrome: A Cohort Study. 98: 2277-2284. 2013: Cushing's.

http://jcem.endojournals.org/content/98/4/1711.abstract

Hernández José L., Olmos José M., Pariente Emilio, Nan Daniel, Martínez Josefina, Llorca Javier, Valero Carmen, Obregón Eduardo and González-Macías Jesús. Influence of Vitamin D Status on Vertebral Fractures, Bone Mineral Density, and Bone Turnover Markers in Normocalcemic Postmenopausal Women With High Parathyroid Hormone Levels. 98: 1711-1717. 2013: Vitamin D.

http://jcem.endojournals.org/content/98/4/1734.abstract

Madeira Miguel, Neto Leonardo Vieira, de Paula Paranhos Neto Francisco, Barbosa Lima Inayá Corrêa, Carvalho de Mendonça Laura Maria, Gadelha Mônica Roberto and Fleiuss de Farias Maria Lucia. Acromegaly Has a Negative Influence on Trabecular Bone, But Not on Cortical Bone, as Assessed by High-Resolution Peripheral Quantitative Computed Tomography. 98: 1734-1741. 2013: Acromegaly.

http://jcem.endojournals.org/content/98/4/1612.abstract

Qiu Changsheng, Chen Hongjie, Wen Junping, Zhu Pengli, Lin Fenghui, Huang Baoying, Wu Peijian, Lin Qingfei, Lin Yinghua, Rao Huiying, Huang Huibin, Liang Jixing, Li Liantao, Gong Xueying, Peng Shushan, Li Meizhi, Chen Ling, Tang Kaka, Chen Zichun, Lin Lixiang, Lu Jieli, Bi Yufang, Ning Guang and Chen Gang. Associations Between Age at Menarche and Menopause With Cardiovascular Disease, Diabetes, and Osteoporosis in Chinese Women. 98: 1612-1621. 2013: Osteoporosis.

The Journal of Clinical Endocrinology & Metabolism

Shields Beverley M., Knight Bridget A., Hill Anita V., Hattersley Andrew T. and Vaidya Bijay. Five-Year Follow-Up for Women With Subclinical Hypothyroidism in Pregnancy. 98: E1941-E1945. 2013: Thyroid.

http://press.endocrine.org/doi/abs/10.1210/jc.2013-2768

http://jcem.endojournals.org/content/98/7/2746.abstract

Simon Dominique, Alberti Corinne, Alison Marianne, Le Henaff Loïc, Chevenne Didier, Boizeau Priscilla, Canal Aurélie, Ollivier Gwenn, Decostre Valérie, Jacqz-Aigrain Evelyne, Carel Jean-Claude, Czernichow Paul and Hogrel Jean-Yves. Effects of Recombinant Human Growth Hormone for 1 Year on Body Composition and Muscle Strength in Children on Long-Term Steroid Therapy: Randomized Controlled, Delayed-Start Study. 98: 2746-2754. 2013: Growth Hormone.

http://jcem.endojournals.org/content/98/4/E638.abstract

van Ballegooijen A. J., Reinders I., Visser M., Dekker J. M., Nijpels G., Stehouwer C. D. A., Pilz S. and Brouwer I. A. Serum Parathyroid Hormone in Relation to All-Cause and Cardiovascular Mortality: The Hoorn Study. 98: E638-E645. 2013: Parathyroid-Hoorn Study.

The Journal of Clinical Endocrinology & Metabolism

Gianatti Emily J., Dupuis Philippe, Hoermann Rudolf, Zajac Jeffrey D. and Grossmann Mathis. Effect of Testosterone Treatment on Constitutional and Sexual Symptoms in Men With Type 2 Diabetes in a Randomized, Placebo-Controlled Clinical Trial. 99: 3821-3828. 2014: Testosterone.

http://press.endocrine.org/doi/abs/10.1210/jc.2014-1872

The Journal of Clinical Endocrinology & Metabolism

Hu Mimi I., Glezerman Ilya G., Leboulleux Sophie, Insogna Karl, Gucalp Rasim, Misiorowski Waldemar, Yu Bennett, Zorsky Paul, Tosi Diego, Bessudo Alberto, Jaccard Arnaud, Tonini Giuseppe, Ying Wendy, Braun Ada and Jain Rajul K. Denosumab for Treatment of Hypercalcemia of Malignancy. 99: 3144-3152. 2014: Calcium.

http://press.endocrine.org/doi/abs/10.1210/jc.2014-1001

Journal of Endocrinology

Nicholls Jonathan J, Brassill Mary Jane, Williams Graham R and Bassett J H Duncan. The skeletal consequences of thyrotoxicosis. 213: 209-221. 2012: Thyroid.

http://joe.endocrinology-journals.org/content/213/3/209.abstract

Back to Top

http://linkinghub.elsevier.com/retrieve/pii/S0140673611608155

Gortmaker Steven L., Swinburn Boyd A., Levy David, Carter Rob, Mabry Patricia L., Finegood Diane T., Huang Terry, Marsh Tim and Moodie Marjory L. Changing the future of obesity: science, policy, and action. 378: 838-847. 2011: Obesity.

http://linkinghub.elsevier.com/retrieve/pii/S014067361160812X

Hall Kevin D., Sacks Gary, Chandramohan Dhruva, Chow Carson C., Wang Y. Claire, Gortmaker Steven L. and Swinburn Boyd A. Quantification of the effect of energy imbalance on bodyweight. 378: 826-837. 2011: Obesity.

http://linkinghub.elsevier.com/retrieve/pii/S0140673611608131

Swinburn Boyd A., Sacks Gary, Hall Kevin D., McPherson Klim, Finegood Diane T., Moodie Marjory L. and Gortmaker Steven L. The global obesity pandemic: shaped by global drivers and local environments. 378: 804-814. 2011: Obesity.

http://linkinghub.elsevier.com/retrieve/pii/S0140673611608143

Wang Y. Claire, McPherson Klim, Marsh Tim, Gortmaker Steven L. and Brown Martin. Health and economic burden of the projected obesity trends in the USA and the UK. 378: 815-825. 2011: Obesity.